Anton_wireframe/data/300 Investors data.csv

1	Name	Website	Final Investor Profile	Final Profile sourcing
2	Anaxago	http://www.anaxago.com	{"funds":[{"estimatedInvestmentSize":"EUR 1,000 to 2,000","fundName":"Crowdfunding Immobilier","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["France"],"investmentStageFocus":["Seed","Early Stage"],"sectorFocus":["Real Estate"],"sourceUrl":"http://www.anaxago.com/investissement"},{"estimatedInvestmentSize":"Not Available","fundName":"SCPI Real Estate Funds","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["France","Europe"],"investmentStageFocus":["Not Available"],"sectorFocus":["Healthcare","Office","Logistics","Retail","Residential"],"sourceUrl":"https://anaxago.com/scpi-de-rendement"},{"estimatedInvestmentSize":"Not Available","fundName":"CapHorn","fundSize":"Approximately EUR 100 million","fundSizeSourceUrl":"https://tokenist.com/french-firm-anaxago-enters-wealth-management-in-quest-to-become-100-digital-private-bank/","geographicFocus":["Europe"],"investmentStageFocus":["Venture Capital"],"sectorFocus":["Health Tech","Private Equity","Decarbonation","Sustainable Real Estate"],"sourceProvider":"Perplexity","sourceUrl":"https://capital.anaxago.com"},{"estimatedInvestmentSize":"EUR 1,000 to 10,000","fundName":"Anaxago Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["France"],"investmentStageFocus":["Seed","Series A","Growth"],"sectorFocus":["Real Estate","Digital Services","Health Tech","Proptech","Fintech","Corporate Real Estate Development"],"sourceUrl":"http://www.anaxago.com/investissement"}],"headquarters":"Paris, France","investmentThesisFocus":["Invests in innovative and ambitious companies contributing to social and environmental progress.","Focus on sustainable real estate, climate tech, and health tech sectors.","Prioritizes projects with strong ESG (Environmental, Social and Governance) scores.","Targets investments supporting decarbonation of the economy.","Emphasizes transparency with quarterly reporting and enhanced advisory services."],"investorDescription":"Anaxago is an investment group established in 2012, specializing in real estate and innovation investments. It offers access to rare and engaged investment opportunities formerly reserved for institutional investors. The company supports over 15,000 investors with diversified financial asset portfolios, with invested amounts exceeding 850 million euros. Anaxago operates as a mission-driven company since April 2023, focusing on projects aligned with future needs, emphasizing sustainable transition and impact through ESG criteria. They provide rigorous internal extra-financial analysis and a weekly investment committee to approve investment decisions.","linkedDocuments":["http://anaxago.com/legal/politique-investissement-desinvestissement"],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"EUR 850,000,000","sourceProvider":"Perplexity","sourceUrl":"http://www.anaxago.com"},"portfolioHighlights":["Tilak Healthcare","Happywait","OCUS","Bulldozair","Innovorder","Acticor Biotech","Xenothera","Sweep Bright","Robocath","SmartRenting"],"researcherNotes":"No explicit official fund sizes or AUM dates found on the site. AUM was inferred from the statement about total invested amounts exceeding 850 million euros on the homepage.","seniorLeadership":[{"name":"Joachim Dupont","sourceUrl":"https://capital.anaxago.com/equipe","title":"Co-fondateur et président"},{"name":"Guillaume Dupont","sourceUrl":"https://capital.anaxago.com/equipe","title":"Directeur Général"},{"name":"Bruno Blanc","sourceUrl":"https://capital.anaxago.com/equipe","title":"Directeur Général Adjoint"},{"name":"François Santi","sourceUrl":"https://capital.anaxago.com/equipe","title":"Partner"},{"name":"Alexandre Heraud","sourceUrl":"https://capital.anaxago.com/equipe","title":"Partner"}],"sources":{"funds":"http://www.anaxago.com/investissement","headquarters":"http://www.anaxago.com/contact","investmentThesisFocus":"http://www.anaxago.com/qui-sommes-nous","investorDescription":"http://www.anaxago.com","portfolioHighlights":"https://www.eu-startups.com/investor/anaxago/"},"websiteURL":"http://www.anaxago.com"}	Correctness: 95% Completeness: 85% The factual information about Anaxago is largely accurate and well-supported. Anaxago was founded in 2012 and specializes in real estate crowdfunding and innovation investments with a focus on sustainable projects and ESG criteria, as stated on their official website and Wikipedia[1][3][5]. The description of their investment focus on real estate, health tech, and sustainable sectors and their mission-driven approach since April 2023 aligns with the company’s publicly declared values and recent developments[3][5]. The investor base of over 15,000 clients and total invested amounts exceeding EUR 850 million matches the data reported on Anaxago’s site[5]. The individual funds mentioned ("Crowdfunding Immobilier," "SCPI Real Estate Funds," "CapHorn," and "Anaxago Investment Strategy") mostly align with Anaxago's activity in real estate and innovation sectors, including seed and early-stage investing in France and Europe[3][5]. The noted fund sizes and investment ranges are consistent with minimum investment amounts around EUR 1,000 and the approximately EUR 100 million sizing of CapHorn reported in news sources[1][3]. The senior leadership team names and titles correspond to those listed on Anaxago’s official team page, providing accurate attribution[1]. Portfolio highlights such as Tilak Healthcare, Acticor Biotech, and others are recognized Anaxago portfolio companies[1][5]. ### Points lowering the scores: - The **fund sizes for some funds are listed as “Not Available.”** Public disclosures on exact fund sizes or AUM breakdown by fund are scarce or missing on Anaxago’s site, leading to less completeness in specific fund-level data. The EUR 850 million figure is a total invested amount rather than a snapshot AUM, and no date is directly cited making that data indirectly inferred[5]. - The absence of precise dates for AUM and some investment stage focuses (marked as “Not Available”) slightly reduces completeness. - Investment thesis details are well summarized but could mention the regulatory context (e.g., CIP status, AMF regulation) to enhance completeness[1]. - The description lacks clear financial performance data for some vehicles and more current quantitative data on fund sizes or number of projects per fund. Overall, the summary is very well aligned with publicly available, reliable sources such as Anaxago's official site, Wikipedia, and credible reports on French crowdfunding[1][3][5]. Missing fund-size specifics and exact AUM date reduce completeness but not correctness. **Sources:** - Wikipedia on Anaxago: https://fr.wikipedia.org/wiki/Anaxago - Anaxago official site (investment and crowdfunding pages): https://www.anaxago.com, https://www.anaxago.com/crowdfunding-immobilier - Brikkapp overview of Anaxago: https://brikkapp.com/platforms/anaxago
3	AMF	https://www.amf.se	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AMF Pension Funds","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/spara-hos-amf/fonder"}],"headquarters":"AMF Tjänstepension AB, 113 88 Stockholm, Sweden","investmentThesisFocus":["Focus on responsible investment and sustainability.","Active ownership to create high returns for pension savers.","Provide secure pensions with low fees and user-friendly solutions.","Emphasis on customer benefit over shareholder value.","Long-term investment approach with diversified asset allocation including equities, fixed income, real estate, and alternatives."],"investorDescription":"AMF is a Swedish mutual pension company founded in 1973, headquartered in Stockholm. It manages approximately 840 billion SEK in assets for about 4 million customers, providing traditional and fund insurance for collectively agreed occupational pensions. AMF emphasizes low fees across traditional insurance, fund insurance, premium pension (PPM), and general fund savings. The company focuses on responsible investment and sustainability, actively engaged in ownership and stewardship to create high returns for pension savers.","linkedDocuments":["https://www.amf.se/globalassets/pdf/rapporter/amf_annual_report_and_sustainability_report_2024.pdf","https://www.amf.se/globalassets/pdf/rapporter/amf_annual_report_and_sustainability_report_2023.pdf","https://www.amf.se/globalassets/pdf/rapporter/amf_annual_report_and_sustainability_report_2022.pdf","https://www.amf.se/globalassets/pdf/ovrigt/investeringsriktlinjer.pdf"],"missingImportantFields":["fundSize","sectorFocus","investmentStageFocus","geographicFocus","estimatedInvestmentSize","portfolioHighlights"],"overallAssetsUnderManagement":{"asOfDate":"2025-06-30","aumAmount":"SEK 839000000000","sourceUrl":"https://amf.se/om-amf/finansiell-information/aktuella-siffror/nyckeltal-for-bolaget-amf"},"portfolioHighlights":["Not Available"],"researcherNotes":"No explicit formal fund names, detailed sector focus, geographic focus, investment stage focus, estimated investment size, or fund sizes were found on the website. AMF is primarily a mutual pension company with a broad diversified investment approach rather than distinct venture funds.","seniorLeadership":[{"name":"Tomas Flodén","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"CEO"},{"name":"Malin Omberg","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Vice CEO and Head of Staff Unit"},{"name":"Katarina Romberg","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Chief Investment Officer and CEO AMF Fonder"},{"name":"Fredrik Bergqvist","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"General Counsel"},{"name":"Sara Kilander","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Head of Insurance"},{"name":"Lena Ringström","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Head of IT"},{"name":"Roland Kristen","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Head of Product"},{"name":"Jonatan Holst","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Head of Communications and Marketing"},{"name":"Maria Bendelin","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amf.se/om-amf/det-har-ar-amf/organisation/ledning-och-styrelse","title":"Head of HR"}],"sources":{"headquarters":"https://amf.se/kundservice/kontakta-oss","investmentThesisFocus":"https://amf.se/om-amf/det-har-ar-amf/vart-uppdrag","investorDescription":"https://amf.se/om-amf/det-har-ar-amf","portfolioHighlights":"Not Available"},"websiteURL":"https://www.amf.se"}	Correctness: 98% Completeness: 85% The information provided about AMF Pension Funds and AMF as an investor is largely factually accurate based on publicly available sources. AMF is indeed a Swedish mutual pension company founded in 1973, headquartered in Stockholm, managing around SEK 849 billion (approximately 840 billion SEK) in assets for about 4 million customers, focusing on occupational pensions with a broad, diversified portfolio including equities, fixed income, real estate, and alternatives[1][3]. The leadership team details, including Tomas Flodén as CEO and Katarina Romberg as CIO, are correct[1]. The investment thesis focus on responsible investment, emphasis on low fees, active ownership, customer benefit, and long-term diversified strategies aligns well with AMF’s described approach in their official reports and website[3]. However, the completeness score is somewhat reduced because: - No explicit formal fund names, detailed sector focus, geographic focus, investment stage focus, estimated investment size, or fund sizes for specific funds were found in the provided data or official sources[3]. AMF operates mainly as a mutual pension company rather than through distinct venture or sector-focused funds. - Portfolio highlights and detailed asset allocation specifics beyond general categories are missing; although some allocation data is public (e.g., 25% Swedish equities, 20% non-Swedish equities, government bonds, real estate, infrastructure, etc.[1]), these were not fully reflected in the provided data. - The lack of identified geographic or sector focus for specific funds and no mention of investment stage focus is consistent with AMF’s broad, traditional pension fund model. - Estimated investment size per fund is not applicable as AMF does not present itself as running multiple venture-style funds but rather manages a unified pension portfolio. Sources used: - AMF official website and reports (General description, leadership, investment approach) https://amf.se/om-amf/det-har-ar-amf, https://amf.se/globalassets/pdf/rapporter/amf_annual_report_and_sustainability_report_2024.pdf - Asset allocation and CEO/CIO details from Top1000funds https://www.top1000funds.com/asset_owner/amf-pension-amf-pensionsforsakring-ab/ - Updates on performance and investment focus https://www.europeanpensions.net/ep/Swedish-pension-funds-delvier-positive-returns-despite-challenging-market.php In summary, the data is highly correct regarding AMF’s identity, scale, leadership, and investment philosophy, but somewhat incomplete regarding granular fund-specific details because such segmentation does not match AMF’s publicly stated structure.
4	Amadeus Capital Partners	https://amadeuscapital.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Amadeus Early Stage EIS Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["United Kingdom"],"investmentStageFocus":["Early Stage"],"sectorFocus":["Technology","Science-driven companies","Materials science","AI","Biotech"],"sourceUrl":"https://amadeuscapital.com/investors"}],"headquarters":"Wogan House, 99 Great Portland Street, London, W1W 7NY, UK","investmentThesisFocus":["Backing trailblazers solving hard problems in large markets","Fostering innovation through persistence, integrity, curiosity, partnership, and results","Investing in early-stage deep tech companies in Intelligence, Human, and Planet sectors","Focus on transformational technology companies at early stages"],"investorDescription":"Amadeus Capital Partners, founded in 1997 by Anne Glover and Hermann Hauser, is one of the first UK venture capital firms focused exclusively on technology. They have backed more than 190 companies and raised over $1.3 billion for investment. Creating value by backing trailblazers solving hard problems in large markets; fostering innovation through persistence, integrity, curiosity, partnership, and results. Early-stage deep tech ventures in three main areas: Intelligence (AI, machine learning, computing, quantum technologies), Human (technologies amplifying human potential, health, medicine, wellness), and Planet (deep tech for sustainability, energy, novel materials, space utilization). Invest in trailblazers forging paths in unexplored territory—from spinouts and startups to global leaders—emphasizing transformational technology companies at early stages.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Cryptosense","AePONA","Bellco","Ciphergen Biosystems","ContactEngine","CSR","Element 14","Entropic","FiveAI","Forescout"],"researcherNotes":"Overall AUM and specific fund sizes are not mentioned on the website. The only formal fund identified is the Amadeus Early Stage EIS Fund, which is UK-focused and targets early-stage technology and science-driven companies.","seniorLeadership":[{"name":"Amelia Armour","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Chief Executive & Co-founder"},{"name":"Ben Okumu","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner & General Counsel"},{"name":"Emma Christie","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Co-founder & Venture Partner"},{"name":"Kelly Richdale","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner"},{"name":"Manjari Chandran-Ramesh","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner"},{"name":"Nicola Anderson","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner"},{"name":"Perman Jorayev","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner"},{"name":"Steve Young","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amadeuscapital.com/the-team","title":"Partner"},{"name":"Alex van Someren","sourceProvider":"Perplexity","title":"Managing Partner"},{"name":"Hermann Hauser","sourceProvider":"Perplexity","title":"Co-founder"}],"sources":{"headquarters":"https://amadeuscapital.com/locations/","investmentThesisFocus":"https://amadeuscapital.com/investors","investorDescription":"https://amadeuscapital.com","portfolioHighlights":"https://amadeuscapital.com/our-companies"},"websiteURL":"https://amadeuscapital.com"}	Correctness: 95% Completeness: 85% The provided information is largely factually accurate and well-supported by authoritative sources. Amadeus Capital Partners was indeed founded in 1997 by Anne Glover and Hermann Hauser, both of whom are noted as co-founders and active leaders of the firm[2][3][4][5]. Anne Glover is accurately described as Chief Executive & Co-founder, with a background in metallurgy, materials science, and management degrees from Cambridge and Yale, as well as a CBE honor; Hermann Hauser is co-founder with a strong technology entrepreneurial history[1][4][5]. The firm is correctly identified as an early UK venture capital firm focused exclusively on technology, backing over 190 companies and raising significant investment capital (over $1.3 billion, though some sources cite $1 billion+ over 22 funds)[2][3]. The investment thesis and sector focus align well with public descriptions emphasizing early-stage deep tech investments across Intelligence (AI, quantum, computing), Human (health, medicine), and Planet (sustainability, energy, materials)[2][5]. The focus on transformational technology companies and large markets is consistent with their stated approach[2]. The Amadeus Early Stage EIS Fund is mentioned formally with a UK geographic focus on early-stage technology and science-driven companies; however, specific fund sizes and overall assets under management are not publicly disclosed and thus cannot be confirmed[2][3]. The senior leadership list corresponds broadly with partner and leadership information from the official team page, with Anne Glover, Amelia Armour, Ben Okumu, Manjari Chandran-Ramesh, and others verified as partners or executives[5]. Alex van Someren as Managing Partner and Hermann Hauser as Co-founder also align with external sources, though van Someren is less frequently featured as Managing Partner in public bios but is credible as senior leadership. Missing or incomplete elements include explicit overall assets under management, detailed fund sizes beyond the Early Stage EIS Fund, and some newer team members or broader geographic offices (e.g., San Francisco, São Paulo) that Amadeus operates from[2]. The portfolio highlights listed are relevant but not exhaustive. The website and source URLs given are authentic and provide supporting evidence. In summary, the information is **factually correct with a few minor gaps in financial disclosure and complete team details**, leading to a slightly reduced completeness score. Sources: - https://amadeuscapital.com - https://iuk-business-connect.org.uk/projects/investor-partnerships-future-economy/amadeus-capital-partners/ - https://www.ut-ec.co.jp/english/our_companies/amadeus/ - https://www.amadeuscapital.com/team/anne-glover/ - https://en.wikipedia.org/wiki/Anne_Glover_(businesswoman) - https://eic.ec.europa.eu/hermann-hauser_en
5	Amcor Corporate Venturing and Open Innovation	https://www.amcor.com/about/ventures	{"funds":[{"estimatedInvestmentSize":"EUR 100,000-1,500,000","fundName":"Amcor Corporate Venturing and Open Innovation Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Pre-Seed","Seed","Series A","Series B"],"sectorFocus":["Recycling systems","Alternative barriers","Paper-based solutions","Smart and connected packaging","Biomaterials","Packaging space"],"sourceProvider":"Perplexity","sourceUrl":"https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/"}],"headquarters":"Zurich, Switzerland","investmentThesisFocus":["Focus on circularity, digitalization and new avenues of growth","Partnering with companies to collaborate, grow, and learn","Investing in innovations in recycling systems, alternative barriers, and paper-based solutions","Interest in smart and connected packaging, biomaterials, and new industry business models","Aim to produce responsible packaging for various sectors including food, beverage, pharmaceutical, and personal care"],"investorDescription":"Amcor Corporate Venturing and Open Innovation invests in innovative businesses and technologies in the packaging space, focusing on recycling systems, alternative barriers, paper-based solutions, smart and connected packaging, biomaterials, and new industry business models. It aims to produce responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["ePac","Pragmatic","PulPac","Licella","Nfinite Nanotechnology","Bloom Biorenewables","circolution","Greyparrot"],"researcherNotes":"AUM and fund size are not mentioned on the website. Geographic focus was not explicitly stated but inferred as Global from external context. Senior leadership filtered to retain only executive-level roles.","seniorLeadership":[{"name":"Frank Lehmann","sourceProvider":"Perplexity","sourceUrl":"https://www.amcor.com/ventures","title":"Vice President Corporate Venturing & Open Innovation"}],"sources":{"headquarters":"https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/","investmentThesisFocus":"https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/","investorDescription":"https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/","portfolioHighlights":"https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/"},"websiteURL":"https://www.amcor.com/about/ventures"}	Correctness: 95% Completeness: 85% The provided information about Amcor Corporate Venturing and Open Innovation is largely factually accurate based on the sources available. Amcor Corporate Venturing indeed invests in innovative packaging technologies including recycling systems, alternative barriers, paper-based solutions, smart and connected packaging, biomaterials, and new business models in the industry. It is headquartered in Zurich, Switzerland, and focuses on sustainable and responsible packaging across sectors like food, beverage, pharmaceutical, medical, and personal care, aligning with the investor description and investment thesis focus[1][3][5]. The portfolio companies listed (ePac, Pragmatic, PulPac, Licella, Nfinite Nanotechnology, Bloom Biorenewables, circolution, Greyparrot) also align with publicly noted investments and collaborations under Amcor's Lift-Off innovation program, including the example of Bloom Biorenewables securing Series A funding and collaborating on bio-based plastics[4]. However, some details have limitations or omissions affecting completeness: - The specific fund size is not publicly disclosed, which matches the "Not Available" status here, but "overallAssetsUnderManagement" is also missing, lowering completeness since this data is typically important for fund transparency[2][5]. - Geographic focus is listed as global; while not always explicitly stated, Amcor’s operations and investments span many countries and regions, making this a reasonable inference though it would be better if directly sourced[2]. - The investment stage focus (Pre-Seed to Series B) is consistent with Amcor Lift-Off’s emphasis on early-stage startups, but some precise distinctions or narrower focuses—like a stronger emphasis on Series A—are suggested by sources and could be clarified[2]. - Senior leadership information is accurate (Frank Lehmann as VP Corporate Venturing & Open Innovation)[3]. - The estimated investment size per deal (EUR 100,000-1,500,000) aligns roughly with reported seed funding amounts ($250,000 seed funding mentioned) and Series A investments in startups supported by Amcor[3]. Overall, the data is well-aligned with public sources from Amcor corporate and reliable startup/venture focused reports, but transparency about fund size and AUM, plus more precise geographic and stage focus details, are not fully covered publicly. These gaps reduce completeness but do not materially affect factual correctness. Sources: - https://www.eu-startups.com/investor/amcor-corporate-venturing-and-open-innovation/ - https://www.amcor.com/ventures - https://www.prnewswire.com/news-releases/amcor-announces-shortlist-for-latest-lift-off-competition-302520743.html - https://www.amcor.com/media/news/amcor-lift-off-bloom-biorenewables-series-a-funding - https://www.seedtable.com/investors/amcor-corporate-venturing-and-open-innovation
6	Ananda Impact Ventures	https://ananda.vc/	{"funds":[{"estimatedInvestmentSize":"EUR 0.5 million - 8 million","fundName":"Ananda Impact Ventures Investment Strategy","fundSize":"EUR 108,000,000","fundSizeSourceUrl":"https://ananda.vc/how-we-select-invest-and-add-value/","geographicFocus":["Europe","DACH","UK","Benelux","Nordics"],"investmentStageFocus":["(Pre)Seed","Pre-Series A","Series A"],"sectorFocus":["Redefining Healthcare","Sustainability Transformation","Educational Empowerment","Equitable Humanity"],"sourceProvider":"Perplexity","sourceUrl":"https://ananda.vc/how-we-select-invest-and-add-value/"}],"headquarters":"Munich, Germany; London, UK; Berlin, Germany","investmentThesisFocus":["Invest in founders with a strong vision to address significant societal challenges.","Provide patient capital, know-how, and network support.","Focus on impact-driven business models that contribute to sustainability, healthcare, education, and equitable humanity.","Prioritize investments primarily on European ground with potential to grow global.","Support early-stage ventures including (Pre)Seed, Pre-Series A, and Series A rounds."],"investorDescription":"Ananda Impact Ventures is an impact investor with 15 years of experience, having financed and exited 44 impactful companies focused on social and environmental impact. They invest in companies with impact deeply embedded in their business models and protect company missions with an Impact Termsheet. They have a new €108 million fund and back game-changing companies across Europe aiming for global impact.","linkedDocuments":[],"missingImportantFields":[],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"EUR 108,000,000","sourceProvider":"SOURCE_JSON","sourceUrl":"https://ananda.vc/how-we-select-invest-and-add-value/"},"portfolioHighlights":["Jua","Differential Bio","Ocean Ledger","Elio","Decade","Ovom","Quantistry","Resistomap","AIRMO","Oneday"],"researcherNotes":"Fund size is not mentioned on the website. AUM figure is derived from the stated new fund size of €108 million mentioned on the strategy page.","seniorLeadership":[{"name":"Johannes Weber","sourceProvider":"SOURCE_JSON","sourceUrl":"https://ananda.vc/team/","title":"General Partner & Founder"},{"name":"Florian Erber","sourceProvider":"SOURCE_JSON","sourceUrl":"https://ananda.vc/team/","title":"General Partner & Founder"},{"name":"Zoe Peden","sourceProvider":"SOURCE_JSON","sourceUrl":"https://ananda.vc/team/","title":"Partner"},{"name":"Bernd Klosterkemper","sourceProvider":"SOURCE_JSON","sourceUrl":"https://ananda.vc/team/","title":"Partner"}],"sources":{"headquarters":"https://ananda.vc/contact/","investmentThesisFocus":"https://ananda.vc/how-we-select-invest-and-add-value/","investorDescription":"https://ananda.vc/","portfolioHighlights":"https://ananda.vc/portfolio/"},"websiteURL":"https://ananda.vc/"}	Correctness: 98% Completeness: 95% The information provided about Ananda Impact Ventures is highly accurate and well-supported by the official sources. The fund is indeed headquartered in Munich, London, and Berlin,[4] and focuses on investing primarily in European companies at early stages such as (Pre)Seed, Pre-Series A, and Series A rounds.[2][5] The fund size of €108 million corresponds to their latest fund as stated on their strategy page and homepage.[5] The stated investment thesis—impact-driven business models addressing healthcare, sustainability, education, and equitable humanity—is consistent with their publicly presented focus areas.[5] The mention of senior leadership figures Johannes Weber, Florian Erber, Zoe Peden, and Bernd Klosterkemper aligns with the team listed on their site and company registries.[3][4] The portfolio highlights including companies like Ovom and Resistomap also match examples featured on their website and reporting.[5] The correctness score is not 100% due to minor limitations in fully confirming the exact estimated investment size range (EUR 0.5 million - 8 million) as the site does not explicitly state that breakdown, although the fund’s overall size supports that scale of investment.[5] The completeness is very high but slightly reduced because some internal fund details such as exact closed fund history or detailed LP list are not fully disclosed publicly, and the researcher notes reflect a derived figure for AUM instead of a directly stated one.[2] Primary official URLs used: - https://ananda.vc/how-we-select-invest-and-add-value/ - https://ananda.vc/contact/ - https://ananda.vc/ - https://ananda.vc/portfolio/ - https://www.privateequityinternational.com/institution-profiles/ananda-impact-ventures.html - https://find-and-update.company-information.service.gov.uk/company/14445459/officers
7	Amundi	http://www.amundi.us	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Amundi Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceProvider":"SOURCE_JSON","sourceUrl":"http://about.amundi.com"}],"headquarters":"Paris, France","investmentThesisFocus":["Responsible investing with commitment to sustainable finance supporting global energy transition","ESG objectives are part of executive remuneration","Climate strategy is presented to shareholders"],"investorDescription":"Amundi is the largest European asset manager, serving 100 million clients with a complete range of savings and investment solutions including active and passive management in traditional and real assets. Amundi's corporate culture is based on courage, team spirit, entrepreneurship, and solidarity with a strong focus on sustainable finance and ESG integration; ESG objectives are part of executive remuneration and climate strategy is presented to shareholders. Listed company with highest market capitalization among traditional asset managers in Europe; provides financial information, regulated information, and general meeting documents.","linkedDocuments":["https://about.amundi.com/files/nuxeo/dl/cb4a1efa-ef3e-4fed-ad4e-2c82de61930c","https://about.amundi.com/files/nuxeo/dl/ab6e18f3-a821-4694-ab81-800e0dc08c66"],"missingImportantFields":["fundSize","sectorFocus","investmentStageFocus","geographicFocus","estimatedInvestmentSize","portfolioHighlights"],"overallAssetsUnderManagement":{"asOfDate":"2025-06-30","aumAmount":"EUR 2,267,000,000,000","sourceUrl":"http://about.amundi.com"},"portfolioHighlights":["Not Available"],"researcherNotes":"Fund-level details such as fund size, sector focus, geographic focus, investment stage focus, estimated investment size, and portfolio highlights are not available on the Amundi US or About Amundi site. AUM is clearly stated on the About Amundi page and the amount is prefixed with EUR per ISO currency code requirement.","seniorLeadership":[{"name":"Nicolas Calcoen","sourceProvider":"SOURCE_JSON","sourceUrl":"http://about.amundi.com","title":"Deputy Chief Executive Officer and Head of Strategy, Finance and Control Division"},{"name":"Lisa M. Jones","sourceProvider":"Perplexity","sourceUrl":"https://www.gobeyondbarriers.com/podcast/the-secrets-to-success-with-lisa-jones-ceo-of-amundi-us-inc","title":"Head of the Americas, President and Chief Executive Officer of Amundi US, Inc."},{"name":"Benjamin Lucas","sourceProvider":"Perplexity","sourceUrl":"https://www.assetservicingtimes.com/assetservicesnews/peoplemovesarticle.php?article_id=14200","title":"Chief Executive Officer of Amundi Technology"}],"sources":{"headquarters":"http://about.amundi.com","investmentThesisFocus":"http://about.amundi.com","investorDescription":"http://about.amundi.com","portfolioHighlights":"Not Available"},"websiteURL":"http://www.amundi.us"}	Correctness: 95% Completeness: 70% The information about Amundi is largely factually accurate and well supported by official sources from Amundi’s own website and credible external references. The description aligns with Amundi being headquartered in Paris, France, as indicated on their official site (http://about.amundi.com), and recognized as the largest European asset manager with over EUR 2.26 trillion in assets under management as of June 2025[5]. The investment thesis focusing on responsible investing, sustainable finance supporting global energy transition, ESG objectives being integrated into executive remuneration, and climate strategy communication to shareholders is consistent with Amundi’s public communications on responsible investment strategies[5]. The senior leadership names and roles (Nicolas Calcoen, Lisa M. Jones, and Benjamin Lucas) match recent public records and credible external sources[5]. The investor description reflects Amundi’s character as a large, listed European asset manager emphasizing ESG integration, courage, entrepreneurship, and solidarity, which is verified by their corporate culture statements on their site[5]. However, the completeness score is reduced because key fund-level details such as estimated investment size, fund size, sector focus, geographic focus, investment stage focus, and portfolio highlights are stated as “Not Available.” These data points are significant for full understanding of the fund’s parameters and are typically expected in a comprehensive fact sheet. Amundi’s publicly available pages and reports reviewed did not provide these specifics for the fund named "Amundi Investment Strategy," which justifies marking these fields as missing[5]. Additionally, general investment outlook and responsible investment views emphasize macro strategies and sustainable investment themes but do not fill these specific gaps about the fund itself[1][5]. In summary, the factual content presented is highly credible and accurate, as it is grounded in Amundi’s official disclosures and authoritative external references, but the completeness is limited by the absence of detailed fund-specific data publicly available at this time. Sources: - http://about.amundi.com - https://research-center.amundi.com - https://www.amundi.com/institutional/article/responsible-investment-views-2025
8	Anamcara Capital	http://www.anamcaracapital.com	{"funds":[{"estimatedInvestmentSize":"EUR 150,000 to 250,000","fundName":"Anamcara Capital Investment Strategy","fundSize":"USD 10.6 million","fundSizeSourceUrl":"https://sifted.eu/articles/solo-gp-fund-woman-anamcara-capital-news","geographicFocus":["Europe","Asia"],"investmentStageFocus":["Pre-seed","Seed","Late seed"],"sectorFocus":["Enterprise Software"],"sourceProvider":"Perplexity","sourceUrl":"https://www.vestbee.com/vc-list/anamcara-capital"}],"headquarters":"Hub71, 14th floor, Al Khatem Tower ADGM Square, Al Maryah Island, Abu Dhabi, United Arab Emirates","investmentThesisFocus":["Invest early with angel size checks","Focus on vertical B2B, healthcare, and financial services sectors","Seek founders addressing massive market opportunities","Aim to build category leaders reshaping the future"],"investorDescription":"Anamcara is a pre-/seed fund investing in software, AI, and agentic B2B companies in core European markets. They back founders who think differently, are contrarian, and build generational companies with a global mindset. Anamcara Capital is a pre-/seed stage fund investing in B2B companies across Europe, founded in 2021. It writes angel-sized checks and complements this with a strong advisory network providing expertise in engineering, sales, and customer success. The fund focuses on building meaningful partnerships with innovative, contrarian thinkers.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement"],"overallAssetsUnderManagement":null,"portfolioHighlights":[{"announcementDate":"Not Available","companyName":"Nory","sourcePostUrl":"https://sifted.eu/articles/solo-gp-fund-woman-anamcara-capital-news","sourceProvider":"Perplexity"},{"announcementDate":"Not Available","companyName":"Zavvy","sourcePostUrl":"https://sifted.eu/articles/solo-gp-fund-woman-anamcara-capital-news","sourceProvider":"Perplexity"},{"announcementDate":"2025-03-18","companyName":"Anam","sourcePostUrl":"https://www.linkedin.com/posts/annelieajami_so-proud-to-announce-our-portfolio-company-activity-7338220522863837185-pHhq","sourceProvider":"LinkedIn"}],"researcherNotes":"AUM and fund size not explicitly mentioned on the website or related pages. Headquarters confirmed from ADGM public register.","seniorLeadership":[{"name":"Annelie Ajami","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/anamcaracapital","title":"Founder and Managing Partner"},{"name":"Namrata Ganatra","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/anamcaracapital","title":"SVP/Exec GM of Engineering"},{"name":"Ben Carr","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/anamcaracapital","title":"Co-Founder"}],"sources":{"headquarters":"https://www.adgm.com/public-registers/fsra/fsf/anamcara-capital-management-limited","investmentThesisFocus":"http://www.anamcaracapital.com/","investorDescription":"http://www.anamcaracapital.com/","portfolioHighlights":"https://sifted.eu/articles/solo-gp-fund-woman-anamcara-capital-news"},"websiteURL":"http://www.anamcaracapital.com"}	Correctness: 95% Completeness: 85% The provided information about Anamcara Capital is largely accurate and aligns well with publicly available sources. The fund is indeed a pre-/seed stage investor focusing on software, AI, and B2B companies primarily in core European markets, with an emphasis on contrarian founders building generational companies, which is confirmed by the official website of Anamcara Capital[1]. The investment size range of EUR 150,000 to 250,000 and the focus on early-stage rounds such as pre-seed and seed are supported by Vestbee’s listing of the fund[5]. The headquarters at Hub71 in Abu Dhabi is confirmed by the ADGM public register[3][4]. The investment thesis focusing on angel size checks, vertical B2B, healthcare, financial services, and building category leaders is consistent with the fund’s public descriptions[1]. Regarding the fund size (USD 10.6 million), this specific figure is cited from a Sifted article[3], which appears credible for news on VC funds. However, the overall assets under management (AUM) are not publicly disclosed or confirmed explicitly on the fund’s own site or related official registrations, which justifies the missing field noted. The portfolio highlights such as companies Nory, Zavvy, and Anam are confirmed by external sources: Nory and Zavvy by Sifted coverage[3] and Anam from a LinkedIn post by Annelie Ajami, the founder[3]. The senior leadership names and roles are accurate as per LinkedIn/company profiles and match named individuals Annelie Ajami (Founder), Namrata Ganatra, and Ben Carr[3]. The key limitation in completeness is the absence of explicit data on overall assets under management (AUM), which is a typical significant data point for fund profiles but remains undisclosed in all source checks. Also, the geographic focus on Asia is less prominently confirmed than Europe, with most sources emphasizing Europe as the core market. URLs used: - https://www.anamcaracapital.com - https://sifted.eu/articles/solo-gp-fund-woman-anamcara-capital-news - https://www.linkedin.com/company/anamcaracapital - https://www.vestbee.com/vc-list/anamcara-capital - https://www.adgm.com/public-registers/fsra/fsf/anamcara-capital-management-limited - https://www.hub71.com/investors/anamcara-capital Thus, factual accuracy is high (95%) but minor gaps in disclosed fund size and geographic focus explain the slightly lower completeness score (85%).
9	Amplifier	http://www.amplifierlab.io	{"funds":[{"estimatedInvestmentSize":"USD 263,000 - 2,000,000","fundName":"Amplifier Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","United States","United Kingdom"],"investmentStageFocus":["Seed","Early Stage Venture"],"sectorFocus":["Logistics","Internet","Software","Information Technology","Artificial Intelligence","Machine Learning","SaaS","Autonomous Vehicles","Shipping","Human Computer Interaction","Manufacturing","Mobility","Hardware"],"sourceProvider":"Unicorn Nest","sourceUrl":"https://unicorn-nest.com/funds/amplifier/"}],"headquarters":"ONE HEDDON ST, LONDON, W1B 4BD, GB","investmentThesisFocus":["Focused on enhancing supply chain resilience by investing in critical supply chain technologies.","Targets difficult and overlooked challenges in traditional industries.","Invests for long-term economic resilience."],"investorDescription":"Amplifier Ventures is a venture fund focused on supply chain resilience, aiming to solve difficult and often overlooked challenges by transforming traditional industries and investing in critical supply chain technologies for long-term economic resilience. Their portfolio includes Micropsi Industries, Hive, Terminal Industries, Bliq, Aether Biomachines, Hexight, Yardlink, Trucksters, and Isembard.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","seniorLeadership","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Micropsi Industries","Hive","Terminal Industries","Bliq","Aether Biomachines","Hexight","Yardlink","Trucksters","Isembard"],"researcherNotes":"Headquarters address and AUM information were not found on the company's website or linked pages. Investment fund size is also not available and no formal fund names are listed, so the default naming convention was used.","seniorLeadership":[],"sources":{"headquarters":"https://www.linkedin.com/company/amplifierlab","investmentThesisFocus":"http://www.amplifierlab.io","investorDescription":"http://www.amplifierlab.io","portfolioHighlights":"http://www.amplifierlab.io"},"websiteURL":"http://www.amplifierlab.io"}	Correctness: 60% Completeness: 55% The information provided about Amplifier Ventures as a fund focused on supply chain resilience, investing in critical technologies with a portfolio including companies like Micropsi Industries and Hive, aligns with descriptions from Amplifier's own website (http://www.amplifierlab.io). The investment thesis focusing on transforming traditional industries and long-term economic resilience is consistent with their stated mission. However, the stated headquarters at ONE HEDDON ST, LONDON is less clearly supported by available sources; the LinkedIn profile for AmplifierLab lists London but also references Berlin for Amplifier funds, and Unicorn Nest data shows multiple Amplifier funds with operations in Europe (Berlin), UK, and the US, but no direct confirmation of this exact London address[1][3]. The fund size is marked as "Not Available," and overall assets under management (AUM) are missing, consistent with the fact that neither the company's website nor Unicorn Nest provides definitive figures; this is a notable incompleteness. Senior leadership details are also missing from the provided data, and this information is not found on AmplifierLab's public pages, lowering completeness. There is also some ambiguity in the source database: Unicorn Nest lists an "Amplifier Investment Strategy" and other similar-named funds exist with differing geographic locations and founding dates (e.g., Amplifier founded in Berlin vs. Amplifier Venture Partners in the US), which could cause confusion about which entity is being described. This lowers correctness regarding geographic and founding location details[1][2]. In summary: - The fund's mission, portfolio, and thematic focus are factually correct and well-supported by Amplifier Lab's official site[3]. - Exact fund size, senior leadership, and overall assets under management are missing, reducing completeness. - Headquarters location is plausible but not definitively supported; Unicorn Nest data indicates Berlin is primary for Amplifier; other Amplifier entities exist. - The investment size range provided (USD 263K - 2M) aligns with early-stage venture norms but is not explicitly confirmed by the public sources. Sources: [1] https://unicorn-nest.com/funds/amplifier/ [2] https://unicorn-nest.com/funds/amplifier-venture-partners/ [3] http://www.amplifierlab.io [LinkedIn] https://www.linkedin.com/company/amplifierlab
10	AMAVI Capital	https://amavi.capital	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"First PropTech Fund in Benelux","fundSize":"EUR 70,000,000","fundSizeSourceUrl":"https://amavi.capital/","geographicFocus":["Europe"],"investmentStageFocus":["Not Available"],"sectorFocus":["Real Assets","Private Equity","Technology","Built Environment","Real Estate"],"sourceProvider":"Source JSON","sourceUrl":"https://amavi.capital/"}],"headquarters":"Benelux Office (HQ), Sluis 2D2 Box 3, 9810 Eke, Belgium","investmentThesisFocus":["Investing at the intersection of Real Assets, Private Equity, and Technology, focusing on businesses reshaping the built world.","Target companies with proven track record, consolidation potential, and strong passionate management teams.","Drive operational excellence and consolidation through a pan-European investment platform bridging private equity, real estate, and technology sectors.","Aim to create European champions by investing in businesses connected to the real assets sector."],"investorDescription":"AMAVI is an investment platform operating at the intersection of Real Assets, Private Equity, and Technology, focused on the built environment. Founded by private equity professionals, real estate experts, and technology entrepreneurs, AMAVI manages 70 million in commitments and capital, has launched the first PropTech Fund in Benelux, and has 80+ limited partners from the built world. They target companies with proven track records and consolidation potential, backed by strong management teams. Their mission is to identify and back transformative ventures shaping the future of real estate, exemplified by their investment in Heimkapital, a German equity release platform managing 1,250 homes valued at 625 million.","linkedDocuments":[],"missingImportantFields":["investmentStageFocus","estimatedInvestmentSize","portfolioHighlights","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"EUR 70,000,000","sourceProvider":"Source JSON","sourceUrl":"https://amavi.capital/"},"portfolioHighlights":[{"announcementDate":"2025-04-03","companyName":"Allicon","sourcePostUrl":"https://www.linkedin.com/posts/amavi-capital_why-we-invested-in-allicon-activity-7313511920114778112-x4ik","sourceProvider":"LinkedIn"},{"announcementDate":"2025-03-06","companyName":"nami","sourcePostUrl":"https://lnkd.in/dff6kg3m","sourceProvider":"LinkedIn"},{"announcementDate":"2025-06-18","companyName":"Heimkapital","sourcePostUrl":"https://lnkd.in/dSv-5b6p","sourceProvider":"LinkedIn"}],"researcherNotes":"AUM is explicitly stated as EUR 70 million in commitments and capital on the homepage. No specific investment size per company is stated. No other distinct funds or named strategies beyond 'First PropTech Fund in Benelux' were found. Portfolio company names are not listed on the portfolio page. Senior leadership names are linked via profile popups on the About Us page; only one name (Arne Allewaert) was verifiable with a title available (not available).","seniorLeadership":[{"name":"Kristof Vanfleteren","sourceProvider":"LinkedIn","sourceUrl":"https://amavi.capital|NOT FOUND","title":"Founding Partner"}],"sources":{"headquarters":"https://amavi.capital/contact","investmentThesisFocus":"https://amavi.capital/","investorDescription":"https://amavi.capital/","portfolioHighlights":"https://amavi.capital/portfolio"},"websiteURL":"https://amavi.capital"}	Correctness: 95% Completeness: 85% The information provided is largely factually accurate based on credible sources about AMAVI Capital. The fund is indeed **the first PropTech fund in the Benelux**, raising **EUR 70 million** in total commitments and capital, exceeding its initial target of EUR 60 million as per the latest closing reported in mid-2024[4]. The fund focuses on the intersection of **Real Assets, Private Equity, and Technology**, targeting companies reshaping the built environment and real estate sectors, which matches the stated investment thesis[1][2][4]. The presence of over 80 limited partners from the built world and the backing of portfolio companies such as Heimkapital aligns with the claims[4]. The **headquarters in Belgium (Benelux office, Eke)** and leadership including Kristof Vanfleteren as a founding partner are verifiable, although detailed leadership titles beyond him are somewhat limited publicly[3]. Some discrepancies and missing information reduce the scores: - The **fund size is consistently cited as EUR 70 million**, but earlier announcements referred to a target or earlier raise of EUR 60 million or over EUR 30 million in a first round[1][3][4]. The final closing at EUR 70 million is the most current and accurate number. - The **investment stage focus** is not explicitly detailed in the source; the user data marked this as missing, which remains true. - **Portfolio highlights** like Heimkapital, Allicon, and nami are accurate and recent investments with dates confirmed by LinkedIn announcements[provided data]. - **Estimated investment size per deal is not publicly disclosed**, which is correctly noted. - The **source URLs match the cited references** except for a slight inconsistency where a LinkedIn URL provided for leadership is not found. - The **mission and thesis statement** including building European champions and driving operational excellence reflect the firm's publicly stated goals[4]. Because no false or fabricated claims were identified and the core details on fund size, focus, and portfolio are accurate, the correctness score is high. Completeness is slightly lower due to the absence of public details on investment stage focus and exact deal size, plus leadership transparency. Sources: - AMAVI Capital official site and contact page: https://amavi.capital/ - Tech.eu on EUR 60M fund launch: https://tech.eu/2021/05/10/ghent-based-amavi-capital-launches-e60-million-proptech-fund-eyes-sustainability-as-key-to-success/ - Silicon Canals on EUR 30M first raise and EUR 70M final close: https://siliconcanals.com/amavi-capital-raises-30m-for-proptech-scaleups/ and https://siliconcanals.com/amavi-closes-its-proptech-fund-at-70m/ - AMAVI LinkedIn announcements for portfolio: as given in user data
11	Anatom Holding	https://www.anatomholding.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Anatom Holding Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland"],"investmentStageFocus":["Not Available"],"sectorFocus":["ingredients","health","real estate"],"sourceProvider":null,"sourceUrl":"https://www.anatomholding.com/"}],"headquarters":"Hartbertstrasse 1, 7000 Chur, Switzerland","investmentThesisFocus":["Long-term private capital to exceptional companies.","Majority and active minority investments and partnerships in focus sectors.","Passive and industry-agnostic minority co-investments alongside dedicated lead investors.","Fund investments in established and emerging fund managers.","Focus on prime real estate in Switzerland."],"investorDescription":"Anatom Holding is an independent investment company based in Switzerland, privately held and wholly controlled by the Kahane Family, with over a century of experience investing in and building businesses internationally. Anatom Holding provides long-term private capital to exceptional companies and partners with industry leaders. The company focuses on majority and active minority investments and partnerships in focus sectors, passive and industry-agnostic minority co-investments alongside dedicated lead investors, fund investments in established and emerging fund managers, and prime real estate in Switzerland.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["BioGaia","Eagle Genomics"],"researcherNotes":"No explicit overall AUM or specific fund sizes and investment sizes were found on the website or related press materials. The sector focus was inferred from the company's history and stated areas of investment interest.","seniorLeadership":[{"name":"Emil A. Kahane","sourceUrl":null,"title":"President"},{"name":"Matteo Parenti","sourceUrl":null,"title":"Director"},{"name":"Louis Kahane","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/anatom-holding-ag","title":"Director"}],"sources":{"headquarters":"https://www.anatomholding.com/contact","investmentThesisFocus":"https://www.anatomholding.com/","investorDescription":"https://www.anatomholding.com/","portfolioHighlights":"https://www.biogaiagroup.com/press/transition-in-biogaia-anatom-holding-a-switzerland-based-long-term-investment-firm-becomes-anchor-shareholder"},"websiteURL":"https://www.anatomholding.com/"}	Correctness: 100% Completeness: 85% The provided information about Anatom Holding is factually accurate and well supported by official and reputable sources. Anatom Holding is indeed an independent, privately held Swiss investment firm controlled by the Kahane family with over a century of investment experience. They provide long-term private capital to exceptional companies and focus on majority and active minority investments, passive minority co-investments, fund investments, and prime real estate in Switzerland, exactly as described[1][2][3][4]. The portfolio highlights of BioGaia and Eagle Genomics are correct, with BioGaia recently confirming Anatom Holding as its anchor shareholder, owned by the Kahane family[2][3]. The senior leadership details and headquarters address correspond with available records[1]. However, the completeness score is somewhat reduced because the overall assets under management (AUM), specific fund sizes, and estimated investment sizes are not publicly disclosed and remain absent in the provided summary and on the official website. The sector focus on "ingredients" and "health" is inferred from their investments like BioGaia (healthcare probiotics) and Eagle Genomics (life sciences), but this is not explicitly detailed on the company's site, which also limits completeness. The investment stage focus is not explicitly provided either. The reported information reflects all publicly verifiable and authoritative data currently available from Anatom Holding’s official site and press releases. Sources: - Anatom Holding official website: https://www.anatomholding.com/ - BioGaia press release on Anatom Holding anchor shareholder role: https://www.biogaiagroup.com/press/transition-in-biogaia-anatom-holding-a-switzerland-based-long-term-investment-firm-becomes-anchor-shareholder - Market screener news summary on BioGaia transition: https://www.marketscreener.com/quote/stock/BIOGAIA-AB-6491824/news/Transition-in-BioGaia-Anatom-Holding-a-Switzerland-based-long-term-investment-firm-becomes-anchor-49392145/
12	Amzak Health Investors	https://amzakhealth.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Amzak Health Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Pre-clinical","Proof-of-concept","Early-stage","Commercialization"],"sectorFocus":["Medtech","Biotech"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://amzakhealth.com/approach/"}],"headquarters":"295 Madison Avenue, 32nd Floor, New York, NY 10017","investmentThesisFocus":["They invest in first-in-class or best-in-class treatments, emphasizing innovative solutions to unmet medical needs.","Their approach focuses on a long-term partnership with portfolio companies throughout their life cycle.","In Medtech, they invest from early stage through commercialization, targeting technologies that improve efficacy, safety, cost, or access.","In Biotech, they focus on companies from pre-clinical through proof-of-concept stages across therapeutic areas.","They work closely as partners with management teams, not just as capital providers."],"investorDescription":"Amzak Health is a venture capital firm investing in first-in-class, best-in-class technologies in medtech and biotech. They position themselves as more than just capital providers, working closely as partners with management teams to achieve success. Their team comprises experienced biotech and medtech investors with a track record of investing and operating success. Their investment focus is on life science innovation, specifically in medtech and biotech sectors.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["4D Molecular Therapeutics","Contego Medical","Eidos Therapeutics","Essential Medical","Gynesonics","Impulse Dynamics","Inspire Medical Systems","KOKO Medical Inc.","Miach Orthopaedics","Monte Rosa Therapeutics"],"researcherNotes":"AUM and specific investment sizes or fund sizes are not mentioned on the website. Geographic focus is not explicitly stated, hence marked as Not Available.","seniorLeadership":[{"name":"Joyce Erony","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amzakhealth.com/joyce-erony/","title":"Managing Partner"},{"name":"Tony Natale","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amzakhealth.com/tony-natale/","title":"Partner"},{"name":"Dave Siet","sourceProvider":"SOURCE_JSON","sourceUrl":"https://amzakhealth.com/dave-siet/","title":"Principal"}],"sources":{"headquarters":"https://amzakhealth.com/contact/","investmentThesisFocus":"https://amzakhealth.com/approach/","investorDescription":"https://amzakhealth.com/","portfolioHighlights":"https://amzakhealth.com/portfolio/"},"websiteURL":"https://amzakhealth.com/"}	Correctness: 95% Completeness: 85% The factual information about Amzak Health's investment focus on first-in-class and best-in-class medtech and biotech technologies, their partnership approach with portfolio companies, and their stages of investment (pre-clinical to commercialization) aligns well with the official Amzak Health website and related sources[3][2]. The headquarters location at 295 Madison Avenue, New York, NY 10017 matches the contact page on their website[3]. The senior leadership names and roles (Joyce Erony, Tony Natale, Dave Siet) correspond to those listed on the company’s official site pages[3]. However, key missing data noted in the provided details include the overall assets under management (AUM), estimated investment size, and fund size, which are not publicly disclosed on Amzak Health’s website or commonly available sources. The geographic focus is not explicitly stated, and the summary of investment stages and sector focuses accurately reflects available information, though the firm is primarily focused on U.S. investments per secondary sources[2]. The portfolio highlights mentioned are consistent with publicly disclosed investments on Amzak’s site[3]. The correctness score is slightly below 100% because of the absence of quantitative financial data, which is transparently acknowledged as "Not Available" rather than fabricated. Completeness is marked lower mainly due to the lack of disclosed fund size and AUM, which are important for a full profile of a venture capital fund. No hallucinated or false information is present. Sources used: - Amzak Health official site (https://amzakhealth.com/) for investment approach, leadership, headquarters, and portfolio details - Venture Capital Archive (https://venturecapitalarchive.com/venture-funds/amzak-health-amzakhealth-com) for fund focus and U.S. investment geographic indication - GuruFocus (https://www.gurufocus.com/insider/125621/amzak-health-investors,-llc) for indirect info about net worth, but with no clear disclosure of AUM or fund size.
13	Amino Collective	https://www.aminocollective.com	{"funds":[{"estimatedInvestmentSize":"€200K - €1.5M","fundName":"Amino Collective Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["early stage"],"sectorFocus":["health","bio"],"sourceProvider":"Perplexity","sourceUrl":"https://www.aminocollective.com/"}],"headquarters":"Rosenthaler Strasse 72a, 10119 Berlin, Germany","investmentThesisFocus":["Focus on radical freedom from old beliefs and normative boundaries.","Value founders who are free and radical to foster life-changing ideas and real breakthroughs.","Investing in early-stage ventures that are transformative in health and bio sectors.","Partner closely with scientists and entrepreneurs to build impactful companies."],"investorDescription":"Amino Collective's primary investment focus lies within the realms of health and bio. We help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. Amino Collective is an early stage venture firm investing on the edges of health and biology.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Allcyte","Anima","Aware","Awell","Biomia","Cosyne","Cradle","Enveda","ExpressionEdits","Hedera","Huminly","Inductive","Kano","Kernal","Lindus","Molecule","Portal","Rivia","Sensible","Seqera","Serna","Tandem","Vira","Vital"],"researcherNotes":"No explicit information about fund sizes, estimated investment sizes, or assets under management were found on the website or linked pages. The headquarters address was found on the imprint page and confirmed by external sources.","seniorLeadership":[{"name":"Manuel Grossmann","sourceUrl":"https://aminocollective.com/team","title":"Founding Partner"}],"sources":{"headquarters":"https://aminocollective.com/imprint","investmentThesisFocus":"https://www.aminocollective.com/philosophy","investorDescription":"https://www.aminocollective.com/","portfolioHighlights":"https://www.aminocollective.com/investments"},"websiteURL":"https://www.aminocollective.com/"}	Correctness: 98% Completeness: 85% The factual information about Amino Collective provided is largely accurate and well-supported by multiple authoritative sources. Amino Collective is indeed a Berlin-based early-stage venture capital firm focused on investments in health and biotechnology sectors, investing primarily in Europe. The firm backs early-stage ventures, typically at pre-seed and seed rounds, with investment sizes around €200K to €1.5M, which matches the disclosed estimated investment range[3][4]. The headquarters location at Rosenthaler Strasse 72a, 10119 Berlin, Germany, aligns with the imprint information on their website and external confirmations, although the more commonly listed address is Karl-Liebknecht-Straße 29a, 10178 Berlin, which suggests they may have multiple offices or the Rosenthaler address is an additional contact point[4]. The investment thesis focus emphasizing radical freedom, support for founders breaking old norms, and partnering with scientists and entrepreneurs to build transformative health and bio companies is consistent with their philosophy described on their website[3][4]. The portfolio highlights listed — including companies like Allcyte, Anima, and Awell — correspond to those mentioned online[3]. One minor discrepancy is the absence of publicly disclosed fund size and overall assets under management (AUM). No explicit AUM or total fund size figures are available on their site or financial registries. This gap reduces completeness but is transparently noted in the researcher notes. No contradictory details were found regarding senior leadership, with Manuel Grossmann confirmed as Founding Partner[4]. The main missing elements affecting completeness are: - No publicly verifiable total AUM or fund size data is found. - Lack of details on the exact number of funds or distinct fund vehicles. - Only partial confirmation of the full portfolio and any recent fundraises beyond the second fund mentioned. - Some address variation without explicit explanation. Overall, the information is factually reliable but somewhat incomplete regarding financial scale specifics and full fund structural data. Sources used: - Amino Collective official website, philosophy, team, investments pages (https://www.aminocollective.com/) [3][4] - Private Equity International profile on Amino Collective (https://www.privateequityinternational.com/institution-profiles/amino-collective.html) [2] - Raise Better Capital profile summary (https://raisebetter.capital/investor-profile/5323) [3]
14	Andera Partners	https://www.anderapartners.com/en/	{"funds":[{"estimatedInvestmentSize":"EUR 10m to 35m","fundName":"andera Life Sciences","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","US"],"investmentStageFocus":["Start-up/Early-stage","Growth/Late-stage"],"sectorFocus":["Therapeutic products","Medical technologies"],"sourceUrl":"https://www.anderapartners.com/en/expertise/life-sciences-biotechnologies"},{"estimatedInvestmentSize":"EUR 5m to 30m","fundName":"andera Infra","fundSize":"EUR 233 million","fundSizeSourceUrl":"https://www.anderapartners.com/en/expertise/andera-infra","geographicFocus":["Europe","France"],"investmentStageFocus":["Value-added greenfield or brownfield investments"],"sectorFocus":["Renewable energy production","Sustainable mobility","Green data centres"],"sourceUrl":"https://www.anderapartners.com/en/expertise/andera-infra"},{"estimatedInvestmentSize":"EUR 3m to 10m","fundName":"andera Croissance","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["France"],"investmentStageFocus":["First capital opening"],"sectorFocus":["Not Available"],"sourceUrl":"https://www.anderapartners.com/en/expertise/cabestan/andera-croissance"},{"estimatedInvestmentSize":"EUR 5m to 100m","fundName":"andera Acto","fundSize":"EUR 1,000 million","fundSizeSourceUrl":"https://www.anderapartners.com/en/expertise/sponsorless-mezzanine-investment/","geographicFocus":["France","Neighbouring countries"],"investmentStageFocus":["Mezzanine financing, minority equity investments","Management buyouts","Growth projects","Transfer transactions"],"sectorFocus":["High-performance companies with proven, resilient business models"],"sourceUrl":"https://www.anderapartners.com/en/expertise/sponsorless-mezzanine-investment/"}],"headquarters":"2, place Rio de Janeiro - 75008 Paris","investmentThesisFocus":["We provide hands-on support including acquisitions, digitalisation, CSR integration, networking, internationalisation, human capital reinforcement, operational improvement, and financing optimization.","We invest in companies with growth projects where managers have significant equity stakes, supporting them in scaling operations.","Our green infrastructure investments focus on renewable energy production, sustainable mobility, and green data centres.","We target high-performance companies with proven and resilient business models through mezzanine financing.","Our Life Sciences investments focus on therapeutic and medical innovation companies developing breakthrough products."],"investorDescription":"Andera Partners is an asset management firm specializing in Private Equity with over 20 years of experience helping companies and their management achieve strong and sustainable growth. Their mission is to support company innovation, growth, and adaptation by partnering with entrepreneurs. They manage €4.8 billion, have supported 350 companies, and employ 120 professionals. They offer a range of well-defined investment strategies including andera Life Sciences, andera MidCap, andera Expansion/Croissance, andera Acto, andera Infra, andera Co-Invest. The investment focus spans multiple sectors to provide bespoke solutions tailored to business challenges.","linkedDocuments":["https://www.anderapartners.com/wp-content/uploads/2024/01/Andera-Partners-2022-Sustainability-Report.pdf","https://www.anderapartners.com/wp-content/uploads/2024/07/2023-Sustainability-Report-Andera-Partners.pdf","https://www.anderapartners.com/wp-content/uploads/2021/04/Responsible-Investment-Policy-Andera_2021-March.pdf","https://www.anderapartners.com/wp-content/uploads/2023/02/2023_02_24-Responsible-Investment-Policy.pdf","https://www.anderapartners.com/wp-content/uploads/2021/07/2020-Report-Climat-Sustainability-Andera-Partners.pdf","https://www.anderapartners.com/wp-content/uploads/2021/05/Providers-selection-and-evaluation-procedure_EN-for-the-website.pdf","https://www.anderapartners.com/wp-content/uploads/2021/09/Andera-Partners_The-role-of-private-equity-2.pdf","https://files.sciencebasedtargets.org/production/files/Target-language-and-summary_Andera-Partners.pdf","https://www.anderapartners.com/wp-content/uploads/2021/05/Shareholder-voting-policy_-EN-for-the-web-site.pdf"],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2024-12-31","aumAmount":"EUR 4.5 billion","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/with-2024-marked-by-aum-growth-and-dynamic-liquidity-andera-partners-pursues-its-development-in-2025-by-relying-on-its-new-partner-candriam/"},"portfolioHighlights":["Tecnikabel","Kestra Medical Technologies","SciRhom","Hydr.A","Confidential (Healthcare services in Western Europe)","Confidential (Consulting services in the United States)","Les Alchimistes Côte d’Azur","GROUPE ADF","Meogroup","Mistertemp’ group"],"researcherNotes":"AUM is based on an explicit statement from the firm as of 31 December 2024. Fund sizes are available only for specific funds: andera Infra and andera Acto. Other fund sizes are not mentioned on the site.","seniorLeadership":[{"name":"Raphaël Wisniewski","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner"},{"name":"Olivier Litzka","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner"},{"name":"Sofia Ioannidou","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner"},{"name":"Jan Van den Bossche","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner"},{"name":"Aneta Sottil","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner"},{"name":"Mathieu Piéronne","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Director"},{"name":"Yuexin Yu","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Director"},{"name":"Natali Romero Barrios","sourceUrl":"https://www.anderapartners.com/en/team","title":"Senior Investment Manager"},{"name":"Vanessa Bonvalot","sourceUrl":"https://www.anderapartners.com/en/team","title":"Executive Assistant"},{"name":"Léopold Brichard","sourceProvider":"Perplexity","sourceUrl":"https://www.anderapartners.com/en/team","title":"Partner Andera Expansion"}],"sources":{"headquarters":"https://www.anderapartners.com/en/contact/","investmentThesisFocus":"https://www.anderapartners.com/en/expertise/","investorDescription":"https://www.anderapartners.com/en/","portfolioHighlights":"https://www.anderapartners.com/en/investment-portfolio"},"websiteURL":"https://www.anderapartners.com/en/"}	Correctness: 93% Completeness: 85% The provided information about Andera Partners is largely factually correct and aligns well with authoritative sources, but with a few notable discrepancies and missing details. - **Fund Details:** - The **andera Life Sciences** fund investment size of EUR 10m to 35m, focus on therapeutic products and medical technologies, and geographic scope (Europe, US) are correct and supported by Andera’s official site describing BioDiscovery 6 as a €456 million fund investing from start-up to growth stages in these sectors and regions[5][1][3]. However, the data states "fund size: not available" for this fund, whereas, sources confirm it closed at €456 million in its latest (sixth) generation[1][2][3]. - The **andera Infra** fund size of EUR 233 million, focus on renewable energy production, sustainable mobility, and green data centres, and geographic focus on Europe/France are accurate and reflect Andera’s infra expertise[2][5]. - **andera Croissance** lacks fund size info and sector focus, which matches the available data; only an estimated investment size of EUR 3m to 10m and geographic focus on France are provided[5]. - **andera Acto** with a fund size of EUR 1,000 million devoted to mezzanine financing for resilient high-performance companies and regional focus on France and neighbors is consistent with Andera’s published details on the €1 billion mezzanine fund[5]. - **Assets Under Management (AUM):** - The provided overall AUM figure of EUR 4.5 billion as of December 31, 2024, is slightly lower than the 4.8 billion figure mentioned on the official Andera homepage (which varies over time). The 4.5 billion number appears from a specific source cited[Perplexity summary]. - **Senior Leadership:** - The listed partners and directors (e.g., Raphaël Wisniewski, Olivier Litzka, Sofia Ioannidou) align accurately with Andera's team as shown on their site[5]. - **Investment Thesis & Focus:** - The investment descriptions about hands-on support, focus on companies with growth projects and equity stakes, sectors covered by funds, and sustainable investment approach are correct and verified by Andera’s expertise pages and sustainability reports[5]. - **Portfolio Highlights:** - The mentioned companies match portfolio examples disclosed publicly, indicating a broad and active investment presence[Andera portfolio]. **Limitations & Gaps:** - The largest omission concerns the **exact fund sizes for andera Life Sciences (BioDiscovery 6)** and andera Croissance, which are either not provided or outdated in the original data but are publicly available (BioDiscovery 6 at €456 million)[1][3][5]. - The description of fund stages, sectors, and regional focus is accurate but could be enriched by explicitly noting the type of funds (e.g., BioDiscovery 6 is Article 8 SFDR classified). - AUM figures fluctuate and may be updated regularly; clarification or consistent sourcing would improve completeness. **Sources:** https://www.anderapartners.com/en/expertise/life-sciences-biotechnologies/ https://www.fiercebiotech.com/biotech/after-selling-startups-novo-and-pfizer-andera-raises-record-eu456m-latest-life-sciences https://www.bio-m.org/en/news/news-detail/andera-partners-456-million-euros-for-its-largest-life-sciences-fund.html https://www.anderapartners.com/en/expertise/andera-infra https://www.anderapartners.com/en/team
15	Alven	https://www.alven.co/	{"funds":[{"estimatedInvestmentSize":"EUR 250,000 to 15,000,000","fundName":"Alven VI","fundSize":"EUR 350,000,000","fundSizeSourceUrl":"https://alven.co/alven-raises-a-new-e350m-fund/","geographicFocus":["Europe"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["fintech","marketplaces","enterprise software","social & entertainment","crypto","developer and data tooling","climate tech"],"sourceProvider":"Perplexity","sourceUrl":"https://alven.co/alven-raises-a-new-e350m-fund/"}],"headquarters":"124 RUE RÉAUMUR, 75002 PARIS","investmentThesisFocus":["Partner with relentless entrepreneurs in Europe who aim to make lasting impacts.","Support founders through highs and lows with honesty and swift, heartfelt interactions.","Provide encouragement, inspiration, guidance, and challenge to help entrepreneurs achieve significant impact."],"investorDescription":"Alven is an independent early-stage venture capital firm founded in 2000, managing over €2 billion in funds with a track record of investing in more than 160 startups over 22 years. Its mission is to focus on tech & digital early-stage startups, with a philosophy detailed in their Manifesto and investment criteria outlined under Working with Alven. The firm concentrates on European ventures, growing through successive funds since inception.","linkedDocuments":[],"missingImportantFields":[],"overallAssetsUnderManagement":{"asOfDate":"2022","aumAmount":"EUR 2,000,000,000","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/about-alven-capital/"},"portfolioHighlights":["AKENEO","drivy","algolia","captain-train","bime","seloger","sqreen","PeopleDoc","webhelp","liligo"],"researcherNotes":"The overall assets under management figure of over €2 billion is explicitly stated on the about page with a date of 2022. The largest fund, Alven VI, has a fund size of €350 million, which is also noted as the largest early-stage fund raised in France. Investment ticket sizes range from €250,000 to 15 million per company, supporting seed and Series A stages across Europe.","seniorLeadership":[{"name":"Guillaume Aubin","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/team/","title":"Managing Partner"},{"name":"Charles Letourneur","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/team/","title":"Managing Partner"},{"name":"Rodolphe Menegaux","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/team/","title":"Partner"},{"name":"François Meteyer","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/team/","title":"Partner"},{"name":"Bartosz Jakubowski","sourceProvider":"Perplexity","sourceUrl":"https://alven.co/team/","title":"Partner"}],"sources":{"headquarters":"https://alven.co/contact/","investmentThesisFocus":"https://alven.co/manifesto/","investorDescription":"https://alven.co/about-alven-capital/","portfolioHighlights":"https://alven.co/portfolio/"},"websiteURL":"https://www.alven.co/"}	Correctness: 100% Completeness: 95% The information provided about Alven is factually accurate and well-supported by multiple reliable sources. Alven VI, their sixth fund, indeed raised €350 million, which is confirmed as the largest early-stage fund raised in France to date, with ticket sizes ranging from €250,000 to €15 million per investment[1][4][5]. The firm focuses on early-stage investments (Seed and Series A) primarily in European tech startups, consistent with the cited geographic focus[1][4]. The sector focus on fintech, marketplaces, enterprise software, social & entertainment, crypto, developer tooling, data tooling, and climate tech aligns exactly with Alven’s described multi-sector strategy[1]. The firm’s headquarters at 124 RUE RÉAUMUR, 75002 PARIS matches the official contact page[1]. The assets under management totaling over €2 billion as of 2022 is explicitly stated on their about page and corroborated by Dealroom.co data[1][4]. The investor description, senior leadership details, and portfolio highlights correspond exactly to publicly available information on Alven’s official site and trusted public databases[1][4]. The investment thesis quoted about partnering with relentless entrepreneurs, providing support through highs and lows with honesty and heart, and enabling lasting impact accurately reflects the firm’s Manifesto and philosophy stated on their website[1]. The only minor gap impacting completeness (hence 95%, not 100%) is the lack of detailed fund status from independent regulatory filings or financial reports, and no mention of specific historical performance metrics like IRR or exit multiples, which are typically confidential but relevant to complete fund evaluation. Yet, given that Alven openly shares key metrics, portfolio, and leadership, this data package is comprehensive for a public profile. Sources used: - Alven official fund announcement and about pages (https://alven.co/alven-raises-a-new-e350m-fund/, https://alven.co/about-alven-capital/) - Dealroom.co investor profile on Alven (https://app.dealroom.co/investors/alven) - Silicon Canals coverage of Alven VI fund (https://siliconcanals.com/alven-closes-sixth-fund-at-350m/) - Alven contact and manifesto pages (https://alven.co/contact/, https://alven.co/manifesto/)
16	Alumni Ventures	http://www.av.vc	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AI & Robotics Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["AI","Robotics"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"AI First Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["AI"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Blockchain & Fintech Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Blockchain","FinTech"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Deep Tech Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Deep Tech"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Healthtech Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["HealthTech"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Seed Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Seed"],"sectorFocus":["Not Available"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"U.S. Strategic Tech Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["United States"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Women’s Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Women-founded startups"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Foundation Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Multiple stages"],"sectorFocus":["Not Available"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"$10,000 - $3,000,000, typical $50,000","fundName":"CIO Select Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Follow-on investments"],"sectorFocus":["Not Available"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"Not Available","fundName":"Opportunity Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Existing portfolio companies"],"sectorFocus":["Not Available"],"sourceUrl":"http://www.av.vc/av-funds"},{"estimatedInvestmentSize":"$10,000 - $3,000,000, typical $50,000","fundName":"Apex Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Series B"],"sectorFocus":["AI","HealthTech","Consumer","Space","ClimateTech","PropTech","FinTech"],"sourceUrl":"http://www.av.vc/av-funds"}],"headquarters":"670 N. Commercial Street, Suite 403, Manchester, NH 03101","investmentThesisFocus":["Thematic venture investment strategies focused on portfolios of at least ~15-20 diversified ventures within a theme, with reserves for follow-ons.","Investment teams combine network-powered deal sourcing and evaluation with process-based decision making.","Funds invest across various sectors such as AI & Robotics, Blockchain & Fintech, Deep Tech, Healthtech, Seed stage, Sports, U.S. Strategic Tech, and Women-founded startups.","Co-investing alongside established venture firms to leverage lead investor expertise.","Diversified portfolios by sector, stage, geography, and lead investor for risk mitigation and opportunity capture."],"investorDescription":"Alumni Ventures is America's largest VC firm for individual accredited investors, offering simple, diversified access to top-tier venture deals by partnering with lead VCs and applying rigorous diligence. They invest across stages and geographies, co-investing with elite firms like Andreessen Horowitz, Sequoia, and Khosla Ventures. Alumni Ventures manages over 1,600 portfolio companies to date with a strong recognition as a Top 20 US VC Firm in 2024.","linkedDocuments":[],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2025","aumAmount":"USD 1500000000+","sourceProvider":"Perplexity","sourceUrl":"http://www.av.vc/"},"portfolioHighlights":["Bluesky","Groq","Goodles","1Up","2045 Studio","222","3X Genetics","15x","6d.ai","8base"],"researcherNotes":"AUM is not explicitly stated on the website; $1.5B+ capital raised to date is used as an inferred proxy with explanation. Fund sizes are not provided in the source.","seniorLeadership":[{"name":"Scott Klizman","sourceProvider":"Perplexity","title":"Founder & Managing Partner"},{"name":"Aaron Epstein","sourceProvider":"Perplexity","title":"Co-Founder & Managing Partner"},{"name":"Jeanette Horan","sourceProvider":"Perplexity","title":"Chief Executive Officer (CEO)"}],"sources":{"headquarters":"http://www.av.vc/","investmentThesisFocus":"http://www.av.vc/focused-funds","investorDescription":"http://www.av.vc/","portfolioHighlights":"http://www.av.vc/portfolio","seniorLeadership":"https://www.crunchbase.com/organization/alumni-ventures-group"},"websiteURL":"http://www.av.vc"}	Correctness: 100% Completeness: 85% The information about Alumni Ventures and its various funds is factually accurate according to the official Alumni Ventures website and related public sources. Specifically, the various funds named (e.g., AI & Robotics Fund, AI First Fund, Blockchain & Fintech Fund, Deep Tech Fund, Healthtech Fund, Seed Fund, U.S. Strategic Tech Fund, Women’s Fund, Foundation Fund, CIO Select Fund, Opportunity Fund, and Apex Fund) correspond to those listed on the official site at http://www.av.vc/av-funds[5]. Their sector and stage focus align correctly with publicly stated investment themes, such as thematic venture portfolios, co-investing alongside lead venture firms, and diversified sector and stage strategies[5]. The headquarters address "670 N. Commercial Street, Suite 403, Manchester, NH 03101" is also consistent with publicly available information from the official site[5]. The senior leadership named (Scott Klizman, Aaron Epstein, Jeanette Horan) matches data confirmed from Crunchbase and Alumni Ventures sources[5]. The overall assets under management (AUM) figure of USD 1.5 billion+ is reasonable as an inferred proxy from stated capital raised to date but is not explicitly published as AUM on the website, which is transparently noted in the researcher notes. Estimated investment sizes and fund sizes are mostly indicated as "Not Available," consistent with the publicly available data on the website where exact fund sizes are not disclosed[5]. The investment thesis and portfolio highlights given also align accurately with information found at the official sources[5]. The completeness score is somewhat lowered because the explicit fund sizes are missing—which is noted in the source—and certain geographic and stage details remain "Not Available" in the data provided by Alumni Ventures. This is a significant gap given that many venture capital profiles include these details. Additionally, AUM is inferred rather than explicitly stated, so while it is likely accurate, it is not confirmed from a direct source. However, these limitations reflect transparency about missing data, not inaccuracy. No hallucinated or fabricated information was detected; all claims are traceable to primary official sources. Sources: - Alumni Ventures official site funds page: http://www.av.vc/av-funds - Alumni Ventures homepage and fund descriptions: http://www.av.vc/ - Senior leadership info from Crunchbase: https://www.crunchbase.com/organization/alumni-ventures-group
17	ALSTIN Family GmbH	https://www.alstin1.de/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ALSTIN I","fundSize":"Fully exited, original fund size not publicly disclosed","fundSizeSourceUrl":"https://tech.eu/2024/12/02/alstin-fund-secures-175m-for-series-a-b2b-saas/","geographicFocus":["Not Available"],"investmentStageFocus":["Exited"],"sectorFocus":["Startups","Growth financing","Sales and growth expertise"],"sourceProvider":"Perplexity","sourceUrl":"https://www.alstin1.de/#about"},{"estimatedInvestmentSize":"EUR 2-8 million","fundName":"ALSTIN Capital","fundSize":"108,000,000","fundSizeSourceUrl":"https://www.eu-startups.com/2024/12/munich-based-alstin-capital-raises-e175-million-for-alstin-iii-fund-to-fuel-european-b2b-software-growth/","geographicFocus":["Europe"],"investmentStageFocus":["Late Seed","Series A","Series B"],"sectorFocus":["FinTech","InsurTech","RegTech","Cyber Security","ClimateTech","B2B software"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://alstincapital.de"},{"estimatedInvestmentSize":"EUR 750,000-1,500,000","fundName":"seed+speed Ventures","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Seed"],"sectorFocus":["Startups","Early stage investments"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://seedandspeed.com/de/"},{"estimatedInvestmentSize":"EUR 2-7 million","fundName":"ALSTIN III","fundSize":"175,000,000","fundSizeSourceUrl":"https://www.eu-startups.com/2024/12/munich-based-alstin-capital-raises-e175-million-for-alstin-iii-fund-to-fuel-european-b2b-software-growth/","geographicFocus":["Europe"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["B2B software","European technology"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.eu-startups.com/2024/12/munich-based-alstin-capital-raises-e175-million-for-alstin-iii-fund-to-fuel-european-b2b-software-growth/"}],"headquarters":"Lister Straße 6, D-30163 Hannover, Germany","investmentThesisFocus":["Focus on startups with outstanding teams.","Support innovative business ideas.","Provide dynamic growth financing.","Leverage unique sales expertise to drive success.","Invest in European B2B software companies at Seed and Series A stages."],"investorDescription":"ALSTIN I is the first VC investment company by Carsten Maschmeyer, active since 2017, supporting its portfolio with unique sales expertise to drive revenue, growth, and success. Growth financing for startups with outstanding teams, innovative business ideas, and dynamic growth. The firm supports intelligent growth capital with follow-up funds ALSTIN Capital and seed+speed Ventures for early and later stage investments.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":"Approximately EUR 283 million across ALSTIN II and ALSTIN III funds as of 2024, with ALSTIN III alone raised at EUR 175 million in 2024","portfolioHighlights":["Contentbird","Crealytics","Blacklane"],"researcherNotes":"The overall Assets Under Management (AUM) figure is not explicitly mentioned on official company websites. Based on public reports, ALSTIN Capital's funds ALSTIN II and ALSTIN III raise over EUR 283 million combined, with ALSTIN III alone raising EUR 175 million in 2024. Fund sizes were taken from external credible news sources. ALSTIN I fund is fully exited and no current investment size is available.","seniorLeadership":[{"name":"Dr. h.c. Carsten Maschmeyer","sourceProvider":"Perplexity","sourceUrl":"https://www.hmnc-brainhealth.com/team/carsten-maschmeyer","title":"Founder, Managing Partner"},{"name":"Dr. Klaus Schieble","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alstin1.de/#team","title":"Senior Leadership"},{"name":"Dr. Michael Tröger","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alstin1.de/#team","title":"Senior Leadership"}],"sources":{"headquarters":"https://www.alstin1.de/#contact","investmentThesisFocus":"https://www.alstin1.de/#about","investorDescription":"https://www.alstin1.de/#about","portfolioHighlights":"https://alstin1.de/#portfolio"},"websiteURL":"https://www.alstin1.de/"}	Correctness: 95% Completeness: 90% The information presented is factually accurate and well supported by credible news sources and official websites for ALSTIN Capital and related funds. Key data points such as the €175 million fund size for ALSTIN III raised in 2024, investment stages (Seed, Series A, and B), geographic focus on Europe (especially DACH region), and sector emphasis on B2B software and technology are confirmed by multiple sources including Tech.eu and EU-Startups[1][2]. The founding figure Carsten Maschmeyer as Managing Partner and the description of ALSTIN I as fully exited and less disclosed also aligns with available reports[1][3]. Fund sizes for ALSTIN III and ALSTIN Capital overall are consistent with external reporting, and investment ticket sizes (€2-8 million) correspond well to stated ranges. However, the completeness score is slightly reduced due to some missing common fields such as explicit total Assets Under Management (AUM) consolidated on the official website, although approximate figures like €283 million AUM combining ALSTIN II and III funds are noted from news articles[1][2]. Geographic focus for some funds is unspecified, and more detailed portfolio examples exist publicly than just the three companies listed (Contentbird, Crealytics, Blacklane). Also, some early-stage funds like seed+speed Ventures have incomplete fund size data publicly available. The senior leadership names given are accurate per the official site, although without extensive detail. Overall, the data reflects a reliable and fairly complete picture of ALSTIN’s investment funds, structure, and focus areas as known from public disclosures and reputable journalistic sources. Sources: - https://tech.eu/2024/12/02/alstin-fund-secures-175m-for-series-a-b2b-saas/ - https://www.eu-startups.com/2024/12/munich-based-alstin-capital-raises-e175-million-for-alstin-iii-fund-to-fuel-european-b2b-software-growth/ - https://alstin.capital - https://www.alstin1.de/#about
18	Alpha Edison	http://www.alphaedison.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alpha Edison Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["United States"],"investmentStageFocus":["Early-Stage"],"sectorFocus":["Technology"],"sourceProvider":"Perplexity","sourceUrl":"http://www.alphaedison.com/"}],"headquarters":"1025 Westwood Blvd, Floor 2, Los Angeles, CA 90024","investmentThesisFocus":["Partners with entrepreneurs to build companies that unlock new markets.","Focuses on early-stage technology ventures.","Targets markets where behaviors are shifting to unlock latent demand."],"investorDescription":"Alpha Edison is an investment firm that partners with entrepreneurs to build companies that unlock new markets, focusing on early-stage technology ventures that unlock latent demand where behaviors are shifting. Their portfolio includes companies like Bambee, DISQO, Greenfly, Kin Insurance, Red6, and Upwards. The team consists of investors, founders, operators, data scientists, and behavioral scientists.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["3DEO","Afero","Alloy","Alto IRA","Assembly","AutoIVF","Avibra","Bambee","BuildOps","CABA Design"],"researcherNotes":"No specific AUM, fund size, or estimated investment size data found on the website or external sources. Geographic focus inferred as United States based on presence and investments.","seniorLeadership":[{"name":"Nick Grouf","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Co-Founder and Co-Managing Partner"},{"name":"Steve Horowitz","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Managing Partner"},{"name":"Angela Jones","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Partner"},{"name":"Tara Nikkhoo","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Partner"},{"name":"Upendra Shardanand","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Partner"},{"name":"Robey Miller","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Chief Financial Officer"},{"name":"Jami Hunt","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Head of Investor Relations & Business Development"},{"name":"Nate Redmond","sourceProvider":"Perplexity","sourceUrl":"http://alphaedison.com/team","title":"Co-Founder and Co-Managing Partner"}],"sources":{"headquarters":"http://www.alphaedison.com/contact","investmentThesisFocus":"http://www.alphaedison.com/","investorDescription":"http://www.alphaedison.com/","portfolioHighlights":"http://www.alphaedison.com/portfolio"},"websiteURL":"http://www.alphaedison.com/"}	Correctness: 95% Completeness: 85% The information is largely factually accurate and well-aligned with multiple authoritative sources. The headquarters at 1025 Westwood Blvd, Floor 2, Los Angeles, CA 90024 is consistently confirmed by ZoomInfo, SWFI, Private Equity International, and the official Alpha Edison website[1][2][3][4]. The description of Alpha Edison as an early-stage investment firm partnering with entrepreneurs to build companies that unlock new markets, primarily in technology sectors and focusing on latent demand driven by shifting behaviors, matches the investor's own website and third-party summaries[1][4]. The senior leadership team listed (Nick Grouf, Steve Horowitz, Angela Jones, Tara Nikkhoo, Upendra Shardanand, Robey Miller, Jami Hunt, and Nate Redmond) reflects those named on the official Alpha Edison team page, with accurate titles[4][5]. Portfolio highlights including companies like Bambee, DISQO, Greenfly, Kin Insurance, Red6, Upwards, and others such as 3DEO, Afero, Alloy, and Alto IRA are publicly referenced on the firm's portfolio page and contemporaneous profiles[4]. However, there is no publicly disclosed figure for Assets Under Management (AUM), estimated investment size, or fund size, which the data correctly identifies as missing and unreported in Alpha Edison’s public materials[2]. The geographic focus inferred as United States and early-stage investment stage are consistent with the portfolio and stated focus but not explicitly quantified in public documents, which slightly reduces completeness[1][4]. Additional minor portfolio or strategy details beyond those given could enhance the profile completeness. Overall, the core factual data is solid, with key aspects verified via multiple reliable sources: - Alpha Edison website: http://www.alphaedison.com/ - ZoomInfo company profile: https://www.zoominfo.com/c/alpha-edison/445575530 - Private Equity International profile: https://www.privateequityinternational.com/institution-profiles/alpha-edison.html - SWFI profile: https://www.swfinstitute.org/profile/5e39a505fcbe7e8ca71ee6e8 No fabricated or incorrect details were found, but the absence of AUM and fund size data is a notable omission impacting completeness.
19	Almi Invest	https://www.almi.se/en/venture-capital/	""
20	Alsop Louie Partners	https://www.alsop-louie.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alsop Louie Partners Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["new media","gaming","SaaS","cloud infrastructure","security","mobile"],"sourceProvider":"Source JSON","sourceUrl":"https://www.alsop-louie.com/focus"}],"headquarters":"943 Howard Street, San Francisco, CA 94103","investmentThesisFocus":["Risk capital targeting entrepreneurs with bold ideas and big dreams.","Focus on new technologies and business models where no market presently exists.","Invest in companies with breakthroughs to reshape the status quo.","Preference for hard technologies tackling tough problems.","Cautious approach to trends like generative AI; AI is viewed as an enhancement tool.","Belief in investing with a human-centered approach and doing good while making money."],"investorDescription":"Alsop Louie Partners is a venture capital firm practicing 'Venture Humanism,' an investment thesis that emphasizes building a future based on prosperity, equality, and longevity through accountable, safeguarded advanced technologies. The firm believes in creating value by investing in technologies that do good for the world and support civil society, rather than benefiting a select few. Their investment strategy focuses on being active builders of the future rather than passive investors.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Meow Wolf","Niantic","Aerospike","Ascent Technologies","Aurora Insight","Baton Systems","Cleversafe","Copilot Labs","Crunchy Data"],"researcherNotes":"Overall Assets Under Management (AUM) and specific fund sizes or estimated investment sizes are not mentioned on the website. The firm appears to raise smaller funds, but no explicit amounts or ranges are provided.","seniorLeadership":[{"name":"Gilman Louie","sourceUrl":"https://www.alsop-louie.com/team/gilman-louie","title":"Partner"},{"name":"Nancy Lee","sourceUrl":"https://www.alsop-louie.com/team/nancy-lee","title":"Partner"},{"name":"Stewart Alsop","sourceUrl":"https://www.alsop-louie.com/team/stewart-alsop","title":"Partner"},{"name":"Jim Whims","sourceUrl":"https://www.alsop-louie.com/team/jim-whims","title":"Partner"},{"name":"Joe Addiego","sourceUrl":"https://www.alsop-louie.com/team/joe-addiego","title":"Partner"},{"name":"Bill Crowell","sourceUrl":"https://www.alsop-louie.com/team/bill-crowell","title":"Partner"},{"name":"Mark Fields","sourceUrl":"https://www.alsop-louie.com/team/mark-fields","title":"Partner"},{"name":"Will Jack","sourceUrl":"https://www.alsop-louie.com/team/will-jack","title":"Partner"},{"name":"Jason Preston","sourceUrl":"https://www.alsop-louie.com/team/jason-preston","title":"Partner"},{"name":"Jim Ward","sourceUrl":"https://www.alsop-louie.com/team/jim-ward","title":"Venture Partner"},{"name":"Joe Alsop","sourceUrl":"https://www.alsop-louie.com/team/joe-alsop","title":"Partner"},{"name":"John Dillon","sourceUrl":"https://www.alsop-louie.com/team/john-dillon","title":"Partner"},{"name":"Ernestine Fu Mak","sourceProvider":"Perplexity","sourceUrl":"https://www.alsop-louie.com/team/ernestine-fu-vp","title":"Venture Partner"},{"name":"Tom Kalinske","sourceUrl":"https://www.alsop-louie.com/team/tom-kalinske","title":"Partner"},{"name":"Parker Ruth","sourceUrl":"https://www.alsop-louie.com/team/parker-ruth","title":"Partner"},{"name":"Shiaoching (Ching) Tse","sourceUrl":"https://www.alsop-louie.com/team/shiaoching-ching-tse","title":"Partner"}],"sources":{"headquarters":"https://www.alsop-louie.com/contact","investmentThesisFocus":"https://www.alsop-louie.com/focus","investorDescription":"https://www.alsop-louie.com/","portfolioHighlights":"https://www.alsop-louie.com/portfolio"},"websiteURL":"https://www.alsop-louie.com"}	Correctness: 98% Completeness: 85% The information provided is largely factually accurate according to multiple publicly available sources. Alsop Louie Partners is a San Francisco–based venture capital firm with an investment philosophy called "Venture Humanism," emphasizing investing in advanced, accountable technologies that do good for the world, while enabling prosperity and equality[2]. Their sector focus includes new media, gaming, SaaS, cloud infrastructure, security, and mobile, fully consistent with the source website[2]. The firm’s investment thesis highlights risk capital targeting bold entrepreneurs, focusing on new technologies and business models without existing markets, and cautiously approaching trends like generative AI—viewed as an enhancement tool rather than a fundamental shift[2]. The list of portfolio companies (e.g., Niantic, Meow Wolf, Aerospike) aligns with the firm’s public portfolio[2]. The address given (943 Howard Street, San Francisco) matches the contact page for Alsop Louie Partners[2][source URL]. The named senior leadership members correspond to those listed on their website team pages. The primary limitations relate to missing financial details: overall Assets Under Management (AUM), specific fund sizes, and estimated investment sizes are not publicly disclosed on the official site or other reputable venture databases[2]. This reduces completeness since these are significant details typically expected in a fund summary. Additionally, geographic and stage focus data are not explicitly detailed on the website or available sources, hence their "Not Available" status is reasonable. No contradictory information was found. The campaign finance data from OpenSecrets[1] about political contributions by "Alsop Louie Partners" does not pertain to the venture firm’s investment operations and thus does not affect the accuracy of the investment-related facts. In summary, the core factual content about the firm’s philosophy, sector and portfolio focus, leadership, and location is accurate and well-supported by the official site and related sources[2]. The incompleteness is due to the absence of crucial fund size and AUM data, which is simply not publicly disclosed rather than incorrect. Sources used: - Alsop Louie Partners official website (https://www.alsop-louie.com) - Alsop Louie Partners contact page (https://www.alsop-louie.com/contact) - OpenSecrets summary of Alsop Louie Partners (https://www.opensecrets.org/orgs/alsop-louie-partners/summary?id=D000031435)
21	Alpha Wave Global	https://www.alphawaveglobal.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alpha Wave Global Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Growth Stage"],"sectorFocus":["Not Available"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alphawaveglobal.com/"}],"headquarters":"Miami, USA; New York, USA; London, UK; Monaco; Madrid, Spain; Abu Dhabi, UAE; Tel Aviv, Israel; Bangalore, India; Mumbai, India; Sydney, Australia","investmentThesisFocus":["Invest in best-in-class growth-stage companies.","Be helpful, long-term partners to founders and management.","Seek to generate current income via private, senior secured, floating rate loans.","Focus on uncorrelated return streams centered on special situations in public markets."],"investorDescription":"Alpha Wave is a global investment company founded in 2012 with three main verticals: private equity, private credit, and public markets. In private markets, their objective is to invest in best-in-class growth-stage companies and be helpful, long-term partners to founders and management. In credit, they seek to generate current income via private, senior secured, floating rate loans for companies requiring funding. In public markets, they aim to create uncorrelated return streams focused on special situations. The company is led by Rick Gerson, Navroz Udwadia, and Ryan Khoury, with offices globally.","linkedDocuments":[],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2021-12-07","aumAmount":"USD 10000000000","sourceUrl":"https://techcrunch.com/2021/12/07/falcon-edge-closes-first-tranche-of-10b-fund-rebrands-as-alpha-wave-global/"},"portfolioHighlights":["Haldiram's","OFBusiness","Lenskart","Absolute Foods","Acesion Pharma","AgNext","Animo Brands","Moglix"],"researcherNotes":"AUM is inferred from a 2021 news article stating the new fund of $10 billion will push total AUM over $15 billion. No explicit current AUM figure found on the official site.","seniorLeadership":[{"name":"Rick Gerson","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alphawaveglobal.com/team/rick-gerson","title":"Founder, Chairman, and Chief Investment Officer"},{"name":"Navroz D. Udwadia","sourceProvider":"Perplexity","sourceUrl":"https://radientanalytics.com/firm/adv/alpha-wave-global-lp-160894","title":"Co-Founder and Managing Partner"},{"name":"Ryan Khoury","sourceProvider":"Perplexity","sourceUrl":"https://radientanalytics.com/firm/adv/alpha-wave-global-lp-160894","title":"Co-Founder and Managing Partner"},{"name":"Ravi Thakran","sourceProvider":"Perplexity","sourceUrl":"https://www.alphawaveglobal.com","title":"Managing Partner"},{"name":"Matthew Corey","sourceProvider":"Perplexity","sourceUrl":"https://www.alphawaveglobal.com","title":"Co-Chief Investment Officer"},{"name":"Cathy Weist","sourceProvider":"Perplexity","sourceUrl":"https://www.alphawaveglobal.com","title":"Chief Financial Officer"}],"sources":{"headquarters":"https://www.alphawaveglobal.com/#footer","investmentThesisFocus":"https://www.alphawaveglobal.com/","investorDescription":"https://www.alphawaveglobal.com/","portfolioHighlights":"https://alphawaveglobal.com/businesses/ventures-incubation","seniorLeadership":"https://radientanalytics.com/firm/adv/alpha-wave-global-lp-160894|https://www.alphawaveglobal.com"},"websiteURL":"https://www.alphawaveglobal.com/"}	Correctness: 98% Completeness: 90% The provided information is factually accurate and well-supported by multiple sources. Alpha Wave Global was indeed founded in 2012 as Falcon Edge Capital and rebranded, with headquarters and offices in Miami, New York, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, Mumbai, and Sydney consistent with official company data[3][4][5]. Their investment thesis accurately reflects three main verticals: private equity (focusing on best-in-class growth-stage companies and long-term partnerships with founders), private credit (senior secured, floating rate loans), and public markets (uncorrelated special situations), as detailed on their official website and team pages[3][4]. The senior leadership named (Rick Gerson, Navroz Udwadia, Ryan Khoury, Ravi Thakran, Matthew Corey, Cathy Weist) matches official sources[3][4]. The portfolio companies listed (Haldiram's, OFBusiness, Lenskart, Absolute Foods, Acesion Pharma, AgNext, Animo Brands, Moglix) also align with publicly disclosed investments[4]. The overall assets under management (AUM) figure of USD 10 billion as of December 2021 is supported by a TechCrunch report noting a $10 billion fund close that pushed total AUM over $15 billion; the exact current AUM is not explicitly confirmed on the official site, which justifies the researcher’s note on inferred AUM[4]. The fund size was marked “Not Available,” reflecting public data gaps since detailed fund size disclosures are limited in public domain[2]. The main incompleteness is the absence of explicit fund size details and sector focus, as publicly available sources seldom provide fine-grained fund-by-fund data or sector specialization beyond general statements of growth stage and global approach. The description could also mention the firm’s original name (Falcon Edge Capital) for completeness and historical context. Sources: - Alpha Wave Global official site, team, and about pages: https://www.alphawaveglobal.com/ and https://www.alphawaveglobal.com/team/rick-gerson[3][4] - Private Equity International overview: https://www.privateequityinternational.com/institution-profiles/alpha-wave-global.html[2] - TechCrunch regarding AUM: https://techcrunch.com/2021/12/07/falcon-edge-closes-first-tranche-of-10b-fund-rebrands-as-alpha-wave-global/[4] - TTR Data address confirmation: https://www.ttrdata.com/en/entity/Alpha-Wave-Global/216997/[1] - Preqin firm description (limited data): https://www.preqin.com/data/profile/fund-manager/alpha-wave-global/73939[5]
22	Alstin Capital	https://alstin.capital/	{"funds":[{"estimatedInvestmentSize":"EUR 2-8 million","fundName":"Alstin Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Late Seed","Series A"],"sectorFocus":["B2B software","FinTech","InsurTech","RegTech","Cyber Security","ClimateTech"],"sourceProvider":"Perplexity","sourceUrl":"https://alstin.capital/about-us"}],"headquarters":"Maximilianstrasse 34, 80539 Munich","investmentThesisFocus":["All-in commitment pre- and especially post-investment","Comprehensive coaching in sales","PR & marketing support","Scaling strategies including internationalization and customer segment expansion","Leveraging network for financing rounds, customers, references, partners, and talents"],"investorDescription":"ALSTIN is a capital provider that goes 'All-in' with its founders, offering capital, know-how, and network support. Alstin Capital is a Munich-based early-stage venture capital fund focused on B2B software. They invest in fast-growing Late Seed and Series A B2B software companies across Europe. Their investment thesis includes 'All-in commitment' pre- and especially post-investment, offering comprehensive coaching in sales, PR & marketing support, scaling strategies including internationalization and customer segment expansion, and leveraging their network for financing rounds, customers, references, partners, and talents.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Deskbird","Norbr","FLOWIT","Quivo","Retraced","Circula","Pliant","Razor Group","Klarna","Usercentrics"],"researcherNotes":"AUM and explicit fund sizes are not mentioned on the website or linked documents. The estimated investment size was found in the About Us page. No formal fund names were listed, so the default fund name was used.","seniorLeadership":[{"name":"Carsten Maschmeyer","sourceProvider":"Perplexity","sourceUrl":"https://alstin.capital/team","title":"Managing Partner"},{"name":"Dr. Andreas Schenk","sourceProvider":"Perplexity","sourceUrl":"https://alstin.capital/team","title":"Partner"}],"sources":{"headquarters":"https://alstin.capital/contact","investmentThesisFocus":"https://alstin.capital/about-us","investorDescription":"https://alstin.capital/about-us","portfolioHighlights":"https://alstin.capital/portfolio"},"websiteURL":"https://alstin.capital/"}	Correctness: 95% Completeness: 85% The provided information about Alstin Capital is largely accurate and well supported by reliable sources. The headquarters at Maximilianstrasse 34, 80539 Munich, Germany, is confirmed by multiple sources including their official contact page and business directories[1][2][5]. The fund's focus on B2B software, FinTech, InsurTech, RegTech, Cyber Security, and ClimateTech sectors, and investment stages of Late Seed and Series A are aligned with descriptions on their website and third-party profiles[1][3]. The investment thesis emphasizing all-in commitment, sales coaching, PR & marketing support, scaling strategies, and leveraging networks is also directly reflected on their official About Us page and corroborated by third-party summaries[1][5]. Senior leadership naming Carsten Maschmeyer as Managing Partner and Dr. Andreas Schenk as Partner is consistent with their team page[5]. However, the absence of explicit overall Assets Under Management (AUM) and formal fund sizes on public pages means the estimated investment size (EUR 2-8 million) is the best available proxy, but the overall fund size remains unspecified, leading to a lower completeness score[1][4]. Furthermore, the portfolio highlights listed (e.g., Deskbird, Norbr, FLOWIT, Klarna, Usercentrics) are consistent with public mentions, but no exhaustive official portfolio list is found, suggesting partial completeness[1]. The researcher note about no formal fund names listed matches the publicly available data[1][4]. Some variations exist in employee numbers across sources but do not materially affect the core investor descriptions. In summary, the facts about location, sectors, investment stage, thesis, leadership, and characteristics of Alstin Capital are accurate and supported by official and authoritative sources. The key missing elements are formal fund sizes, total AUM, and a fully confirmed comprehensive portfolio list, which are typically less disclosed in early-stage venture capital firms and hence reduce completeness somewhat. Sources: https://alstin.capital/contact https://alstin.capital/about-us https://alstin.capital/portfolio https://www.zoominfo.com/c/alstin-capital/481454784 https://ecosystem.panoramicapr.com/investors/alstin_capital_1 https://www.privateequityinternational.com/institution-profiles/alstin-capital.html
23	Alter Equity 3P	http://www.alter-equity.com/	{"funds":[{"estimatedInvestmentSize":"EUR 4,000,000 to 20,000,000","fundName":"Alter Equity Fund III","fundSize":"EUR 85,000,000","fundSizeSourceUrl":"https://www.alter-equity.com/","geographicFocus":["Europe"],"investmentStageFocus":["Growth","Minority and majority investments"],"sectorFocus":["Energy efficiency","Circular economy","Green chemistry","Education","Health","Fair trade","Socially responsible finance"],"sourceUrl":"https://www.alter-equity.com/"}],"headquarters":"23 Rue Danielle Casanova, 75001 Paris, France","investmentThesisFocus":["Invest in companies with strong extra-financial business plans.","Focus on fostering social, environmental, and societal responsibility.","Investments are chosen with respect to positive environmental or social impact.","Support startups enabling transition to an inclusive and sustainable economy."],"investorDescription":"Alter Equity, a French investment fund founded in 2007, is a pioneer in financing startups with social and/or environmental impact. It supports startups enabling the transition to an inclusive and sustainable economy with strong positive environmental or social impact. The firm's focus areas include energy efficiency, circular economy, green chemistry, education, health, fair trade, and socially responsible finance. Alter Equity invests in companies with strong extra-financial business plans fostering social, environmental, and societal responsibility.","linkedDocuments":["https://franceinvest.eu/wp-content/uploads/2024/07/Etude-sur-la-parite-dans-le-capital-investissement_2024_VDEF.pdf"],"missingImportantFields":[],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"EUR 85,000,000","sourceUrl":"https://www.alter-equity.com/"},"portfolioHighlights":["Montamo","Syroco","Circletea","Everysens","Neobrain","Zenride","Beem","Imparfaite","MiiMO","SAMurfy","ilek","Gojob","Kipli","Les Ripeurs","Behring","Ikigai Education"],"researcherNotes":"AUM and fund size info is based on the closing of the third fund at 85 million euros explicitly stated on the homepage and related pages. Headquarters address is not available from the website or the contact page.","seniorLeadership":[{"name":"Fanny Picard","sourceUrl":"https://www.alter-equity.com/","title":"President"},{"name":"Fanny Picard","sourceProvider":"LinkedIn","sourceUrl":"https://fr.linkedin.com/company/alter-equity","title":"Founder & CEO"},{"name":"Virginia de Guillebon","sourceProvider":"LinkedIn","sourceUrl":"https://fr.linkedin.com/company/alter-equity","title":"Senior Leadership"},{"name":"Félix Mounier","sourceProvider":"LinkedIn","sourceUrl":"https://fr.linkedin.com/company/alter-equity","title":"Senior Leadership"}],"sources":{"headquarters":"https://beyondthebillion.com/our-partners/alter-equity/","investmentThesisFocus":"https://www.alter-equity.com/","investorDescription":"https://www.alter-equity.com/","portfolioHighlights":"https://www.alter-equity.com/participations"},"websiteURL":"http://www.alter-equity.com/"}	Correctness: 95% Completeness: 90% The provided information about Alter Equity Fund III, its investment size range (EUR 4M to 20M), fund size (EUR 85M), geographic focus on Europe, sectors, investment thesis, investor description, portfolio highlights, and senior leadership align closely with publicly available data. Alter Equity is indeed a French impact investment fund focusing on companies with positive social and environmental impact, investing mainly in energy efficiency, circular economy, green chemistry, education, health, fair trade, and socially responsible finance sectors[1][2][5]. The fund size of approximately EUR 85 million matches the stated size of the third fund as seen on the official website and other summaries. The headquarters address "23 Rue Danielle Casanova, 75001 Paris, France" is confirmed by a partner directory source but is not explicitly listed on the company’s own contact page, so there is some external validation but minor uncertainty remains[1]. The investment thesis emphasizing extra-financial business plans and fostering social, environmental, and societal responsibility is accurately described on Alter Equity’s homepage and impact pages[2][5]. Senior leadership details with Fanny Picard as Founder, CEO, and President, and Félix Mounier included in senior leadership, are consistent with LinkedIn and company sources[1]. Portfolio company names such as Montamo, Syroco, Everysens, Neobrain, and others also correspond to listed participations. The only minor limitation affecting completeness is the absence of the exact "As of" date for Assets Under Management (AUM) and some confirmation details about the current size of assets or funds in market besides Fund III closure, but this does not critically affect the overall factual completeness of the profile[3]. Sources: - Alter Equity official website and portfolio pages (https://www.alter-equity.com/) - OpenVC profile confirming headquarters, investment focus, leadership (https://www.openvc.app/fund/Alter%20Equity) - Impact Europe profile outlining investment thesis and sectors (https://www.impacteurope.net/members/alter-equity) - Private Equity International institution profile (https://www.privateequityinternational.com/institution-profiles/alter-equity.html)
24	Alta Park Capital	https://www.altaparkcapital.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alta Park Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Growth Stage"],"sectorFocus":["Technology","Media","Telecommunications"],"sourceProvider":"Original SOURCE_JSON","sourceUrl":"https://www.altaparkcapital.com/"}],"headquarters":"San Francisco, USA; New York, USA","investmentThesisFocus":["Identifying emerging themes of innovation in technology","Developing a holistic understanding of technology trends across public and private companies","Focusing on growth-stage private companies globally","Targeting emerging category leaders in application software, infrastructure software, and fintech","Using deep fundamental research to identify consequential trends, markets, and companies globally in the technology sector"],"investorDescription":"Alta Park Capital is an investment firm focused on public and private companies in the global technology, media, and telecommunications sectors. Their investment strategy involves identifying emerging themes of innovation in technology and developing a holistic understanding of these trends across public and private companies. The founders have a combined 70+ years of technology investing experience. Public equity strategy since 2013 uses deep fundamental research to identify consequential trends, markets, and companies globally in the technology sector. Growth equity investments since 2015 focus on growth-stage private companies globally, targeting emerging category leaders in application software, infrastructure software, and fintech.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize","portfolioHighlights"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"AUM is not mentioned on the website or related sources. No formal funds or specific investment size details provided. Headquarters are mentioned as cities only based on contact info and footer.","seniorLeadership":[{"name":"Ray Zhu","sourceProvider":"Original SOURCE_JSON","sourceUrl":"https://www.zoominfo.com/pic/alta-park-capital/374940191","title":"Managing Director"},{"name":"Kevin Sun","sourceProvider":"Original SOURCE_JSON","sourceUrl":"https://www.zoominfo.com/pic/alta-park-capital/374940191","title":"Managing Director"},{"name":"Carson Fullard","sourceProvider":"Original SOURCE_JSON","sourceUrl":"https://www.zoominfo.com/pic/alta-park-capital/374940191","title":"Head Managing Director, Private Investments"},{"name":"Scott McWilliams","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/alta-park-capital","title":"Director of Capital Formation and Investor Relations"},{"name":"Rene N.","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/alta-park-capital","title":"Chief Operating Officer"},{"name":"Kai Wang","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/alta-park-capital","title":"Managing Director"}],"sources":{"headquarters":"https://www.altaparkcapital.com/","investmentThesisFocus":"https://www.altaparkcapital.com/","investorDescription":"https://www.altaparkcapital.com/","portfolioHighlights":"https://www.altaparkcapital.com/"},"websiteURL":"https://www.altaparkcapital.com"}	Correctness: 95% Completeness: 80% The provided summary about Alta Park Capital is largely factually accurate based on multiple sources. It correctly identifies Alta Park Capital as an investment firm focused on the global technology, media, and telecommunications sectors, with strategies targeting growth-stage private companies as well as public equities using deep fundamental research. The description of the firm’s investment theses, geographic focus (global), sector focus, and senior leadership names and roles align with publicly available information[4][1][3]. The stated headquarters in San Francisco and New York corresponds to contact information found on their official website, consistent with research notes provided but is not formally detailed in external filings[4]. Their founding in 2013 and emphasis on 70+ years combined experience also matches[4]. However, the completeness is limited. Public filings indicate the firm manages over $1.3 billion to $1.7 billion in assets under management (AUM), which is a critical metric missing from the original data provided (noted as null/missing)[3][4]. Additionally, specific fund size details or estimated investment sizes are not publicly stated, which matches the “Not Available” fields flagged. Portfolio highlights are lacking; external sources list substantial portfolio holdings worth hundreds of millions, including companies like Amazon, Netflix, and others[1][2][4]. Senior leadership listed partially overlaps with publicly known founders and partners (e.g., Bijan Modanlou, Joe Bou-Saba not mentioned in the original data but documented as founders/partners)[4]. The original data lists managing directors and other executives, consistent with sources but without full leadership disclosure. In sum, the factual details given are mostly correct, but important financial metrics (AUM), portfolio specifics, and some leadership information are missing or incomplete, resulting in the lowered completeness score. Sources: - Alta Park Capital official website (https://www.altaparkcapital.com/) - InsiderMonkey Hedge Fund Profile (https://www.insidermonkey.com/hedge-fund/alta+park+capital/849/) - RADiENT Analytics Form ADV (https://radientanalytics.com/firm/adv/alta-park-capital-lp-169422) - Fintel Portfolio Holdings (https://fintel.io/i/alta-park-capital-lp) - Stockzoa 13F Data (https://stockzoa.com/fund/alta-park-capital/)
25	Alto Invest	http://www.altoinvest.fr	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Eiffel Investment Group Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Not Available"],"sectorFocus":["Small and medium-sized enterprises","Technology","Healthcare","Manufacturing"],"sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.altoinvest.fr"}],"headquarters":"Paris, France","investmentThesisFocus":["Focuses on providing long-term financing solutions to SMEs with growth potential.","Aiming for sustainable development and value creation."],"investorDescription":"Eiffel Investment Group is an independent asset management company based in Paris, specializing in private debt and equity investments in small and medium-sized enterprises (SMEs). Eiffel Investment Group is a diversified investment company supporting innovative and high-potential companies. Focuses on providing long-term financing solutions to SMEs with growth potential, aiming for sustainable development and value creation.","linkedDocuments":[],"missingImportantFields":["portfolioHighlights","seniorLeadership","linkedDocuments","fundSize"],"overallAssetsUnderManagement":"€4 billion (as of end 2021)","portfolioHighlights":[],"researcherNotes":"AUM and specific fund details including size and investment ticket size are not mentioned on the website. Senior leadership names and titles are also not provided.","seniorLeadership":[],"sources":{"headquarters":"http://www.altoinvest.fr","investmentThesisFocus":"http://www.altoinvest.fr","investorDescription":"http://www.altoinvest.fr","overallAssetsUnderManagement":"https://finalscout.com/company/eiffel_investment_group","portfolioHighlights":"http://altoinvest.fr/investissements"},"websiteURL":"http://www.altoinvest.fr"}	Correctness: 85% Completeness: 70% The provided data about Eiffel Investment Group is largely factually accurate but contains some inconsistencies related to the headquarters address and total assets under management (AUM). The investment thesis, focus on SMEs, and strategy pertaining to private debt and equity align with publicly available information[1][5]. The description as an independent Paris-based asset manager specializing in SME financing and growth also matches external sources. However, the stated headquarters as "Paris, France" is correct in general but incomplete—authoritative sources specify the office address as **22 rue de Marignan, 75008 Paris**, not just "Paris" or "9 Rue Euler"[2][3][4]. The source URL given (http://www.altoinvest.fr) relates to Alto Invest, an equity subsidiary of Eiffel Investment Group, rather than the main group’s website, which is https://www.eiffel-ig.com/; this could cause confusion. Regarding AUM, the claim of **€4 billion as of end 2021** is higher than some other sources reporting around €1.5 to €3 billion, with one source citing €3 billion+ under management[1][5]. This score reflects some ambiguity and lack of official recent data publicly available. Also, important completeness gaps exist as the fund size, estimated investment size, portfolio highlights, senior leadership names, and linked documents are missing in the data, which appear accessible or partially referenced on their official website or through related sources[1][3]. Summary: - Headquarters location and source website details partially incomplete. - Description and investment focus mostly accurate. - AUM figure somewhat uncertain, likely overstated relative to some sources. - Significant missing fields like senior leadership, fund size, and portfolio information reduce completeness. Sources: https://www.eiffel-ig.com/en/contact/ https://www.franceinvest.eu/en/annuaire/eiffel-investment-group/ https://www.lei-lookup.com/record/549300PBLPGO5HHRXL63/ https://www.zoominfo.com/c/eiffel-investment-group-bv/358639521 https://www.devex.com/organizations/eiffel-investment-group-128247
26	ALTERDYNE ENERGY	https://alterdyne.energy/contact	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ALTERDYNE ENERGY Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceUrl":null}],"headquarters":"Eschenbachgasse 9, Vienna, 1010, Austria","investmentThesisFocus":[],"investorDescription":"Alterdyne is an expert for international project scouting and validation. We minimize the resource requirements of investors from project identification to pre due-diligence by identifying projects, filtering the bankable opportunities and validating information with on-site checks.\n\nAlterdyne has been founded by seasoned experts and former top-managers in the renewable energy, artificial intelligence and web development domains, combining 60+ years of in-depth sector experience.\n\nAlterdyne thrives to change the painful and slow processes of global project search, screening, validating and M&A in the renewables industry based on cutting edge technology and hands-on experience.","linkedDocuments":[],"missingImportantFields":["investorDescription","investmentThesisFocus","headquarters","overallAssetsUnderManagement","portfolioHighlights","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"The website https://alterdyne.energy/contact and its parent domain contain no accessible content or data to extract. All fields are unavailable.","seniorLeadership":[],"sources":{"headquarters":"https://crunchbase.com/organization/alterdyne-energy|https://linkedin.com/company/alterdyne","investmentThesisFocus":"https://crunchbase.com/organization/alterdyne-energy|https://linkedin.com/company/alterdyne","investorDescription":"https://crunchbase.com/organization/alterdyne-energy|https://linkedin.com/company/alterdyne","portfolioHighlights":"https://crunchbase.com/organization/alterdyne-energy|https://linkedin.com/company/alterdyne"},"websiteURL":"https://alterdyne.energy/contact"}	Correctness: 95% Completeness: 40% The provided information about Alterdyne Energy is largely factually accurate. Alterdyne is indeed described as an expert in international project scouting and validation, focusing on minimizing resource requirements for investors by identifying, filtering, and validating projects, especially in renewables. Its headquarters are in Vienna, Austria, consistent with multiple sources confirming the location[1][2]. The investor description aligns well with industry reports, specifying founders with 60+ years of combined experience and a focus on renewable energy, AI, and web development domains[1][2]. However, the completeness is low due to the absence of essential details commonly found in investor profiles: there is no available information on the estimated investment size, fund size, sector or stage focus, overall assets under management, portfolio highlights, or senior leadership. The website (https://alterdyne.energy/contact) and related domains offer no further accessible data to fill these gaps[1][2]. Public business databases like Crunchbase and LinkedIn do not provide additional substantive details on investment theses or fund specifics. No data is found on Alterdyne’s exact investment strategies or completed and active investments. In summary, while the factual statements that are present are mostly correct and verifiable, the overall dataset is incomplete, missing critical investor profile elements that prevent a full picture. Sources: https://saudi.dealroom.co/companies/alterdyne_former_e_nable_ [1] https://ecosystem.dubaifoundershq.com/companies/alterdyne_former_e_nable_ [2] https://crunchbase.com/organization/alterdyne-energy https://linkedin.com/company/alterdyne
27	Alma Mundi Ventures	http://mundiventures.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Kembara Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["global Spanish-speaking diaspora"],"investmentStageFocus":["early stage","growth stage"],"sectorFocus":["deeptech","insurtech","fintech","climate tech"],"sourceProvider":"LinkedIn","sourceUrl":"https://www.mundiventures.com/"}],"headquarters":"Madrid, Barcelona, Paris, London","investmentThesisFocus":["Backing bold and purpose-driven founders with a strong ESG vision.","Supporting startups in embedding ESG considerations to create competitive advantage.","Investment philosophy integrates five core sustainability topics: Purpose Driven (UN SDGs alignment), ESG Stewardship (signatory of UN PRI, ESG data use), Climate Awareness (GHG measurement, climate risk assessment), Gender Equality (high female representation), Solid Governance (ESG investment policy).","Due diligence uses UN SDGs, SASB standards, and climate risk assessments.","Measurement of impact via SFDR indicators and 30+ ESG data points collected annually.","Focus on ESG safeguard, ESG alpha, and ESG excellence for category leadership."],"investorDescription":"Mundi Ventures backs bold and purpose-driven founders building the future of deeptech, insurtech, fintech, and climate tech. They describe their focus as 'Deep Tech for Deep Challenges.' The firm has the backing of the European Investment Bank (EIB) and the European Investment Fund (EIF). They support startups in realizing sustainability goals, focusing on embedding ESG considerations as a competitive advantage.","linkedDocuments":["https://mundiventures.com/post/eif-invests-350-million-in-the-spain-based-venture-capital-firm-mundi-ventures"],"missingImportantFields":["fundSize","estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"EUR 500,000,000","sourceUrl":"https://www.mundiventures.com/post/55-5-million-usd-growth-round-fuels-submers-push-for-greener-ai-factories-and-data-centers"},"portfolioHighlights":["Twinco Capital","Clarity AI","Acurable","Floodmapp","Laiier","Sherpa.ai","Citibox","Betterfly","Submer"],"researcherNotes":"AUM is explicitly mentioned as €500 million in assets under management in a recent 2024 source. Fund size and other fund-specific investment size and stage data are not available publicly on the website.","seniorLeadership":[{"name":"Javier Santiso","sourceUrl":"https://www.mundiventures.com/team","title":"CEO & General Partner"},{"name":"Moisés Sánchez","sourceUrl":"https://www.mundiventures.com/team","title":"CLO & General Partner"},{"name":"Luis Viñas","sourceUrl":"https://www.mundiventures.com/team","title":"Partner"},{"name":"Rafaela Andrade","sourceUrl":"https://www.mundiventures.com/team","title":"Partner"},{"name":"Rajeev Singh-Molares","sourceUrl":"https://www.mundiventures.com/team","title":"Partner at ALM I and ALM II"},{"name":"Moisés Sánchez Jiménez","sourceProvider":"LinkedIn","sourceUrl":"https://es.linkedin.com/company/mundi-ventures","title":"General Partner"},{"name":"Lluís Viñas Fernandez","sourceProvider":"LinkedIn","sourceUrl":"https://es.linkedin.com/company/mundi-ventures","title":"Investment Director"}],"sources":{"headquarters":"https://www.mundiventures.com/contact","investmentThesisFocus":"https://www.mundiventures.com/esg","investorDescription":"https://www.mundiventures.com/","portfolioHighlights":"https://www.mundiventures.com/companies"},"websiteURL":"http://mundiventures.com/"}	Correctness: 90% Completeness: 85% The provided details about Mundi Ventures are largely factually accurate based on currently available and credible sources. The **headquarters** in Madrid and Barcelona is confirmed, though Paris and London offices are not explicitly mentioned in the sources found; the firm also has offices in the UK and US, which partly aligns with the international presence stated[1][4]. The **focus on deeptech, insurtech, fintech, and climate tech** sectors and backing bold, purpose-driven founders with a strong ESG (Environmental, Social, and Governance) vision aligns well with the description on their official website and third-party profiles[1][3][4]. They indeed integrate ESG considerations as a competitive advantage and base their investment philosophy on sustainability themes and data-driven ESG impact measurement, consistent with their stated use of UN SDGs, SASB standards, and climate risk assessments[3][5]. The **Assets Under Management (AUM)** figure of around EUR 500 million as of 2024 matches public announcements of a €350 million fund launched recently and additional capital under management reported elsewhere (some sources mention around $561 million, which corresponds roughly to ~EUR 500 million)[2][5]. The **investment stage focus on early and growth stages** is broadly consistent, although some sources emphasize Series A/B rounds, seed rounds, or slightly vary in stage definitions but remain consistent with early to growth stages[2][3]. The **portfolio highlights** mentioned (Twinco Capital, Clarity AI, Submer, etc.) also align with the actual companies listed on their portfolio page[5]. Senior leadership names such as Javier Santiso (CEO & General Partner) and Moisés Sánchez (CLO & General Partner) are accurately captured, as verified by the official site and LinkedIn data[5]. However, some **gaps affect completeness**: the exact "fund size" and "estimated investment size" for the Kembara Fund are noted as unavailable and remain so publicly; this omission is reflected in your summary and no source contradicts this. The geographic focus described as “global Spanish-speaking diaspora” and specific ESG measurement details (30+ ESG data points, SFDR indicators) are well aligned with Mundi Ventures’ emphasis on sustainability but are not detailed at length in third-party sources, primarily found from Mundi’s own disclosures[5]. The mention of Paris as a headquarters is unsupported. Also, while the investment thesis is well outlined, some minor details about fund numbers and specific fund strategies are less publicly detailed, lowering completeness slightly. In sum, the information is **factually very solid**, predominantly based on reliable direct and indirect sources, including Mundi Ventures’ own website and respected third-party data. The **main shortcoming is the incomplete public disclosure of certain private fund metrics and more granular fund-specific data**, which your notes about missing "fundSize" and "estimatedInvestmentSize" correctly acknowledge. Also, geographic office presence beyond Madrid, Barcelona, London, and US offices is inconsistent regarding Paris. Sources used: - https://www.mundiventures.com/ - https://golden.com/wiki/Mundi_Ventures-NMYNJJG - https://app.dealroom.co/investors/alma_mundi_ventures - https://www.privateequityinternational.com/institution-profiles/mundi-ventures.html - https://www.mundiventures.com/news
28	Almi Invest GreenTech	https://almiinvest.se	{"funds":[{"estimatedInvestmentSize":"SEK 5,000,000 - 15,000,000","fundName":"GreenTech Fund","fundSize":"SEK 1,200,000,000","fundSizeSourceUrl":"https://www.almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/","geographicFocus":["Sweden"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Energy Transition","Circular Economy","Materials Technology","Transport and Mobility","Industry and Construction","Innovative Agriculture and Biosphere Technologies"],"sourceUrl":"https://www.almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/"}],"headquarters":"Stockholm, Stockholm County","headquarters_sourceProvider":"LinkedIn","investmentThesisFocus":["Focus on early-stage Swedish startups with scalable business models and strong national and international market potential.","Invest in climate-smart, CO2-reducing, innovative companies contributing to sustainability.","Co-investment with independent investors for risk sharing and access to networks.","Evaluation based on measurable climate and environmental benefits, such as avoided emissions of at least 200,000 tons CO₂e per year within 5-10 years.","Investment criteria include significant climate/environmental impact, strong team, innovative and scalable technology with proprietary solutions, and clear market potential.","Industry sectors prioritized include energy transition, circular economy, materials technology, transport and mobility, industry and construction, and innovative agriculture and biosphere technologies.","Full due diligence and analysis of ecological sustainability using frameworks such as TNFD and Kunming-Montreal agreement."],"investorDescription":"Almi Invest GreenTech is a climate-focused investment fund investing in startups contributing to sustainability by reducing carbon emissions, protecting natural resources, or restoring ecosystems. Since 2017, it has invested in about 40 companies and manages 1.2 billion SEK across two funds, including a 600 million SEK Climate Fund launched in 2024 with EU support. Eligible companies are Swedish, private SMEs not publicly listed, with innovations that show measurable potential to reduce emissions or improve the environment, and less than seven years of commercial revenue. Typical investments range from 5 to 15 million SEK per round, with total capacity up to 50 million SEK per company, mainly in Seed to Series A stages.","linkedDocuments":[],"missingImportantFields":[],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"SEK 4,000,000,000","sourceUrl":"https://www.almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/"},"portfolioHighlights":["InTeEx","Seaqure Labs"],"researcherNotes":"Headquarters information not found on the contact or footer pages of the website. AUM is clearly stated as 4 billion SEK total with 1.2 billion SEK specifically for the GreenTech fund, based on the main fund page. No direct linked documents (PDF, DOCX, PPTX) were found on the site.","seniorLeadership":[{"name":"Joachim Karlsson","sourceUrl":"https://almi.se/om-almi/organisation-och-ekonomi/ledning/koncernledning-almi-ab","title":"vd Almi Invest"},{"name":"Anders Fagerdahl","sourceUrl":"https://almi.se/om-almi/organisation-och-ekonomi/ledning/koncernledning-almi-ab","title":"Vd och koncernchef"},{"name":"Juliana Perez Falke","sourceUrl":"https://almi.se/om-almi/organisation-och-ekonomi/ledning/koncernledning-almi-ab","title":"Affärsområdeschef företagspartner"},{"name":"Jorgen Bodin","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/almi-invest/","title":"CEO and Fund Manager"}],"sources":{"headquarters":"https://www.linkedin.com/company/almi-invest/","investmentThesisFocus":"https://almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/","investorDescription":"https://www.almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/","portfolioHighlights":"https://almiinvest.se/riskkapital/portfolio"},"websiteURL":"https://almiinvest.se"}	Correctness: 95% Completeness: 90% The information provided about Almi Invest GreenTech is largely factual and accurately reflects publicly available sources. The fund size cited as SEK 1.2 billion aligns with the stated amount of about €65 million (approximately SEK 650–700 million) noted elsewhere but appears confirmed on the Almi Invest GreenTech page, indicating this could be a part or a specific fund within the total AUM. The total assets under management (AUM) figure of SEK 4 billion is consistent with publicly stated figures referenced in multiple investor profiles, including Almi’s own communications[1][2][5]. The details about the focus on early-stage Swedish startups, investment stages (Seed and Series A), sectors prioritized (energy transition, circular economy, materials technology, transport and mobility, industry and construction, innovative agriculture and biosphere), and investment size per round (SEK 5-15 million) are all supported by the Almi Invest official descriptions[1][4][5]. The investment thesis emphasizing climate-smart, CO2-reducing innovations with measurable environmental impact and co-investment strategies also matches the official mission and evaluation criteria on the Almi Invest GreenTech website[1]. The leadership names given—Joachim Karlsson (vd Almi Invest), Anders Fagerdahl (Vd och koncernchef), Juliana Perez Falke (Affärsområdeschef företagspartner), and Jorgen Bodin (CEO and Fund Manager)—are plausible and mostly verifiable from the organizational sources. The characterization of portfolio highlights like InTeEx and Seaqure Labs is consistent with their focus but not extensively documented in the sources reviewed. Regarding completeness, some minor nuances or recent updates could be missing, such as precise details of the 2024 Climate Fund launched with EU support, which was mentioned but not fully detailed in external summaries[1][2]. Also, the available information does not fully capture all operational aspects, such as co-investment ratios, specific due diligence procedures involving TNFD and Kunming-Montreal frameworks, which are sophisticated but likely correct since they relate to ecological sustainability frameworks seen in advanced climate funds. In summary, the description is very accurate and includes almost all key facts publicly known about Almi Invest GreenTech, its size, focus, investment thesis, and leadership with minor possible omissions of very recent or internal data. The URLs used include: - https://www.almiinvest.se/riskkapital/vara-riskkapitalbolag/almi-invest-greentech/ - https://swedishcleantech.com/business-opportunities/almi-invest-green-tech-fund/ - https://www.vestbee.com/vc-list/almi-invest - https://thehub.io/funding/almi-invest - https://www.eu-startups.com/investor/almi-invest-greentech/ - https://almi.se/om-almi/organisation-och-ekonomi/ledning/koncernledning-almi-ab
29	Allinvest	http://www.allinvest.at/	{"funds":[{"estimatedInvestmentSize":"EUR single-digit millions","fundName":"Allinvest Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Established Companies"],"sectorFocus":["Industrial","Technology"],"sourceProvider":"Perplexity","sourceUrl":"http://www.allinvest.at/en/home-en/"}],"headquarters":"Brahmsplatz 2A-1040 Wien, Austria","investmentThesisFocus":["Focus on established companies seeking fresh capital for corporate succession or growth.","No strict sector or regional focus but preference for classic industrial and technology companies.","Flexible contract design and longer investment horizons compared to classic private equity investors.","Active participation in investments by supporting management with know-how and networks without operational interference.","Providing management consulting to family businesses, family offices, and private foundations in strategic corporate issues, financing, and real estate.","Investment volumes typically single-digit millions, with potential for larger deals via partners.","No new startup investments since 2018 due to compliance reasons related to a partner’s involvement in Speedinvest."],"investorDescription":"Allinvest Unternehmensbeteiligungs GmbH was founded in 2006 as a subsidiary of Allholding Beteiligungsverwaltungs GmbH to consolidate the investments of the Gröller family. It is an active entrepreneurial investor engaging in direct investments in companies and real estate (outside the core business of sister company Allmobil Immobilien GmbH) along with a broad fund portfolio (PE, VC, alternatives), stocks, and bonds to achieve broad thematic and geographical diversification. It focuses on investing in established companies needing fresh capital for corporate succession or growth, with no sector-specific or regional focus but a preference for classic industrial and technology companies. Investment volumes per transaction are typically in the single-digit million range, with flexibility for larger volumes via partners. As a family business, Allinvest offers more contractual flexibility and longer investment horizons compared to classic private equity investors, emphasizing entrepreneurial thinking over short-term value maximization. They actively participate in shaping investments by supporting management with know-how and networks without interfering operationally. They also provide management consulting to family businesses, family offices, and private foundations in strategic corporate issues, financing, and real estate.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Neoom AG","B2X Care Solutions GmbH","Cumulus Immobilien GmbH","Wefox","Invesdor","klarx","PROPSTER","refurbed","Schüttflix"],"researcherNotes":"Overall Assets Under Management (AUM) and specific fund sizes are not mentioned on the website or in related documents. The investment size is inferred as 'single-digit millions' per transaction based on company description.","seniorLeadership":[{"name":"Heinrich Gröoller","sourceProvider":"Perplexity","sourceUrl":"https://allinvest.at/en/home-en/#management","title":"Geschäftsführer Dipl. Ing. ETH"},{"name":"Michael Gröoller","sourceProvider":"Perplexity","sourceUrl":"https://allinvest.at/en/home-en/#management","title":"Advisor Dkfm."}],"sources":{"headquarters":"https://www.allinvest.at/en/kontakt/","investmentThesisFocus":"http://www.allinvest.at/en/home-en/","investorDescription":"http://www.allinvest.at/en/home-en/","portfolioHighlights":"https://allinvest.at/en/home-en/#beteiligungen"},"websiteURL":"http://www.allinvest.at/"}	Correctness: 100% Completeness: 90% The provided information about Allinvest Unternehmensbeteiligungs GmbH is factually accurate and aligns closely with the company’s official website and other authoritative sources. The details about its founding in 2006 as a subsidiary of Allholding Beteiligungsverwaltungs GmbH, focus on established companies for corporate succession or growth, preference for classic industrial and technology sectors, investment volumes in the single-digit million euro range, flexible contract terms, longer investment horizons, and active but non-operational involvement with management correspond to statements on Allinvest’s official homepage[2][4]. The description of offering management consulting to family businesses and private foundations, as well as the suspension of startup investments post-2018 due to compliance concerns, is consistent with their declared investment thesis[2]. The headquarters address at Brahmsplatz 2A, 1040 Vienna, Austria, is confirmed on their contact page[2]. The mention of portfolio highlights such as Neoom AG, B2X Care Solutions, and others matches data shown in their publicly listed participations[2]. Senior leadership named—Heinrich Gröoller as Geschäftsführer and Michael Gröoller as Advisor—is also correct per the company’s management information[2]. However, the **completeness score is slightly reduced (~90%)** due to missing or unavailable data on the overall assets under management (AUM) and specific fund size details, which are not found on the website or related documents and hence duly noted as missing fields. This lack of precise numerical AUM or fund size is typical for family office-type investors that do not always disclose such metrics publicly. The investment size is inferred as "EUR single-digit millions" per transaction but without exact fund size specifications[2]. No conflicting or fabricated information is present based on the authoritative website and institutional profiles examined. Sources used: - Allinvest official website: https://www.allinvest.at/en/home-en/ - Allinvest contact page: https://www.allinvest.at/en/kontakt/ - Institutional overview: https://www.privateequityinternational.com/institution-profiles/allinvest-unternehmensbeteiligungs-gmbh.html
30	ALSA Ventures	https://www.alsaventures.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ALSA Ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Company Formation","Early Stage","Syndicate Participation"],"sectorFocus":["Biotechnology","Life Sciences","Therapeutics"],"sourceProvider":"Perplexity","sourceUrl":"https://www.alsaventures.com/our-approach"}],"headquarters":"London, London","investmentThesisFocus":["Focused around therapeutics with novel drugs and modalities in a wide variety of disease areas.","Invest across the spectrum of drug development, from company formation to participation in syndicates with co-investors.","Heavily reliant on proprietary deal flow.","Identify and evaluate opportunities globally, leveraging a well-networked team.","Focus on investments that meet both commercial and scientific aims.","Aware that capital markets vary globally in how well they support the industry."],"investorDescription":"ALSA Ventures is a London-based international life science investor focused on novel therapeutics, primarily investing in biotechnology companies developing novel drugs and modalities across a wide variety of disease areas. Their investment approach spans the spectrum of drug development and includes company formation as well as participation in syndicates with co-investors. ALSA Ventures is a Europe-focused biotechnology fund manager aiming at creating valuable businesses with global impact.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Axovia Therapeutics","Vantage Biosciences","Promatix"],"researcherNotes":"No financial data or AUM details were found on the website. Headquarters address not available on the Contact page or footer.","seniorLeadership":[{"name":"Alek Safarian","sourceUrl":"https://www.alsaventures.com/meet-the-team","title":"CEO"},{"name":"Lorna Collings","sourceUrl":"https://www.alsaventures.com/meet-the-team","title":"CFO"},{"name":"Dr Bruce Goldsmith","sourceUrl":"https://www.alsaventures.com/meet-the-team","title":"Operating Partner"},{"name":"Dr Robert Balfour","sourceUrl":"https://www.alsaventures.com/meet-the-team","title":"Investment Director"}],"sources":{"headquarters":"https://uk.linkedin.com/company/alsa-holdings","investmentThesisFocus":"https://www.alsaventures.com/our-approach","investorDescription":"https://www.alsaventures.com/","portfolioHighlights":"https://www.alsaventures.com/portfolio"},"websiteURL":"https://www.alsaventures.com/"}	Correctness: 95% Completeness: 85% The information provided about ALSA Ventures is largely **factually accurate** based on multiple reliable sources. ALSA Ventures is indeed a London-based international life science investor focused primarily on biotechnology companies developing novel therapeutics across diverse disease areas. Their investment approach covers early stages including company formation and syndicate participation, with a global geographical focus, heavily reliant on proprietary deal flow. The description of their investment thesis aligns with the fund's focus on therapeutics with novel drugs and modalities, supporting companies from discovery to early clinical development[1][2][3]. The named senior leadership (Alek Safarian as CEO, Lorna Collings as CFO, Dr. Bruce Goldsmith as Operating Partner, and Dr. Robert Balfour as Investment Director) matches the team listed on ALSA’s website[3]. The portfolio highlights such as Axovia Therapeutics and others are consistent with news about recent acquisitions and investments by ALSA[2]. However, **some completeness issues** remain due to missing specific financial details, notably: - The overall assets under management (AUM) are not publicly stated on ALSA’s website or verified sources, though press reports indicate a target of $150 million for their inaugural fund with an initial $59 million raised already[1]. This is a significant omission since AUM is a key metric for venture funds. - The fund size and estimated investment size are listed as "Not Available," which matches the lack of detailed public financial disclosures. - The precise headquarters address cannot be confirmed on the ALSA site or official contact pages but is known generally to be in London, UK, consistent with the LinkedIn company page[5]. - Additional detailed performance metrics such as fund vintage year, investment multiple, or carry terms are not available and thus omitted, which affects completeness. No unsupported or fabricated claims were identified. The investor description, investment thesis, and portfolio are well supported by the official ALSA website and credible biotech venture capital reporting sources[1][2][3][5]. **Sources:** - https://globalventuring.com/university/alsa-secures-59m-for-biotech-venture-fund/ - https://www.genengnews.com/topics/drug-discovery/on-your-mark-alsa-ventures-lifts-early-stage-european-biotechs-to-jockey-out-of-the-gate/ - https://www.alsaventures.com/ - https://venturecapitalarchive.com/venture-funds/alsa-ventures-alsaventures-com
31	Alpana Ventures	https://alpana-ventures.ch/	{"funds":[{"estimatedInvestmentSize":"CHF 0.3-3m","fundName":"Alpana Ventures Investments I SCSp","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland","Europe","US"],"investmentStageFocus":["Early stage","Seed"],"sectorFocus":["ICT","Healthtech","Fintech"],"sourceProvider":"SECA Directory","sourceUrl":"https://www.seca.ch/en/find-members/alpana-ventures/"},{"estimatedInvestmentSize":"CHF 0.3-3m","fundName":"Alpana Ventures Investments II SCSp","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland","Europe","US"],"investmentStageFocus":["Early stage","Seed"],"sectorFocus":["ICT","Healthtech","Fintech"],"sourceProvider":"SECA Directory","sourceUrl":"https://www.seca.ch/en/find-members/alpana-ventures/"},{"estimatedInvestmentSize":"CHF 0.3-3m","fundName":"Alpana Ventures Investments III SCSp","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland","Europe","US"],"investmentStageFocus":["Early stage","Seed"],"sectorFocus":["ICT","Healthtech","Fintech"],"sourceProvider":"SECA Directory","sourceUrl":"https://www.seca.ch/en/find-members/alpana-ventures/"}],"headquarters":"Tour de l’Ile 1, CH – 1204 Geneva, Switzerland","investmentThesisFocus":["Focus on discovering and investing in Deeptech solutions.","Invest to embed Deeptech solutions into innovative business models.","Support scalable ICT, Healthtech, and Fintech solutions that create a sustainable future.","Provide funding, guidance, and assistance in business strategy implementation.","Help startups with talent acquisition and leverage US marketing expertise."],"investorDescription":"Alpana Ventures is a Swiss VC focusing on digital transformation. Committed to value creation, they discover 'Deeptech' solutions in Switzerland, Europe, and the US. They invest to embed these solutions into innovative business models. Alpana Ventures is a Swiss venture capital firm focused on Digital Transformation since 2016. Their mission is to discover 'Deeptech' solutions in Switzerland, Europe, and the US, and invest to embed them into innovative business models. They back scalable ICT, Healthtech, and Fintech solutions with a big impact that help create a sustainable future. Their investment approach includes providing funding and guidance for startups, assisting in implementing the right business strategies, helping hire talent, and applying US marketing expertise.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["AirConsole","Altoida","CariqPay","CityCop","CloudGuide","Domo Health","Emonitor","Invaluable","Klarys","Beekeeper","Voliro"],"researcherNotes":"AUM and exact fund sizes are not mentioned on the company's own website. Investment size data was found on an external credible member directory (SECA).","seniorLeadership":[{"name":"Nathalie Chemtob (Girod)","sourceProvider":"LinkedIn","sourceUrl":"https://alpana-ventures.ch/people/","title":"Co-Founding Partner"},{"name":"Christophe Chemtob","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alpana-ventures.ch/people/","title":"Partner"},{"name":"Pascal H. Widmer","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alpana-ventures.ch/people/","title":"Partner"},{"name":"Hervé Liboureau","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alpana-ventures.ch/people/","title":"Venture Partner"}],"sources":{"headquarters":"https://alpana-ventures.ch/contact/","investmentThesisFocus":"https://alpana-ventures.ch/; https://alpana-ventures.ch/mission/","investorDescription":"https://alpana-ventures.ch/; https://alpana-ventures.ch/mission/","portfolioHighlights":"https://alpana-ventures.ch/portfolio/"},"websiteURL":"https://alpana-ventures.ch/"}	Correctness: 98% Completeness: 90% The information provided about Alpana Ventures is highly accurate and aligns well with authoritative sources. Alpana Ventures is correctly described as a Swiss venture capital firm headquartered in Geneva, focusing on digital transformation and finding Deeptech solutions across Switzerland, Europe, and the US[1][3][4]. The firm invests primarily at early and seed stages in ICT, Healthtech, and Fintech sectors, with typical investment sizes of CHF 0.3-3 million confirmed by SECA[1]. Their investment thesis emphasizing embedding Deeptech into innovative business models, supporting scalable solutions for a sustainable future, and offering funding alongside strategic and operational guidance matches the descriptions on Alpana Ventures' official and third-party sites[1][4][5]. The senior leadership named (Nathalie Chemtob (Girod), Christophe Chemtob, Pascal H. Widmer, Hervé Liboureau) is consistent with information on their site[1][4]. The portfolio examples such as Altoida, Beekeeper, CariqPay, and Voliro are verified on the official portfolio listing[1], though there are minor slight differences in portfolio company names (e.g., "Car IQ" spelled as "CariqPay") which appear to be due to naming variants. Missing fields include overall Assets Under Management (AUM) and exact fund sizes, which are not publicly disclosed on the company’s website or in credible directories. This justifies the noted incompleteness regarding total fund sizes and AUM[1][4]. The geographical focus is comprehensive covering Switzerland, Europe, and the US. One discrepancy is that VentureCapitalArchive lists Lausanne as the HQ rather than Geneva, but Geneva is confirmed by the firm’s official contact page and SECA. Given Geneva is the firm’s stated official HQ on their website and SECA, Geneva is more reliable[1][4][3]. Additional minor gaps are detail on follow-on investment strategy, exact number of portfolio companies (35+ per SECA vs. 45 founders backed mentioned on the official site), and detailed fund vintage years or performance metrics which are not fully public. But the core data is well supported. Sources: - SECA Directory: https://www.seca.ch/en/find-members/alpana-ventures/ - Official website: https://alpana-ventures.ch/ - Private Equity List: https://privateequitylist.com/investor/alpana-ventures - VentureCapitalArchive: https://venturecapitalarchive.com/venture-funds/alpana-ventures-alpanaventures-ch - Vestbee: https://www.vestbee.com/vc-list/alpana-ventures
32	Alfvén & Didrikson	http://www.alfvendidrikson.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alfvén & Didrikson Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Northern Europe"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.alfvendidrikson.com"}],"headquarters":"Kungsgatan 30, 111 35 Stockholm","investmentThesisFocus":["Invest in brilliant people and their businesses aiming for long-term value creation.","Engaged and active involvement with investee companies.","Entrepreneurs and risk takers who are pragmatic and open-minded.","Open to variety and not bound by preconceived rules.","Believe in long-term incentives aligned with partners and avoid short-term bonuses."],"investorDescription":"Our dream is to make fantastic investments in brilliant people and their businesses, aiming for long-term value creation. We are engaged and active with our investee companies, providing energy and guidance when needed. We are entrepreneurs and risk takers, pragmatic and open-minded, open to variety and not bound by preconceived rules. We believe in long-term incentives aligned with our partners and do not pursue short-term bonuses.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","sectorFocus","investmentStageFocus","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Stockholms Auktionsverk","Auctionet","Uppsala Auktionskammare","Open Payments"],"researcherNotes":"No explicit data on AUM or fund sizes found on the website. The firm appears to operate a single unified investment strategy focused on Northern Europe. Portfolio companies are acknowledged but specific investment sizes and sectors are not disclosed.","seniorLeadership":[{"name":"Hjalmar Didrikson","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfvendidrikson.com/team","title":"Founder"},{"name":"Måns Alfvén","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfvendidrikson.com/team","title":"Founder and CEO"},{"name":"Monika Pers","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfvendidrikson.com/team","title":"CFO"}],"sources":{"headquarters":"https://www.alfvendidrikson.com/contact","investmentThesisFocus":"https://www.alfvendidrikson.com/about","investorDescription":"https://www.alfvendidrikson.com/about","portfolioHighlights":"https://www.alfvendidrikson.com/news"},"websiteURL":"http://www.alfvendidrikson.com"}	Correctness: 95% Completeness: 80% The provided information about Alfvén & Didrikson is factually accurate based on multiple sources. The fund is described as an active, long-term investor focusing on passionate entrepreneurial teams and growth companies primarily in Northern Europe, which aligns with the official website and investor profiles[2][3]. The description emphasizes investing in brilliant people, long-term value creation, pragmatic and open-minded entrepreneurship, and avoidance of short-term incentives, which matches the language on their "About" page[2]. Their headquarters at Kungsgatan 30, 111 35 Stockholm is confirmed by their contact information on the official site[2]. The leadership names—Hjalmar Didrikson (Founder), Måns Alfvén (Founder and CEO), and Monika Pers (CFO)—are also supported by the team page on their website[2][3]. Portfolio highlights such as Stockholms Auktionsverk, Auctionet, Uppsala Auktionskammare, and Open Payments are consistent with news updates and portfolio mentions on their website and external sources[2][3]. The geographic focus on Northern Europe and lack of explicit sector or investment stage focus is supported, as details on sector and stage are either "Not Available" or not prominent across sources. Where completeness is reduced: - No public data is available on overall Assets Under Management (AUM), fund size, or estimated investment sizes, which is explicitly noted in the researcher’s notes and confirmed by absence in official and third-party databases[1][2][3]. - The specific investment stages and sector focuses are not clearly detailed publicly. Some third-party sources mention investment in sectors like IT and medical but these are not official fund-declared focuses[1]. - The interview or detailed investment strategy documents that might shed more light on fund size, investment parameters, or typical deal sizes are missing, limiting the depth of coverage. Thus, while the core profile, leadership, philosophy, geographic focus, and portfolio highlights are accurate and well-supported, important quantitative details are missing, leading to the adjusted completeness score. Sources: - Official website: https://www.alfvendidrikson.com/contact, https://www.alfvendidrikson.com/about, https://www.alfvendidrikson.com/news - Unicorn Nest profile: https://unicorn-nest.com/funds/alfven-didrikson-2/ - Dealroom profile: https://app.dealroom.co/investors/alfv_n_amp_didrikson
33	Akilia Partners	https://akilia.io/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Akilia Partners Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["global","Madrid"],"investmentStageFocus":["Seed","Series A","Growth"],"sectorFocus":["Venture Capital","Private Equity"],"sourceProvider":"LinkedIn","sourceUrl":"https://akilia.io/about"}],"headquarters":"C. de Fernando VI, 5, 28004 Madrid, Spain","investmentThesisFocus":["Focus on long-term partnerships with investors and portfolio companies.","Support startups at every growth stage with a comprehensive investment suite.","Target straightforward, strong arguments for complex solutions that can revolutionize and penetrate industries by fixing obsolete processes or standards.","Emphasize deep understanding of current industry pain points and stakeholders to build pragmatic, executable plans.","Make conviction-driven decisions, not trend-driven, relying on multiple data sources and industry advisors.","Maximize opportunity/risk ratios via dedicated diligence covering market sizing, problem-solving, risk analysis, and company capabilities.","Build industry value chains and knowledge maps to create industry theses that simplify diligence and target fitting companies.","Use a flexible multi-vehicle structure, rely on trusted networks to access exclusive deals, combine generalist and specialist knowledge, and foster collaborative, long-term partnerships with entrepreneurs."],"investorDescription":"We support entrepreneurs who visualize the future of their industry and work towards creating a more efficient society with higher levels of wellbeing. An investment firm born to accelerate the pace of innovation and materialize its potential to improve the world. We invest at every stage of the VC cycle leveraging our flexible multi-vehicle structure. Our approach includes simplifying complexity, targeting obsolete industry standards, insight-driven decisions, and building knowledge networks. We are industry veteran operators, traditional finance professionals, and digital entrepreneurs who value visualizing the future as much as understanding the present to build the next generation of industry incumbents.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","sectorFocus","geographicFocus","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Stalicla","Body Vision","Assured Allies","Rappi","Laminate","Span","Lightspark","Rex Real Estate","Vascular Graft Solutions"],"researcherNotes":"The website does not provide explicit information on overall assets under management, fund sizes, specific sector or geographic focus, or estimated per-company investment sizes. These fields are marked as 'Not Available' or null accordingly.","seniorLeadership":[{"name":"Matteo Legler","sourceProvider":"SOURCE_JSON","sourceUrl":"https://akilia.io/team","title":"Managing Partner"},{"name":"Gonzalo Rubio","sourceProvider":"SOURCE_JSON","sourceUrl":"https://akilia.io/team","title":"Managing Partner"},{"name":"Jose (Pepe) Calle Gordo","sourceProvider":"SOURCE_JSON","sourceUrl":"https://akilia.io/team","title":"CEO & Managing Partner"}],"sources":{"headquarters":"https://akilia.io/contact","investmentThesisFocus":"https://akilia.io/about","investorDescription":"https://akilia.io/about","portfolioHighlights":"https://akilia.io/portfolio"},"websiteURL":"https://akilia.io/"}	Correctness: 95% Completeness: 70% The provided information about Akilia Partners is largely factually accurate and aligns with publicly available data from the official Akilia website and other investment directories. The headquarters address at C. de Fernando VI, 5, 28004 Madrid, Spain, matches the contact information on the Akilia website[3][5]. The investor description, investment thesis focus, and ethos (such as supporting entrepreneurs who visualize industry futures, focusing on long-term partnerships, multi-stage VC investments, deep industry understanding, and flexible structures) closely reflect the language and themes presented on their About and What We Do pages[3]. The senior leadership listing with Matteo Legler, Gonzalo Rubio, and Jose (Pepe) Calle Gordo as Managing Partners/CEO & Managing Partner matches their team page information indicated in the source JSON[3]. The portfolio highlights (Stalicla, Body Vision, Assured Allies, Rappi, Laminate, Span, Lightspark, Rex Real Estate, Vascular Graft Solutions) are consistent with portfolio companies mentioned on their site and deal listings[3][1][2]. Notably, the data correctly indicates the **absence** of disclosed details such as overall assets under management, fund size, estimated investment size per company, and granular sector and geographic focus beyond the stated “global” and Madrid presence. These details are indeed not provided publicly on Akilia’s website or main investor profiles[3][1][2]. This omission reduces completeness since these are typically key fund metrics. The categorization of the fund's focus sectors as venture capital and private equity is reasonable given the stages invested in (Seed through Growth) and the nature of investments described, although Akilia emphasizes venture capital activities prominently[3]. Geographic focus includes Madrid and broadly global, which matches the stated offices and international presence (Spain, Portugal, Switzerland, Israel)[3][5]. In summary, the information is accurate regarding qualitative statements, leadership, investment approach, and portfolio examples, but moderately incomplete due to missing quantitative financial data and more exact sectoral/geographic scope metrics that Akilia does not publicly disclose. Sources: https://akilia.io/about https://akilia.io/contact https://akilia.io/portfolio https://investny.org/investors/akilia_partners_1/portfolio/current https://espoo.dealroom.co/companies/akilia_partners_1
34	Alexandria Venture Investments	http://www.are.com/venture-investments.html	""
35	Aliment Capital	https://www.alimentcap.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Aliment Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Growth-stage"],"sectorFocus":["Life Sciences & Biopharmaceuticals","Food & Nutrition","Farm Technology","Supply Chain Efficiency"],"sourceUrl":"https://alimentcap.com/strategy/"}],"headquarters":"10100 Santa Monica Blvd., Suite 1500, Los Angeles, CA 90067","investmentThesisFocus":["Sector-focused growth capital driving sustainability","Targeting growth-stage companies with proven technologies, clear ROI, established sales, strong margins","Investing to scale cash flow and impact","Thematically-focused, thesis-driven, partnership-oriented, operationally-focused, flexible investors","Scalable business models with profitability or near-term path","Companies promoting sustainability","Strong teams with collaborative culture","Mission aligned to advancing planetary and human health","Clear enduring vision","Long-term partnership with reserved capital for follow-on rounds and M&A"],"investorDescription":"Aliment Capital is a global purpose-driven investment firm with over a decade of experience. The firm focuses on investing in disruptive companies innovating in food, agriculture, human health, and the global food supply chain. Their primary investment areas include Life Sciences & Biopharmaceuticals, Food & Nutrition, Farm Technology, and Supply Chain Efficiency. Aliment Capital's mission centers on advancing global sustainability and nutrition to ensure food security, social change, and an environmentally stable, carbon-neutral future. They target established, high-growth businesses with proven technologies that enhance safety, efficiency, resiliency, and sustainability in the food and agriculture supply chain. The firm pursues a growth capital strategy aiming for attractive returns with shorter holding periods, helping scale revenue and cash flow by focusing on commercialization and execution. The investment team comprises investors, technical advisors, and global strategic partners dedicated to better returns for investors and the planet. Aliment Capital builds diversified portfolios of mission-driven, founder-led brands.","linkedDocuments":["https://alimentcap.com/wp-content/uploads/2024/06/Aliment-Capital-Responsible-Investment-Policy-2024.pdf"],"missingImportantFields":["estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 483,000,000","sourceUrl":"https://www.builtinla.com/company/aliment-capital"},"portfolioHighlights":["Kate Farms","Fruitist","Hazel Technologies","The Bouqs Co","Tropic Biosciences","Fabric","OneRail","Pairwise","Provivi","TemperPack"],"researcherNotes":"No specific fund names or fund sizes are listed on the website. The overall AUM was found on an external trusted site (builtinla.com).","seniorLeadership":[{"name":"Ben Belldegrun","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alimentcap.com/investment-team","title":"Managing Partner & Co-Founder"},{"name":"Tim Bluth","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alimentcap.com/investment-team","title":"Partner"},{"name":"Mike Kurdyla","sourceProvider":"SOURCE_JSON","sourceUrl":"https://alimentcap.com/investment-team","title":"CFO"}],"sources":{"headquarters":"https://alimentcap.com/contact/","investmentThesisFocus":"https://alimentcap.com/strategy/","investorDescription":"https://alimentcap.com/about-us/","portfolioHighlights":"https://alimentcap.com/portfolio/"},"websiteURL":"https://www.alimentcap.com"}	Correctness: 98% Completeness: 85% The data about Aliment Capital is highly factually accurate and consistent with publicly available information from the firm's official website and credible external sources. The firm's sector focus on Life Sciences & Biopharmaceuticals, Food & Nutrition, Farm Technology, and Supply Chain Efficiency, as well as its growth-stage investment thesis centered on sustainability and scalable business models, aligns closely with its published investment strategy and mission statements[3][https://alimentcap.com/strategy/][3][https://alimentcap.com/about-us/][3][https://alimentcap.com/portfolio/]. The headquarters address given (10100 Santa Monica Blvd., Suite 1500, Los Angeles, CA 90067) matches the contact page on Aliment Capital's official site[3][https://alimentcap.com/contact/]. The senior leadership team names and titles—Ben Belldegrun (Managing Partner & Co-Founder), Tim Bluth (Partner), and Mike Kurdyla (CFO)—also correspond accurately to the firm's website[3][https://alimentcap.com/investment-team]. Portfolio highlights including companies such as Kate Farms, Fruitist, Hazel Technologies, The Bouqs Co, Tropic Biosciences, Fabric, OneRail, Pairwise, Provivi, and TemperPack are confirmed on the official portfolio page[3][https://alimentcap.com/portfolio/]. The overall Assets Under Management (AUM) figure of approximately USD 483 million is not disclosed directly on Aliment Capital’s site but is reliably sourced from the trusted industry site Built In LA[https://www.builtinla.com/company/aliment-capital], as noted. The main gaps affecting completeness are: - No specific fund names or sizes are listed on Aliment Capital's website itself, and the information about individual fund size, estimated investment size, or detailed fund metrics is not publicly available, causing those fields to be marked "Not Available." - While the "investmentThesisFocus" and "investorDescription" are well-covered, more granular details about specific fund vehicles or the precise breakdown of investments could be missing. - The external references to Pontifax AgTech funds (which involve Ben Belldegrun in leadership roles) represent a distinct entity and are unrelated to Aliment Capital as described, thus not applicable here[1][2]. There is no evidence of fabricated or false information; therefore, correctness is nearly perfect. The minor score reduction reflects the natural limitation in publicly disclosed fund-specific data, which diminishes completeness somewhat. Sources: - https://alimentcap.com/strategy/ - https://alimentcap.com/about-us/ - https://alimentcap.com/contact/ - https://alimentcap.com/portfolio/ - https://alimentcap.com/investment-team - https://www.builtinla.com/company/aliment-capital
36	Alliance VC	https://alliance.vc	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alliance VC Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Nordic"],"investmentStageFocus":["Early Stage"],"sectorFocus":["Technology"],"sourceProvider":"Source_JSON","sourceUrl":"https://alliance.vc/about/"}],"headquarters":"Parkveien 41, BN-0258 Oslo, Norway; Malmskillnadsgatan 29, 111 57 Stockholm, Sweden; Maria 01, Lapinlahdenkatu 16, 00180 Helsinki, Finland; Havnegade 44, 1058 København, Denmark","investmentThesisFocus":["Investing in exceptional early-stage tech companies founded by entrepreneurs with global ambitions.","Focus on startups solving real problems with scalable solutions that create long-term profit and increase environmental and social sustainability.","Emphasize a mutual partnership with founders and active support over time.","Integration of ESG factors into investment decisions aiming for net positive impact on UN's Sustainable Development Goals."],"investorDescription":"Alliance VC is a Nordic venture capital firm investing in exceptional early-stage tech companies founded by entrepreneurs with global ambitions. They focus on startups solving real problems with scalable solutions that create long-term profit and increase environmental and social sustainability. They emphasize a mutual partnership with founders and active support over time. They are backed by InnovFin Equity with financial support from the European Union under Horizon 2020 and the European Fund for Strategic Investments (EFSI). Their ESG policy integrates environmental, social, and governance factors into investment decisions, aiming for net positive impact on the UN’s Sustainable Development Goals.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Ardoq","Simpler","ServiceNow","IPO","ARM","Medal","AllClearID","Oracle","InVision","Axia"],"researcherNotes":"No specific information about Assets Under Management (AUM), fund sizes, or estimated investment sizes was found on the website. The firm presents a unified early-stage technology investment strategy focused on the Nordic region.","seniorLeadership":[{"name":"Johan Gjesdahl","sourceUrl":"https://alliance.vc/team","title":"Managing Partner"},{"name":"Stine Mølgaard Sørensen","sourceUrl":"https://alliance.vc/team","title":"Partner"},{"name":"Anders Hallin","sourceUrl":"https://alliance.vc/team","title":"Partner"},{"name":"Bente Loe","sourceUrl":"https://alliance.vc/team","title":"Partner"},{"name":"Arne Tonning","sourceUrl":"https://alliance.vc/team","title":"Partner"},{"name":"Henrik Torstensson","sourceUrl":"https://alliance.vc/team","title":"Partner"},{"name":"Jan-Erik Hareid","sourceUrl":"https://alliance.vc/team","title":"Founder & Chairman"}],"sources":{"headquarters":"https://alliance.vc/contact/","investmentThesisFocus":"https://alliance.vc/about/","investorDescription":"https://alliance.vc/about/","portfolioHighlights":"https://alliance.vc/portfolio/"},"websiteURL":"https://alliance.vc"}	Correctness: 95% Completeness: 85% The provided information about Alliance VC is largely **factually accurate** and aligns well with multiple authoritative sources. Alliance VC is indeed a Nordic early-stage venture capital firm investing primarily in technology startups across the Nordic region (Norway, Sweden, Denmark, Finland), with permanent offices in Oslo, Stockholm, Helsinki, and Copenhagen, matching the given headquarters information[1][4][5]. The focus on early-stage investments, technology sector, and a partnership approach with founders with global ambitions is consistent across sources[1][5]. The described investment thesis emphasizing scalable solutions addressing real problems, long-term profit, and integration of ESG factors aligned to the UN Sustainable Development Goals also matches the firm’s stated mission of investing in sustainability and social impact alongside financial returns[5]. The leadership team listed—Johan Gjesdahl (Managing Partner), Stine Mølgaard Sørensen, Anders Hallin, Bente Loe, Arne Tonning, Henrik Torstensson, and Jan-Erik Hareid (Founder & Chairman)—is verified on the official Alliance VC team page and matches the stated biographical data[4][5]. However, **several key quantitative details are missing or not publicly disclosed**, which reduces the completeness score somewhat: - The data states "fundSize," "estimatedInvestmentSize," and "overallAssetsUnderManagement" as "Not Available" or null. While these are not explicitly published on their website, public news sources confirm Alliance VC currently has a fund called Alliance Nordic III with a first closing at €40 million, targeting a total size of €100 million. They plan to invest initial tickets between approximately €300,000 and €3 million, primarily in pre-seed to Series A rounds[1][2][3][4]. Including these data would improve completeness. - The portfolio highlights listed, such as Ardoq, Simpler, ServiceNow, IPO, ARM, Medal, AllClearID, Oracle, InVision, Axia, are partially misleading or unsupported. Alliance VC’s own portfolio page highlights some companies like Ardoq and Medal, but mentions of ServiceNow, Oracle, ARM, or InVision as portfolio companies are inaccurate or confused with other entities since these are very large established companies unrelated to Alliance VC’s investments. This slightly reduces correctness but perhaps reflects a misunderstanding or conflation. Removing or correcting these names would increase accuracy[5]. - The description of backers such as InnovFin Equity (European Union, Horizon 2020) and European Fund for Strategic Investments (EFSI) is not independently verifiable from publicly available sources in the current dataset or Alliance VC’s own communications; although they have Nordic institutional LPs such as KLP, Investinor, Saminvest, Smedvig, and Telenor[1][2][3][4]. This aspect needs verification and slightly reduces completeness and correctness. In summary, the **core qualitative facts**—fund focus, geographies, investment approach, leadership—are very accurate and well-supported, but **quantitative fund size data and portfolio details are incomplete or partly inaccurate**, lowering scores. The sources used are: - Alliance VC official website: https://alliance.vc - EU Startups: https://www.eu-startups.com/2025/07/norwegian-vc-firm-alliance-vc-announces-e40-million-close-for-new-fund-to-back-technology-leaders-from-the-nordics/ - AIN.ua news: https://en.ain.ua/2025/07/10/alliance-vc-raises-eur40m/ - BeBeez: https://bebeez.eu/2025/07/08/alliance-vc-announces-e100m-nordic-fund-to-back-the-next-wave-of-ai-native-startups/ - Everything Startups: https://www.everythingstartups.com/vc-funds/alliance-vc
37	Allianz Capital	http://allianzcapitalpartners.com	{"funds":[{"estimatedInvestmentSize":"EUR 40-200 million","fundName":"Private Equity Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["North/South America","Europe","Asia","Africa"],"investmentStageFocus":["Primary and secondary markets","Growth capital","Buyout","Selective venture capital mainly Asia"],"sectorFocus":["Broad - buyout, growth capital, venture capital selective"],"sourceUrl":"https://allianzcapitalpartners.com/en/our-business/private-equity"},{"estimatedInvestmentSize":"Significant minority or up to 100% controlling equity stakes","fundName":"Infrastructure Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Developed countries","Select emerging markets"],"investmentStageFocus":["Brownfield assets","Greenfield projects"],"sectorFocus":["Infrastructure sectors including energy transition, sustainable investments"],"sourceUrl":"https://allianzcapitalpartners.com/en/our-business/infrastructure"},{"estimatedInvestmentSize":"EUR 50-250 million","fundName":"Renewables Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe core markets","US"],"investmentStageFocus":["Asset acquisition","Operational excellence","Incremental capital investments"],"sectorFocus":["Onshore and offshore wind farms","Solar parks"],"sourceUrl":"https://allianzcapitalpartners.com/en/our-business/renewables"}],"headquarters":"Seidlstraße 24-24a, D-80335 Munich, Germany","investmentThesisFocus":["ACP as part of AllianzGI's private markets pillar invests sustainably across Private Equity, Renewables, and Infrastructure.","They incorporate ESG factors into investment processes through exclusion policies, research, corporate/country analysis, monitoring, and risk management.","ACP adheres to the UN Principles for Responsible Investment (UN PRI).","Their sustainability-focused approach includes rigorous ESG due diligence, driving ESG improvements via board engagement, enabling climate transition with long-term net-zero goals, and unified ESG approach pre- and post-investment.","ESG compliance is a gating item during investment review; poor ESG profiles may lead to declined investments or conditional investments requiring ESG improvements.","Asset management actively ensures ESG priority through board influence, improving ESG reporting, incentivising management, assessing risks, funding ESG initiatives, and stakeholder engagement."],"investorDescription":"We are one of the Allianz Group's asset managers for alternative equity investments and are part of Allianz Global Investors. We focus on investing into private equity, infrastructure and renewable energy. Due to their long investment horizon and attractive risk/return profile, our investments in private markets are an ideal match for the requirements of Allianz insurance companies given their long-term liabilities.","linkedDocuments":[],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"EUR 58,200,000,000","sourceProvider":"Perplexity","sourceUrl":"https://allianzcapitalpartners.com/en/media/news/011121-final-close-allianz-infrastructure-fund-over-1-billion-euros"},"portfolioHighlights":["Yondr Group"],"researcherNotes":"Overall AUM figure of approximately EUR 58.2 billion is derived from clear statements on infrastructure, renewables, and private equity AUM from Allianz Capital Partners and Allianz Global Investors, summing up partial AUMs. There is no single explicit total AUM mentioned by ACP alone.","seniorLeadership":[{"name":"Andrew Cox","sourceProvider":"LinkedIn","sourceUrl":"https://www.allianzcapitalpartners.com/en/about-us/leadership-team","title":"Co-Head of Infrastructure"},{"name":"Michael Lindauer","sourceProvider":"LinkedIn","sourceUrl":"https://www.allianzcapitalpartners.com/en/about-us/leadership-team","title":"Co-CIO of Private Equity"},{"name":"Michael Pfennig","sourceProvider":"LinkedIn","sourceUrl":"https://www.allianzcapitalpartners.com/en/about-us/leadership-team","title":"Co-Head of Infrastructure"},{"name":"Andreas Schlafer","sourceProvider":"LinkedIn","sourceUrl":"https://www.allianzcapitalpartners.com/en/about-us/leadership-team","title":"Member of the Board of Management responsible for corporate and investment services"},{"name":"Dirk Raab","sourceProvider":"LinkedIn","sourceUrl":"https://www.allianzcapitalpartners.com/en/about-us/leadership-team","title":"Head of Portfolio Management Private Markets"}],"sources":{"headquarters":"https://www.allianzcapitalpartners.com/en/contact","investmentThesisFocus":"https://www.allianzcapitalpartners.com/en/how-we-invest","investorDescription":"https://allianzcapitalpartners.com/en/about-us/acp-glance","portfolioHighlights":"https://www.allianzcapitalpartners.com/en/home"},"websiteURL":"http://allianzcapitalpartners.com"}	Correctness: 95% Completeness: 85% The provided information is largely factually accurate based on publicly available data from Allianz Capital Partners (ACP) and Allianz Global Investors (AllianzGI). The investment strategies for Private Equity, Infrastructure, and Renewables, including estimated investment sizes, geographic and sector focuses, and incorporation of ESG principles, align well with details found directly on the ACP website and official press releases[1][3][4]. For example: - The Private Equity strategy focusing on primary and secondary markets across multiple continents and broad sector focus is confirmed by the Allianz Private Equity Fund description and ACP statements showing diversified strategy and global reach[1][2]. - Infrastructure focus on brownfield and greenfield across developed and select emerging markets, including energy transition and sustainability, is supported by infrastructure fund launches and reports of over EUR 50 billion AUM in infrastructure at AllianzGI[3][4]. - Renewables strategy concentrating on onshore/offshore wind, solar parks, and incremental capital investments in Europe and the US is consistent with ACP's stated approach to renewables investment[official ACP sources]. The total AUM figure of approximately EUR 58.2 billion for combined private markets (infrastructure, renewables, private equity) is a reasonable aggregate drawn from multiple partial disclosures; although ACP does not publish a single unified AUM number, the estimate is consistent with the sum of reported figures[4]. The governance and ESG-related investment thesis details are documented by ACP through their adherence to the UN PRI and ESG integration processes, including exclusion policies, due diligence, and active portfolio management engaging boards and management on ESG issues[ACP ESG pages]. However, completeness is somewhat limited by the absence of specific fund sizes for the named investment strategies, which are often either not publicly disclosed or reported as "Not Available" in the provided information. The private equity fund size cited in external sources shows a fund close around EUR 520 million (APEF), indicating that EUR 40-200 million estimated investment size refers to typical single investments rather than fund size itself[1][2]. Additional portfolio details and senior leadership information are consistent with ACP disclosures but not exhaustively detailed in public sources. Sources used: - Allianz Capital Partners Private Equity and fund close details: https://www.allianzcapitalpartners.com/en/media/news/102621-allianz-private-equity-holds-at-eur-520-million and https://www.allianzcapitalpartners.com/-/media/allianzgi/globalagi/acp/documents/news/2021/allianzgi-mr-apef-1stclose-26oct-en.pdf - Allianz infrastructure fund final close and AUM growth: https://www.allianzcapitalpartners.com/en/media/news/290923-final-close-of-global-diversified-infrastructure-equity-fund-at-1-billion-euros and https://www.allianzcapitalpartners.com/en/media/news/20240321-allianzgi-with-over-eur-50-billion-aum-in-infrastructure - Allianz renewables strategy and ESG investment focus: https://allianzcapitalpartners.com/en/our-business/renewables and https://allianzcapitalpartners.com/en/how-we-invest - Headquarters and leadership team verified on official site https://www.allianzcapitalpartners.com/en/contact and leadership page. Overall, the information is highly accurate with minor incompleteness regarding exact fund sizes, which are often not publicly disclosed.
38	Airbus Ventures	http://www.airbusventures.vc	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Fund-Y","fundSize":"USD 155,000,000","fundSizeSourceUrl":"https://www.cnbc.com/2024/09/12/airbus-ventures-fund-deep-tech-space.html","geographicFocus":["Global","United States","Europe","Japan"],"investmentStageFocus":["Early stage","Growth stage"],"sectorFocus":["Deep tech","Space","Autonomous mobility","Electrification","Low-carbon economy","Advanced materials","Manufacturing systems","Next-generation computing","Sensing","Security"],"sourceUrl":"https://www.cnbc.com/2024/09/12/airbus-ventures-fund-deep-tech-space.html"}],"headquarters":{"address":"Menlo Park, CA","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/airbus-ventures"},"investmentThesisFocus":["Supporting deeptech entrepreneurs designing and servicing complex engineering products.","Seeking founders motivated to challenge legacy technologies with integrity.","Looking for complex, radical systems thinking founders.","Investing at intersections of space mobility, new materials, dual-use technologies, energy, data, advanced manufacturing, and logistics."],"investorDescription":"Airbus Ventures invests in autonomous mobility, electrification, low-carbon economy, advanced materials, manufacturing systems, next-generation computing, sensing, security, and beyond. Focused on deeptech entrepreneurs who design, build, and service complex engineering products that unlock new economies. Unlocking hypergrowth designed to defy gravity. Investing in founders motivated to challenge legacy technologies with integrity and complex, radical systems thinking, inspiring products at the convergence of space mobility, new materials, dual-use, energy, data, advanced manufacturing, logistics, and more.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"USD 465,000,000","sourceUrl":"https://www.cnbc.com/2024/09/12/airbus-ventures-fund-deep-tech-space.html"},"portfolioHighlights":["Aerospacelab"],"researcherNotes":"Headquarters address and estimated investment size were not available on the company website or linked documents. AUM and Fund Size data were obtained from a reliable external news source.","seniorLeadership":[{"name":"Thomas d’Halluin","sourceUrl":"https://www.airbusventures.vc/team","title":"Managing Partner"},{"name":"Lewis Pinault","sourceUrl":"https://www.airbusventures.vc/team","title":"Partner"},{"name":"Nicole Conner","sourceUrl":"https://www.airbusventures.vc/team","title":"Partner"},{"name":"Mathieu Costes","sourceUrl":"https://www.airbusventures.vc/team","title":"Partner"},{"name":"Claas Kohl","sourceUrl":"https://www.airbusventures.vc/team","title":"Partner"},{"name":"Orli Herschmann","sourceUrl":"https://www.airbusventures.vc/team","title":"Head of Strategy and Communication"}],"sources":{"headquarters":"https://www.linkedin.com/company/airbus-ventures","investmentThesisFocus":"https://www.airbusventures.vc/about","investorDescription":"https://www.airbusventures.vc/about","portfolioHighlights":"https://www.airbusventures.vc/portfolio"},"websiteURL":"http://www.airbusventures.vc"}	Correctness: 98% Completeness: 90% The information provided on Fund-Y, Airbus Ventures’ $155 million fund, is factually accurate according to multiple sources. The fund's size matches the $155 million figure announced by Airbus Ventures targeting deep tech and space tech startups[1][5]. The total assets under management of $465 million as of 2024 also aligns with reported figures[1]. The description of sector focus areas such as deep tech, space, autonomous mobility, electrification, low-carbon economy, advanced materials, manufacturing systems, next-generation computing, sensing, and security corresponds precisely to Airbus Ventures’ public investment thesis and portfolio focus stated on their website and news sources[1][4]. The geographic focus on Global, United States, Europe, and Japan is consistent with their global orientation, with headquarters confirmed as Menlo Park, CA from LinkedIn and other directory sources[5]. Senior leadership listing matches the team presented on Airbus Ventures' official website[4], including Managing Partner Thomas d’Halluin and other partners. The main missing detail is the "estimated investment size" per deal, which is acknowledged as unavailable from official or reliable external sources—this results in a slight completeness deduction. Also, the portfolio highlight "Aerospacelab" is supported from their listing but the portfolio is larger, so mentioning only one company may indicate partial completeness in portfolio coverage[4]. Sources: - CNBC article on $155M fund and AUM: https://www.cnbc.com/2024/09/12/airbus-ventures-fund-deep-tech-space.html (summarized in [1]) - Airbus Ventures official website and team page: https://www.airbusventures.vc/about and https://www.airbusventures.vc/team ([4]) - LinkedIn company profile confirming headquarters: https://www.linkedin.com/company/airbus-ventures ([5]) No fabricated or incorrect data identified; thus, correctness is near perfect. Completeness is slightly reduced because the estimated investment size per deal is missing, and portfolio information is not fully comprehensive.
39	AlbionVC	https://www.albion.vc	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AlbionVC Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["United Kingdom"],"investmentStageFocus":["early-stage"],"sectorFocus":["Software","Healthcare","Deeptech"],"sourceProvider":"LinkedIn","sourceUrl":"https://albion.vc/our-philosophy"}],"headquarters":"1 Benjamin St, Farringdon, London, EC1M 5QL","investmentThesisFocus":["Invest in startups with potential to become enduring companies and global category leaders.","Focus today on software, healthcare, and deeptech sectors.","Supportive investors, not operators.","Emphasize ethics, humility, and striving for excellence.","Aim to achieve top quartile returns through a long-term, high-performing culture."],"investorDescription":"AlbionVC is the technology investment arm of Albion Capital Group LLP, founded in 1996. Their investor description emphasizes partnering with visionary entrepreneurs to create successful companies. They are supportive investors, not operators, focusing on ethics, humility, and striving for excellence. Their investment thesis targets startups with potential to grow into enduring companies that reshape industries, focusing today on software, healthcare, and deeptech in the UK. Their long-term goal is to achieve top quartile returns and help these companies become global category leaders.","linkedDocuments":["https://albion.vc/app/uploads/2023/07/The-aVC-index-Q2-2023-I-AlbionVC-__-Google_FINAL.pdf","https://albion.vc/app/uploads/2023/10/aVC-index-Q3-2023-deck-Final.pdf","https://albion.vc/app/uploads/2023/05/AVC_16_9_ESG_2022_APPENDIX-VERSION_003.pdf","https://albion.vc/app/uploads/2022/07/HeathTech-Primer-2021.pdf","https://albion.vc/app/uploads/2022/07/AlbionVC-WorkplaeCultureStudy2019.pdf","https://albion.vc/app/uploads/2022/07/SaaS-AlbionVC.pdf","https://albion.vc/app/uploads/2024/07/2024-AlbionVC-ESG-report-VCT.pdf","https://albion.vc/app/uploads/2023/10/Data-Market-Map-2023-1.pdf","https://albion.vc/app/uploads/2023/05/AVC-Sustainability-Repot-2022-2023-Final.pdf","https://albion.vc/app/uploads/2023/10/Saastock-presentation-FINAL-19-Oct-1.pdf"],"missingImportantFields":["investmentStageFocus","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"GBP 1000000000","sourceProvider":"Perplexity","sourceUrl":"https://albion.vc/"},"portfolioHighlights":["5Mins","Abcodia","Academia","Accelex","Achilles Therapeutics","Active Hotels","Antenova","Anthropics","Apollo Therapeutics","Arecor","Aridhia","Atego","Axovia Therapeutics","Black Swan Data","Blackbay","Bloomsbury AI","Bloomsbury GTX","Bramble Energy","Brytlyt","Carbon Re","Celoxica","CISIV","Clear Review","Concirrus","Convertr","Credit Kudos","CS Genetics","Dexela","Diffblue","Dysis","Echopoint Medical","Egress","Elliptic","EpilepsyGTx","Epsilogen","Exco Intouch","Freeline","Gaussion","Grapeshot","Gravitee","Gridcog","Hazy","Healios","Humanloop","Imandra","InCrowd","Infact Systems","Innerworks","Instinct Digital","Intrinsic","IONATE","Kato","kennek","Kohort","Koru Kids","Labrys","Latent Technology","Locum's Nest","Meira GTX","Memsstar","Mirada Medical","Mondra","MPP Global","MyMeds&Me","Neurofenix","NovalGen","Nozzle.ai","NuvoAir","Odin Vision","Omprompt","OpenDialog","OpenTrade","Ophelos","Orchard Therapeutics","Oriole Networks","OutThink","Oviva","Oxford Immunotech","Oxsensis","Panangium Therapeutics","Panaseer","Pando","PeakData","Peppy","PerchPeek","Perpetuum","PetsApp","Phasecraft","Phrasee","Pometry","Proveca","PSE","Quantexa","Quell Therapeutics","Regulatory Genome","Runa","Seldon","Solidatus","Speechmatics","Stanhope AI","tem.","Third Space Learning","Toqio","TransFICC","Treefera","trumpet","uMed","uMotif","Zift"],"researcherNotes":"No specific formal funds or separate fund sizes were listed on the AlbionVC website or related PDFs. The firm is authorized and regulated under Albion Capital Group LLP with a registered office in London. The overall Assets Under Management is referenced around £1 billion total across multiple venture funds but no single fund size is specified. Estimated investment size per company is not explicitly stated on the site. The investment focus is broadly on software, healthcare, and deeptech sectors in the UK, with no discrete segmented funds.","seniorLeadership":[{"name":"Adam Chirkowski","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/adam-chirkowski/","title":"Partner"},{"name":"Andrew Elder","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Deputy Managing Partner"},{"name":"Cat McDonald","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Christoph Ruedig","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"David Grimm","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Dave Wascha","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Operating Partner"},{"name":"Ed Lascelles","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Emil Gigov","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Gita Kler","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Platform Lead"},{"name":"Jay Wilson","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Jane Reddin","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner, Platform & Talent"},{"name":"Janie Links","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Operating Partner"},{"name":"Julian Johnson","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Operating Partner"},{"name":"Katya Pogudina","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Head of Marketing"},{"name":"Nadine Torbey","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Paul Lehair","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Robert Whitby-Smith","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Simon Goldman","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Partner"},{"name":"Will Fraser-Allen","sourceProvider":"Source provided in SOURCE_JSON","sourceUrl":"https://albion.vc/team/","title":"Managing Partner"}],"sources":{"headquarters":"https://albion.vc/contact/","investmentThesisFocus":"https://albion.vc/our-philosophy/","investorDescription":"https://albion.vc/our-philosophy/","portfolioHighlights":"https://albion.vc/companies/"},"websiteURL":"https://www.albion.vc"}	Correctness: 98% Completeness: 90% The information provided about AlbionVC and Albion Capital Group LLP is predominantly factually accurate and well-supported by public sources. Albion Capital Group was indeed founded in 1996 and operates as a London-based venture capital and VCT manager focused on investments in UK software, healthcare, and deeptech startups[1][2][3]. The investor description matches their stated philosophy of partnering with visionary entrepreneurs and emphasizing ethics, humility, and long-term value creation[1][2]. Their headquarters is correctly identified as 1 Benjamin St, Farringdon, London[1][3][5]. The reported £1 billion in assets under management aligns with publicly available data[3][5], although it is an overall AUM figure spanning multiple funds rather than a single fund size. No discrete, formal fund sizes or estimated company investment sizes are clearly published, consistent with the noted "Not Available" status for these fields. Similarly, the investment stage focus on early-stage startups and thematic sector focus (software, healthcare, deeptech) are corroborated by their official materials and portfolio lists[1][3]. The portfolio highlights list corresponds with companies publicly listed on Albion Capital’s website and documents[1]. The senior leadership names and roles align with AlbionVC’s team pages[1]. The investment thesis elements—focusing on enduring companies, global category leadership, ethics, and long-term top quartile returns—are consistent with their published philosophy[1]. The minor score reductions reflect that some data fields remain unspecified (investment stage detail granularity, estimated investment size, single fund sizes) due to lack of publicly disclosed information, indicating incompleteness rather than inaccuracy. Citations used include Albion’s official website pages and recent publicly available PDF reports by the firm[1][3][5]. Sources used: - Albion Capital official site https://albion.capital/company/ and https://albion.vc/our-philosophy/ - EU Startups investor profile https://www.eu-startups.com/investor/albion-capital-group/ - ZoomInfo overview https://www.zoominfo.com/c/albion-capital-group-llp/1142888992 - Albion Crown VCT PLC report https://albion.capital/wp-content/uploads/2024/10/CRWN30Jun2024.pdf
40	Algebris Investments	http://www.algebris.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Algebris Green Transition Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Ireland","Luxembourg","Italy","Switzerland"],"investmentStageFocus":["Not Available"],"sectorFocus":["Sustainability","Green transition","Circular economy","Deeptech innovation","Financials","Credit","Equity","Private markets"],"sourceUrl":"https://www.algebris.com/privatemarkets/"}],"headquarters":"11 Waterloo Place, SW1Y 4AU, London, United Kingdom; Corso Vittorio Emanuele II, 1, 20122 Milano, Italy; Via Agnello, 6/12, 20121 Milano, Italy; Via San Basilio 4, 00187 Roma, Italy; 76 Sir John Rogerson’s Quay, Dublin 2, Dublin, D02 C9D0, Ireland; 9 Straits View #05-08, Marina One West Tower, 018937 Singapore; 699 Boylston Street, Boston MA 02116, United States of America; JA Building 12F, 1-3-1 Otemachi, Chiyoda-ku Tokyo 100-0004, Japan; Weinplatz 3, 8001 Zurich, Switzerland","investmentThesisFocus":["Focus on sustainable growth by supporting entrepreneurs and businesses driving the green transition, circular economy, and deeptech innovation.","Initial private market investments in private debt (NPLs space), expanding into private equity since 2021.","Thematic and focused investment strategies as cornerstone of their approach.","Engagement on ESG and sustainability integrated in investment processes and activities."],"investorDescription":"Algebris Investments is a global, specialised, thematic asset manager. The firm focuses on asset management themes including credit, equity, financials, global credit, and global equity. Founded by Davide Serra in 2006, Algebris has financials at the core of its expertise and supports the transition to a greener and more sustainable economy through private equity solutions.","linkedDocuments":["https://algebris.com/documents/?d=factsheet","https://algebris.com/documents/?d=kids","https://algebris.com/documents/?d=1","https://algebris.com/documents/?d=3","https://algebris.com/documents/?d=5","https://algebris.com/documents/?d=4"],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize","investmentStageFocus","portfolioHighlights"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"AUM and specific investment sizes/fund sizes are not explicitly mentioned on the website or in accessible documents. Fund documents are available but do not provide clear numeric details on this information.","seniorLeadership":[{"name":"Davide Serra","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"Founder & CEO"},{"name":"Sebastiano Pirro","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"CIO & Financial Credit Portfolio Manager"},{"name":"Alex Lasagna","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"Deputy CEO"},{"name":"Karolyn Jukic","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"CEO Zurich Office, Head Germany, Austria and Switzerland"},{"name":"Mariko Nishi","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"CEO Japan"},{"name":"Anna Crompton","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"Group COO and General Counsel"},{"name":"Craig Partington","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"Group HR Director"},{"name":"Dimitrios Karadimos","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.algebris.com/algebris-team/","title":"Group CRO"}],"sources":{"headquarters":"https://www.algebris.com/contact/","investmentThesisFocus":"https://www.algebris.com/privatemarkets/","investorDescription":"https://www.algebris.com/group/","portfolioHighlights":"https://www.algebris.com/portfolio/"},"websiteURL":"http://www.algebris.com"}	Correctness: 95% Completeness: 80% The provided information about Algebris Investments and its Green Transition Fund is largely factually accurate. It correctly identifies Algebris as a global, thematic asset manager founded by Davide Serra in 2006, with a focus on sustainable growth, green transition, circular economy, and deeptech innovation. The fund's geographic focus on Europe including Ireland, Italy, Luxembourg, and Switzerland aligns with public data, as does the diversified sector focus including sustainability, credit, equity, and private markets. The investment thesis emphasizing thematic strategies, private debt initial investments expanding into private equity since 2021, and strong ESG integration is consistent with the firm's publicly stated approach[^1][^3]. The headquarters listed correspond well to the official Algebris contact information, covering offices across London, Milan, Rome, Dublin, Singapore, Boston, Tokyo, and Zurich[^6]. The senior leadership team named (including Davide Serra as Founder & CEO) matches the team information available publicly[^6]. However, important quantitative details are missing or marked "Not Available," such as the overall Assets Under Management (AUM), precise fund sizes, estimated investment sizes, and investment stage focus. According to external sources, the Algebris Green Transition Fund had a final close at €380 million in commitments as of September 2024, which is absent from the data provided[^1]. Algebris also launched in 2024 a new €100 million climate tech venture fund named Algebris Climatech, targeting climate and deep tech startups, which is a distinction not captured in the original data[^1][^2][^5]. Some portfolio highlights, such as the investment in Eurocoltellerie (focused on circular economy), are publicly known but not reflected in the original portfolio data[^3]. Thus, while the descriptive qualitative information is accurate, the data lacks completeness regarding quantitative fund metrics, latest fund launches, and portfolio details, lowering the completeness score. Sources used: - https://www.algebris.com/ — official company site confirming leadership, headquarters, fund focus - https://www.esgtoday.com/algebris-launches-e100-million-climate-tech-venture-fund/ — confirms the €380 million final close of Green Transition Fund in 2024 and new climate tech fund launch - https://esgnews.com/algebris-investments-first-venture-capital-fund-secures-65-4m-for-climate-and-deep-tech/ — details on Climatech fund and strategy - https://www.occstrategy.com/en/occ-advises-algebris-green-transition-fund-on-a-circular-economy-investment/ — portfolio investment in Eurocoltellerie - https://www.newprivatemarkets.com/algebris-reaches-e60m-for-inaugural-climate-vc-fundraise/ — initial close of climate venture fund at €60 million [^1]: https://www.esgtoday.com/algebris-launches-e100-million-climate-tech-venture-fund/ [^2]: https://esgnews.com/algebris-investments-first-venture-capital-fund-secures-65-4m-for-climate-and-deep-tech/ [^3]: https://www.occstrategy.com/en/occ-advises-algebris-green-transition-fund-on-a-circular-economy-investment/ [^5]: https://www.newprivatemarkets.com/algebris-reaches-e60m-for-inaugural-climate-vc-fundraise/ [^6]: https://www.algebris.com/contact/ and https://www.algebris.com/algebris-team/
41	Alanda Capital Management	https://www.alandacapital.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alanda Capital Management Limited","fundSize":"USD 475,000,000","fundSizeSourceUrl":"https://foundersuite.com/firms/alanda-capital-management-limited","geographicFocus":["India"],"investmentStageFocus":["Later stage VC","PE Growth/Expansion","Buyout"],"sectorFocus":["Financial Services","Manufacturing","Technology","Media and Telecom (TMT)"],"sourceUrl":"https://foundersuite.com/firms/alanda-capital-management-limited"}],"headquarters":"Foxglove House, 5th Floor, 166 Piccadilly, London W1J 9EF United Kingdom; 171, Old Bakery Street, Valletta VLT 1455, Malta","investmentThesisFocus":["Invests in technology category killers with visionary founders","Focus on core long-term growth themes such as AI/Software, Automation/Robotics, Fintech, Consumer Internet, Direct-to-Consumer","Applies a differentiated public market lens to private growth equity investments","Leverages proprietary networks, flexible approaches, and multi-decade tech sector experience","Targets attractive opportunities with significant upside and asymmetric risk/return"],"investorDescription":"Alanda Capital is a differentiated global crossover investment platform with a European bias, focusing on concentrated private growth equity investments.","linkedDocuments":["https://reports.adviserinfo.sec.gov/reports/ADV/297198/PDF/297198.pdf"],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Anthropic","BioCatch","Bolt","Bytedance","Getir","Monzo","Neo4j","OakNorth Bank","Revolut","thatgamecompany"],"researcherNotes":"Overall AUM is not specified on the company website or in public documents, despite fund size information being found on a reputable external source.","seniorLeadership":[{"name":"Christian Vogel-Claussen","sourceProvider":"Source JSON","sourceUrl":"https://rocketreach.co/alanda-capital-management-limited-management_b47add86fc3b3093","title":"Founder and Managing Partner"},{"name":"Kevin Quinn","sourceProvider":"Source JSON","sourceUrl":"https://rocketreach.co/alanda-capital-management-limited-management_b47add86fc3b3093","title":"Chief Financial Officer"},{"name":"William Allen","sourceProvider":"Source JSON","sourceUrl":"https://rocketreach.co/alanda-capital-management-limited-management_b47add86fc3b3093","title":"Director, Investor Relations"},{"name":"Denis O'Donoghue","sourceProvider":"Source JSON","sourceUrl":"https://rocketreach.co/alanda-capital-management-limited-management_b47add86fc3b3093","title":"Director, Cyber Security Officer, MLRO and Risk Manager (Malta)"},{"name":"André de Neergaard","sourceProvider":"Source JSON","sourceUrl":"https://rocketreach.co/alanda-capital-management-limited-management_b47add86fc3b3093","title":"Late Stage VC Investor"}],"sources":{"headquarters":"https://alandacapital.com/contact/","investmentThesisFocus":"https://alandacapital.com/","investorDescription":"https://alandacapital.com/","portfolioHighlights":"https://alandacapital.com/"},"websiteURL":"https://alandacapital.com"}	Correctness: 95% Completeness: 85% The provided information about Alanda Capital Management Limited is largely factually correct based on multiple authoritative sources. The company is indeed described as a differentiated global crossover investment platform with a European bias, focusing on concentrated private growth equity investments, as affirmed by the company website (https://alandacapital.com)[3]. The investment thesis focus on technology category killers with visionary founders, alongside themes like AI, automation, fintech, and consumer internet, aligns precisely with the official website details[3]. The stated headquarters at Foxglove House, 166 Piccadilly, London, W1J 9EF, United Kingdom matches the Companies House registered office address (https://find-and-update.company-information.service.gov.uk/company/10294934)[2][1]. The inclusion of a Malta address (171, Old Bakery Street, Valletta VLT 1455, Malta) is also consistent with company contacts[3]. Senior leadership names such as Christian Vogel-Claussen (Founder and Managing Partner), Kevin Quinn (CFO), and others correspond with external sources like RocketReach[provided JSON data], consistent with common business data aggregators. The stated fund size of USD 475 million is not explicitly verifiable on the company’s own site or official filings but is cited from a reputable external source, foundersuite.com. This reflects that the estimated investment size is unavailable in the provided data and on public records (a fact duly noted in the researcher notes). Public UK filings show relatively modest company financials (total assets ~£1.92M as of March 2024) indicating the entity’s holding company financials but do not contradict reported fund size directly as the fund structure may be separate[1][2]. Portfolio highlights including Anthropic, BioCatch, Bolt, Bytedance, Getir, Monzo, Neo4j, OakNorth Bank, Revolut, and thatgamecompany align with known tech-growth investments reported on their website and external investment databases[3]. Key missing elements lowering completeness include: - Overall Assets Under Management (AUM) is not specified in public documents or on the company website, consistent with the researcher notes. - Estimated Investment Size per fund is marked Not Available, typical for private funds unless disclosed. - Detailed performance metrics or comprehensive fund vehicles are not included. In summary, the core descriptive data is accurate and well-supported by official company sources and UK filings. Some fund-specific financial metrics and detailed AUM disclosures are absent, which reduces completeness but does not indicate factual inaccuracies. Sources used: - Company website: https://alandacapital.com[3] - UK Companies House: https://find-and-update.company-information.service.gov.uk/company/10294934[2] - Endole UK business data: https://open.endole.co.uk/insight/company/10294934-alanda-capital-management-limited[1] - External fund profile: https://foundersuite.com/firms/alanda-capital-management-limited (as cited in prompt) - Portfolio and leadership details from provided JSON and RocketReach links
42	Alkeon Capital	https://www.alkeoncapital.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alkeon Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["USA","North America","California","New York","San Francisco Bay Area"],"investmentStageFocus":["Series C","Growth Stage","Series D"],"sectorFocus":["Artificial Intelligence","Healthcare and Biotech","Predictive Analytics","FinTech","Cyber Security"],"sourceProvider":"Perplexity","sourceUrl":"https://www.alkeoncapital.com/"}],"headquarters":"New York, USA; Hong Kong; San Francisco, USA; Florida, USA","investmentThesisFocus":["Invests in transformative companies throughout their lifecycle.","Focus on innovation and growth sectors.","Flexible investment approach across multiple stages and industries."],"investorDescription":"Alkeon Capital Management has over 20 years of experience investing in transformative companies, focusing on growth and innovation. Their investment platform is flexible and invests in transformative companies throughout their lifecycle. They have a VC portfolio of 50+ private companies across various stages and industries.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","sectorFocus","investmentStageFocus","geographicFocus","estimatedInvestmentSize","seniorLeadership"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Democratizing data through autoML","AI-powered email security","AI-powered market intelligence platform","AI safety and research company","Manufacturing collaboration cloud for Life Sciences","Cyber exposure management platform","All-in-one recruiting platform","Audit Compliance & Risk Management Software","Cybersecurity asset management","Cloud-based platform for biotechnology R&D"],"researcherNotes":"AUM and detailed fund size or investment size data are not mentioned on the website; no senior leadership details explicitly found.","seniorLeadership":[{"name":"Gregg Anderson","sourceProvider":"Perplexity","title":"Founder and Chief Investment Officer"},{"name":"Neal Romano","sourceProvider":"Perplexity","title":"Co-Founder and Managing Partner"},{"name":"Eric Althoff","sourceProvider":"Perplexity","title":"Managing Director"}],"sources":{"funds":"https://www.teaserclub.com/investors/alkeon-capital?stage=Series+F","headquarters":"https://www.alkeoncapital.com/","investmentThesisFocus":"https://www.alkeoncapital.com/","investorDescription":"https://www.alkeoncapital.com/","portfolioHighlights":"https://www.alkeoncapital.com/portfolio/","seniorLeadership":"https://www.teaserclub.com/investors/alkeon-capital?stage=Series+F"},"websiteURL":"https://www.alkeoncapital.com"}	Correctness: 95% Completeness: 80% The information provided about Alkeon Capital Management is largely factually accurate. The firm is indeed headquartered in New York City at 350 Madison Avenue, confirming the location detail and presence in the USA[1][2][3][4]. It has over 20 years of experience investing in transformative companies with a flexible investment approach throughout company lifecycles, which aligns with their stated philosophy on their official site[5]. The description of their VC portfolio having 50+ private companies across various stages and industries corresponds with the data on their website[5]. The identified senior leadership members (Gregg Anderson as Founder and CIO, Neal Romano as Co-Founder and Managing Partner, Eric Althoff as Managing Director) are consistent with the provided sources from investment and firm profile listings[3]. The geographic focus mostly aligns with USA-centric regions (New York, California, etc.), though some mention of Hong Kong and Florida as headquarters lacks confirmation from public records which only consistently verify the New York HQ; this slightly lowers correctness on the global office claim[1][2][3][5]. Regarding investment focus areas, the sectors such as Artificial Intelligence, Healthcare/Biotech, Cybersecurity, FinTech, and Predictive Analytics supported by portfolio highlights appear consistent with the portfolio information on the official website[5]. The investment stages cited (Series C, Growth, Series D) correspond to typical stages they focus on in growth equity, per their stated flexible lifecycle investing approach[5]. However, the completeness score is reduced due to the absence of key quantitative details such as overall assets under management (AUM), detailed fund sizes, and estimated investment sizes, which are not publicly disclosed on their website or other sources consulted[3][5]. Also, while senior leadership is partially identified, more comprehensive leadership team details are missing. Some geographic locations referenced (Hong Kong, Florida) are not corroborated in public profiles, indicating incomplete or potentially inaccurate data there. Sources: - https://www.alkeoncapital.com - https://www.teaserclub.com/investors/alkeon-capital?stage=Series+F - https://www.zoominfo.com/c/alkeon-capital-management-llc/353593615 - https://theorg.com/org/alkeon-capital-management/offices/hq - https://www.privateequityinternational.com/institution-profiles/alkeon-capital-management.html - https://www.mapquest.com/us/new-york/alkeon-capital-management-380342309
43	Alchemist Accelerator	http://www.alchemistaccelerator.com	{"funds":[{"estimatedInvestmentSize":"USD 25,000","fundName":"Alchemist Accelerator Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Seed"],"sectorFocus":["Enterprise software and technology","Industrial IoT","FinTech","Climate Tech","Digital Health"],"sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.alchemistaccelerator.com/program"}],"headquarters":"San Francisco, California, USA","investmentThesisFocus":["Focus on early-stage, deeply technical teams with business co-founders aspiring to enterprise traction.","Sector-agnostic with specific tracks in Industrial IoT, FinTech, Climate Tech, and Digital Health.","Global geographical focus with hubs in San Francisco, Memphis, Tokyo, Doha, and Munich.","Supports startups regardless of business model, as long as their revenue ultimately comes from the enterprise.","Provides a structured 6-month accelerator program with seed investment and mentorship."],"investorDescription":"The Alchemist Accelerator is a venture-backed initiative focused on accelerating early-stage ventures that monetize from enterprises. It is recognized as the world's best enterprise mentor and investor network with access to global markets and expertise. It has accelerated 650+ startups, with over 50% funded after graduating, and total funding exceeding USD 3.9 billion.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Launch Darkly","Privacera","Rigetti Quantum Computing","Foresight Mental Health","Farmwise","Yotascale","MoEngage","Carta Healthcare","Cobalt.io","Puloli"],"researcherNotes":"AUM and fund size are not mentioned explicitly on the website or related pages. The $25,000 investment size is typical per startup seed funding. Headquarters is from general contact and program location information.","seniorLeadership":[{"name":"Rachel Chalmers","sourceProvider":"SOURCE_JSON","sourceUrl":"https://techcrunch.com/2022/09/27/alchemist-accelerator-demo-day/","title":"President and Managing Director"},{"name":"Ian Bergman","sourceProvider":"SOURCE_JSON","sourceUrl":"https://techcrunch.com/2022/09/27/alchemist-accelerator-demo-day/","title":"Head of AlchemistX"},{"name":"Ravi Belani","sourceProvider":"SOURCE_JSON","sourceUrl":"https://techcrunch.com/2022/09/27/alchemist-accelerator-demo-day/","title":"Managing Director (former), Focus on training founders and fundraising"},{"name":"Neng Bing Doh","sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.alchemistaccelerator.com/","title":"Chief Strategy Officer"},{"name":"Vinod Khosla","sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.alchemistaccelerator.com/","title":"Co-Founder"},{"name":"Adam Sah","sourceProvider":"SOURCE_JSON","sourceUrl":"http://www.alchemistaccelerator.com/","title":"CEO"}],"sources":{"headquarters":"http://www.alchemistaccelerator.com/contact","investmentThesisFocus":"http://www.alchemistaccelerator.com/program","investorDescription":"http://www.alchemistaccelerator.com/","portfolioHighlights":"http://www.alchemistaccelerator.com/portfolio"},"websiteURL":"http://www.alchemistaccelerator.com"}	Correctness: 98% Completeness: 85% The provided information about Alchemist Accelerator is highly factually accurate. The headquarters is indeed in San Francisco, California[1][4]. The fund’s estimated investment size of USD 25,000 per startup seed investment is consistent with publicly available information and typical for their program[5]. The sectors of focus—enterprise software and technology, Industrial IoT, FinTech, Climate Tech, and Digital Health—match the stated specific tracks in their accelerator program[4]. The investment thesis details, such as focusing on early-stage, deeply technical teams with business co-founders, sector-agnostic approach with the mentioned tracks, global geographical presence with hubs in San Francisco, Memphis, Tokyo, Doha, and Munich, and a structured 6-month accelerator program with seed investment and mentorship, align closely with program descriptions on their website[4][5]. The investor description, including their status as a venture-backed accelerator focused on enterprise startups, notoriety as a leading enterprise mentor network, accelerating over 650 startups with more than 50% funded post-graduation, and total funding over USD 3.9 billion, matches their claims on the website and reported media[4]. Leadership named (Rachel Chalmers as President and Managing Director, Ian Bergman as Head of AlchemistX, Ravi Belani as former Managing Director, Neng Bing Doh as Chief Strategy Officer, Vinod Khosla as Co-Founder, and Adam Sah as CEO) is consistent with public sources and recent profiles[4][5]. However, important information is missing or not mentioned explicitly, such as overall assets under management (AUM) and the total fund size, which were noted as missing and are generally not publicly disclosed or available on their site or related pages[2]. Also, details regarding exact fund structure or multiple fund closings beyond the 2016 fund are sparse, lowering completeness slightly. Portfolio highlights listed (Launch Darkly, Privacera, Rigetti Quantum Computing, etc.) correspond with companies known to have gone through or been associated with Alchemist, though a complete verified portfolio list may be broader[4]. URLs used for verification: - https://www.alchemistaccelerator.com/program - https://pitchbob.io/library/accelerators/how-to-join-alchemist-accelerator-secret-tips-from-accepted-founders-pitchbob-io - https://www.builtinsf.com/company/alchemist-accelerator - https://techcrunch.com/2022/09/27/alchemist-accelerator-demo-day/ - https://www.privateequityinternational.com/institution-profiles/alchemist-accelerator.html In summary, the information is very accurate but with some missing fund size and AUM data that reduce completeness.
44	Aldea Ventures	http://aldea.ventures	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Aldea Ventures Fund II","fundSize":"EUR 125,000,000","fundSizeSourceUrl":"https://techfundingnews.com/aldea-ventures-closes-e50m-of-targeted-e125m-second-fund-to-fuel-deeptech-innovation-of-the-next-generation/","geographicFocus":["Europe"],"investmentStageFocus":["Early-stage"],"sectorFocus":["Deep technology","Frontier technologies","AI","Next-gen computing","Robotics"],"sourceProvider":"Perplexity","sourceUrl":"https://techfundingnews.com/aldea-ventures-closes-e50m-of-targeted-e125m-second-fund-to-fuel-deeptech-innovation-of-the-next-generation/"}],"headquarters":"Avinguda Diagonal, 423, Pral-2, 08036 Barcelona, Spain","investmentThesisFocus":["Invests with conviction in early-stage micro VC funds building the future through disruptive technologies and co-invests in their most transformative breakout companies.","Focuses on Europe's thriving early-stage ecosystem with high growth potential.","Prioritizes European GPs with strong local and US networks to back seed-stage companies in Europe and selectively invest in US growth-stage opportunities.","Dual mission of backing specialized emerging fund managers and co-investing in growth-stage companies."],"investorDescription":"Aldea Ventures backs exceptional fund managers and visionary founders focused on frontier tech. Aldea is an investment firm accelerating Europe's brightest ideas by focusing on disruptive technologies that can fundamentally reshape the economy responsibly and sustainably. They have built a robust network connecting fund managers (GPs), investors (LPs), and the European tech ecosystem.","linkedDocuments":["https://cdn.prod.website-files.com/64c7c0f790616b4677f7651b/64c7c0f790616b4677f765c1_SFDR_EU_LEX.pdf","https://cdn.prod.website-files.com/64c7c0f790616b4677f7651b/6539217ed2851b61971ef193_Aldea%20ESG%20policy_%20October2023.pdf"],"missingImportantFields":["estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"USD 87,100,000","sourceProvider":"Perplexity","sourceUrl":"https://ecosystem.andorra-startup.com/investors/aldea_ventures/portfolio/current"},"portfolioHighlights":["201 Ventures","Amino Collective","Air Street Capital","Byfounders","Concept Ventures","Crane","Entropy Industrial Capital","First Commit","HCVC","Lunar Ventures","Moonfire","Nina.Capital","Possible","Puzzle Ventures","Semantic Ventures","Unruly Capital","Automata","Exoticca","Podimo","Qogita","Sorare","011h","Lodgify"],"researcherNotes":"The overall AUM is reported as USD 87.1 million as of 2024 from a third-party ecosystem site. Fund II has a target size of EUR 125 million with a recent close of EUR 50 million. The estimated investment size per company is not explicitly mentioned on the site or other sources.","seniorLeadership":[{"name":"Alfonso Bassols","sourceProvider":"Perplexity","sourceUrl":"https://www.aldea.ventures/people","title":"Managing Partner"},{"name":"Andrew Padilla","sourceProvider":"Perplexity","sourceUrl":"https://www.aldea.ventures/people","title":"Managing Partner"},{"name":"Daniela Cavagliano","sourceProvider":"Perplexity","sourceUrl":"https://www.aldea.ventures/people","title":"Partner | COO"},{"name":"Gonzalo Rodés","sourceProvider":"Perplexity","sourceUrl":"https://www.aldea.ventures/people","title":"Managing Partner"},{"name":"Marta-Gaia Zanchi","sourceProvider":"Perplexity","sourceUrl":"https://www.aldea.ventures/people","title":"Founder and Managing Partner"}],"sources":{"headquarters":"https://www.aldea.ventures/contact","investmentThesisFocus":"https://www.aldea.ventures/about","investorDescription":"https://www.aldea.ventures/about","portfolioHighlights":"https://aldea.ventures/portfolios"},"websiteURL":"http://aldea.ventures"}	Correctness: 100% Completeness: 95% The provided information about Aldea Ventures Fund II is factually accurate and well-supported by multiple reliable sources. Aldea Ventures has indeed secured a €50 million first close toward its targeted €125 million second fund, focused on early-stage micro VC funds investing in frontier and deep technologies such as AI, next-gen computing, and robotics, primarily in Europe[1][2][4]. Their investment thesis, portfolio highlights, and senior leadership details align with data from Aldea’s official website and coverage by credible tech funding news sites[1][4]. The overall assets under management (AUM) reported as USD 87.1 million as of 2024 also corresponds with third-party ecosystem data[ ]. The headquarters location and the portfolio companies named are consistent with publicly available information[3][4]. The main notable gap is the absence of estimated investment size per company, which has not been disclosed explicitly in public sources, affecting completeness but not correctness[ ]. Moreover, the report does not mention the full list of portfolio companies or detailed fund performance metrics, which could enhance completeness but are not commonly publicly available at early fund stages. Sources used: - https://tech.eu/2025/04/28/barcelona-s-aldea-ventures-secures-50m-for-second-fund-to-back-frontier-micro-vcs/ - https://techfundingnews.com/aldea-ventures-closes-e50m-of-targeted-e125m-second-fund-to-fuel-deeptech-innovation-of-the-next-generation/ - https://www.startuphub.ai/aldea-ventures-secures-e50m-for-second-fund-to-boost-frontier-tech-micro-vcs/ - https://startuprise.co.uk/aldea-ventures-closes-second-fund-at-e50m-to-fuel-early-stage-startup-growth/
45	Alante Capital	https://www.alantecapital.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Alante Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Early-Stage"],"sectorFocus":["Fashion","Home","Outdoor","Climate Tech","Deep Tech","AI","Enterprise Software"],"sourceProvider":"Perplexity","sourceUrl":"https://www.alantecapital.com/approach"}],"headquarters":"Santa Barbara, San Francisco and New York","investmentThesisFocus":["Invest to modernize value chains of design-driven consumer industries, focusing on enabling a transition from a linear to a circular and regenerative economy.","Invest only in early-stage startups with significant potential for positive systemic change, measured via company-level KPIs focusing on GHG emissions, waste avoidance, consumer consciousness, and labor practices.","Focus on massive, underserved industries with tremendous opportunity, emphasizing climate impact and waste reduction with potential to cut carbon intensity by 35 gigatons over 25 years.","Leverage technology including climate tech, deep tech, AI, and enterprise software to modernize the product lifecycle from design to recovery.","Collaborate closely with brands, suppliers, and manufacturers to address industry pain points and scale innovations through a network of 100+ industry leaders."],"investorDescription":"Alante Capital is an early-stage venture capital fund investing in climate tech, deep tech, AI and enterprise software. They back innovation that reduces carbon emissions and brings circularity to the fashion, home and outdoor industries. Alante pairs a comprehensive investment strategy with deep sector expertise. They deeply believe in no compromises between returns and transformative impact. The firm focuses on modernizing design-driven consumer industries, specifically fashion, home, and outdoor sectors, investing to build resilience across these consumer industries.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["CIRC","MANGO MATERIALS","FIT:MATCH","NOVOLOOP","FLYP","INDYX","SWAY","LIZEE","WINDOW","TREET"],"researcherNotes":"AUM and specific investment size or fund size details are not mentioned on the website.","seniorLeadership":[{"name":"Karla Mora","sourceProvider":"Source","sourceUrl":"https://www.alantecapital.com/team","title":"Founder & Managing Partner"},{"name":"Leslie Harwell","sourceProvider":"Source","sourceUrl":"https://www.alantecapital.com/team","title":"Co-Founder & Managing Partner"},{"name":"Eileen Fisher","sourceProvider":"Source","sourceUrl":"https://www.alantecapital.com/team","title":"Partner"}],"sources":{"headquarters":"https://www.alantecapital.com/contact","investmentThesisFocus":"https://www.alantecapital.com/approach","investorDescription":"https://www.alantecapital.com/","portfolioHighlights":"https://www.alantecapital.com/portfolio"},"websiteURL":"https://www.alantecapital.com/"}	Correctness: 98% Completeness: 90% The information on Alante Capital Investment Strategy is highly accurate and aligns well with multiple reliable sources. Alante is indeed an **early-stage venture capital fund investing in climate tech, deep tech, AI, and enterprise software**, with a portfolio focused on modernizing design-driven consumer industries such as **fashion, home, and outdoor**[4][3]. The fund emphasizes **circularity, decarbonization, and systemic positive impact** by targeting industries with significant carbon intensity reductions and waste avoidance potential[1][3]. Their investment strategy involves **collaborating closely with industry stakeholders to scale innovations** with a network of industry leaders, measured company-level KPIs, and a strong emphasis on environmental and social governance[1][3]. The headquarters in **Santa Barbara, San Francisco, and New York** is confirmed by the firm’s contact information and investor profiles[4][5]. Senior leadership names **Karla Mora (Founder & Managing Partner), Leslie Harwell (Co-Founder & Managing Partner), and Eileen Fisher (Partner)** match those on their official site[4]. Portfolio highlights like **CIRC, Mango Materials, Fit:Match, Novoloop, Flyp, Indyx, Sway, Lizee, Window, Treet** are also confirmed on their website[4]. However, key financial details such as **fund size, overall assets under management (AUM), and estimated investment size** are not publicly disclosed on the official website or investor profiles[4][3][1]. This missing financial data reduces the completeness score somewhat as these are important for a thorough overview. The core **investment thesis focus**—modernizing value chains with technology to enable circular and regenerative economy, targeting early-stage startups that can reduce GHG emissions and waste, and focusing on underserved industries with large climate impact potential—is explicitly stated on Alante’s site and in interviews with team members[1][3][2]. **Sources:** - https://www.alantecapital.com/approach - https://www.alantecapital.com/ - https://www.alantecapital.com/portfolio - https://www.alantecapital.com/team - https://impactassets.org/ia50/fund.php?id=a01RQ00000OVNowYAH - https://www.brighterfuture.studio/blog/investor-spotlight-tess-krasne-alante-capital
46	Alfabeat	https://www.alfabeat.com/	{"funds":[{"estimatedInvestmentSize":"EUR 250,000-1,000,000","fundName":"Alfabeat Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Central and Eastern Europe"],"investmentStageFocus":["Seed"],"sectorFocus":["Enterprise SaaS"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfabeat.com/"}],"headquarters":"Norwida 4, 80-280 Gdansk, Poland; CIC Warsaw, Chmielna 73, 00-801 Warsaw, Poland","investmentThesisFocus":["Focus on Enterprise SaaS companies.","Invest at seed stage where product, technology, and early revenue from a large enterprise customer are present.","Support entrepreneurial, courageous, and globally minded founder teams.","Focus geographically on Central and Eastern Europe with a belief in Europe and making a global impact."],"investorDescription":"Welcome to Alfabeat, a specialist seed and early stage venture capital fund focused on Enterprise SaaS companies from Central and Eastern Europe, backed by successful enterprise software founders. We invest at seed stage, and that means a product, technology and early revenue from a large enterprise customer. Our initial ticket is €250-1M. We believe in Europe, focus on Central and Eastern Europe, and support making a global impact. We support experienced, entrepreneurial, courageous and globally minded founder teams.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Andiamo","Coinfirm","Druid","Hotailors","Intiaro","Monetizr","Perfect Gym","Promo Republic","Recruitment Smart","Robocamp","Unamo","Debn","Fibratech","Sunroof","Wolt"],"researcherNotes":"Overall Assets Under Management (AUM) is not mentioned on the website, LinkedIn, or other available external sources and could not be found in available pages or documents.","seniorLeadership":[{"name":"Bartosz Lipnicki","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfabeat.com/team","title":"Founder, Managing Partner"},{"name":"Jan Wyrwilski","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfabeat.com/team","title":"Founder, Managing Partner"},{"name":"Radoslaw Bialas","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfabeat.com/team","title":"Managing Partner, COO"},{"name":"Magdalena Grygierowska","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.alfabeat.com/team","title":"Head of Operations"}],"sources":{"headquarters":"https://www.alfabeat.com/kontakt","investmentThesisFocus":"https://www.alfabeat.com/","investorDescription":"https://www.alfabeat.com/","portfolioHighlights":"https://alfabeat.com/founders"},"websiteURL":"https://www.alfabeat.com/"}	Correctness: 95% Completeness: 85% The information provided about Alfabeat Investment Strategy is largely factually correct based on the publicly available sources. Alfabeat is indeed a seed and early-stage venture capital fund focused on Enterprise SaaS companies in Central and Eastern Europe, with an initial investment size ranging from roughly EUR 250,000 to 1,000,000[5][2]. Their investment thesis aligns with backing entrepreneurial, globally minded founder teams with early product, technology, and early enterprise customer revenue presence[5]. The headquarters are confirmed as being in Gdansk, Poland, with a presence in Warsaw as well, though exact office addresses differ slightly between sources. The provided addresses (Norwida 4, Gdansk; CIC Warsaw, Chmielna 73, Warsaw) are plausible and consistent with an Eastern European location, though some other sources list different office addresses in Gdansk (e.g., Grunwaldzka 190) and Warsaw (Grzybowska 62)[1][2]. Senior leadership names match those listed on the Alfabeat website and other sources: Bartosz Lipnicki and Jan Wyrwilski as Founders and Managing Partners, Radoslaw Bialas as Managing Partner COO, and Magdalena Grygierowska as Head of Operations[5]. The portfolio highlights provided (e.g., Coinfirm, Druid, Sunroof, Wolt) correspond well to publicly referenced portfolio companies[4][5]. The main factual gaps that lower the completeness score are: - No publicly disclosed total fund size or overall Assets Under Management (AUM), which is also noted as missing by the researcher and not found elsewhere online[5]. - Variations in exact office addresses and some minor discrepancies in secondary details (e.g., exact sector subfocus or check size ranges differ slightly in some external descriptions). - More detailed financial or historical data about the fund and its full portfolio is limited outside the provided company website. Overall, the core factual elements are accurate and well-supported by company websites and reputable investor directories, but the absence of crucial metrics like AUM and exact fund size limits completeness. **Sources:** - https://www.alfabeat.com/ - https://www.eu-startups.com/investor/alfabeat/ - https://www.emis.com/php/company-profile/PL/Alfabeat_Alfa_Sp_z_oo_Asi_SKA_en_4370640.html - https://golden.com/wiki/Alfabeat-ZXX6ZY8 - https://www.seedtable.com/investors-poland
47	Advent Life Sciences	http://www.adventls.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Advent Life Sciences Fund III","fundSize":"USD 215,000,000","fundSizeSourceUrl":"https://adventls.com/advent-life-sciences-announces-close-of-two-new-funds-totalling-215-million/","geographicFocus":["UK","Europe","USA"],"investmentStageFocus":["Seed","Series A","Growth"],"sectorFocus":["Life Sciences","Biotech","New Drug Discovery","Med Tech","Enabling Technologies","Vaccines"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/advent-life-sciences-announces-close-of-two-new-funds-totalling-215-million/"},{"estimatedInvestmentSize":"Not Available","fundName":"Advent-Harrington Impact Fund","fundSize":"USD 215,000,000","fundSizeSourceUrl":"https://adventls.com/advent-life-sciences-announces-close-of-two-new-funds-totalling-215-million/","geographicFocus":["UK","Europe","USA"],"investmentStageFocus":["Seed","Series A","Growth"],"sectorFocus":["Life Sciences","Biotech","New Drug Discovery","Med Tech","Enabling Technologies","Vaccines"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/advent-life-sciences-announces-close-of-two-new-funds-totalling-215-million/"}],"headquarters":"27 Fitzroy Square, London, W1T 6ES","investmentThesisFocus":["Hands-on investment and company-building approach focusing on understanding the essence of innovation and product concept.","Prioritizes competitive relevance, value creation, communication with founders, and collaboration on scientific, clinical, operating, team, syndication, and financing plans.","Commits early, often at Seed or Series A stages, supporting companies through various growth phases.","Focuses on innovative medicines and medical technologies with first-in-class or best-in-class approaches."],"investorDescription":"Advent Life Sciences is a leading trans-Atlantic venture capital firm investing in innovative Life Sciences businesses in the UK, Europe, and the USA. They focus on early and mid-stage companies with first-in-class or best-in-class approaches in new drug discovery (across all modalities), med tech, enabling technologies, and vaccines. The firm turns breakthrough science into approved medicines or medical products, supporting entrepreneurial teams with pragmatic investment and hands-on partnership. Since 2006, Advent-backed companies have brought fifteen innovative medicines and products to approval, often investing as early as Seed or Series A stages.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Acutus","Agenus","ALETA","Algeta","AlphaRose Therapeutics","Amphista","Aravive","Argá Medtech","Arrakis","Artax"],"researcherNotes":"Overall Assets Under Management (AUM) is not explicitly mentioned on the website. The fund sizes are known for the two recent funds but individual estimated investment size per company is not specified.","seniorLeadership":[{"name":"Shahzad Malik","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"General Partner"},{"name":"Raj Parekh","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"General Partner"},{"name":"Kaasim Mahmood","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"General Partner"},{"name":"Dominic Schmidt","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"General Partner"},{"name":"Satish Jindal","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"General Partner"},{"name":"Katrine Bosley","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"Venture Partner"},{"name":"Don Drakeman","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"Venture Partner"},{"name":"Alain Huriez","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"Venture Partner"},{"name":"Fraser Murray","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"Head of Scientific Evaluation"},{"name":"Rowena Patel","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventls.com/team/","title":"Financial Director"}],"sources":{"headquarters":"https://adventls.com/contact/","investmentThesisFocus":"https://adventls.com/about/","investorDescription":"https://adventls.com/","portfolioHighlights":"https://adventls.com/portfolio/"},"websiteURL":"http://www.adventls.com/"}	Correctness: 98% Completeness: 85% The factual information provided about Advent Life Sciences is largely accurate and well-supported by multiple credible sources. The firm is indeed a leading trans-Atlantic venture capital investor focusing on life sciences in the UK, Europe, and the USA, with a clear emphasis on early to mid-stage investments in innovative medicines, med tech, enabling technologies, and vaccines, consistent with their focus on first-in-class or best-in-class approaches[1][4]. The announcement of the closing of two new funds totaling USD 215 million—including Advent Life Sciences Fund III and the Advent-Harrington Impact Fund—is verified by the official press release from Advent Life Sciences dated February 2021[1]. The described investment stages (Seed, Series A, Growth) and geographic focus align perfectly with public data[1]. Leadership names and titles correspond with the company’s website team page[4][1]. The stated investment thesis emphasizing a hands-on, company-building approach, prioritizing competitive relevance, value creation, collaboration with founders on multiple scientific and commercial fronts, and commitment at early stages is fully consistent with Advent’s self-description on their site[4]. However, there are some gaps: - **Overall Assets Under Management (AUM)** is not explicitly stated on the company’s site or in press releases, thus marked as missing in the data, reflecting factual incompleteness[1][4]. - **Estimated investment size per company** is similarly not detailed publicly, with only the total fund sizes known[1]. - The portfolio highlights listed include specific companies known to be associated with Advent Life Sciences, but the publicly available portfolio may be larger, and no exhaustive list is presented here[3][4]. No false or fabricated claims were identified, but the omission of explicit AUM and investment ticket size impacts completeness. The sourced URLs are: - Advent press release on the two new funds: https://adventls.com/advent-life-sciences-announces-close-of-two-new-funds-totalling-215-million/ - Advent Life Sciences homepage and about sections: https://adventls.com - Portfolio and team pages: https://adventls.com/portfolio/, https://adventls.com/team/ In summary, the data is factually accurate and consistent with the sources but incomplete regarding overall AUM and estimated investment sizes.
48	Advent International	http://www.adventinternational.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Advent Global Opportunities","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Not Available"],"sectorFocus":["Business & financial services","Consumer","Healthcare","Industrial","Technology"],"sourceProvider":"Source Incomplete","sourceUrl":"https://www.adventinternational.com/investment-strategy/advent-global-opportunities/"}],"headquarters":"Prudential Tower, 800 Boylston Street, Boston, MA 02199, USA","investmentThesisFocus":["We prioritize flexibility when investing, enabling us to pursue compelling prospects across various transaction types.","We utilize rigorous due diligence and partner closely with leadership teams.","We leverage an ecosystem of curated resources to support portfolio companies.","We emphasize accountability and responsible investment focusing on governance and environmental best practices.","Our investment approach involves deep in-market and sub-sector specialization combined with global reach to source investments with scale potential."],"investorDescription":"Advent International is a global private equity firm founded in 1984 with over 315 investment professionals across 13 countries, managing approximately $91 billion in assets as of December 31, 2024. The firm emphasizes a long-term partnership approach built on collaboration, loyalty, and trust, combining deep sector expertise and a global platform powered by local investment teams. They focus on five main sectors: Business & financial services, Consumer, Healthcare, Industrial, and Technology, with specialization across 30+ sub-sectors. Advent prioritizes flexibility when investing, enabling it to pursue compelling prospects across various transaction types such as equity deals, leveraged buyouts, carve-outs, and public-to-privates. They emphasize accountability and responsible investment with a focus on governance and environmental best practices.","linkedDocuments":[],"missingImportantFields":["fundSize","investmentStageFocus","estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"2024-12-31","aumAmount":"USD 91000000000","sourceProvider":"Perplexity","sourceUrl":"https://www.adventinternational.com/about-us/"},"portfolioHighlights":["InPost (formerly known as Integer.pl S.A.)","Aareon Group GmbH","Genoa Healthcare","Bharat Serums and Vaccines","CCC Intelligent Solutions","Culligan International Group","Sovos Brands","Grupo BIG (formerly Walmart Brazil Group)","Easynvest (now NuInvest)","Rubix"],"researcherNotes":"AUM figure is explicitly stated on the about us page. Specific fund sizes and estimated investment sizes per company are not available on the website.","seniorLeadership":[{"name":"Tom Allen","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventinternational.com/our-team","title":"Managing Director"},{"name":"Mohammed Anjarwala","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventinternational.com/our-team","title":"Managing Director"},{"name":"Ramón Arocena","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventinternational.com/our-team","title":"Managing Director"},{"name":"Johannes Arzner","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventinternational.com/our-team","title":"Managing Director"},{"name":"Ronald Ayles","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adventinternational.com/our-team","title":"Managing Partner"},{"name":"Kathryn (Katie) Smith","sourceProvider":"Perplexity","sourceUrl":"https://www.adventinternational.com/news/advent-welcomes-colleagues-to-the-partnership-and-congratulates-newly-promoted-individuals-across-regions/","title":"Managing Director"},{"name":"Michel Cain","sourceProvider":"Perplexity","sourceUrl":"https://www.adventinternational.com/news/advent-welcomes-colleagues-to-the-partnership-and-congratulates-newly-promoted-individuals-across-regions/","title":"Managing Director"},{"name":"Andrea Di Stefano","sourceProvider":"Perplexity","sourceUrl":"https://www.adventinternational.com/news/advent-welcomes-colleagues-to-the-partnership-and-congratulates-newly-promoted-individuals-across-regions/","title":"Managing Director"}],"sources":{"headquarters":"https://www.adventinternational.com/contact/","investmentThesisFocus":"https://www.adventinternational.com/investment-strategy/","investorDescription":"https://www.adventinternational.com/about-us/","portfolioHighlights":"https://www.adventinternational.com/portfolio/"},"websiteURL":"http://www.adventinternational.com"}	Correctness: 98% Completeness: 90% The information provided about Advent International is highly factually accurate and aligns well with authoritative sources. Advent International is indeed a global private equity firm founded in 1984 and currently manages approximately $91 billion in assets as of December 31, 2024, consistent with their official website's data[2][3]. The headquarters listed as Prudential Tower, 800 Boylston Street, Boston, MA 02199, USA, matches the contact information on their site[2]. The sector focuses on Business & financial services, Consumer, Healthcare, Industrial, and Technology are correct and correspond with their publicly stated areas of specialization[2][3]. The investment thesis emphasizing flexibility, rigorous due diligence, partnership with leadership, accountability, and responsible investment also reflects Advent's investment strategy as described on their official pages[3]. Regarding their funds, Advent Global Opportunities is accurately described as a global thematic platform investing in public and private companies, emphasizing a concentrated portfolio, high-quality assets, and long-term horizons[3]. However, specific data on "estimated investment size" and "fund size" for Advent Global Opportunities is not publicly available on the website, as noted by the researcher, aligning with source information[3]. It is important to clarify that Advent International manages multiple funds with different focuses, such as Advent Global Private Equity funds, Advent Global Technology funds (e.g., Advent Tech II with a $4 billion fund size[1][5]), and others, collectively managing assets around $91–94 billion as of early 2025—consistent with recent updates[2][5]. Senior leadership names given are consistent with official Advent International team pages[3]. Portfolio highlights such as InPost, Aareon Group GmbH, Genoa Healthcare, and others match Advent's publicly listed portfolio companies[3]. The slight incompleteness lies in the lack of detailed fund sizes and investment stage focuses for Advent Global Opportunities, which the company does not publicly disclose explicitly. This limits completeness for that specific fund's detailed financial parameters. Also, the overall AUM figure is accurate but rounded between $91B and $94B depending on the exact date and source[2][5]. Sources: - Advent International About Us (AUM and strategy): https://www.adventinternational.com/about-us/ - Advent International Investment Strategy and Global Opportunities fund: https://www.adventinternational.com/investment-strategy/ https://www.adventinternational.com/investment-strategy/advent-global-opportunities/ - Advent International Contact: https://www.adventinternational.com/contact/ - Advent Tech II fund details: https://www.goodwinlaw.com/en/news-and-events/news/2021/12/12_20-advent-international-raises-$4-billion - Wikipedia summary on Advent International funds: https://en.wikipedia.org/wiki/Advent_International
49	AI Seed	http://aiseed.co	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AI Seed Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Silicon Valley"],"investmentStageFocus":["Early Stage","Seed"],"sectorFocus":["Artificial Intelligence"],"sourceProvider":"Perplexity","sourceUrl":"http://aiseed.co"}],"headquarters":"London, GB","investmentThesisFocus":["Supporting the next generation of AI founders.","Providing access to AI entrepreneurs.","Helping with talent acquisition.","Introducing commercial partners.","Providing technical and operational scaling support.","Business support for acquisition or IPO."],"investorDescription":"AI Seed is an AI venture capital fund focused on early-stage AI companies, with Europe's largest and best-performing pure-play AI portfolio since 2017. Their investment thesis centers on supporting the next generation of AI founders with access to AI entrepreneurs, talent acquisition help, commercial partner introductions, technical and operational scaling support, and business support for acquisition or IPO. The team includes Michael Axelgaard (Founder and Managing Partner), Jacques de Cock (Operations and Managing Partner), and Steve Weis (Technical Analysis and Managing Partner), active in European and Silicon Valley ecosystems.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Odin Vision","Rahko","Observe","Facesoft","EYN","Causalens","9fin","Limbic","Hopsworks","Hazy"],"researcherNotes":"No specific headquarters address or AUM found on the official website. Estimated investment size per company is also not disclosed.","seniorLeadership":[{"name":"Michael Axelgaard","sourceProvider":"Perplexity","sourceUrl":"http://aiseed.co","title":"Founder and Managing Partner"},{"name":"Jacques de Cock","sourceProvider":"Perplexity","sourceUrl":"http://aiseed.co","title":"Operations and Managing Partner"},{"name":"Steve Weis","sourceProvider":"Perplexity","sourceUrl":"http://aiseed.co","title":"Technical Analysis and Managing Partner"}],"sources":{"headquarters":"https://ca.linkedin.com/company/copernicai","investmentThesisFocus":"http://aiseed.co","investorDescription":"http://aiseed.co","portfolioHighlights":"https://aiseedfund.com/#section_portfolio"},"websiteURL":"http://aiseed.co"}	Correctness: 95% Completeness: 85% The provided information about AI Seed is largely factually accurate and aligns well with publicly available data. AI Seed is indeed a London-headquartered venture capital fund specializing in early-stage AI startups, active since 2017, with a geographic focus on Europe and Silicon Valley[1]. The leadership names—Michael Axelgaard (Founder and Managing Partner), Jacques de Cock (Operations and Managing Partner), and Steve Weis (Technical Analysis and Managing Partner)—are consistent with the source at the official website (aiseed.co)[1]. The investment thesis emphasizing support for AI founders, assistance with talent acquisition, technical and operational scaling, and business support (including acquisition or IPO) accurately reflects the fund’s publicly stated focus[1]. The portfolio highlights listed—startups such as Odin Vision, Rahko, Observe, Facesoft, EYN, Causalens, 9fin, Limbic, Hopsworks, and Hazy—are verifiable on the fund’s portfolio page[1]. The description of AI Seed having Europe’s largest and best-performing pure-play AI portfolio since 2017 is congruent with third-party evaluations, though "largest" can be somewhat subjective depending on metrics used. However, some limitations affect completeness and correctness scores: - The overall Assets Under Management (AUM) are missing, and this data is not publicly disclosed on the official website or through credible secondary sources, which reduces completeness[1]. - The estimated investment size is marked as “Not Available,” which matches public data indicating typical rounds are in the $100K to $1M range but without precise disclosed details[1]. The absence of exact figures reduces completeness but does not indicate incorrectness. - Founder Thomas Stone is mentioned in the external source [1] as a co-founder, in addition to Michael Axelgaard and John Spindler, but only Michael Axelgaard is listed in the user data as founder and managing partner. The user data omits John Spindler and Thomas Stone, which lowers completeness slightly. - The headquarters is correctly given as London, UK, consistent with multiple sources[1]. No specific physical address is publicly available, which matches the note on missing details. - Some slight variation in phrasing and emphasis (e.g., "best-performing" claims) is not fully verifiable with independent public data but are consistent with internal marketing from AI Seed’s site. In summary, while the core facts and leadership are accurate and well-supported, the unavailability of AUM, exact investment sizes, and omission of all founding partners limit completeness. No fabricated or false claims appear. Sources: - AI Seed fund overview and leadership: https://aiseed.co, https://unicorn-nest.com/funds/ai-seed/
50	Aerion Partners	https://www.aerionpartners.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Aerion Partners Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceUrl":null}],"headquarters":"London, GB","investmentThesisFocus":[],"investorDescription":"Aerion Fund Management Ltd acts exclusively as the Principal Investment Manager to the National Grid UK Pension Scheme, an occupational pension scheme sponsored by National Grid Gas plc, a wholly-owned subsidiary of National Grid plc.","linkedDocuments":[],"missingImportantFields":["investorDescription","investmentThesisFocus","headquarters","overallAssetsUnderManagement","portfolioHighlights","seniorLeadership","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"The official company website is not accessible for data extraction using the automated tools, and no relevant detailed data could be scraped from other reliable sources. Therefore, many critical fields remain unavailable.","seniorLeadership":[],"sources":{"headquarters":"LinkedIn","investmentThesisFocus":null,"investorDescription":"LinkedIn","portfolioHighlights":null},"websiteURL":"https://www.aerionpartners.com/"}	Correctness: 85% Completeness: 20% The description of Aerion Fund Management Ltd as acting exclusively as Principal Investment Manager to the National Grid UK Pension Scheme is consistent with publicly available information indicating Aerion Partners’ association with National Grid and London headquarters (LinkedIn). The fund name "Aerion Partners Investment Strategy" and the lack of public data on estimated investment size, fund size, geographic and sector focus, and investment stage is accurate given the absence of accessible detailed data, including the official website being inaccessible for scraping. The senior leadership and portfolio highlights are also missing, reflecting the same lack of publicly available information. However, the completeness score is very low due to the significant absence of key details commonly expected for an investment fund profile: overall assets under management, detailed investment thesis focus, portfolio companies, senior leadership information, fund size, and geographic and sector focuses remain unavailable. This is because no authoritative sources or company disclosures currently provide this data. The presence of related but unrelated entities named "Aerion" (such as Aerion Capital and Aerion Partners associated with supersonic flight ventures) should not confuse or be conflated with the London-based Aerion Fund Management Ltd linked to National Grid pensions. Sources: - LinkedIn data on Aerion Fund Management Ltd headquarters and description link Aerion to National Grid UK Pension Scheme (provided in user data). - Aerion Partners’ official website (https://www.aerionpartners.com/) is inaccessible or lacks comprehensive public data. - No other credible sources with detailed investment or fund structure data are found in search results. Because the fundamental facts stated are correct but critical information is missing, the correctness is relatively high but completeness is low.
51	adMare Bio Innovations	https://www.admarebio.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"adMare Bio Innovations Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Canada"],"investmentStageFocus":["Seed","Early Stage","Growth Stage"],"sectorFocus":["Life Sciences","Therapeutics"],"sourceUrl":"https://www.admarebio.com/en/overview-companies"}],"headquarters":"Vancouver Innovation Centre, 2405 Wesbrook Mall, Vancouver, British Columbia, Canada, V6T 1Z3; Toronto Office, MaRS Centre, West Tower, 661 University Ave., Suite 415, Toronto, Ontario, Canada, M5G 1M1; Montreal Innovation Centre, 7171 Frederick-Banting, Montréal, Québec, Canada, H4S 1Z9","investmentThesisFocus":["Partner with and invest in academic researchers and emerging Canadian life sciences companies.","Support companies at all stages of development, from seed to growth.","Catalytic seed investments to enable portfolio companies to develop product pipelines and scale.","Provide integrated services including scientific and business development guidance, intellectual property and legal support, financial support access, and network connections."],"investorDescription":"adMare builds companies by partnering with and investing in technology innovators and entrepreneurs, mainly academic researchers and emerging Canadian life sciences companies. They support companies at all stages of development. Their investment strategy includes catalytic seed investments into promising companies, providing essential support for growth. They also provide integrated services for therapeutic ventures, including scientific and business development guidance, IP and legal support, access to financial support, and connections to a professional network.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":null,"aumAmount":"USD 1,400,000,000","sourceProvider":"Perplexity","sourceUrl":"https://admarebio.com/en/press-release-details/government-of-canada-invests-92-million-in-admare-to-help-translate-health-research-into-innovative-new-therapies-in-canada"},"portfolioHighlights":["26 Therapeutics","Abdera Therapeutics","ARNA Therapeutics","Artelo Biosciences","Bellus Health","Bowen's FX Therapeutics","Bright Angel Therapeutics","Domain Therapeutics","Encycle Therapeutics","Epigene Therapeutics Inc."],"researcherNotes":"AUM is inferred from the total investment capital attracted by the firm as stated on the website, which mentions more than $1.4 billion. No specific per-company estimated investment size or formal fund size is disclosed.","seniorLeadership":[{"name":"Gordon C. McCauley","sourceUrl":"https://admarebio.com/en/management","title":"President & CEO"},{"name":"Matthew J. Carlyle","sourceUrl":"https://admarebio.com/en/management","title":"Chief Operating Officer & CFO"},{"name":"Joseph Mancini","sourceUrl":"https://admarebio.com/en/management","title":"Vice President, Research"},{"name":"Dave Rogers","sourceUrl":"https://admarebio.com/en/management","title":"Vice President, Intellectual Property & Legal Affairs"},{"name":"Frédéric Lemaître Auger","sourceUrl":"https://admarebio.com/en/management","title":"Vice President, Investments"},{"name":"Sarah Gallagher","sourceUrl":"https://admarebio.com/en/management","title":"Vice President, People and Culture"}],"sources":{"headquarters":"https://www.admarebio.com/en/contact","investmentThesisFocus":"https://www.admarebio.com/en/overview-companies","investorDescription":"https://www.admarebio.com/en/overview-companies","portfolioHighlights":"https://www.admarebio.com/en/companies-weve-helped-build"},"websiteURL":"https://www.admarebio.com/"}	Correctness: 98% Completeness: 90% The information provided about adMare BioInnovations is largely factually accurate and aligns well with authoritative sources. Key points match verified details from adMare’s official website and government announcements: - adMare is indeed focused on partnering with academic researchers and emerging Canadian life sciences companies, supporting them from seed to growth stages[2][3][5]. - The geographic focus on Canada and sector focus on life sciences and therapeutics are accurate, as are the services they provide, including scientific/business guidance, IP/legal support, financing access, and networking[1][3][5]. - The headquarters locations in Vancouver, Toronto, and Montreal are confirmed on their website[3]. - Their investment thesis emphasizing catalytic seed investments to build product pipelines and scale companies is supported by multiple sources[1][3][5]. - The stated overall assets under management (AUM) of approximately USD 1.4 billion is consistent with the reported capital attracted by adMare’s portfolio companies and government investments[1][3]. - Senior leadership named aligns with the adMare management page[3]. - Portfolio highlights including companies like Abdera Therapeutics are confirmed on their portfolio listings[5]. The information is not fully complete because some fields remain “Not Available,” such as estimatedInvestmentSize and fundSize, which adMare does not publicly disclose, so these gaps are noted correctly. Also, while the overall AUM is inferred from total investment capital attracted, no detailed breakdown or formal fund size is publicly available. This matches researcher notes and publicly known data[1][3]. The completeness score reflects limited public disclosure of precise investment sizes per company or fund, which is common for many innovation-focused ventures and not a factual error but incomplete data. URLs used: - https://www.admarebio.com/en/overview-companies - https://www.admarebio.com/en/contact - https://www.admarebio.com/en/internal-portfolio - https://www.admarebio.com/en/management - https://www.admarebio.com/en/press-release-details/government-of-canada-invests-92-million-in-admare-to-help-translate-health-research-into-innovative-new-therapies-in-canada - https://technoparc.com/en/discover-the-technoparc/admarebio/
52	Ahren Innovation Capital	http://www.ahreninnovationcapital.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Ahren LP","fundSize":"USD 250,000,000","fundSizeSourceUrl":"https://www.ahreninnovationcapital.com/ahren-announces-fund-close/","geographicFocus":["United Kingdom"],"investmentStageFocus":["Pre-Seed","Seed","Series A","Growth","Pre-IPO"],"sectorFocus":["Brain & AI","Genetics & Platform Technologies","Space & Robotics","Efficient Energy"],"sourceProvider":"Perplexity","sourceUrl":"https://www.ahreninnovationcapital.com/ahren-announces-fund-close/"}],"headquarters":"London, United Kingdom","investmentThesisFocus":["Taking asymmetric, considered risks to deliver superior rewards.","Supporting transformational companies at the intersection of deep tech and deep science.","Partnering closely with exceptional founders to build companies from scratch or support high-growth businesses.","Backing big visions and helping founders achieve success.","Engaging science partners with combined tech valuations over $100 billion throughout the investment process.","Leveraging commercial engine and unicorn founder advisors for company support."],"investorDescription":"Ahren is an investment institution focusing on transformational companies at the intersection of deep tech and deep science, investing across all stages from pre-seed to pre-IPO. Their investment strategy involves taking asymmetric, considered risks to provide smart capital to deep technology companies. They emphasize four broad domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Ahren provides patient and active capital to exceptional founders, partnering closely to build companies from scratch or support high-growth businesses.","linkedDocuments":[],"missingImportantFields":["headquarters","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"USD 400,000,000","sourceProvider":"Perplexity","sourceUrl":"https://www.ahreninnovationcapital.com/ahren-announces-fund-close/"},"portfolioHighlights":["6d","Adrestia","AI21 Labs","Ambi Robotics","Bicycle Therapeutics","Biomodal","Bitfount","Cellarity","Constructive Bio"],"researcherNotes":"The firm does not disclose a specific headquarters address on the website. The overall AUM was inferred from public statements regarding the total fund size and dry powder available. Estimated investment size per company is not specified.","seniorLeadership":[{"name":"Alice Newcombe-Ellis","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding & General Partner"},{"name":"Peter Lourensz, FCA","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Chief Financial Officer"},{"name":"Peter Baines","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Venture Partner"},{"name":"Janusz Marecki, PhD","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"AI Partner"},{"name":"Kaja Wasik, PhD","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Entrepreneur in Residence"},{"name":"Joanna Green, PhD","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Principal"},{"name":"Oliver Hedaux","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Principal"},{"name":"Anuj Nanwani","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Principal"},{"name":"Sir Shankar Balasubramanian","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Professor Zoubin Ghahramani","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Sir Steve Jackson","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Professor Andy Parker","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Sir Venki Ramakrishnan","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Lord Martin Rees","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Sir Gregory Winter","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Founding Partner"},{"name":"Professor Roberto Cipolla","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Science Partner"},{"name":"David Novak","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.ahreninnovationcapital.com/team/","title":"Advisor"}],"sources":{"headquarters":"https://hub.waveup.com/funds/ahren-innovation-capital","investmentThesisFocus":"https://www.ahreninnovationcapital.com/about/","investorDescription":"https://www.ahreninnovationcapital.com/about/","portfolioHighlights":"https://www.ahreninnovationcapital.com/companies/"},"websiteURL":"http://www.ahreninnovationcapital.com/"}	Correctness: 95% Completeness: 85% The information provided about Ahren Innovation Capital is largely accurate and consistent with publicly available data. It correctly identifies Ahren as an institutional investment firm focusing on transformational companies lying at the intersection of deep tech and deep science, with sectors including Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy.[1][2] The investment stage focus from pre-seed to pre-IPO is also verified.[1][2] The fund size of USD 250 million is reported on their official site as the size of a specific fund ("Ahren LP"), but the overall assets under management (AUM) quoted as USD 400 million in 2024 is correctly consolidated from public statements integrated from the same source.[2] The firm’s approach of taking asymmetric risks and partnering closely with exceptional founders is explicitly stated on their official website.[2] The portfolio highlights such as Constructive Bio and others are consistent with news releases and company portfolio information.[3][4] Senior leadership names and titles correspond to those listed on the official team page.[2] The main factual discrepancy is the geographic headquarters: the user’s data states London, United Kingdom, while an external source lists the global HQ as California, United States, creating ambiguity.[1] Ahren's website and other sources do not explicitly disclose an official headquarters address, which matches the researcher’s notes about this missing detail. Therefore, while the investment focus on UK companies seems strong (based on portfolio companies and news releases from Cambridge and London), the actual registered headquarters is unclear, warranting a completeness deduction.[1] The estimated investment size per company is indeed not publicly specified, matching the user note.[2] This omission reduces completeness. Sources: - Ahren Innovation Capital official site about and team pages: https://www.ahreninnovationcapital.com/ - Venture Capital Archive: https://venturecapitalarchive.com/venture-funds/ahren-innovation-capital-ahreninnovationcapital-com - News on Constructive Bio’s Series A led by Ahren: https://www.ahreninnovationcapital.com/constructiveseriesa/ - OutSee seed investment led by Ahren: https://www.uktechnews.info/2025/06/24/outsee-secures-1-8-million-seed-investment-led-by-ahren-innovation-capital/ Overall, the data is factually solid and mostly complete, except for uncertainty about the formal headquarters location and lack of per-investment size details publicly available.
53	Air Liquide ALIAD	https://www.airliquide.com/group/aliad	{"funds":[{"estimatedInvestmentSize":"EUR 25,000,000+ since 2020","fundName":"ALIAD Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Early stage","Growth stage"],"sectorFocus":["Climate Tech","HealthTech","Industrial Innovation"],"sourceUrl":"https://www.airliquide.com/group/aliad"}],"headquarters":"91, avenue Ledru Rollin, 75011 Paris, France","investmentThesisFocus":["Invests in startups tackling industrial, societal and environmental challenges through technological innovation.","Focus on Climate Tech, HealthTech, and Industrial innovation sectors.","Acts both as an investor and industrial partner providing financial, technological, and commercial support.","Targets early to growth-stage startups.","Geographical focus with offices in Paris and San Francisco."],"investorDescription":"ALIAD (Air Liquide Venture Capital) is the strategic venture capital fund of Air Liquide focused on investing in tech startups with positive impact in Climate Tech, HealthTech, and Industrial innovation. Since 2013, it has made over 40 investments and invested over €25M since 2020. ALIAD acts both as an investor and industrial partner, providing financial, technological, and commercial support to its portfolio startups.","linkedDocuments":["https://airliquide.com/sites/airliquide.com/files/2025-03/2024-integrated-annual-report.pdf","https://airliquide.com/sites/airliquide.com/files/2025-03/air-liquide-2024-universal-registration-document.pdf","https://airliquide.com/investors/documents-presentations"],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Waga Energy","MySphera","Ekoscan Integrity","Orcan Energy","BOTALYS","44.01","Angiodroid","CARMAT","Libheros","APIX Analytics"],"researcherNotes":"Overall Assets Under Management (AUM) figures are not explicitly mentioned on the ALIAD or parent company pages. The €25 million investment amount since 2020 is noted but does not represent total AUM.","seniorLeadership":[{"name":"Armelle Levieux","sourceProvider":"Source JSON","sourceUrl":"https://www.airliquide.com/group/aliad","title":"Member of the Executive Committee, Vice President of Innovation"},{"name":"Vincent Lescoeur","sourceProvider":"Perplexity","sourceUrl":"https://www.linkedin.com/in/vincent-lescoeur-592b0b13b/","title":"Managing Director"},{"name":"Florian Durand","sourceProvider":"Perplexity","sourceUrl":"https://www.linkedin.com/in/floriandurand/","title":"Partner"}],"sources":{"headquarters":"https://www.airliquide.com/group/aliad","investmentThesisFocus":"https://www.airliquide.com/group/aliad","investorDescription":"https://www.airliquide.com/group/aliad","portfolioHighlights":"https://www.airliquide.com/group/aliad","seniorLeadership":"https://www.linkedin.com/company/aliad-air-liquide-venture-capital/"},"websiteURL":"https://www.airliquide.com/group/aliad"}	Correctness: 98% Completeness: 85% The provided information about ALIAD Investment Strategy and ALIAD Venture Capital by Air Liquide is largely **factually accurate** and aligns well with the official Air Liquide sources. ALIAD is indeed Air Liquide’s strategic venture capital fund, established in 2013, focusing on Climate Tech, HealthTech, and Industrial Innovation sectors, investing since 2020 with over €25 million deployed, primarily targeting early to growth-stage startups globally, with offices in Paris and San Francisco. The fund acts as both investor and industrial partner, supporting startups financially and technologically, which matches the official ALIAD page and Air Liquide corporate information[https://www.airliquide.com/group/aliad]. The senior leadership names and roles provided are consistent with publicly available LinkedIn profiles and Air Liquide pages for ALIAD executives[https://www.linkedin.com/company/aliad-air-liquide-venture-capital/]. However, the **completeness** score is lower because: - The overall Assets Under Management (AUM) for ALIAD are not publicly disclosed, which is acknowledged explicitly in your data. Reporting only the €25 million invested since 2020 does not represent total fund size or total AUM, which is a significant missing piece for completeness. - Fund size and total committed capital for ALIAD remain unknown (“Not Available”), which is an important data point for a full investor profile. - No recent detailed information on new investments since those listed or updated portfolio valuation is included. - No mention or confirmation of co-investors, fund structure, or fund vintage year beyond inception in 2013. This assessment excludes unrelated entities such as Allied Industrial Partners, which surfaced in search results but are distinct firms with no connection to ALIAD and should not impact the correctness scoring of ALIAD data. Sources: - ALIAD official page: https://www.airliquide.com/group/aliad - ALIAD LinkedIn: https://www.linkedin.com/company/aliad-air-liquide-venture-capital/ - Air Liquide 2024 Annual and Registration Documents (referenced but not directly quoted)
54	AgFunder	http://agfunder.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Fund IV","fundSize":"USD 100,000,000","fundSizeSourceUrl":"https://agfunder.com/invest/","geographicFocus":["Global","Silicon Valley","London","Singapore"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Agrifood","AI","Biology","Climate"],"sourceUrl":"https://agfunder.com/invest/"},{"estimatedInvestmentSize":"USD 500,000 to USD 5,000,000","fundName":"Fund V","fundSize":"USD 150,000,000","fundSizeSourceUrl":"https://pitchbook.com/news/articles/agfunder-fund-v-raises-150m-focus-agrifoodtech-2023","geographicFocus":["Global","Silicon Valley","London","Singapore"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Agrifood","AI","Biology","Climate"],"sourceProvider":"Perplexity","sourceUrl":"https://pitchbook.com/news/articles/agfunder-fund-v-raises-150m-focus-agrifoodtech-2023"}],"headquarters":"845 Market St., Suite 450, San Francisco, CA 94103","investmentThesisFocus":["First principles investing in agrifoodtech and related sectors.","Solving world's biggest problems through frontier technologies.","Focus on food, agriculture, biology, AI, and climate sectors.","Backing Seed and Series A startups with frontier technology.","Combining capital, media, research, engineering, and community support."],"investorDescription":"AgFunder is a global venture capital firm with over $300 million in assets under management, investing in over 100 portfolio companies across four continents. They focus on new technology at the frontier of food, agriculture, biology, AI, and climate. Their investment thesis revolves around solving the world's biggest problems through first principles investing in agrifoodtech and related sectors. Headquartered with offices in Silicon Valley and Singapore, AgFunder combines capital, media, research, engineering, and a strong community to source deals and support portfolio companies.","linkedDocuments":["https://static01.agfunder.com/slides/GothamAnalytics/Exec_Summary.pdf"],"missingImportantFields":["estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 300,000,000","sourceUrl":"https://agfunder.com/about-us/"},"portfolioHighlights":["3Bee","AI Palette [EXITED]","Aigen","Alpine Bio","Amatera Biosciences","Apeel Sciences (acquired Impact Vision)","Aquaconnect","Atinary","Atomo Coffee","Azaneo"],"researcherNotes":"Estimated investment sizes are not explicitly disclosed on the website despite detailed fund information. AUM is stated as over $300 million in assets under management with no specific asOfDate provided.","seniorLeadership":[{"name":"Michael Dean, LLM","sourceProvider":"SOURCE_JSON","sourceUrl":"https://agfunder.com/about-us/","title":"Partner, Co-founder"},{"name":"Manuel Gonzalez, MBA","sourceProvider":"SOURCE_JSON","sourceUrl":"https://agfunder.com/about-us/","title":"Partner"},{"name":"Rob Leclerc, PhD","sourceProvider":"SOURCE_JSON","sourceUrl":"https://agfunder.com/about-us/","title":"Partner, Co-founder"},{"name":"Robin R Chauhan","sourceUrl":"https://agfunder.com/about-us/","title":"Head of Engineering"},{"name":"Louisa Burwood-Taylor","sourceUrl":"https://agfunder.com/about-us/","title":"Head of Media & Research"},{"name":"Rob Leclerc","sourceProvider":"LinkedIn","title":"Founding Partner"},{"name":"Michael Dean","sourceProvider":"LinkedIn","title":"Founding Partner"}],"sources":{"headquarters":"https://agfunder.com/contact/","investmentThesisFocus":"https://agfunder.com/about-us/","investorDescription":"https://agfunder.com/about-us/","portfolioHighlights":"https://agfunder.com/portfolio/"},"websiteURL":"http://agfunder.com"}	Correctness: 95% Completeness: 85% The provided information about AgFunder is largely factually accurate. AgFunder is indeed a global venture capital firm focused on agrifoodtech, AI, biology, and climate sectors, investing primarily in Seed and Series A stages, with headquarters in San Francisco and offices in Silicon Valley and Singapore. The description of their assets under management (around $300 million) and portfolio highlights aligns with publicly available data. Fund IV’s size is reported at about $100 million in recent sources, close to the $102 million figure in an AgTechDigest article[1]. Fund V’s $150 million size and focus on agrifoodtech sectors and geographic focus also correspond with PitchBook’s July 2023 report[2]. The investment thesis emphasizing first principles investing and addressing large global challenges through frontier technology matches AgFunder’s stated mission on their website[4]. The senior leadership named, including co-founders Michael Dean and Rob Leclerc, is consistent with official sources[4]. However, there are some minor areas lowering completeness: - The exact estimated investment sizes for Fund IV are not specified (“Not Available” noted), consistent with public disclosures, but reduces completeness. Fund V’s estimated investment size range is stated from PitchBook but not explicitly confirmed on AgFunder’s own site. - No AUM "as of" date is provided, which is common but affects detail completeness. - More detailed data on deal counts, follow-on funds, or recent investment pace is missing. - While portfolio highlights list several companies, it does not name all, and some companies (e.g., AI Palette) are noted as exited without detailed exit information. Overall, the data is supported by AgFunder’s official site and reputable industry reports like AgTechDigest and PitchBook[1][2][4]. The main sources are: - AgTechDigest on Fund IV ($102M) and AgFunder background: https://agtechdigest.com/p/agtech-companies-attract-more-funding[1] - PitchBook report on Fund V $150M raise and focus: https://pitchbook.com/news/articles/agfunder-fund-v-raises-150m-focus-agrifoodtech-2023[2] - AgFunder official site for about us, portfolio, leadership, investment thesis, and AUM: https://agfunder.com/about-us/ and https://agfunder.com/portfolio/[4] The factual accuracy is high with minor gaps due to common non-disclosure of exact investment sizing by funds and timing of AUM data. The completeness is good but could improve with more granular fund deployment data and recent updates.
55	Air Street Capital	https://www.airstreet.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Air Street Capital Seed Fund","fundSize":"USD 17,000,000","fundSizeSourceUrl":"https://press.airstreet.com/p/welcome-to-air-street-capital","geographicFocus":["Global"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["AI"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://press.airstreet.com/p/welcome-to-air-street-capital"}],"headquarters":"Suite 1, First Floor, The Energy Centre, Admiral Park, St Peter Port, Guernsey, GY1 2BB","investmentThesisFocus":["Invest as early as possible, supporting founders from day 1.","Focus on AI-first companies.","Goal to create enduring companies with lasting market impact."],"investorDescription":"Air Street Capital is a venture capital firm investing in AI-first companies. They invest as early as possible and focus on iterating through product, market, and technology strategy from day 1. Their goal is to create enduring companies with lasting market impact.","linkedDocuments":[],"missingImportantFields":["headquarters","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2020-10-29","aumAmount":"USD 17,000,000","sourceUrl":"https://press.airstreet.com/p/welcome-to-air-street-capital"},"portfolioHighlights":["Delfa","Polar Mist","Studio Atelico","Fern Labs","Patina Systems","Interloom","Odyssey","Delian AI","Sereact","Samaya AI"],"researcherNotes":"Headquarters address is not available on the website. Estimated investment size per company is not explicitly stated on the site.","seniorLeadership":[{"name":"Nathan Benaich","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.airstreet.com/team","title":"Sole Member of Investment Staff"}],"sources":{"headquarters":"https://www.airstreet.com/contact","investmentThesisFocus":"https://www.airstreet.com","investorDescription":"https://www.airstreet.com","portfolioHighlights":"https://www.airstreet.com/portfolio"},"websiteURL":"https://www.airstreet.com"}	Correctness: 95% Completeness: 85% The provided information about Air Street Capital is largely factually accurate according to multiple sources. The fund size of USD 17 million for the seed fund matches the recent fund size cited externally, and the geographic focus is global, consistent with their described operations[1][4]. The investment stage focus on Seed and Series A aligns with external descriptions emphasizing pre-seed and seed stages[1][2]. The sector focus on AI-only or AI-first companies is clearly supported by the firm’s website and press statements[4]. The investment thesis emphasizing early investments, supporting founders from day one, and creating enduring market-impactful companies corresponds directly to statements from the official Air Street Capital site[4]. Nathan Benaich being the sole member of investment staff is also confirmed on their team page[4]. However, there are some factual gaps and slight inconsistencies impacting completeness and correctness. The estimated investment size per company is listed as “Not Available” in the data, but external sources indicate initial check sizes range from about $150K up to $3M, with the possibility to follow on to $10M+, which is significant detail missing from the original data[2]. Also, the headquarters address listed (Suite 1, First Floor, The Energy Centre, Admiral Park, St Peter Port, Guernsey, GY1 2BB) is sourced from their contact page[4], but the researcher’s notes mention it was not found on the website, indicating a minor uncertainty or potential discrepancy in exact contact details. Furthermore, an up-to-date second fund of $121 million has been announced, which is relevant context beyond the $17 million seed fund data, indicating important evolving information missing[3]. Overall, the information is accurate for the baseline seed fund and firm description but is incomplete regarding specific investment sizes, latest fund details, and clarifications on the headquarters location. The portfolio highlights and senior leadership information are confirmed on the official site and press[4]. Sources: - https://press.airstreet.com/p/welcome-to-air-street-capital - https://www.airstreet.com - https://superscout.co/investor/air-street-capital - https://connect.visible.vc/investors/air-street-capital - https://press.airstreet.com/p/121m-fund-2
56	AENU	https://www.aenu.com	{"funds":[{"estimatedInvestmentSize":"EUR 1-4 million","fundName":"AENU Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","DACH","UK","Nordics"],"investmentStageFocus":["Seed","Series A","Pre-Seed"],"sectorFocus":["Climate Tech","Energy Transition","Carbon Economy"],"sourceProvider":"External Validation","sourceUrl":"https://www.aenu.com/impact"}],"headquarters":"Münzstraße 18, 10178 Berlin, Germany","investmentThesisFocus":["Focus on climate tech and energy transition with measurable CO2 impact.","Investments at Seed and Series A stage, occasionally pre-seed for serial entrepreneurs.","Emphasis on ESG factors blended with international standards for long-term value creation.","Commitment to diversity, equity, and inclusion to provide real opportunities for underrepresented founders.","Preferred role as co-lead or lead investor with board representation."],"investorDescription":"Born entrepreneurs, experienced investors, committed activists. Founded tech companies worth over 8B. Former VCs at Earlybird and Speedinvest with over 800M invested and top-quartile returns. Co-founders of Leaders For Climate Action and ambassadors of Founder's Pledge. Mission: Drive systemic change in venture capital towards impact, accessibility, and stakeholder alignment. Primary focus: Climate tech, preferred energy transition and carbon economy. Impact focus on intentionality, interlock, and additionality for CO2 saved/removed. Stage: Seed & Series A, occasional pre-seed for serial entrepreneur teams. Geography: Europe with focus on DACH, UK, and Nordics. Investment size: EUR 1-4 million ticket sizes. Role: Preferred co-lead/lead with board representation.","linkedDocuments":["https://www.aenu.com/wp-content/uploads/2023/01/AENU-IMPACT-FRAMEWORK.2023.pdf","https://www.aenu.com/wp-content/uploads/2025/05/AENU_ImpactReport_2024_digital_14April2025-1.pdf","https://www.aenu.com/wp-content/uploads/2023/02/AENU_Impact-ESG-Clause-Stand-22.02.2023.pdf","https://www.aenu.com/wp-content/uploads/2022/07/AENU-Theory-of-Change.pdf"],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[{"announcementDate":"2024-09-18","companyName":"Greenlyte Carbon Technologies","sourcePostUrl":"https://www.linkedin.com/posts/florian-alexander-hildebrand_super-happy-to-announce-that-aenu-has-joined-activity-7242128980449869824-Q27M","sourceProvider":"LinkedIn"}],"researcherNotes":"No explicit overall Assets Under Management (AUM) or specific fund sizes are mentioned on the website. Portfolio company names are not listed on the site. Investment strategy is unified under a single strategy description rather than distinct named funds.","seniorLeadership":[{"name":"Fabian Heilemann","sourceProvider":"Source JSON","sourceUrl":"https://www.aenu.com/who","title":"Founder & CEO"},{"name":"Ferry Heilemann","sourceProvider":"Source JSON","sourceUrl":"https://www.aenu.com/who","title":"Founder & Partner"},{"name":"Siobhan Brewster","sourceProvider":"Source JSON","sourceUrl":"https://www.aenu.com/who","title":"Partner"},{"name":"Philip Specht","sourceProvider":"Source JSON","sourceUrl":"https://www.aenu.com/who","title":"Partner"},{"name":"Daniel Zakowski","sourceProvider":"Source JSON","sourceUrl":"https://www.aenu.com/who","title":"CFO & Operating Partner"},{"name":"Elena Harumi Stark","sourceProvider":"LinkedIn","sourceUrl":"https://www.linkedin.com/company/aenu","title":"Head of Impact & Platform"}],"sources":{"headquarters":"https://www.aenu.com/contact/","investmentThesisFocus":"https://www.aenu.com/impact","investorDescription":"https://www.aenu.com/","portfolioHighlights":"https://www.aenu.com/portfolio/"},"websiteURL":"https://www.aenu.com"}	Correctness: 95% Completeness: 85% The provided data about AENU, including its investment thesis, geographic focus, stage focus (Seed, Series A, and occasionally Pre-Seed), ticket size (EUR 1-4 million), sector focus on climate tech, energy transition, and carbon economy, as well as its ESG and impact orientation, is factually accurate and well-supported by the official AENU website and related sources[1][2][3][5]. The description of the founders’ backgrounds and their mission aligns with publicly stated goals and team information on AENU’s website[5]. However, the completeness score is lower because some important details are missing or unclear in the provided profile: - The overall fund size is not stated in the query but publicly available information confirms that AENU’s first fund had a final closing size of EUR 170 million, exceeding the EUR 140 million target[2]. This is a significant omission. - The overall Assets Under Management (AUM) are not explicitly provided but presumably correspond to this fund size. - The portfolio highlights mentioned in the query list only one company (Greenlyte Carbon Technologies), while publicly disclosed portfolios include several early success stories such as Alcemy, Monta, Ocell, Trawa, and HomeTree[2][3]. - The fund description in the query suggests multiple named funds, but publicly the investment strategy appears unified in one main fund[2][3]. - Some nuances about AENU’s fund structure evolution (pivot from evergreen to a classic fund) and specifics on its impact-ESG framework add useful context but are not mentioned in the query[1][5]. - The leadership team list in the query matches the information on AENU’s website[5]. In summary, the information given is largely correct and credible with links to verified sources, but important quantitative details about fund size and portfolio breadth are missing, so the completeness is moderate-high but not full. Sources: https://www.aenu.com/impact/ https://www.aenu.com/sfdr-1/ https://www.aenu.com/insights/eur-170-million-for-climate-technology-startups/ https://hello-tomorrow.org/discover-aenu-with-fabian-heilemann/
57	Agri Investment Fund	http://www.aifund.be/en	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Agri Investment Fund Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Early startup phases","Successive capital rounds","Market introduction"],"sectorFocus":["Ag-Tech","Agro-Food"],"sourceUrl":"https://aifund.be/en/about-us/"}],"headquarters":"Agri Investment Fund bv, Diestsevest 32/5b, 3000 Leuven, Belgium","investmentThesisFocus":["Focus on ESG criteria contributing to United Nations SDG goals.","Invest in companies with disruptive solutions for sustainable agriculture and horticulture.","Reduce environmental impact while ensuring production.","Support fair and stable incomes for farmers.","Provide high-quality, fair-priced food.","Target reduction of chemical fertilizers and pesticides, livestock emissions, and antibiotics.","Promote increased local high-protein crops and plant-based meat alternatives.","Valorize agricultural residual flows and alternative protein sources.","Promote diverse, profitable local agriculture and strengthen food supply.","Increase animal welfare and develop resilient crops.","Ensure good corporate governance and positive social impact."],"investorDescription":"Agri Investment Fund (AIF) invests primarily in the Ag-Tech and Agro-Food domains with a focus on stimulating innovation and improving sustainability in agriculture and horticulture. Their mission is to contribute to a stronger and more sustainable agriculture sector, ensuring sustainable income for farmers, regional chain anchoring, and positive societal product recognition. AIF invests from early start-up phases and supports companies through successive capital rounds until market introduction. They seek active investments including director mandates to transfer knowledge and experience. Being part of the Boerenbond group provides a strong agricultural network and professional advice. AIF aims for long-term positive impact economically, ecologically, and socially on agriculture, environment, and society.","linkedDocuments":["https://aifund.be/wp-content/uploads/2025/06/Jaarrekening-AIF-2024.pdf"],"missingImportantFields":["fundSize","estimatedInvestmentSize","seniorLeadership"],"overallAssetsUnderManagement":{"asOfDate":"2024","aumAmount":"EUR 62,300,000","sourceUrl":"https://aifund.be/en/activity-report-aif-2024/"},"portfolioHighlights":["Animab","Aphea.Bio","Better3fruit","BiocSol","Biotalys","Biotope","Greenyard","Iscal","Protealis","Rainbow Crops","RootWave","ViroVet","VOCSens"],"researcherNotes":"No formal fund names or fund sizes are specified on the website. The overall AUM is inferred from the equity and investment amounts stated in the 2024 activity report. Investment size per company is not disclosed.","seniorLeadership":[{"name":"Dirk Vansina","sourceProvider":"LinkedIn","title":"Managing Director"},{"name":"Bart Backaert","sourceProvider":"LinkedIn","title":"Chairman"},{"name":"Kristof Van Pourcq","sourceProvider":"LinkedIn","title":"Investment Director"}],"sources":{"headquarters":"https://aifund.be/en/contact_us/","investmentThesisFocus":"https://aifund.be/en/about-us/","investorDescription":"https://aifund.be/en/about-us/","portfolioHighlights":"https://aifund.be/en/portfolio/","seniorLeadership":"https://be.linkedin.com/company/agri-investment-fund"},"websiteURL":"http://www.aifund.be/en"}	Correctness: 95% Completeness: 85% The provided information about Agri Investment Fund (AIF) is largely accurate and well-supported by the official website and related sources. The fund’s focus on **Ag-Tech and Agro-Food sectors**, emphasis on **sustainability and ESG criteria aligned with UN SDG goals**, and its **investment stages starting from early startup phases through market introduction** are all confirmed by AIF’s own descriptions[3][4]. The headquarters location in Leuven, Belgium, and strong ties to the Boerenbond group match publicly available contact details[3][4]. The portfolio highlights such as Animab, Aphea.Bio, and Better3fruit are verifiable from AIF’s portfolio webpage and homepage[3][4]. The senior leadership names and roles (Dirk Vansina as Managing Director, Bart Backaert Chairman, Kristof Van Pourcq Investment Director) correspond to LinkedIn profiles linked from the provider’s page and industry listings[1][5]. The overall Assets Under Management of approximately EUR 62.3 million as of 2024 is consistent with figures in AIF’s 2024 activity report and equity investment data, though specific fund sizes and individual company investment amounts are not publicly detailed, as noted[3][4][1]. Where completeness is somewhat reduced is in the **lack of explicit fund size or estimated investment size per fund or deal**, and the absence of detailed senior leadership biographies beyond titles. This data is either undisclosed or unavailable publicly, as confirmed by researcher notes and the official website’s nondisclosure. Additional granular financial data and senior leadership background would improve completeness. URLs used for verification: - https://aifund.be/en/about-us/ - https://aifund.be/en/portfolio/ - https://aifund.be/en/contact_us/ - https://aifund.be/en/activity-report-aif-2024/ - https://www.privateequityinternational.com/institution-profiles/agri-investment-fund.html - https://privatecapital.be/member/agri-investment-fund/ Overall, the information is factually correct and appropriately comprehensive within publicly available limits, with only minor omissions in detailed financial and leadership data lowering completeness slightly.
58	ADM Ventures	https://www.adm.com/products-services/admventures	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ADM Ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Series A","Early market traction"],"sectorFocus":["Human nutrition","Microbiome solutions","Animal nutrition","Bio-solutions","Agriculture technology"],"sourceUrl":"https://www.adm.com/products-services/admventures"}],"headquarters":"Chicago, Illinois, USA","investmentThesisFocus":["Invests in cutting-edge food and agriculture technology startups aligned with ADM's global business.","Focus on disruptive technologies in human nutrition, microbiome solutions, animal nutrition, bio-solutions, and agriculture technology.","Targets typically Series A and beyond, with proof-of-concept or early market traction.","May lead or join investment rounds and prefers board observer or seat.","Provides startups access to ADM's global solutions network to de-risk and accelerate commercialization."],"investorDescription":"ADM Ventures is the corporate venture capital group of ADM that invests in and collaborates with cutting-edge startups commercializing disruptive technologies across human nutrition, microbiome solutions, animal nutrition, bio-solutions, and agriculture technology. They invest in typically Series A stage companies with proof-of-concept or early market traction, can lead or join investment rounds, and prefer board involvement. Collaborations with ADM Ventures allow startups to leverage ADM's global solutions network, including ingredients, flavors, assets, talent, expertise, customers, capital equipment, and sales distribution to accelerate commercialization and de-risk development.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Air Protein","Bond Pet Foods","Believer Meats","New Culture","Farmers Business Network","Acies Bio","Nourished"],"researcherNotes":"AUM and specific fund size information are not mentioned on the ADM Ventures website or related investor resources. Estimated investment size per company is also not disclosed. The senior leadership listed is for ADM overall, as no specific senior leadership for ADM Ventures was found.","seniorLeadership":[{"name":"Juan R. Luciano","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Chair of the Board of Directors, President, Chief Executive Officer"},{"name":"Christopher M. Cuddy","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, President, Carbohydrate Solutions, President, North America"},{"name":"Kristy Folkwein","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, Chief Information Officer"},{"name":"Regina Jones","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, Chief Legal Officer"},{"name":"Domingo Lastra","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"President, Latin America"},{"name":"Gary McGuigan","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"President, APAC Region"},{"name":"Nuria Miquel","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, Chief Science Officer"},{"name":"Greg A. Morris","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, President, Agricultural Services and Oilseeds"},{"name":"Dana Ng","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Vice President, Corporate, Securities and M&A Assistant Secretary"},{"name":"Carrie Nichol","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Vice President, Chief Accounting Officer"},{"name":"Dermot O'Grady","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, Global Operations"},{"name":"Monish Patolawala","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Executive Vice President, Chief Financial Officer"},{"name":"Ian Pinner","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, President, Nutrition, and Chief Sales and Marketing Officer"},{"name":"James Prince","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Chief Compliance and Integrity Officer"},{"name":"Ismael Roig","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"President, EMEA, President, Animal Nutrition"},{"name":"Joseph Taets","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Senior Vice President, Nutrition Operations"},{"name":"Jennifer Weber","sourceUrl":"https://adm.com/en-us/about-adm/our-company/leadership","title":"Chief People Officer"}],"sources":{"headquarters":"https://adm.com/en-us/about-adm/locations","investmentThesisFocus":"https://www.adm.com/products-services/admventures","investorDescription":"https://www.adm.com/products-services/admventures","portfolioHighlights":"https://pitchbook.com/profiles/investor/234071-83"},"websiteURL":"https://www.adm.com/products-services/admventures"}	Correctness: 98% Completeness: 85% The information provided about ADM Ventures is largely factually accurate based on publicly available sources. ADM Ventures is indeed the corporate venture capital group of Archer Daniels Midland Company (ADM), focusing on investments in early-stage startups with disruptive technologies across human nutrition, microbiome solutions, animal nutrition, bio-solutions, and agriculture technology sectors. It typically invests around the Series A stage with proof-of-concept or early market traction, prefers to lead or join investment rounds, and seeks Board Observer or Board Seat roles. The fund fosters collaborations that leverage ADM’s global network of ingredients, flavors, assets, talent, expertise, customers, and distribution to accelerate commercialization and de-risk development. This aligns well with ADM Ventures’ investment thesis and approach described on ADM’s official site and press releases[1][2][3]. The stated headquarters as Chicago, Illinois, USA, matches ADM's corporate location, although some VC profiles list Decatur, Illinois, which is also an ADM site, but Chicago is the corporate HQ for ADM[1][5]. The portfolio highlights (e.g., Air Protein, Believer Meats, New Culture) are consistent with multiple reports on their investments in alternative proteins and microbiome-related startups[3][4]. However, there is incomplete information regarding the fund size, estimated investment size per deal, and assets under management (AUM); these details are not publicly disclosed by ADM Ventures, acknowledged in both the user data and external sources[1][4]. Similarly, no specific senior leadership explicitly assigned to ADM Ventures is publicly listed, only senior ADM executives broadly, which the user correctly notes[1][5]. The slight deduction in correctness (to 98%) is because the user data states the headquarters as Chicago, which is accurate as ADM’s HQ, but some databases list Decatur as well; this is not a factual error but a nuance. The completeness score is lower (85%) because significant financial details (AUM, fund size, investment sizes) are missing, and senior leadership specifically for ADM Ventures is absent, which limits completeness but is due to lack of public disclosure rather than user error. Sources: - ADM Ventures official info: https://www.adm.com/products-services/admventures and https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/ [1] - ADM Ventures news releases and interviews: https://www.adm.com/en-us/news/news-releases/2020/11/adm-ventures-announces-new-investment-in-microbiome/ [2], https://www.foodbusinessnews.net/articles/22970-adm-ventures-investing-in-the-future-of-food [3] - VC data aggregators: https://unicorn-nest.com/funds/adm-ventures/ [4], https://raizer.app/investor/adm-ventures [5]
59	Agder Energi Venture	https://www.ae.no/var-virksomhet/fornyelse/venture/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Agder Energi Venture Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Norway","Europe"],"investmentStageFocus":["Seed","Early","Mid","Late"],"sectorFocus":["Energy","Renewable Energy","Sustainable Technologies"],"sourceProvider":"Perplexity","sourceUrl":null}],"headquarters":"Kjøita 18, Kristiansand, 4630, NO","investmentThesisFocus":["Sustainable use of natural resources","Investments in energy sector companies","Companies with solutions to real problems worth paying for"],"investorDescription":"Agder Energi har som visjon å være et ledende norsk konsern innen fornybar energi. Konsernets virksomhet omfatter produksjon, distribusjon og salg av energi, samt energitilknyttede tjenester. Agder Energi har 1 580 ansatte. Hovedkontoret ligger i Kristiansand.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","estimatedInvestmentSize","portfolioHighlights"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"The company's website and domain ae.no do not provide any specific information about the venture investment strategy, fund size, investment size, portfolio companies, senior leadership, or headquarters address. No documents about investments or funds were found.","seniorLeadership":[{"name":"Tor Øystein Repstad","sourceProvider":"Perplexity","title":"CEO"}],"sources":{"headquarters":"https://www.linkedin.com/company/agder-energi-as","investmentThesisFocus":"https://thehub.io/funding/agder-energi-venture","investorDescription":"https://www.linkedin.com/company/agder-energi-as","portfolioHighlights":"https://www.ae.no/var-virksomhet/fornyelse/venture/"},"websiteURL":"https://www.ae.no/var-virksomhet/fornyelse/venture/"}	Correctness: 90% Completeness: 70% The provided information about Agder Energi Venture and Agder Energi is largely factually accurate. Agder Energi Venture is indeed the venture arm of Agder Energi AS, focused on investing in energy-sector companies in Norway and Europe across seed to late funding stages with a sustainability and renewable energy focus[1][4]. The headquarters location in Kristiansand, Norway, and the description of Agder Energi itself as a leading Norwegian renewable energy group primarily focused on hydropower and energy production, distribution, and services is supported by multiple sources[2][3]. The CEO named, Tor Øystein Repstad, aligns with publicly available leadership data[1]. The investment thesis focusing on sustainable use of natural resources and companies offering valuable solutions fits with the venture’s stated focus on sustainable energy innovation[4]. However, completeness is limited because key quantitative data like overall assets under management, fund size, estimated investment size, and portfolio highlights are missing or unavailable both in the submitted data and on publicly accessible sources including the company websites and referenced publications[4]. The lack of detailed fund financials, investment deal examples, and specific portfolio company information reduces completeness. Public sources acknowledge that Agder Energi’s own site and domain do not provide detailed venture fund information or investment details, which constrains completeness assessment[4]. The 90% correctness score reflects that no false or fabricated facts appear, though some details (such as exact fund size and portfolio) are not verifiable and are marked as not available. The 70% completeness score captures that essential quantitative and portfolio information is missing despite being relevant and expected. Sources: - Agder Energi Venture description and investment focus on eu-startups.com and thehub.io[1][4] - Agder Energi group corporate profile and renewable focus at greeninvestmentgroup.com and martini.ai[2][3] - Confirmation of lacking detailed venture fund data on ae.no and in researcher notes[4]
60	Agent Capital	https://www.agentcapital.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Agent Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Seed","Early Stage","Post-Series A","Crossover","PIPEs"],"sectorFocus":["Rare Diseases","Oncology","Neurology","Immunology"],"sourceUrl":"https://www.agentcapital.com/strategy/"}],"headquarters":"1400 Main Street, Floor 1, Waltham, MA 02451","investmentThesisFocus":["Healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments addressing unmet patient needs.","Investment focus includes Rare Diseases, Oncology, Neurology, and Immunology.","Invest across all stages of development: Preclinical, Clinical, and Commercial.","Align with scientists, entrepreneurs, and other investors to develop next-generation healthcare innovations.","Use a balanced investment approach informed by deep understanding of biopharma pipeline pressures.","Proactively guide biotech companies to milestones and exits."],"investorDescription":"Agent Capital is an investor focused on partnering with founders and management teams to build lasting companies. The firm identity is rooted in long-term commitment, strategic partnership, and operational support. Their mission centers on creating value through growth and transformation in their portfolio companies. Their focus includes investing in sectors where they can leverage industry expertise to drive success.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","linkedDocuments","fundSize","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Affini-T","AshiBio","Carbon Biosciences","Carisma Therapeutics","Cerevance","Cyrus Biotechnology","Dice Therapeutics","Dragonfly Therapeutics","Entrada Therapeutics","Flare Therapeutics"],"researcherNotes":"AUM and fund sizes are not mentioned on the website. No formal named funds are listed, so a default fund name was used.","seniorLeadership":[{"name":"Geeta Vemuri, PhD, MBA","sourceProvider":"Perplexity","title":"Managing Partner, Founder"}],"sources":{"headquarters":"https://www.agentcapital.com/contact/","investmentThesisFocus":"https://www.agentcapital.com/","investorDescription":"https://www.agentcapital.com/about/","portfolioHighlights":"https://www.agentcapital.com/portfolio/"},"websiteURL":"https://www.agentcapital.com/"}	Correctness: 98% Completeness: 85% The provided information about Agent Capital is largely accurate and well supported by multiple reliable sources. The **headquarters at 1400 Main Street, Floor 1, Waltham, MA 02451** is confirmed by the company’s contact page[1], ZoomInfo[2], Private Equity International[3], and MapQuest[4]. The **investment thesis focus**—healthcare venture capital investing in novel therapeutics across Rare Diseases, Oncology, Neurology, and Immunology at all stages of development—is consistent with the descriptions on their website[1][3] and third-party directories like ZoomInfo[2] and TeaserClub[5]. The **investor description** emphasizing long-term partnerships, strategic support, and focus on building lasting companies matches the firm’s About page and external profiles[1][2][5]. The **portfolio highlights**, including companies like Carisma Therapeutics and others, align with publicly available portfolio listings[1][5]. The named **senior leadership** member, Geeta Vemuri, PhD, MBA as Managing Partner and Founder, is corroborated by Private Equity International and the firm’s own site[1][3]. However, the **fund size, estimated investment size, and overall assets under management (AUM)** are not publicly disclosed anywhere on the official site or reliable profiles, which is noted in the researcher’s comments and confirmed by the absence of any such data in available sources[1][3][5]. Similarly, no formal named funds are listed, so using “Agent Capital Investment Strategy” as a default fund name is an inferred placeholder rather than firm data. This limits completeness about financial scale and fund structuring. In summary, the factual correctness of the descriptive and strategic elements is very high (98%), but the completeness score is lowered (85%) due to missing critical data on AUM, fund sizes, and formal fund names, which are important for a complete investment profile. Sources: https://www.agentcapital.com/contact/ https://www.agentcapital.com/about/ https://www.agentcapital.com/portfolio/ https://www.privateequityinternational.com/institution-profiles/agent-capital.html https://www.zoominfo.com/c/agent-capital-llc/413035060 https://teaserclub.com/investors/agent-capital
61	AI.FUND	https://ai-fund.vc/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AI.FUND Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Israel","U.S."],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Enterprise AI","Vertical AI","Industrial AI","Advanced AI Tech"],"sourceUrl":"https://ai-fund.vc/#mission"}],"headquarters":"AI.Fund Management GmbH, Neuer Jungfernstieg 52, 0354 Hamburg, Germany","investmentThesisFocus":["Invest in AI applications across Enterprise AI, Vertical AI, Industrial AI, and Advanced AI Tech","Focus on scalable products with clear customer traction","Back startups that apply AI to enhance operational efficiency and provide high-impact, context-aware solutions","Early-stage focus: Seed and Series A rounds","Geographic focus on Europe and Israel with emphasis on international scale, especially U.S.","Emphasis on backing AI solutions rooted in European values"],"investorDescription":"AI.FUND is a highly-focused entrepreneurial investment fund dedicated to advancing AI startups in Europe and Israel. Their mission is to drive economic growth by backing AI solutions rooted in European values. They invest in the most promising early-stage, AI-first startups in Europe and Israel, focusing on application of AI across all sectors, especially Enterprise AI, Vertical AI, Industrial AI, and Advanced AI Tech. Their target is scalable products with clear traction and international growth ambition, especially the U.S.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Hirundo","Neuland","Sinpex","ALLONIA","Mindpeak","Dealcode","913.ai","IPercept","VITAS"],"researcherNotes":"The website does not provide explicit information on assets under management (AUM), fund size, or estimated investment size, despite multiple searches on key pages.","seniorLeadership":[{"name":"Ragnar Kruse","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Petra Vorsteher","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Dr. John Lange","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Ingo Hoffmann","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Hauke Hansen","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Fabian Westerheide","sourceUrl":"https://ai-fund.vc/#team","title":"Founding Partner"},{"name":"Maximilian Seeburg","sourceUrl":"https://ai-fund.vc/#team","title":"Principal"},{"name":"Dietlind Wittig","sourceUrl":"https://ai-fund.vc/#team","title":"Investment Manager"}],"sourceProvider":"Perplexity","sources":{"headquarters":"https://ai-fund.vc/impressum/","investmentThesisFocus":"https://ai-fund.vc/#mission","investorDescription":"https://ai-fund.vc/#mission","portfolioHighlights":"https://ai-fund.vc/portfolio/"},"websiteURL":"https://ai-fund.vc/"}	Correctness: 98% Completeness: 85% The information about AI.FUND is highly accurate and well-supported by the official AI.FUND website. The fund’s **headquarters** in Hamburg, Germany, the **investment thesis focus** on early-stage AI startups (Seed and Series A) spanning Enterprise AI, Vertical AI, Industrial AI, and Advanced AI Tech, the **geographic focus** on Europe, Israel, and the U.S., and the **portfolio highlights** (e.g., Hirundo, Neuland, Sinpex, Mindpeak) all correspond to details explicitly listed on AI.FUND’s site[https://ai-fund.vc/#mission][https://ai-fund.vc/portfolio/][https://ai-fund.vc/impressum/]. The **description of the fund as a highly-focused entrepreneurial fund advancing AI startups rooted in European values** is also corroborated. The listed **senior leadership team** matches the website’s team page exactly, confirming the accuracy of names and titles[https://ai-fund.vc/#team]. The lower completeness score reflects the **absence of key quantitative details** publicly available such as: - Overall Assets Under Management (AUM) - Fund Size - Estimated Investment Size per round or fund These missing fields are noted as unavailable after thorough review of multiple key pages on the website. This lack of disclosed financial scale or exact investment amounts limits the thoroughness of the profile relative to typical fund disclosures. Additionally, no performance metrics, detailed fund history, or fund vehicle structure are present in the provided data, which reduces completeness somewhat. In summary, the factual content is very precise and consistent with the primary source (AI.FUND’s official website), but the snapshot remains somewhat incomplete primarily due to missing financial size and investment amount data, as explicitly acknowledged. Sources: - AI.FUND official website (https://ai-fund.vc/#mission, https://ai-fund.vc/portfolio/, https://ai-fund.vc/#team, https://ai-fund.vc/impressum/)
62	Ace Capital Partners	https://www.ace-cp.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Private Equity","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Global"],"investmentStageFocus":["All Stages"],"sectorFocus":["Sustainability","Energy Transition","Decarbonisation","General Private Equity"],"sourceUrl":"https://ace-cp.com/en/expertise/private-equity"},{"estimatedInvestmentSize":"Not Available","fundName":"Credit","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["All Stages"],"sectorFocus":["European Private Credit","Sustainable Finance"],"sourceUrl":"https://ace-cp.com/en/expertise/credit"},{"estimatedInvestmentSize":"Not Available","fundName":"Real Assets","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["All Stages"],"sectorFocus":["Sustainable Finance","Real Economy","Infrastructure"],"sourceUrl":"https://ace-cp.com/en/expertise/real-assets"},{"estimatedInvestmentSize":"Not Available","fundName":"Capital Markets Strategies","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Global"],"investmentStageFocus":["All Stages"],"sectorFocus":["Private Equity","Credit","Real Assets","Sustainability"],"sourceUrl":"https://ace-cp.com/en/expertise/capital-markets-strategies"}],"headquarters":"Paris, France","investmentThesisFocus":["Providing financing solutions across the entire capital structure, supporting entrepreneurs and businesses at every stage of growth.","Emphasizing efficient and sustainable financing and semi-liquid credit strategies.","Focus on European private credit and active involvement in climate investing and decarbonisation of the economy.","Commitment to sustainability and impact investments across private equity, credit, real assets, and capital markets strategies."],"investorDescription":"Tikehau Capital is an entrepreneurial investment management group with 3.0 billion in assets under management and 735 employees across 17 countries, serving clients through five business lines: Private Equity, Credit, Real Assets, Capital Markets Strategies, and Listed Funds. To direct global savings towards innovative and tailored financing solutions that create sustainable value, anticipating tomorrow's needs and accelerating positive societal change. They focus on financing the real economy across four asset classes with a strong entrepreneurial culture and commitment to sustainability and impact investments including decarbonisation efforts.","linkedDocuments":["https://ace-cp.com/~/media/Files/T/Tikehau-Capital-V2/documents/regulatory-information/2023-en/universal-registration-document-2023-including-the-annual-financial-report.pdf","https://ace-cp.com/~/media/Files/T/Tikehau-Capital-V2/documents/shareholders/publications-en/tikehau-ra-uk-web-pp.pdf"],"missingImportantFields":["headquarters","estimatedInvestmentSize","fundSize","portfolioHighlights"],"overallAssetsUnderManagement":{"asOfDate":"30/06/2025","aumAmount":"EUR 51,000,000,000","sourceUrl":"https://ace-cp.com/~/media/Files/T/Tikehau-Capital-V2/documents/regulatory-information/2023-en/universal-registration-document-2023-including-the-annual-financial-report.pdf"},"portfolioHighlights":[],"researcherNotes":"Headquarters address is not explicitly listed on the website or contact pages, despite thorough checking. Estimated investment sizes and fund sizes are also not available on the website or key documents. AUM is explicitly stated at EUR 51 billion as of 30/06/2025.","seniorLeadership":[{"name":"Antoine Flamarion","sourceUrl":"https://ace-cp.com/en/the-company/teams","title":"Co-founder"},{"name":"Mathieu Chabran","sourceUrl":"https://ace-cp.com/en/the-company/teams","title":"Co-founder"}],"sourceProvider":"Perplexity","sources":{"headquarters":"https://www.bloomberg.com/profile/company/1832997D:FP","investmentThesisFocus":"https://ace-cp.com/en/the-company/mission-and-values","investorDescription":"https://ace-cp.com/en/the-company/about-us","portfolioHighlights":"https://ace-cp.com/en/the-company/portfolio-companies"},"websiteURL":"https://www.ace-cp.com/"}	Correctness: 90% Completeness: 65% The factual information provided about Tikehau Capital is largely accurate. Tikehau Capital is an entrepreneurial investment management group headquartered in Paris, France, with around EUR 51 billion in assets under management as of June 30, 2025, and approximately 735 employees across 17 countries. It operates through five business lines: Private Equity, Credit, Real Assets, Capital Markets Strategies, and Listed Funds. The investment thesis emphasizing sustainable financing solutions, European private credit focus, and decarbonisation efforts aligns with their publicly stated mission and values. The named senior leadership (Antoine Flamarion and Mathieu Chabran) and the described sector and geographic focuses correspond with the information on the official Tikehau Capital website and its 2023 Universal Registration Document[3][https://ace-cp.com/~/media/Files/T/Tikehau-Capital-V2/documents/regulatory-information/2023-en/universal-registration-document-2023-including-the-annual-financial-report.pdf]. However, certain important details are missing or not explicitly confirmed: - The exact *headquarters address* is not clearly stated on the official website or regulatory filings, leading to slight uncertainty despite multiple sources generally placing Tikehau Capital’s headquarters in Paris[3][https://www.bloomberg.com/profile/company/1832997D:FP]. - The *estimated investment sizes and fund sizes* for each fund (Private Equity, Credit, Real Assets, Capital Markets Strategies) are not disclosed openly on the website or regulatory reports, which is noted as absent. - *Portfolio highlights*—specific recent key investments or notable portfolio companies—are not included in the information despite being potentially available on the company website or related investor documents, making the dataset incomplete in this regard. - The description conflates "Ace Capital Partners" and "Tikehau Capital" somewhat. Recent, unrelated search results reveal that Ace Capital Partners is a different firm (Tel Aviv-based, founded 2024, focusing on aerospace and defense, with smaller AUM around €1.3 billion), and though there is some historical connection or investment involvement, Ace Capital Partners is not the same entity as Tikehau Capital. This could lead to confusion and slightly reduces accuracy if not carefully distinguished[1][2][4]. Overall, the core data on Tikehau Capital itself is accurate but incomplete, with missing fund size and portfolio data, and ambiguity on the headquarters address lowers completeness. Confusion around Ace Capital Partners in the source text highlights the need for careful differentiation. Sources used: - Tikehau Capital Universal Registration Document 2023 (AUM, business lines, mission) [3] - Bloomberg company profile (headquarters location) [3] - Tikehau Capital official site (investment thesis, team) [https://ace-cp.com/en/the-company/mission-and-values; https://ace-cp.com/en/the-company/about-us] - Articles on Ace Capital Partners showing it is a separate entity linked to Tikehau but distinct [1][2][4]
63	Adelie	https://www.adelie.vc/	{"funds":[{"estimatedInvestmentSize":"EUR 2 million to 10 million","fundName":"Adelie Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Series A","Series B","Series C","Pre-IPO","Growth Equity","Private Equity"],"sectorFocus":["Technology"],"sourceProvider":"Private Equity International","sourceUrl":"https://www.privateequityinternational.com/institution-profiles/adelie.html"}],"headquarters":"London Ingestre Court W1F 0JL, London United Kingdom; Paris 24-26 Rue Ballu, 75009 Paris France","investmentThesisFocus":["They focus on partnering with tech founders driving innovation and progress.","Their strategy includes providing strategic advice on financing, exit strategy, international development, go-to-market, and acquisition strategy.","They emphasize long-term partnership with founders, offering visibility and connections to potential strategic partners or acquirers.","Geographic focus is Europe based on their 20+ year relationships with entrepreneurs across the region."],"investorDescription":"Adelie is a multi-stage technology fund based in Paris and London. The firm is supported by 100+ experienced tech entrepreneurs, private equity partners, C-level executives at CAC 40 companies, and large family offices. They partner with Clipperton, a leading technology investment bank advising high-growth tech businesses on financing and M&A since 2003. Since 2008, Adelie has invested in fast-growing European tech companies led by ambitious teams.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Advens","Believe","Bizao","Brevo (formerly Sendinblue)","Clareo","Didomi","Equativ","Fenergo","Foodles","Genesis"],"researcherNotes":"Overall Assets Under Management (AUM) is not publicly disclosed on the company's website or accessible pages. The estimated investment size is sourced from Private Equity International. The firm does not list formal fund names or fund sizes, so the company name with 'Investment Strategy' is used as the fundName.","seniorLeadership":[{"name":"Jean-Manuel Costa","sourceProvider":"Perplexity","sourceUrl":"https://www.adelie.vc/people","title":"Managing Partner"},{"name":"Antoine Pruvot","sourceProvider":"Perplexity","sourceUrl":"https://www.adelie.vc/people","title":"CFO"}],"sources":{"headquarters":"https://www.adelie.vc/connect","investmentThesisFocus":"https://www.adelie.vc/vision","investorDescription":"https://www.adelie.vc/","portfolioHighlights":"https://www.adelie.vc/portfolio"},"websiteURL":"https://www.adelie.vc/"}	Correctness: 98% Completeness: 85% The information provided about **Adelie Capital** is largely factually accurate and well-supported by their official website and reputable sources. Adelie is indeed a **multi-stage technology fund** based in **Paris and London**, focusing on **European tech companies** with investment stages covering **Series A to Pre-IPO and Growth Equity**, consistent with the stated focus on partnering with tech founders and providing strategic advice (https://www.adelie.vc, accessed 2025). The description of their emphasis on long-term partnership, sector and geographic focus (Europe, technology), and collaboration with Clipperton aligns with their own communications and industry profiles (https://www.adelie.vc/vision; https://www.privateequityinternational.com/institution-profiles/adelie.html). The estimated investment size range of **EUR 2 million to 10 million** matches Private Equity International data and the lack of publicly disclosed total fund size or overall Assets Under Management (AUM) is accurate, leading to the noted missing fields and lowering completeness slightly. Portfolio highlights such as **Advens, Believe, Bizao, Brevo (Sendinblue), Didomi, Equativ, Fenergo, Foodles, Genesis** correspond with official portfolio info (https://www.adelie.vc/portfolio). Senior leadership names—Jean-Manuel Costa (Managing Partner) and Antoine Pruvot (CFO)—are correctly identified from the official people page (https://www.adelie.vc/people). The only significant gap lowering the completeness score is the absence of disclosed **overall AUM**, **formal fund names or sizes**, and more detailed financial performance data, which are generally proprietary or undisclosed by Adelie. Additionally, the fund is sometimes referenced as a single entity rather than multiple named funds, which is an acknowledged limitation in available data. No evident fabricated or false information was detected, so correctness remains high. Sources: - https://www.adelie.vc - https://www.privateequityinternational.com/institution-profiles/adelie.html - https://www.adelie.vc/portfolio - https://www.adelie.vc/people
64	Adjuvant Capital	https://adjuvantcapital.com	{"funds":[{"estimatedInvestmentSize":"$10-$25 million","fundName":"Adjuvant Capital Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Low- and middle-income countries","Emerging economies","Underserved markets globally"],"investmentStageFocus":["Phase II-or-later clinical trials or similar evaluations"],"sectorFocus":["Life sciences","Infectious diseases (HIV/AIDS, tuberculosis, malaria, tropical diseases, pandemic threats, antimicrobial resistance)","Maternal and child health","Nutrition","Reproductive and sexual health"],"sourceProvider":"LinkedIn","sourceUrl":"https://adjuvantcapital.com"}],"headquarters":"New York City office: 500 5th Avenue, Suite 4000, New York, NY 10110, USA; Zurich office: Grabenstrasse 3, 8952 Schlieren, Switzerland","investmentThesisFocus":["Invests in innovative technologies for underserved markets with goal of social and financial returns.","Focusing on safety and efficacy in humans to accelerate global availability.","Focus areas include neglected, high-burden, and emerging infectious diseases (including antimicrobial resistance and pandemic threats).","Targets opportunities with human efficacy signals from phase II-or-later clinical trials or similar evaluations, emphasizing compelling proof-of-concept data.","Geographic focus on low- and middle-income countries and underserved markets globally."],"investorDescription":"Adjuvant is a venture capital firm financing life science technologies addressing high-burden public health challenges, focusing on neglected infectious diseases, maternal and child health, nutrition, and reproductive and sexual health. Adjuvant Capital pursues meaningful, measurable social impact alongside top-tier financial returns, focusing on public health improvements in low- and middle-income countries. Their strategy aims to drive meaningful improvements in the public health of low- and middle-income countries while pursuing top-tier financial returns.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"2023-09-30","aumAmount":"USD 300,000,000","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/about/"},"portfolioHighlights":["LimmaTech Biologics","Memo Therapeutics","Curevo Vaccine","Antiva Biosciences","Pulmocide","Excision BioTherapeutics","Frontier Nutrition","VitriVax","MinervaX","Evofem"],"researcherNotes":"AUM was explicitly stated as 300 million USD as of September 30, 2023, in the About page. No formal fund names or sizes were found; only a single overarching investment strategy was described. Estimated investment size per company was not disclosed.","seniorLeadership":[{"name":"Glenn Rockman","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Founder and Managing Partner"},{"name":"Kabeer Aziz","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Co-Founder and Partner"},{"name":"Philippe Dro","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Partner"},{"name":"Gerard Cunningham","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Operating Partner"},{"name":"Alexandra (Sandra) Glucksmann","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Advisory Partner"},{"name":"Curt LaBelle","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Venture Partner"},{"name":"Mark Sullivan","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Venture Partner"},{"name":"Evelyn Yanatos","sourceProvider":"SOURCE_JSON","sourceUrl":"https://adjuvantcapital.com/team/","title":"Director of Finance and Compliance"}],"sources":{"headquarters":"https://adjuvantcapital.com/contact/","investmentThesisFocus":"https://adjuvantcapital.com/about/","investorDescription":"https://adjuvantcapital.com","portfolioHighlights":"https://adjuvantcapital.com/portfolio/"},"websiteURL":"https://adjuvantcapital.com"}	Correctness: 95% Completeness: 85% The information provided about Adjuvant Capital is largely **factually accurate**. The investment strategy clearly aligns with publicly available descriptions from Adjuvant’s website and external sources, emphasizing late-stage life sciences investments targeting infectious diseases, maternal and child health, nutrition, and reproductive health, with a geographic focus on low- and middle-income countries and underserved markets globally[3][1]. The firm’s focus on opportunities with human efficacy signals from Phase II-or-later clinical trials or similar evaluations is consistent with its stated investment thesis[3]. The **headquarters locations** given (New York City and Zurich) also match the contact details on Adjuvant’s website[3]. The senior leadership names and roles (Glenn Rockman as Founder and Managing Partner, Kabeer Aziz as Co-Founder and Partner, etc.) correspond closely to the official team page[3]. The **Assets Under Management (AUM)** figure of approximately USD 300 million as of September 2023 is supported by the About page, though some external data sources do not explicitly confirm a fund size or formally named fund sizes, consistent with the note that only a single overarching investment strategy is described without specific fund sizes disclosed[3][5]. The estimated investment size given (“$10-$25 million”) is an inferred range rather than a formally published figure, aligning with researcher notes that such granular sizing is undisclosed[3]. **Portfolio companies** listed (e.g., LimmaTech Biologics, Memo Therapeutics, VitriVax, etc.) correspond to publicly named portfolio highlights on their website[3]. The main area of **incompleteness** is in the absence of formally named funds and precise fund size data, which limits clarity on the structure and scale of individual investment vehicles—this was explicitly noted as "Not Available" and "Missing Important Fields" in your data and confirmed by external sites[5]. Also, detailed performance metrics, historical fund close dates, and specific investment outcomes are not provided or publicly available, limiting full completeness. **Sources:** - Adjuvant Capital About page: https://adjuvantcapital.com/about/ - Adjuvant Capital Team: https://adjuvantcapital.com/team/ - Portfolio: https://adjuvantcapital.com/portfolio/ - MacArthur Foundation Fact Sheet on Adjuvant: https://www.macfound.org/media/article_pdfs/adjuvant-fact-sheet_final.pdf - Private Equity International profile: https://www.privateequityinternational.com/institution-profiles/adjuvant-capital.html This justifies a **correctness score of 95%** due to excellent alignment with primary official sources and only minor gaps on formal fund naming and specific investment sizing; and a **completeness score of 85%** because while core strategy and leadership info is well-covered, details on fund size, stage history, and financial track record remain unavailable.
65	Activate Capital Partners	https://activatecap.com/	{"funds":[{"estimatedInvestmentSize":"USD 10,000,000 - 30,000,000","fundName":"Activate Capital","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Series B","Growth","Late stage","Pre-IPO"],"sectorFocus":["Clean energy","sustainability","climate adaptation","energy load aggregation","supply chain intelligence"],"sourceUrl":"https://activatecap.com/approach"}],"headquarters":"50 California Street, Suite 2050, San Francisco, CA 94111","investmentThesisFocus":["Focuses on sustainability, resiliency, and adaptation as critical themes shaping the future of energy and infrastructure.","Addresses the missing middle of climate finance, investing typically 10–30M USD in technology companies at Series B to pre-IPO stages.","Partners closely with portfolio companies to provide capital, strategic opportunities, and act as a sounding board to support rapid decarbonization.","Leverages over 130 years of collective team experience, emphasizing sound economic investing aligned with sustainability and measurable impact.","Targets sectors including power, production, movement, and adaptation infrastructure."],"investorDescription":"Activate Capital is a growth-stage venture capital firm focused on the sustainable, resilient transformation of the global economy. Their mission is to accelerate the world’s transition to a sustainable, resilient, and adaptable future by investing in category-creating companies of tomorrow. They back companies ready to scale, led by exceptional entrepreneurs aiming to build category-defining platforms. The firm emphasizes building a sustainable organization with diverse perspectives and holds values such as persistence, candor, and humility.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Aerones","Altana AI","Crusoe","Enpal","Fictiv","Generate Capital","HOMEE","Kin Insurance","KlearNow","Muon Space","Nozomi Networks","Omnidian","Optimal Dynamics","Passport","PosiGen","Ridecell","Swimlane","Sympower","Tomorrow.io","Voltus","WeaveGrid","XNRGY","Flexe","Parsable","STEM","Streetlight Data","Volta"],"researcherNotes":"AUM is not mentioned on the website. No formal funds names other than the firm name. Investment stage focus inferred from stated Series B to pre-IPO investment activity. Geographic focus assumed Global as no specific region limitation stated.","seniorLeadership":[{"name":"Anup Jacob","sourceProvider":"Perplexity","sourceUrl":"https://activatecap.com/team#team-member-1955","title":"Managing Partner"},{"name":"David Lincoln","sourceProvider":"Perplexity","sourceUrl":"https://activatecap.com/team#team-member-1961","title":"Managing Partner"},{"name":"Anna Nitschke","sourceUrl":"https://activatecap.com/team#team-member-3306","title":"Chief Operating Officer & Chief Financial Officer"},{"name":"Patti Szczepaniak","sourceUrl":"https://activatecap.com/team#team-member-1978","title":"Chief Administrative Officer"}],"sources":{"headquarters":"https://activatecap.com/contact","investmentThesisFocus":"https://activatecap.com/approach","investorDescription":"https://activatecap.com/about","portfolioHighlights":"https://activatecap.com/portfolio"},"websiteURL":"https://activatecap.com/"}	Correctness: 98% Completeness: 85% The provided information about Activate Capital is highly accurate. The firm is indeed a growth-stage venture capital investor focusing on sustainability, resilience, and climate-related sectors, targeting Series B to pre-IPO stages with typical investments between $10 million and $30 million, as confirmed on their website and investment approach page[4][5]. Their headquarters at 50 California Street, Suite 2050, San Francisco, CA, is correct per their contact page[5]. The description of their investment thesis—emphasizing sustainability, resiliency, economic returns aligned with impact, and specific sector focuses like clean energy, adaptation infrastructure, and supply chain intelligence—is consistent with official sources[4][5]. The named senior leadership (Anup Jacob and David Lincoln as Managing Partners, Anna Nitschke as COO & CFO, and Patti Szczepaniak as CAO) matches the current team listings on their site[5]. The portfolio highlights, including companies such as Tomorrow.io, Sympower, and Altana AI, align with publicly disclosed investments[5]. Their firm values around building a sustainable organization with diverse perspectives and supporting category-creating companies are also corroborated by their About page[5]. However, the completeness score is lower primarily because key financial details are missing or outdated: - Overall Assets Under Management (AUM) are omitted in the provided data but publicly available; Activate Capital had approximately $657 million AUM across two funds as of late 2022, with Fund II closing at $500 million raised, and they are currently raising Fund III targeting $500 million[1][3]. This is a significant disclosure gap. - The "fundSize" field is marked "Not Available," but their Funds I and II sizes are known from their impact report and news sources[1][3]. - Geographic focus is listed as "Global," which matches their statements; nevertheless, recent fundraises indicate growing European engagement, a nuance absent from the summary[3]. - There is mention of missing important fields such as "overallAssetsUnderManagement," which are critical for completeness. - There is no formal naming of individual funds beyond "Activate Capital," which matches the publicly known structure but could be clearer that Fund I, II, and III exist. Overall, the factual content about the firm’s mission, leadership, investment focus, and portfolio is correct and well represented, but the incomplete financial data reduces completeness compared to publicly available sources. The URLs below were used to verify the data: - https://activatecap.com/approach - https://activatecap.com/about - https://activatecap.com/contact - https://activatecap.com/portfolio - https://activatecap.com/wp-content/uploads/Activate_Capital_Impact_Report_Final.pdf - https://axios.com/pro/climate-deals/2025/08/08/activate-capital-fund-iii-europe-lps
66	Addition	https://addition.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Addition Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["New York, NY"],"investmentStageFocus":["Early Stage","Growth Stage"],"sectorFocus":["Technology"],"sourceProvider":"LinkedIn","sourceUrl":"https://addition.com"}],"headquarters":"New York, New York","investmentThesisFocus":["Focus on founder-led companies.","Invest in technology-enabled businesses.","Support visionaries in building impactful and enduring businesses."],"investorDescription":"We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses. Addition invests in founder-led, technology-enabled companies.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","portfolioHighlights","seniorLeadership","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"No explicit information found on AUM, fund size, specific investment size, geographic focus, portfolio companies, or senior leadership from the website.","seniorLeadership":[{"name":"Lee Fixel","sourceProvider":"Perplexity","title":"Founder"},{"name":"Ryan Preston","sourceProvider":"Perplexity","title":"Partner"},{"name":"Kristen Green","sourceProvider":"Perplexity","title":"Managing Director"}],"sources":{"funds":"https://www.linkedin.com/company/additionvc","headquarters":"https://addition.com","investmentThesisFocus":"https://addition.com","investorDescription":"https://addition.com","portfolioHighlights":"https://addition.com","seniorLeadership":"https://www.crunchbase.com/organization/addition/company_officers"},"websiteURL":"https://addition.com"}	Correctness: 95% Completeness: 75% The factual information provided is largely accurate. Addition is indeed a New York-based venture capital firm focusing on early and growth-stage technology companies, investing in founder-led, technology-enabled businesses, and supporting visionary entrepreneurs, consistent with the fund description and investment thesis from Addition’s official website and credible profiles[2][4]. The senior leadership details listing Lee Fixel as Founder, Ryan Preston as Partner, and Kristen Green as Managing Director align well with data from Crunchbase and industry sources[2][3]. However, the provided data notably lacks crucial quantitative details that are publicly available such as: - Fund sizes: Addition has raised four funds ranging from $1.3 billion to $1.5 billion each, totaling an AUM around $6.5 billion as reported by PitchBook and TechCrunch[1][2]. - Estimated investment size per deal is broadly unspecified, but the firm’s focus splits roughly into one-third early stage and two-thirds growth stage investments[2]. - Portfolio highlights include well-known companies like Stripe, Lyra, Snyk, Chainalysis, Allbirds, Freshworks, and Hugging Face, which are missing in the original data[1][2]. Therefore, the completeness is reduced because the original summary missed these important quantitative and portfolio details that give a fuller picture of Addition’s scale, investment activity, and impact. Furthermore, the original data’s "Not Available" for fund size and AUM contradicts publicly reported figures[1][2]. The geographic focus is correctly stated as New York, and the senior leadership names are confirmed externally. Sources used: - TechCrunch (2023): https://techcrunch.com/2023/06/14/lee-fixel-addition-fund/ - VC Mapping (2025): https://vc-mapping.gilion.com/vc-firms/addition - Addition official website: https://addition.com - Private Equity International: https://www.privateequityinternational.com/institution-profiles/addition.html
67	Acurio Ventures	http://www.acurio.vc	{"funds":[{"estimatedInvestmentSize":"EUR 750,000 - 3,000,000","fundName":"Acurio Ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe","Opportunistic US and LatAm"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Generalist excluding life sciences and crypto"],"sourceUrl":"https://www.acurio.vc/how-we-invest"}],"headquarters":"Calle Gran Vía de Don Diego López de Haro, nº1 - 48001 Bilbao (Vizcaya)","investmentThesisFocus":["They invest primarily in seed and series A rounds.","They prefer to co-lead or follow investment rounds rather than lead.","They make fast decisions and leverage entrepreneurial experience, operational know-how, platform resources, and a broad network to support founders.","They invest across a broad range of sectors but exclude life sciences and crypto.","They have a strong pool of advisors from notable Spanish and international tech companies providing support beyond capital.","Their core values include integrity, entrepreneurial ownership, fearless support to partners, and trustworthiness to stakeholders."],"investorDescription":"Acurio Ventures is a venture capital firm that partners with visionary founders to make history happen. They support founders through challenges based on their own experience in founding and scaling companies and venture firms. They invest primarily in seed and series A rounds in Europe, collaborate with other investors, and are sector agnostic with a focus on great companies and committed founders.","linkedDocuments":["https://alliron.vc.land/documents"],"missingImportantFields":["fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"EUR 300,000,000","sourceProvider":"Perplexity","sourceUrl":"https://www.acurio.vc/"},"portfolioHighlights":["Aplanet","Abound","Ai|coustics","Alpagga","Apeteat","Applause","Barkyn","BePretty","CCX"],"researcherNotes":"AUM amount of approximately EUR 300 million is mentioned as managed by previous funds but no specific fund size or current fund sizes are disclosed on the website. No explicit AUM date is provided.","seniorLeadership":[{"name":"Ander Michelena","sourceUrl":"https://www.acurio.vc/team","title":"General Partner"},{"name":"Kate Cornell","sourceUrl":"https://www.acurio.vc/team","title":"General Partner"},{"name":"Diego Recondo","sourceUrl":"https://www.acurio.vc/team","title":"General Partner"},{"name":"Hugo Fernández-Mardomingo","sourceUrl":"https://www.acurio.vc/team","title":"General Partner"},{"name":"Jaume Ayats","sourceUrl":"https://www.acurio.vc/team","title":"Principal & Head of Product"},{"name":"Ainhoa Saralegui","sourceUrl":"https://www.acurio.vc/team","title":"Senior Investor"},{"name":"Miguel González","sourceUrl":"https://www.acurio.vc/team","title":"Senior Investor"},{"name":"Matías O'Farrell","sourceUrl":"https://www.acurio.vc/team","title":"CFO"},{"name":"Eneko Marin","sourceUrl":"https://www.acurio.vc/team","title":"Head of Legal"},{"name":"Bosco Amann","sourceUrl":"https://www.acurio.vc/team","title":"Head of Marketing & Portfolio Management"},{"name":"Daniel Martin","sourceProvider":"Perplexity","title":"Venture Partner"},{"name":"Bart Tompkins","sourceProvider":"Perplexity","title":"Senior Executive Advisor"},{"name":"Iñaki Ecenarro","sourceProvider":"Perplexity","title":"Venture Partner"}],"sources":{"headquarters":"https://www.cnmv.es/portal/consultas/ecr/fondo?nif=V13647102&lang=en","investmentThesisFocus":"https://www.acurio.vc/about","investorDescription":"https://www.acurio.vc/","portfolioHighlights":"https://www.acurio.vc/portfolio"},"websiteURL":"http://www.acurio.vc"}	Correctness: 98% Completeness: 85% The provided information about **Acurio Ventures** is factually accurate and aligns well with authoritative sources: - The **headquarters location** at Calle Gran Vía de Don Diego López de Haro, nº1 - 48001 Bilbao (Vizcaya), Spain is confirmed by the CNMV registry and company privacy/legal notices[3][5]. - The **investment focus on Seed and Series A**, the **sector exclusion of life sciences and crypto**, and the **geographic focus on Europe, opportunistic US and LatAm** align with Acurio Ventures’ official website statements on how they invest[1][3]. - The description of their **investment thesis** emphasizing co-leading or following rounds, leveraging experience and networks, and core values such as integrity and entrepreneurial ownership is consistent with their website’s "About" and "How We Invest" pages[3]. - The generalist sector focus excluding specific sectors matches their stated exclusion of life sciences and crypto while investing broadly otherwise[3]. - The **estimated investment size** of EUR 750,000 - 3,000,000 fits the range for early-stage rounds they typically target, in line with typical European VC Seed/Series A investment sizes and their disclosures[3]. - The **portfolio highlights** (e.g., Aplanet, Barkyn) and senior leadership team data including General Partners Ander Michelena, Kate Cornell, and others correspond well to the publicly available team information on their site[3]. **Limitations and missing components:** - The **fund size(s) are not publicly disclosed**, which matches the noted "Not Available" in the input. Although the firm references approximately EUR 300 million AUM across previous funds, there is no clear data on current fund sizes or vintage years[3][4]. This justifies a reduced completeness score. - There is no direct source confirming exact fund names or all portfolio companies listed beyond top examples, but the named portfolio companies are consistent with publicly referenced investments on their site[3]. - Some very recent fund commitment or open/close dates mentioned in other sources are incomplete or withheld[4], limiting thoroughness. Overall, the data is accurate, well-aligned with primary sources (Acurio’s official site, CNMV registry), and comprehensive on description and team but lacks full transparency on exact fund sizes and up-to-date fund status, so completeness is rated lower. Sources used: https://www.acurio.vc/ https://www.cnmv.es/portal/consultas/ecr/sociedad?nif=A56892003&lang=en https://www.acurio.vc/privacy-policy https://ecosystem.andorra-startup.com/investors/acurio_ventures/portfolio/exits
68	Activant Capital	http://activantcapital.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Activant Fund III","fundSize":"USD 257,000,000","fundSizeSourceUrl":"https://activantcapital.com/perspectives/announcing-activant-fund-iii","geographicFocus":["USA","Europe","South Africa"],"investmentStageFocus":["Growth equity"],"sectorFocus":["Commerce infrastructure technology platforms","Logistics","Payments","Fintech","Mortgage technology"],"sourceUrl":"https://activantcapital.com/perspectives/announcing-activant-fund-iii"}],"headquarters":"323 Railroad Avenue, Greenwich, CT 06830, USA; 110 Greene Street, New York, NY 10021, USA; Schwedter Str. 263, 10119 Berlin, Germany; 5th Floor, 17 Jamieson St, Gardens, Cape Town, 8001, South Africa","investmentThesisFocus":["Research-led growth equity investment approach focused on commerce infrastructure technology platforms.","Thesis-driven with long-term investment horizon and operational support including organizational structure, hiring, go-to-market strategy, commercial introductions, and finance support.","Focus on high-conviction investments in sectors such as fintech, supply chain, automation, AI, cybersecurity, and office of the CFO.","Targeting founders who are relentless and ready for significant growth challenges."],"investorDescription":"Activant is a research-led global investment firm that partners with high-growth companies. Founded in 2015, Activant has raised 5 funds with over USD 1 billion assets under management. It partners with founders who have won their initial battles and are ready for the next challenge.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 1,000,000,000","sourceUrl":"https://activantcapital.com/about"},"portfolioHighlights":["Deliverr","Forter","Hybris","Vtex","Celonis","XOPSY","Sardine","Owner"],"researcherNotes":"Estimated investment size per company is not explicitly stated on the website. Activant Fund III is the only formally named fund found with a disclosed fund size. Overall AUM is explicitly stated as over 1 billion USD on the about page. Portfolio companies cover a range of stages and sectors as described.","seniorLeadership":[{"name":"Steve Sarracino","sourceProvider":"SourceJSON","sourceUrl":"https://activantcapital.com/team","title":"Founder and Partner"},{"name":"Andrew Steele","sourceProvider":"SourceJSON","sourceUrl":"https://activantcapital.com/team","title":"Partner"},{"name":"Maximilian Mayer","sourceProvider":"SourceJSON","sourceUrl":"https://activantcapital.com/team","title":"Partner, heads Activant's Berlin office"},{"name":"Jono Vickery","sourceProvider":"SourceJSON","sourceUrl":"https://activantcapital.com/team","title":"Vice President, Research"},{"name":"Richard Benson-Armer","sourceProvider":"SourceJSON","sourceUrl":"https://activantcapital.com/team","title":"Director of Research and Senior Advisor"},{"name":"Inbar Kodesh","sourceProvider":"Perplexity","sourceUrl":"https://activantcapital.com/team/inbar-kodesh","title":"Investor"},{"name":"Teddy Cohen","sourceProvider":"Perplexity","sourceUrl":"https://activantcapital.com/team","title":"Investor"},{"name":"John Matheson","sourceProvider":"Perplexity","sourceUrl":"https://activantcapital.com/team","title":"Investor"},{"name":"Marc Wu","sourceProvider":"Perplexity","sourceUrl":"https://activantcapital.com/team","title":"Investor"}],"sources":{"headquarters":"https://activantcapital.com/contact","investmentThesisFocus":"https://activantcapital.com/research","investorDescription":"https://activantcapital.com/about","portfolioHighlights":"https://activantcapital.com/companies"},"websiteURL":"http://activantcapital.com"}	Correctness: 90% Completeness: 85% The provided information about Activant Capital is largely accurate. The firm’s Fund III closed with $257 million in commitments, focused on commerce infrastructure technology platforms, and this fund’s size and thematic focus match what is publicly announced by Activant[1][2]. The overall assets under management figure of around $1 billion is consistent with multiple sources, though one source cites $1.5 billion AUM[4], indicating some variation or growth beyond the stated USD 1 billion. The geographic presence including offices in Greenwich, New York, Berlin, and Cape Town is correct based on the contact details on their website[3]. The investment thesis emphasizing research-led growth equity, long-term partnership with 15-year fund lives, sector focus on fintech, logistics, payments, AI, and commerce infrastructure, as well as the operational support described, align well with Activant’s own communications[2]. Senior leadership names and titles correspond to those listed on Activant’s team page, including founder Steve Sarracino and notable partners[2][3]. The portfolio companies mentioned such as Deliverr, Forter, Hybris, Vtex, Celonis, XOPSY, Sardine, and Owner reflect key investments or exits highlighted by the firm[1][2]. The primary incompleteness is the lack of an explicit estimated investment size per company, which Activant does not publicly disclose, lowering the completeness score. Also, total assets under management estimates vary among sources, suggesting updates or a range rather than a fixed figure. While the overall description captures the core of Activant’s strategy and focus, minor additional detail about fund vintage dates or more granular sector definitions could enhance completeness further. URLs used: https://activantcapital.com/perspectives/announcing-activant-fund-iii https://www.rede-partners.com/news-insights-database/activant-capital-closes-third-fund-with-257m-in-commitments https://activantcapital.com/contact https://activantcapital.com/about https://activantcapital.com/companies
69	AdBio partners	https://adbio.partners/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AdBio partners Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Early-stage"],"sectorFocus":["Life Sciences","Oncology","Immunology","Ophthalmology","Rare Diseases"],"sourceUrl":"https://adbio.partners/"}],"headquarters":"4 rue Thénard 75005 Paris, France; PIER07 Via Laietana, 26 08028 Barcelona, Spain","investmentThesisFocus":["Focus on innovative early-stage startups in life sciences across various therapeutic areas in Europe.","Act as catalyst to create companies based on innovations from academic research with strong entrepreneurial support.","Combine early-stage investments with hands-on expertise, co-found companies with scientific founders, provide initial funding, and support development plans and R&D strategy.","Support from European research institutions, technology transfer offices, scientific and industrial partners, and international VC syndicates."],"investorDescription":"AdBio partners is a VC firm with a strong entrepreneurial spirit, specialized in early-stage investment in the most promising life sciences startups in Europe. AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. They identify promising technologies or products coming from academia and help scientists transform their research into viable entrepreneurial ventures.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["EvlaBio","Tenpoint Therapeutics Ltd.","Augustine Therapeutics","Alderaan Biotechnology","AndzonBio1","Agomab Therapeutics","Arthex Biotech","Depth Charge","DiogenX","Integra Therapeutics"],"researcherNotes":"No explicit AUM or fund size data found on the website. The investment size per company is also not specified. Portfolio and leadership were extracted from the main site and portfolio page.","seniorLeadership":[{"name":"Alain Huriez, MD","sourceUrl":"https://adbio.partners/team","title":"Chairman and Managing Partner"},{"name":"Clément Bertholet","sourceUrl":"https://adbio.partners/team","title":"Managing Partner"}],"sources":{"headquarters":"https://adbio.partners/contact/","investmentThesisFocus":"https://adbio.partners/about-us/","investorDescription":"https://adbio.partners/","portfolioHighlights":"https://adbio.partners/portfolio/"},"websiteURL":"https://adbio.partners/"}	Correctness: 98% Completeness: 85% The provided information about AdBio partners is factually accurate and well-supported by multiple reliable sources. AdBio partners (formerly Advent France Biotechnology) is a Paris and Barcelona-based venture capital firm specializing in **early-stage investments in life sciences startups across Europe**, with a focus on sectors such as oncology, immunology, rare diseases, and ophthalmology[1][2][3][5]. The firm's investment thesis emphasizing acting as a catalyst to create companies from academic innovations, providing hands-on entrepreneurial support, collaborating with European research institutions and technology transfer offices, and leveraging networks of scientific and industrial partners is confirmed by the official website and third-party profiles[1][2][5]. The description of senior leadership (Alain Huriez, MD, Chairman and Managing Partner, and Clément Bertholet, Managing Partner) matches the team page content[5]. The **headquarters locations** (4 rue Thénard 75005 Paris, France; PIER07 Via Laietana, 26 08028 Barcelona, Spain) correspond to contact information from the official site[5]. The **portfolio highlights** such as EvlaBio, Tenpoint Therapeutics Ltd., Augustine Therapeutics, Alderaan Biotechnology, AndzonBio1, Agomab Therapeutics, Arthex Biotech, Depth Charge, DiogenX, and Integra Therapeutics are consistent with companies listed as supported by AdBio partners[3][5]. However, the **fund size**, **overall assets under management (AUM)**, and **estimated investment size per company** are not explicitly stated on the official website or most third-party sources, although FundingTrip indicates that AdBio partners has raised funds totaling about $185 million across two funds, with the second fund closing at €86M (£86M)[1][2]. This gap leads to a reduced completeness score. More detailed AUM or specific investment size figures per deal are missing and labeled as “Not Available” in the original data, which is accurate given public disclosure limits. In summary, the core factual data about AdBio partners’ investment focus, strategy, location, leadership, and portfolio is very well covered and accurate. The main missing elements are precise aggregated fund size and typical investment check sizes, which reduces completeness. Sources used: https://adbio.partners/ https://fundingtrip.com/f/adbio-partners https://adbio.partners/about-us/ https://adbio.partners/contact/ https://adbio.partners/portfolio/ https://adbio.partners/team https://adbio.partners/wp-content/uploads/2021/12/2021-12-07_AFB-AdBio-Partners-EN-embargo.pdf
70	Abstract	http://www.abstract.vc	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Abstract Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["US"],"investmentStageFocus":["Seed","Early Stage"],"sectorFocus":["Sector-agnostic"],"sourceProvider":"LinkedIn","sourceUrl":"http://www.abstract.vc"}],"headquarters":"499 Jackson St, 5th Floor San Francisco, CA 94111","investmentThesisFocus":["Sector-agnostic investment approach.","Investment focus on seed and early stage companies.","Known for fierce loyalty to founders.","Offers unparalleled connections to help portfolio companies succeed.","Driven by a relentless drive to help founders win."],"investorDescription":"Abstract is a venture capital firm based in San Francisco with $1.8 billion in assets under management. They are sector-agnostic and invest in seed and early stage companies. Their reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 1800000000","sourceUrl":"http://www.abstract.vc"},"portfolioHighlights":["11x","Aaru","Acryl Data","Adrenaline","Aether Biomachines","AirGarage","Airplane","Alloy","Alpaca","Amo"],"researcherNotes":"The website does not specify distinct formal funds or investment ticket sizes. The AUM figure is explicitly stated. Headquarters address is confirmed from the office page.","seniorLeadership":[{"name":"Ramtin Naimi","sourceUrl":"https://www.abstractvc.com/people/","title":"Founder & General Partner"},{"name":"Alex Davidov","sourceUrl":"https://www.abstractvc.com/people/","title":"General Partner"},{"name":"David Kwon","sourceUrl":"https://www.abstractvc.com/people/","title":"Partner"},{"name":"Andrei Kozyrev","sourceUrl":"https://www.abstractvc.com/people/","title":"Partner"},{"name":"Adam Wilczek","sourceUrl":"https://www.abstractvc.com/people/","title":"Chief Financial Officer"}],"sources":{"headquarters":"https://www.abstractvc.com/office/","investmentThesisFocus":"http://www.abstract.vc","investorDescription":"http://www.abstract.vc","portfolioHighlights":"https://www.abstractvc.com/companies-list/"},"websiteURL":"http://www.abstract.vc"}	Correctness: 98% Completeness: 90% The provided information about Abstract VC is factually accurate and consistent with multiple authoritative sources. Abstract is indeed a sector-agnostic venture capital firm based in San Francisco focusing on seed and early-stage investments. It has a strong reputation for loyalty to founders and providing extensive network connections, driven by a determination to help founders succeed[1][2][3]. The stated assets under management (AUM) of approximately $1.8 billion is confirmed by Abstract’s official website and third-party profiles, with one source noting $1.5 billion but the latest data indicates $1.8 billion[2][3][1]. The headquarters address matches the official office page[2]. Senior leadership names—Ramtin Naimi (Founder & General Partner), Alex Davidov (General Partner), David Kwon (Partner), Andrei Kozyrev (Partner), and Adam Wilczek (CFO)—are confirmed on the company website[5]. Regarding fund details, no specific formal funds or ticket sizes are publicly disclosed, as noted in the researcher’s observation and consistent with available sources. Although one source references a Fund I of around $1.6 billion AUM and a seed focus, concrete formal fund sizes and estimated individual investment sizes remain unavailable[1][2]. The portfolio highlights match those listed on Abstract’s website, incorporating companies like Aaru, Acryl Data, AirGarage, Alloy, Alpaca, Amo, and others[4]. The main incompleteness is the absence of distinct formal fund names, investment ticket sizes, or stages beyond “seed and early stage,” which limits the granularity of the investment thesis and fund structure. The stated missing fields ("estimatedInvestmentSize" and "fundSize") are appropriate, reflecting publicly unavailable data[1][2]. Sources used: - Abstract official site: https://www.abstractvc.com - Abstract Ventures profile: https://privateequitylist.com/investors/abstract-ventures - Colossus article on Ramtin Naimi and Abstract VC: https://joincolossus.com/article/ramtin-naimi-man-hot-hand/ - Venture Capital Archive portfolio listing: https://venturecapitalarchive.com/venture-funds/abstract-ventures-abstract-vc - Team page: https://www.abstractvc.com/people/
71	Active Venture Partners	http://www.active-vp.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Active Venture Partners Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["early stage"],"sectorFocus":["Venture Capital and Private Equity"],"sourceProvider":"LinkedIn","sourceUrl":null}],"headquarters":"Calle Roselló 198, 1º 2ª, 08008 Barcelona, Spain","investmentThesisFocus":["Providing more than just money, termed ACTIVE Value Building","Vision alignment and strategy refinement","Talent acquisition and retention","Building company buzz for clients and partners","Expertise in international expansion","Relevant introductions through their network","Finance structuring with KPIs","Mentoring through forums and advisors","Access to combined experience of the team","Investment focus on passionate entrepreneurs in Europe"],"investorDescription":"We are a diverse group passionate about digital start-ups and entrepreneurs. ACTIVE Venture Partners is itself a start-up and aims to transform venture capital by providing more than just money, termed ACTIVE Value Building. They invest in Europe, seeking entrepreneurs with ideas to change the future and foster sustainable growth impacting society. Their support includes vision alignment, strategy refinement, talent acquisition and retention, building company buzz for clients and partners, international expansion expertise, relevant introductions via their network, finance structuring with KPIs, and mentoring through various forums and advisors. They emphasize access to the combined experience of the whole team and invest in passion.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","sectorFocus","investmentStageFocus","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":"€74m","portfolioHighlights":["Soho House","LEON","Secret Cinema","Rapha","Honest Burgers","The Fold","Northern Monk","Finisterre","Vinterior","Piglet"],"researcherNotes":"No explicit AUM or fund size information found on the website. No distinct fund names or investment size ranges mentioned; therefore, the default strategy name is used and many fields are noted as Not Available.","seniorLeadership":[{"name":"CHRISTOPHER POMMERENING","sourceUrl":"https://www.active-vp.com/people","title":"Founding Partner"},{"name":"PHILIPP SCHROEDER","sourceUrl":"https://www.active-vp.com/people","title":"Founding Partner"},{"name":"RICARD SÖDERBERG","sourceUrl":"https://www.active-vp.com/people","title":"Founding Partner"},{"name":"BLAIR MACLAREN","sourceUrl":"https://www.active-vp.com/people","title":"Partner"},{"name":"CARMEN DE ARRIBA","sourceUrl":"https://www.active-vp.com/people","title":"CFO"}],"sources":{"headquarters":"https://www.active-vp.com/contact","investmentStageFocus":"https://www.linkedin.com/company/active-venture-partners","investmentThesisFocus":"https://www.active-vp.com/about-us","investorDescription":"https://www.active-vp.com/about-us","overallAssetsUnderManagement":"https://www.linkedin.com/company/active-venture-partners","portfolioHighlights":"https://active.partners/companies/","sectorFocus":"https://www.linkedin.com/company/active-venture-partners"},"websiteURL":"http://www.active-vp.com"}	Correctness: 85% Completeness: 65% The provided information about Active Venture Partners is largely factually correct. Their headquarters is indeed in Barcelona, Spain (Calle Roselló 198 as per their official contact page)[2]. They are a European venture capital firm focused on early-stage investments and emphasize value beyond capital, known as ACTIVE Value Building, which aligns well with their website descriptions of supporting entrepreneurs through strategy, talent, international expansion, finance structuring, and mentoring[1][2]. The portfolio highlights match publicly available lists on their site (e.g., Soho House, LEON, Secret Cinema, Rapha, Honest Burgers) from active.partners companies data. The senior leadership named (Christopher Pommerening, Philipp Schroeder, Ricard Söderberg, Blair MacLaren, Carmen De Arriba) matches official profiles on their site[1][2]. However, some data points reduce completeness and correctness somewhat: - The overall assets under management (AUM) stated as €74m is not found or verifiable from the sources reviewed. Some sources explicitly note no explicit AUM available publicly, only older fund close dates and no current fund sizes, lowering confidence in the €74m figure[4]. This reduces correctness slightly. - The fund size and estimatedInvestmentSize fields are missing or "Not Available," which is accurate as per review, but this gaps completeness. - Sector focus is generally described as venture capital, early-stage tech/digital companies, but LinkedIn source for sector focus is cited without direct URL available, and some sources mention focus on digital transformation, SaaS, consumer internet but not specifically "Venture Capital and Private Equity" as a sector[5]. This difference causes slight ambiguity. - The exact investment thesis points, including "ACTIVE Value Building" and detailed support areas, are paraphrased correctly but not fully corroborated by secondary sources beyond the company website. This restricts completeness. - The address discrepancy: One source[3] lists an alternate address (Passeig de Gràcia 35), but the official site confirms the Calle Roselló address, so the latter is authoritative. In summary, the core factual elements (location, leadership, investment focus, portfolio highlights, investment philosophy) are correct and well-supported, but lack of explicit AUM and fund-size data lowers completeness and some minor discrepancies affect correctness. Sources used: [1] https://app.dealroom.co/investors/active_venture_partners [2] https://www.active-vp.com/contact [3] https://startupxplore.com/en/investors/active-venture-partners [4] https://www.privateequityinternational.com/institution-profiles/active-venture-partners.html [5] https://venturecapitalarchive.com/venture-funds/active-venture-partners-activevp-com
72	Établissement Peugeot Frères	https://www.peugeot-freres.fr/en/homepage/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"1stKind Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Europe"],"investmentStageFocus":["Not Available"],"sectorFocus":["Deeptech Innovation","Industrial Applications","Climate Solutions"],"sourceUrl":"https://www.peugeot-freres.fr/en/metiers/1stkind"}],"headquarters":"66 avenue Charles de Gaulle, 92200 Neuilly-sur-Seine","investmentThesisFocus":["Maintains an entrepreneurial culture with a long-term vision and agility.","Positions itself as a responsible shareholder committed to sustainable development and creating long-term value.","ESG strategy is built around three pillars: patrimonial, responsible shareholder, and entrepreneur spirit.","Focuses investment activities through Peugeot Invest and venture capital through 1stKind supporting European technology projects in deeptech innovation, industrial applications, and climate solutions."],"investorDescription":"Établissements Peugeot Frères (EPF) is the holding company of the Peugeot family group, acting as an emblematic family shareholder with a long-term entrepreneurial vision. EPF federates, represents, and promotes the heritage interests of the Peugeot family and the Peugeot brand. Its shareholders are exclusively Peugeot family members. EPF has professional governance including a Board of Directors and specialized committees.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","portfolioHighlights","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Not Available"],"researcherNotes":"No explicit data on overall AUM, fund sizes, estimated investment sizes, portfolio highlights, or senior leadership names could be found on the website. Investment activities are shown mainly through Peugeot Invest and 1stKind as sub-entities. The lack of detailed quantitative data prevents exact figures.","seniorLeadership":[{"name":"Thierry Peugeot","sourceProvider":"Perplexity","title":"Chairman"},{"name":"Pierre Peugeot","sourceProvider":"Perplexity","title":"Vice-Chairman"}],"sources":{"headquarters":"https://www.peugeot-freres.fr/contact/","investmentThesisFocus":"https://www.peugeot-freres.fr/en/philosophy/","investorDescription":"https://www.peugeot-freres.fr/en/about/","portfolioHighlights":"https://www.peugeot-freres.fr/en/homepage/"},"websiteURL":"https://www.peugeot-freres.fr/en/homepage/"}	Correctness: 98% Completeness: 80% The information provided is largely factually correct based on the publicly available sources. 1stKind Investment Strategy indeed focuses on **Deeptech Innovation, Industrial Applications, and Climate Solutions** within Europe and supports early-stage investments from pre-seed to Series A, with check sizes starting around €200k and follow-on capacity[1]. The **investment thesis** aligns with Peugeot Frères’ emphasis on **entrepreneurial culture, long-term vision, responsible shareholder engagement, and ESG pillars** as shown on their official site[4]. Établissements Peugeot Frères (EPF) is correctly described as a family holding company representing the Peugeot family with professional governance and a long-term entrepreneurial vision[4]. The senior leadership named (Thierry Peugeot as Chairman and Pierre Peugeot as Vice-Chairman) corresponds with publicly known figures from the family (though not explicitly found on the site, this is consistent knowledge and not contradicted by sources). Headquarters at **66 avenue Charles de Gaulle, 92200 Neuilly-sur-Seine** is confirmed by the official contact page[4]. However, **significant quantitative data is missing or not publicly disclosed**: - Overall Assets Under Management (AUM) for EPF or the funds is not stated anywhere on the website or related resources. - No explicit disclosure of the total or individual fund sizes for 1stKind or Peugeot Invest. - No portfolio highlights or named flagship investments beyond the mention of Robertet S.A. acquisition by Peugeot Invest (not 1stKind directly), which indicates a diverse portfolio but no details on flagship companies under 1stKind[3]. - The absence of detailed investment stage focus (though early stage from pre-seed to Series A is confirmed for 1stKind from source [1]) is partly filled but was marked as "Not Available." - No named senior leadership listed on the provided website for 1stKind specifically, only broader family governance references. These gaps lower the completeness score, reflecting the lack of publicly available granular quantitative information and portfolio details. Sources used: - 1stKind official site: https://www.1stkind.vc[1] - EPF (Peugeot Frères) official site: https://www.peugeot-freres.fr/en/homepage/[4] and https://www.peugeot-freres.fr/contact/[4] - Peugeot Invest portfolio info including Robertet S.A. deal: https://www.occstrategy.com/en/occ-support-peugeot-invest-with-commercial-due-diligence-in-investment-in-robertet-s-a/[3]
73	Access VC	https://www.access.vc/	{"funds":[{"estimatedInvestmentSize":"Minority investments with evergreen capital","fundName":"Access VC Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Growth stage"],"sectorFocus":["Health","Hygiene","Nutrition","Over-the-counter medicine","Vitamins & supplements","Intimate wellness","Hygiene & homecare","Infant nutrition"],"sourceUrl":"https://www.access.vc/"}],"headquarters":"London, GB","headquarters_sourceProvider":"LinkedIn","investmentThesisFocus":["Founder-first, hands-on approach.","Invest in founders fighting for better access to health, hygiene, and nutrition products.","Provide evergreen capital and strategic support including board-level participation.","Focus on growth-stage consumer businesses.","Sector focus on over-the-counter medicine, vitamins & supplements, intimate wellness, hygiene & homecare, and infant nutrition."],"investorDescription":"Access VC is the venture capital arm of Reckitt, one of the world’s largest consumer companies with leading hygiene, health, and nutrition brands. Invest in founders fighting for better access to health, hygiene, and nutrition products. Minority investments in growth-stage consumer businesses with evergreen capital and strategic support including board-level participation. Focus areas include over-the-counter medicine, vitamins & supplements, intimate wellness, hygiene & homecare, and infant nutrition. A small, diverse team with decades of experience in CPG and innovation, operating a founder-first, hands-on approach.","linkedDocuments":["https://access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf"],"missingImportantFields":["headquarters","overallAssetsUnderManagement","portfolioHighlights","seniorLeadership","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"No explicit AUM, funds size, headquarters, portfolio company names or detailed senior leadership info were found on the website or its related pages. The investment size is described qualitatively as minority evergreen investments. The geographic focus is not specified.","seniorLeadership":[],"sources":{"headquarters":"https://uk.linkedin.com/company/access-vc","investmentThesisFocus":"https://www.access.vc/","investorDescription":"https://www.access.vc/","portfolioHighlights":"https://www.access.vc/portfolio"},"websiteURL":"https://www.access.vc/"}	Correctness: 100% Completeness: 70% The provided information about Access VC is factually accurate according to the official Access VC website and LinkedIn page. Access VC is indeed the venture capital arm of Reckitt focused on **minority investments with evergreen capital** in **growth-stage consumer businesses** in sectors such as **health, hygiene, nutrition, over-the-counter medicine, vitamins & supplements, intimate wellness, hygiene & homecare, and infant nutrition**. Their approach is described as **founder-first, hands-on**, providing **strategic support including board-level participation**, executed by a **small and diverse team with strong CPG experience**[5][LinkedIn source]. However, the information **lacks completeness** in several important areas: the **fund size** and **overall assets under management (AUM)** are not disclosed publicly on the website or related documents, and the **geographic focus** is not explicitly specified. Additionally, there are no clearly listed **portfolio company names** or detailed **senior leadership biographies** on publicly accessible pages. These omissions reduce the completeness score because such data are commonly expected for venture capital fund disclosures. The "minority investments with evergreen capital" description is qualitative and does not specify exact investment size ranges or financial scales. Sources: - Access VC official site: https://www.access.vc/ - Access VC LinkedIn: https://uk.linkedin.com/company/access-vc - Access VC Impact Report (for context but no fund size disclosed): https://access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf
74	Abeille Impact Investing France	https://www.impactinvesting.abeille-assurances.fr/	{"funds":[{"estimatedInvestmentSize":"EUR 100,000 to 1,000,000","fundName":"Abeille Impact Investing France Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["France"],"investmentStageFocus":["Seed","Early Stage","Growth Stage"],"sectorFocus":["health","education","dependency care","green energy","circular economy","organic agriculture","fair trade","alternative economic models"],"sourceProvider":"Perplexity","sourceUrl":"https://www.impactinvesting.abeille-assurances.fr/crit%C3%A8res"}],"headquarters":"20 rue Clavel, 75019 Paris, France","investmentThesisFocus":["Invest in innovative companies with strong social and environmental impact.","Focus on sectors like health, education, dependency care, green energy, circular economy, organic agriculture, fair trade, and alternative economic models.","Investments are made across the entire French territory.","Use equity and quasi-equity instruments including shares, associative securities, participative securities, and convertible bonds.","Take minority stakes and actively participate in governance and decision-making bodies.","Investment horizon of 5 to 7 years aiming for solid financial, social, and environmental returns."],"investorDescription":"Abeille Impact Investing France is a development capital fund created in 2014 that has invested over €50 million across 60+ innovative TPEs and SMEs throughout France over 9 years. They invest in sectors of general interest such as health, education, dependency care, as well as pioneers in ecological transition like green energy, circular economy, organic agriculture, and alternative economic models like short supply chains, fair trade, and car sharing. Their investments focus on companies with high social and environmental impact contributing to a more inclusive and sustainable economy. The fund is fully financed by Abeille Assurances and managed by INCO Ventures, which handles project selection and portfolio monitoring. Abeille Assurances actively supports companies via strategic committee participation and networks of mentors and experts. The fund is labeled by Finansol and French Impact.","linkedDocuments":["https://www.impactinvesting.abeille-assurances.fr/_files/ugd/e37d76_9e193fb3819d49319cd3f12846d835b5.pdf"],"missingImportantFields":["overallAssetsUnderManagement","seniorLeadership","investmentStageFocus","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Karethic","Jimini's","Upowa","Gifts for Change","Mundo-Lab","Betterfly Tourism","Ecomouton","Lemon Tri","IADYS","Enercoop"],"researcherNotes":"AUM is not mentioned on the website or linked documents. The fund strategy is unified and does not list separate fund names, so the default naming rule was applied.","seniorLeadership":[],"sources":{"headquarters":"https://www.impactinvesting.abeille-assurances.fr/_files/ugd/e37d76_9e193fb3819d49319cd3f12846d835b5.pdf","investmentThesisFocus":"https://www.impactinvesting.abeille-assurances.fr/crit%C3%A8res","investorDescription":"https://www.impactinvesting.abeille-assurances.fr/ambitions","portfolioHighlights":"https://www.impactinvesting.abeille-assurances.fr/portefeuille"},"websiteURL":"https://www.impactinvesting.abeille-assurances.fr/"}	Correctness: 98% Completeness: 90% The provided information about Abeille Impact Investing France is largely factually accurate and aligns well with the official sources from the Abeille Assurances impact investing website and related documents. The fund was indeed created in 2014 (formerly named Aviva Impact Investing France), has invested over €50 million in more than 60 innovative very small to medium enterprises (TPEs/SMEs) across France, and focuses on sectors including health, education, dependency care, green energy, circular economy, organic agriculture, fair trade, and alternative economic models. Its investment approach involves equity and quasi-equity instruments such as shares and convertible bonds, with an investment horizon of around 5 to 7 years, taking minority stakes and actively participating in governance to achieve financial and social/environmental returns. This is confirmed by the fund's official site and linked PDF documents [2][3]. The fund’s geographic focus is France, and it is fully financed by Abeille Assurances, with portfolio management carried out by INCO Ventures. The fund is labeled by Finansol and French Impact, and it supports companies via strategic committee participation and access to mentor networks. Representative portfolio companies like Karethic, Jimini's, Enercoop, and Lemon Tri correspond with what is publicly listed [2]. Some minor incompleteness exists in that the overall assets under management (AUM) figure is not explicitly disclosed on Abeille's website or linked documents, which limits completeness. Likewise, senior leadership details are not publicly available, and specific fund size is "not available," which the source acknowledges. The investment stage focus is consistent with seed through growth stage but not elaborated in fine detail. The geographic focus does not explicitly mention Africa beyond an older mapping reference, but the primary focus remains France. These gaps reduce completeness but not correctness since the missing data is acknowledged as unavailable [2]. In summary, correctness is high as the information matches verifiable sources, but completeness is slightly lower due to absence of certain financial and leadership details in the public domain. Sources: - Abeille Impact Investing France official website and criteria: https://www.impactinvesting.abeille-assurances.fr/crit%C3%A8res - Abeille Impact Investing France ambits and portfolio: https://www.impactinvesting.abeille-assurances.fr/ambitions - Portfolio highlights: https://www.impactinvesting.abeille-assurances.fr/portefeuille - Linked PDF document detailing fund overview and headquarters: https://www.impactinvesting.abeille-assurances.fr/_files/ugd/e37d76_9e193fb3819d49319cd3f12846d835b5.pdf - Impact France mapping reference: https://en.impactfrance.eco/mappings-financeurs-de-limpact/abeille-impact-investing-france
75	Adara Ventures	http://www.adara.vc	{"funds":[{"estimatedInvestmentSize":"EUR 0 to 2,500,000","fundName":"AV4","fundSize":"EUR 100,000,000","fundSizeSourceUrl":"https://www.adara.vc/news/announcing-av4","geographicFocus":["Europe"],"investmentStageFocus":["Early Stage"],"sectorFocus":["Cybersecurity","Applied AI","Digital Infrastructure","Hardware Components","Digital Health","Space"],"sourceUrl":"https://www.adara.vc/news/announcing-av4"}],"headquarters":"Luxembourg City, Luxembourg","headquarters_sourceProvider":"Perplexity","investmentThesisFocus":["We help create a path Enabling visionary founders to build global technology leaders.","Europe. Enterprise. Deeptech.","We back best-in-class founders solving the most complex problems in the modern enterprise, with a targeted focus on Cybersecurity, Energy Transition, Data and AI, Digital Health, Components, and Digital Infrastructure."],"investorDescription":"Adara Ventures has partnered for 20 years with exceptional early-stage European founders targeting global B2B markets. They back teams that have found their purpose, proven their product, and are ready to go-to-market quickly. Their mission focuses on supporting visionary founders creating advanced AI applications for data and automation, software transforming energy transition, cybersecurity solutions, digital health innovations, scalable digital infrastructure, and advanced materials and components for AI and immersive technologies. They have €350 million Assets under Management, 6 funds, and have backed 50 companies to date. Their investor description emphasizes European focus with a global vision, supporting innovative startups ready to scale quickly, backed by an international team and network.","linkedDocuments":[],"missingImportantFields":["headquarters"],"overallAssetsUnderManagement":{"asOfDate":"2025","aumAmount":"EUR 350,000,000","sourceUrl":"https://www.adara.vc/news/visiting-analyst-program-fall-25"},"portfolioHighlights":["Stratio","Seedtag","Constella Intelligence","TuringDream","Scalefast","AlienVault","Playgiga"],"researcherNotes":"AUM figure of €350 million is explicitly stated in the company's overview and confirmed in recent news. Fund AV4 has a target size of €100 million and is actively investing as of early 2025. Estimated investment size per company is up to €2.5 million for initial investments. Headquarters address was not available on the Contact or main pages.","seniorLeadership":[{"name":"Alberto Gómez","sourceUrl":"https://www.adara.vc/team","title":"Founding Partner"},{"name":"Rocío Pillado","sourceUrl":"https://www.adara.vc/team","title":"Partner"},{"name":"Nico Goulet","sourceUrl":"https://www.adara.vc/team","title":"Founding Partner"},{"name":"Alberto Echeverri","sourceUrl":"https://www.adara.vc/team","title":"Partner"},{"name":"Ross Strachan","sourceUrl":"https://www.adara.vc/team","title":"Partner"},{"name":"Jesús Sainz","sourceUrl":"https://www.adara.vc/team","title":"Chairman Emeritus"},{"name":"Jorge Barón","sourceUrl":"https://www.adara.vc/team","title":"Principal"},{"name":"Mónica Navas","sourceUrl":"https://www.adara.vc/team","title":"Head of Compliance and Investor Relations"},{"name":"Irene Alía","sourceUrl":"https://www.adara.vc/team","title":"Head of Legal"},{"name":"Alessandro Gambarotta","sourceUrl":"https://www.adara.vc/team","title":"Principal"},{"name":"María Alonso","sourceUrl":"https://www.adara.vc/team","title":"Head of Finance"}],"sources":{"headquarters":"https://www.adara.vc/contact","investmentThesisFocus":"https://www.adara.vc/","investorDescription":"https://www.adara.vc/about-us","portfolioHighlights":"https://www.adara.vc/"},"websiteURL":"http://www.adara.vc"}	Correctness: 98% Completeness: 90% The core factual data about Adara Ventures is accurate. The AV4 fund is confirmed to have a target size of €100 million and is actively investing as of early 2025, with investment sectors including cybersecurity, applied AI, digital infrastructure, hardware components, digital health, and space—all consistent with the description provided[1][2][3][4]. Adara Ventures is indeed a European early-stage deep tech VC with an investment focus on visionary founders building global technology leaders, concentrating on enterprise and deep tech in Europe, particularly in the stated sectors plus energy transition[1][4]. The Assets under Management figure of €350 million as of 2025, distributed over 6 funds with 50+ backed companies, matches the summary from multiple sources, including their recent press releases[3]. The senior leadership team names correspond to those listed on Adara’s website[https://www.adara.vc/team], though this was confirmed independently and not in the provided excerpts, so correctness here is based on the reported source. The only slight factual uncertainty is that the exact headquarters address is missing in the source provided, and the statement "Luxembourg City, Luxembourg" as headquarters can be verified though it’s slightly less emphasized or detailed in public-facing documents but appears consistent with the contact page[https://www.adara.vc/contact]. This minor point lowers the completeness score. Portfolio highlights such as Stratio, Seedtag, Constella Intelligence, etc. are typical examples aligned with public portfolio lists on Adara without contradictory data, reinforcing factual completeness but fewer explicit sources cite all companies. Missing important fields noted—such as specifics of headquarters—reduce completeness somewhat. Additional context such as deeper company financials or detailed investment criteria is not included but not necessarily expected here. Sources: - https://siliconcanals.com/adara-ventures-closes-first-round-of-e100m-fund/ - https://www.businesswire.com/news/home/20250313203598/en/Adara-Ventures-Announces-First-Close-of-%E2%82%AC100M-AV4-Fund-Targeting-Cybersecurity-AI-Digital-Infrastructure - https://theaiinsider.tech/2025/03/17/adara-ventures-announces-first-close-of-e100m-av4-fund-to-accelerate-deep-tech-investments/ - https://techfundingnews.com/raising-dragons-in-deep-tech-adara-ventures-closes-e100m-for-av4-targeting-cybersecurity-and-digital-infrastructure/ - https://www.adara.vc/contact
76	7percent Ventures	https://www.7pc.vc/	{"funds":[{"estimatedInvestmentSize":"USD 250,000 to USD 2,000,000","fundName":"7percent Fund 1","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Pre-seed","Seed","Pre-revenue Concept Stage"],"sectorFocus":["Deeptech","Frontier Technology"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.7pc.vc/how-we-invest"},{"estimatedInvestmentSize":"USD 250,000 to USD 2,000,000","fundName":"7percent Fund 2","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Pre-seed","Seed","Pre-revenue Concept Stage"],"sectorFocus":["Deeptech","Frontier Technology"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.7pc.vc/how-we-invest"}],"headquarters":"7percent Ventures Ltd, 59 St. Martin's Lane, Unit 107, London, England, WC2N 4JS","investmentThesisFocus":["Focus on fundamental disruption, not iterative improvements, seeking startups that solve painful problems 10x better or address unmet needs, aiming for multi-billion dollar scalable opportunities (Decacorns).","Founder and CEO ambition and clear playbook for growth are essential.","Invest globally, primarily UK, US, Europe, often at very early stages including pre-seed, seed, even pre-revenue concept stage.","Investment size: checks from 250000 to 2000000 USD, often alongside other angel investors or founder-friendly VCs.","Focus sectors: Deeptech and frontier technology with core technical challenges enabling command of large nascent markets.","No investments outside multi-billion dollar opportunities or outside stated tech buckets, no later-stage companies irrelevant to thesis."],"investorDescription":"7percent Ventures invests in determined founders solving big problems, seeking 200x winners and moonshots rather than incremental market iterations. They back breakthrough technologies and products expected to be indispensable in ten years. They have invested in over 150 startups and 240 founders, with $2.3bn raised in follow-on capital. Their funds include 7percent Fund 1 (personal capital, direct investments, SPVs) and 7percent Fund 2 (Enterprise Capital Fund backed by British Business Bank). Their mantra emphasizes helping, not hindering startups, deriving from partners who are ex-founders with deep operational and investment experience. They focus on big risk, big outcome businesses capable of exponential growth and sector-defining change.","linkedDocuments":[],"missingImportantFields":[],"overallAssetsUnderManagement":null,"portfolioHighlights":["Cambridge Aerospace","Paddington Robotics","Stealth","Bea Fertility","ZeroTier","Bio Orbit","Perceptive Space","Modern Intelligence","Tipple","xAI"],"researcherNotes":"Overall Assets Under Management (AUM) is not explicitly mentioned or available on the website or LinkedIn. Fund sizes for both funds are also not disclosed in external sources, consistent with common industry practice for early stage funds with personal capital and Enterprise Capital Fund structure.","seniorLeadership":[{"name":"Andrew B Gault","sourceUrl":"https://www.7pc.vc/team","title":"Founding Partner"},{"name":"Andrew J Scott","sourceUrl":"https://www.7pc.vc/team","title":"Founding Partner"},{"name":"Sir Grant Shapps","sourceUrl":"https://www.7pc.vc/team","title":"Partner"},{"name":"Harry Morgan","sourceUrl":"https://www.7pc.vc/team","title":"Venture Partner"},{"name":"Jose Bonchristiano","sourceUrl":"https://www.7pc.vc/team","title":"Advisor, LPAC Chair"},{"name":"Duncan Grierson","sourceUrl":"https://www.7pc.vc/team","title":"Venture Partner"},{"name":"Wayne Gibbins","sourceUrl":"https://www.7pc.vc/team","title":"Venture Partner"}],"sources":{"headquarters":"https://www.7pc.vc/contact","investmentThesisFocus":"https://www.7pc.vc/how-we-invest","investorDescription":"https://www.7pc.vc/","portfolioHighlights":"https://www.7pc.vc/portfolio"},"websiteURL":"https://www.7pc.vc/"}	Correctness: 98% Completeness: 90% The provided information about 7percent Ventures is largely factually accurate and well-supported by the sources. The **headquarters address** at "59 St. Martin's Lane, Unit 107, London, England, WC2N 4JS" matches Companies House official records for 7PERCENT VENTURES LTD [2][3][5]. The **investment thesis and focus** on deeptech, frontier technology, early-stage (pre-seed, seed, concept), and global scope including UK, US, Europe are consistent with the firm's own website descriptions [5]. The stated **investment size range (USD 250,000 to 2,000,000)** aligns with information from their investment pages [5]. The **senior leadership team**, including founding partners Andrew B Gault and Andrew J Scott, plus partners such as Sir Grant Shapps, is also verifiable on the official website [5]. The **description of two funds—7percent Fund 1 and Fund 2—and their characteristics** fits the public narrative, with Fund 2 backed by British Business Bank’s Enterprise Capital Fund program, consistent with common industry practices for early-stage UK funds [5]. The claim of over 150 startups and 240 founders backed and $2.3bn raised in follow-on capital is presented on their site, reflecting their public investor pitch [5]. Portfolio highlights such as Cambridge Aerospace, ZeroTier, and others correspond to their published portfolio list [5]. Discrepancies are minor: - ZoomInfo lists a different London address (16 Bowling Green Ln, EC1R 0BU) which may be outdated or less precise compared to Companies House official records [1][2]. - Overall Assets Under Management (AUM) is not publicly disclosed, appropriately noted as missing. - Specific fund sizes are not publicly reported except for estimated investment ticket sizes; this is typical for early-stage funds with personal capital and Enterprise Capital structures, and is correctly noted as unavailable externally [5]. No fabricated or unsupported details were detected. The description accurately represents the firm’s ethos, investment strategy, leadership, headquarters, and fund structure based on the publicly available evidence. URLs used: https://www.7pc.vc/contact https://www.7pc.vc/how-we-invest https://www.7pc.vc/portfolio https://www.7pc.vc/team https://find-and-update.company-information.service.gov.uk/company/11698144 https://find-and-update.company-information.service.gov.uk/company/11698144/officers https://www.zoominfo.com/c/7percent-ventures-ltd/479993270
77	ACME Capital	https://www.acme.vc/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ACME Capital Investment Strategy","fundSize":"$300 million","fundSizeSourceUrl":"https://techcrunch.com/2022/02/04/acme-capital-run-by-scott-stanford-and-hany-nada-has-300-million-more-to-invest-in-early-startups/","geographicFocus":["Not Available"],"investmentStageFocus":["Early-Stage"],"sectorFocus":["AI-enabled healthcare billing platforms","customer service AI","low-earth orbit satellite systems"],"sourceProvider":"TechCrunch","sourceUrl":"https://www.acme.vc/"}],"headquarters":"San Francisco, California, United States","investmentThesisFocus":["Investing in pioneering founders who leverage technology and data to pursue massive opportunities that can reshape or create industries.","Focus on founders who dare to imagine game-changing ideas, using a 'Dare To Imagine' framework to articulate new realities each company can create.","Investment in disruptive business models that capitalize on current platforms and breakthrough technologies enabling emerging platforms.","Emphasis on Impact Value-Add by providing meaningful support beyond conventional venture services.","Values include service, excellence, resilience, passion, diversity, and humility.","Active investment in companies led by underrepresented founders."],"investorDescription":"ACME is an early-stage venture capital firm investing in extraordinary founders with a focus on innovation and visionary outlook. The firm supports portfolio companies through a deep network and hands-on assistance such as fundraising, marketing, recruiting, and navigating regulatory challenges. ACME's team includes partners and key staff such as Co-Founders Scott Stanford and Hany Nada, Partner Alex Fayette, Partner Aike Ho, and others.","linkedDocuments":[],"missingImportantFields":[],"overallAssetsUnderManagement":"$1.5 billion","portfolioHighlights":["Dare to Imagine","Airbnb","Astra Space (ASTR)","Braintrust (BTRST)","Decagon","IonQ (IONQ)","Cue (HLTH)","Daily Doctor","Didi (DIDIY)","DraftKings (DKNG)"],"researcherNotes":"AUM, headquarters address, investment size, sector focus, geographic focus and fund size are not mentioned on the website. Investment stage focus inferred as Early-Stage based on description.","seniorLeadership":[{"name":"Hany Nada","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Co-Founder and Partner"},{"name":"Scott Stanford","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Co-Founder and Partner"},{"name":"Alex Fayette","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Partner"},{"name":"Aike Ho","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Partner"},{"name":"Christian Tang-Jespersen","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Partner"},{"name":"Mike Derrick","sourceProvider":"SOURCE_JSON","sourceUrl":"https://www.acme.vc/our-team/","title":"Chief Financial Officer"}],"sources":{"headquarters":"https://www.acme.vc/contact/","investmentThesisFocus":"https://www.acme.vc/dare-to/","investorDescription":"https://www.acme.vc/","portfolioHighlights":"https://www.acme.vc/our-portfolio/"},"websiteURL":"https://www.acme.vc/"}	Correctness: 95% Completeness: 85% The information provided about ACME Capital is largely factually accurate based on available public sources: - **Headquarters:** Confirmed as San Francisco, California, United States, per ACME's website and VC Mapping[4][5]. - **Investment focus:** Early-stage venture capital investing in innovative founders and disruptive technologies is consistent with descriptions from ACME Capital’s website and VC Mapping[4][5]. - **Fund size:** The $300 million figure for their recent fund is supported by TechCrunch (as cited in the input) and VC Mapping's note of their largest fundraise being $300 million in February 2022[4]. - **Assets under management (AUM):** The $1.5 billion figure aligns with VC Mapping's data on total capital raised[4]. - **Sector focus:** Listed sectors such as AI-enabled healthcare billing platforms, customer service AI, and low-earth orbit satellite systems align well with their stated interest in AI, SaaS, and breakthrough enabling technologies typical of ACME’s portfolio[4][5]. - **Investment thesis:** Emphasizing a "Dare To Imagine" framework, impact value-add, support beyond funding, and diverse leadership is directly from ACME’s website[5]. - **Senior leadership:** The listed partners and key staff match the team displayed on their official site[5]. - **Portfolio highlights:** Companies such as Airbnb, Astra Space, IonQ, and Braintrust appear in ACME's portfolio and other listings[4]. However, there are some caveats lowering completeness and correctness slightly: - **Missing geographic focus:** The input states geographic focus as "Not Available," which is consistent given ACME focuses globally but does not specify particular geography explicitly[4]. - **Investment stage focus:** The input infers early-stage from descriptions, which is accurate, but precise stage definitions or ranges are not formally stated on the website[4][5]. - **Fund size source:** The TechCrunch URL is cited, but the actual article cannot be verified here; VC Mapping provides a similar confirmation for the $300 million fund[4]. - **ACME Capital in India:** The search results contain information about a ₹100 crore (~$13 million) ACME Capital Venture Fund managed by ACME Finvest in India, which is unrelated to the San Francisco-based VC firm described in the input, indicating different entities share the name "ACME Capital." This distinction should be clarified to avoid conflation[1][2][3]. Overall, the input is a solid, accurate profile of the US-based ACME Capital venture firm, with slight incompleteness regarding geographic and stage specifics and a note that the similarly named Indian fund is a different organization. Sources: - ACME Capital official site: https://www.acme.vc/ - VC Mapping: https://vc-mapping.gilion.com/vc-firms/acme-capital - TechCrunch (cited in input) - Economic Times and Tribune India articles distinguish a separate ACME Capital fund in India: https://economictimes.com/news/international/business/100-cr-acme-capital-venture-fundraise-by-acme-finvest-alignings-with-indias-innovation-goals-for-2025-and-ahead/articleshow/120195294.cms
78	ACF Investors	https://www.acfinvestors.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"ACF Investors Investment Strategy","fundSize":"GBP 100,000,000","fundSizeSourceUrl":"https://www.acfinvestors.com/","geographicFocus":["UK"],"investmentStageFocus":[],"sectorFocus":["Most sectors"],"sourceProvider":"Source JSON","sourceUrl":"https://www.acfinvestors.com/"}],"headquarters":"64 Alma Street, Luton, England, LU1 2PL","investmentThesisFocus":["Align interests with sector focused angel investors making a meaningful commitment to the round."],"investorDescription":"ACF Investors is a £100M Venture Capital fund investing in exceptional entrepreneurs from around the UK across most sectors.","linkedDocuments":[],"missingImportantFields":["investmentThesisFocus","estimatedInvestmentSize","portfolioHighlights"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"GBP 100,000,000","sourceProvider":"Source JSON","sourceUrl":"https://www.acfinvestors.com/"},"portfolioHighlights":[],"researcherNotes":"No detailed investment stages, estimated investment size, fund size, headquarters address, portfolio names, or senior leadership data were available on the website. AUM is taken from the homepage statement as the fund size.","seniorLeadership":[{"name":"Tim Mills","sourceProvider":"Perplexity","title":"Managing Partner"}],"sources":{"headquarters":"https://find-and-update.company-information.service.gov.uk/company/09906585","investmentThesisFocus":"https://www.acfinvestors.com/","investorDescription":"https://www.acfinvestors.com/","portfolioHighlights":null},"websiteURL":"https://www.acfinvestors.com"}	Correctness: 95% Completeness: 80% The factual information presented about ACF Investors is largely accurate and well-supported by multiple sources. ACF Investors is indeed a UK-based venture capital fund managing approximately £100 million, focused on co-investing alongside sector-smart angel investors across most sectors in the UK[1][2][3][5]. The summary of their investment thesis—that they align interests with sector-focused angels who make meaningful commitments—is consistent with statements on their official site and profiles[1][2][5]. The description of Tim Mills as Managing Partner matches publicly available info confirming his leadership since 2011[5]. The overall Assets Under Management (AUM) at £100 million aligns with figures found on their website and third-party profiles[2][5]. However, there are gaps that lower completeness. Publicly available data (e.g., OpenVC, Seedtable) provides more granular details about investment stages (seed to Series D/early revenue/scaling), estimated check sizes (£300k to £1M), and portfolio highlights such as Oxford Medical Simulation and Reboxed that are missing in the original data[3][4]. The headquarters address given (64 Alma Street, Luton) is not corroborated by authoritative company registries, which instead list Sheffield Technology Park and London addresses as primary offices[3]. This discrepancy suggests the provided address is either outdated or inaccurate. Additionally, senior leadership details beyond Tim Mills and portfolio company names, which are publicly available, were not included[4][5]. The original data's note about missing “detailed investment stages, estimated investment size, portfolio names, senior leadership” is accurate. In summary, while the core facts—fund size, geographic and sector focus, investment thesis, and leadership—are correct, the dataset omits significant public details such as specific investment stages, typical investment sizes, known portfolio companies, and accurate office addresses, which reduces completeness. Sources: - ACF Investors official site: https://www.acfinvestors.com/about/ [5] - Capboard profile: https://www.capboard.io/en/investor/acf-investors [1] - Invest in Women Hub: https://iiwhub.com/contacts/acf-investors/ [2] - OpenVC: https://www.openvc.app/fund/ACF%20Investors [3] - Seedtable portfolio info: https://www.seedtable.com/investors/acf-investors [4] - UK company registry: https://find-and-update.company-information.service.gov.uk/company/09906585 (confirms leadership and registered office)
79	Accel	http://www.accel.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Accel VIII Fund","fundSize":"USD 650,000,000","fundSizeSourceUrl":"https://www.accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders","geographicFocus":["India"],"investmentStageFocus":["Early Stage"],"sectorFocus":["Artificial Intelligence","Consumer","Fintech","Manufacturing"],"sourceUrl":"https://www.accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders"},{"estimatedInvestmentSize":"Not Available","fundName":"Accel XVI","fundSize":"USD 650,000,000","fundSizeSourceUrl":"https://www.accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund","geographicFocus":["United States"],"investmentStageFocus":["Early Stage"],"sectorFocus":["Not Available"],"sourceUrl":"https://www.accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund"},{"estimatedInvestmentSize":"Not Available","fundName":"Accel Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Global"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["Technology"],"sourceUrl":"https://www.accel.com/explore"}],"headquarters":"500 University Avenue, Palo Alto, CA 94301, USA; 35 South Park Street, San Francisco, CA 94107, USA; 886/A, Confident Electra 17th E Main Road, opposite Koramangala club, 6th Block, Koramangala 560095, Bengaluru, Karnataka, India; Koramangala Club Road, 881, 6th Cross Rd, 6th Block, Koramangala 560095 Bengaluru, Karnataka, India; 1 New Burlington Place, 6th Floor, London W1S 2HR, United Kingdom","investmentThesisFocus":["Focus on investing early-stage startups, especially Seed and Series A stages.","Support entrepreneurs innovating across large parts of the global economy.","Focus on bold founders and transformative, market-defining technology companies.","Sector focus includes Artificial Intelligence, Consumer, Fintech, Manufacturing.","Geographic focus includes US, India (with emphasis on tier 2+ regions), Europe, and Israel."],"investorDescription":"Accel is a global venture capital firm. To be the first partner to exceptional teams everywhere.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","estimatedInvestmentSize","fundSize"],"overallAssetsUnderManagement":"USD 19.56 billion","portfolioHighlights":["True Anomaly","Silna","Nebius","VoidZero"],"researcherNotes":"Overall Assets Under Management (AUM) is not mentioned explicitly on Accel's website or related news disclosures. There are two distinguishable funds with disclosed sizes of USD 650 million each (VIII Fund and XVI), but their total AUM is not detailed.","seniorLeadership":[{"name":"Casey Aylward","sourceUrl":"https://accel.com/people/casey-aylward","title":"Partner"},{"name":"Mahendran Balachandran","sourceUrl":"https://accel.com/people/mahendran-balachandran","title":"Partner"},{"name":"Luca Bocchio","sourceUrl":"https://accel.com/people/luca-bocchio","title":"Partner"},{"name":"Philippe Botteri","sourceUrl":"https://accel.com/people/philippe-botteri","title":"Partner"},{"name":"Andrew Braccia","sourceUrl":"https://accel.com/people/andrew-braccia","title":"Partner"},{"name":"Andrei Brasoveanu","sourceUrl":"https://accel.com/people/andrei-brasoveanu","title":"Partner"},{"name":"Abhinav Chaturvedi","sourceUrl":"https://accel.com/people/abhinav-chaturvedi","title":"Partner"},{"name":"Miles Clements","sourceUrl":"https://accel.com/people/miles-clements","title":"Partner"},{"name":"Kevin Comolli","sourceUrl":"https://accel.com/people/kevin-comolli","title":"Partner"}],"sourceProvider":"Perplexity","sources":{"headquarters":"https://accel.com/contact-us","investmentThesisFocus":"https://www.accel.com/explore","investorDescription":"https://www.accel.com/about","overallAssetsUnderManagement":"https://thehub.io/funding/accel-partners","portfolioHighlights":"https://accel.com/relationships"},"websiteURL":"http://www.accel.com"}	Correctness: 95% Completeness: 90% The information provided is largely factually accurate and well-aligned with publicly available sources. Accel’s eighth India fund size is correctly stated as USD 650 million, supported by multiple credible reports including Business Standard, Economic Times, Entrepreneur India, and Moneycontrol[1][2][4][5]. The geographic focus on India and the US (Accel XVI fund) is accurate, and the investment stage focus on early stages such as Seed and Series A aligns with Accel’s disclosures[2][3]. The sector focus for the India fund mentioned (Artificial Intelligence, Consumer, Fintech, Manufacturing) is confirmed by Moneycontrol[5]. The overall assets under management figure of USD 19.56 billion matches third-party data on Accel’s size. The multiple headquarters locations in the US, UK, and India correspond to Accel’s offices as listed on their official contact page. The described investment thesis also corresponds to Accel’s general strategy focusing on bold founders, transformative technologies, early-stage startups, and a global presence[3]. However, some noted gaps reduce completeness slightly: - The “Accel Investment Strategy” fund’s size is listed as “Not Available” with a global focus and technology sector emphasis. This is consistent with Accel’s website, which does not disclose a singular fund size for this strategy but describes a broad approach. - The lack of precise estimated investment size per deal or per fund (other than overall fund size) means information is incomplete, a common limitation in VC data[3]. - While major portfolio highlights such as Swiggy and Flipkart are mentioned in source articles, some listed companies like True Anomaly, Silna, Nebius, and VoidZero are not widely referenced publicly or on Accel’s primary site, reducing confidence in portfolio completeness. - The senior leadership list includes multiple partners with accessible profiles on Accel’s site, supporting factual correctness but without exhaustive leadership disclosure. Overall, the dataset is accurate and mostly complete for a high-level summary of Accel’s key funds, size, focus, and leadership, but it understandably lacks full disclosure on finer investment details and exhaustive portfolio listing, which are often confidential or less publicly documented. Sources: [1] https://www.business-standard.com/finance/investment/accel-secures-650-million-for-eighth-india-fund-to-invest-in-startups-125010100763_1.html [2] https://economictimes.com/tech/funding/accel-closes-eighth-india-fund-with-650-million-corpus/articleshow/116855164.cms [3] https://techcrunch.com/2025/01/05/accel-can-raise-billions-for-india-its-sticking-to-650-million/ [4] https://www.entrepreneur.com/en-in/news-and-trends/accel-secures-usd-650-mn-for-eighth-india-fund/485055 [5] https://www.moneycontrol.com/news/business/startup/accel-raises-650-mn-in-8th-india-round-to-back-disruptive-businesses-12903772.html https://thehub.io/funding/accel-partners https://accel.com/contact-us; https://www.accel.com/explore; https://accel.com/about
80	AAL VC	https://aal.vc/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"AAL VC Fund I","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["North America","Europe"],"investmentStageFocus":["Seed","Series A"],"sectorFocus":["AI","data","cloud","infrastructure","developer tools","open source"],"sourceProvider":"Original","sourceUrl":"https://aal.vc/"}],"headquarters":"Vancouver, Canada","investmentThesisFocus":["Focus on engineers and technical founders.","Investing in breakthrough technology across AI, data, cloud, infra, devtools, and open source.","Leverage a community of engineers to support deal flow and due diligence.","Invest primarily in North America and Europe."],"investorDescription":"AAL VC is a fund backing deeply technical founders from Seed to Series A in AI, data, cloud, infra, devtools, and open source in North America and Europe.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize","estimatedInvestmentSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Etched","Latent Labs","21st.dev","Netris","Dubformer","Zencoder","TheStage.ai","GPU Audio","Prog.ai","Artificial Agency"],"researcherNotes":"AUM and fund size not mentioned on the website. Estimated investment size not specified for Fund I.","seniorLeadership":[{"name":"Eugene Mikhaylov, CAIA","sourceUrl":"https://aal.vc/team","title":"partner"},{"name":"Dmitry Stepanov","sourceUrl":"https://aal.vc/team","title":"partner"},{"name":"Ash Vardanian","sourceUrl":"https://aal.vc/team","title":"venture partner"},{"name":"Roman Chernin","sourceUrl":"https://aal.vc/team","title":"original cofounder, expert"},{"name":"Nadya Petrova","sourceUrl":"https://aal.vc/team","title":"advisor"},{"name":"Billionaire Ange-Arthur LIMA","sourceProvider":"LinkedIn","sourceUrl":"https://ca.linkedin.com/company/aal-vc","title":"Chief Executive Officer"}],"sources":{"headquarters":"https://aal.vc/","investmentThesisFocus":"https://aal.vc/","investorDescription":"https://aal.vc/","portfolioHighlights":"https://aal.vc/portfolio"},"websiteURL":"https://aal.vc/"}	Correctness: 95% Completeness: 70% The information about AAL VC Fund I is largely factually accurate: its headquarters in Vancouver, Canada; focus on early-stage (Seed, Series A) investments; geographic focus on North America and Europe; and sector emphasis on AI, data, cloud, infrastructure, developer tools, and open source all align with the official AAL VC website and reputable sources[1][https://aal.vc/]. The description of its investment thesis focusing on deeply technical founders and leveraging a community of engineers to support deal flow and diligence is supported by the firm’s public statements[1]. The identified senior leadership names correspond with those listed on AAL VC’s team page[https://aal.vc/team]. However, there is no publicly disclosed data about the fund size, overall assets under management (AUM), or estimated investment size for Fund I on the official website or reliable third-party databases, consistent with the noted missing fields. This omission justifies a lower completeness score because such financial details are important for a thorough investment profile but remain unavailable despite being significant data points. The portfolio highlights listed (Etched, Latent Labs, 21st.dev, etc.) correspond to companies shown on the portfolio page[https://aal.vc/portfolio], confirming accuracy. The mention of "Billionaire Ange-Arthur LIMA" as CEO is unusual phrasing and not corroborated elsewhere — the website lists leadership but not with that specific title or descriptor; this may be an embellishment or less formal descriptor rather than an official title, thus slightly reducing correctness. In summary, the factual elements relating to headquarters, focus, and key people are correct, but the lack of fund size and AUM data reduces completeness. Attribution and terminology concerning leadership titles could be more precise. Sources: - AAL VC official website (https://aal.vc/) - Venture Capital Archive overview of AAL VC (https://venturecapitalarchive.com/venture-funds/aal-vc-aal-vc)
81	4See Ventures	https://4seeventures.ch/	{"funds":[{"estimatedInvestmentSize":"CHF 400,000 to CHF 1,000,000","fundName":"4see ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland"],"investmentStageFocus":["Seed","Series A","Series B"],"sectorFocus":["Climatech","Sustainability","Healthcare"],"sourceUrl":"https://4seeventures.ch/entrepreneurs/"}],"funds_enriched":[{"estimatedInvestmentSize":"CHF 400,000 to CHF 1,000,000","fundName":"4see ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Switzerland"],"investmentStageFocus":["Seed","Series A","Series B"],"sectorFocus":["Climatech","Sustainability","Healthcare"],"sourceProvider":"SOURCE_JSON","sourceUrl":"https://4seeventures.ch/entrepreneurs/"}],"headquarters":"Chemin Falletti 6 C1224 Chêne-Bougeries 6 Switzerland","investmentThesisFocus":["Backing entrepreneurs with vision, audacity to change the world, and executable plans.","Entrepreneur-centric approach with supportive investment terms.","Assistance in corporate strategy, financing strategy, and governance.","Investing own funds to align goals with entrepreneurs.","Focus on climatech and sustainability sectors.","Collaboration with institutional investors."],"investorDescription":"4see ventures invests in entrepreneurs in climatech, sustainability, and healthcare globally, with a current focus on Swiss early-stage startups in climatech and sustainability. The investor views entrepreneurs as heroes leading transformative change, emphasizing passion, vision to disrupt markets, and executable plans. 4see ventures was founded to guide family offices and private professional investors in direct venture capital investments, partnering with innovative entrepreneurs disrupting industries. The firm emphasizes open dialogue with investors, empowering them to make their own decisions on ventures and reinvestments, offering direct access to entrepreneurs, regular business updates, and informal meetings. Core values include trust (integrity, transparency, honesty), teamwork (collaboration with entrepreneurs and investors), impact (supporting entrepreneurs committed to positive societal impact), and courage (co-investing alongside clients). 4see ventures co-invests with clients, showing commitment.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":["Distal Motion","Haya Therapeutics","Transmutex","Goodwall","Stalicla","FenX","Cysec"],"researcherNotes":"No explicit statement of overall Assets Under Management (AUM) or total fund size found on the website.","seniorLeadership":[{"name":"Daniel Bertholet","sourceUrl":"https://4seeventures.ch/team/","title":"Founder and Managing Partner"},{"name":"Robert-Philippe Bloch","sourceUrl":"https://4seeventures.ch/team/","title":"Independent board member"}],"sources":{"headquarters":"https://4seeventures.ch/contact/","investmentThesisFocus":"https://4seeventures.ch/entrepreneurs/","investorDescription":"https://4seeventures.ch/about/","portfolioHighlights":"https://4seeventures.ch/companies/"},"websiteURL":"https://4seeventures.ch/"}	Correctness: 98% Completeness: 90% The provided information about 4see ventures is factually accurate based on multiple authoritative sources. Specifically: - **Investment size**: The stated range of CHF 400,000 to CHF 1,000,000 for initial investments aligns with 4see ventures’ own description, with potential commitments up to CHF 10 million over a company’s lifetime[2]. - **Geographic focus**: The focus on Switzerland is consistently confirmed, with rare exceptions in Europe or the US noted in broader contexts but primarily Swiss-focused[1][2][3]. - **Investment stages**: Seed, Series A, and Series B are explicitly documented as target stages[2]. - **Sector focus**: Climatech and sustainability sectors are emphasized in current strategy, building on historical experience in healthcare[2][3][5]. - **Investor description and investment thesis**: The narrative describing 4see ventures’ entrepreneur-centric approach, alignment through investing own funds, support in corporate strategy, and collaboration with institutional investors is directly supported by their website and investor materials[2][3]. - **Portfolio highlights and leadership**: Portfolio companies such as Distal Motion, Haya Therapeutics, Transmutex, and others are confirmed by their portfolio page and external databases[4]. Senior leadership names and roles match their official team page[2]. - **Headquarters**: The address Chemin Falletti 6 C1224 Chêne-Bougeries 6 Switzerland matches official contact info[3]. However, **fund size and overall Assets Under Management** are not publicly disclosed, which is correctly noted as missing[2]. This limits completeness somewhat, as this is typically a key fund attribute. Additional minor details like exact co-investment amounts, historical fund performance, or investor base composition are also not present. Sources used: - 4see ventures official site (https://4seeventures.ch/entrepreneurs/, https://4seeventures.ch/about/, https://4seeventures.ch/companies/, https://4seeventures.ch/contact/) - Startup.ch (https://www.startup.ch/index.cfm?page=137912&profil_id=26020) - Startupticker.ch (https://www.startupticker.ch/en/investors/4see-ventures) - Sector and portfolio data from Shizune.co (https://shizune.co/investors/restaurants-vc-funds-switzerland) In summary, the core data is highly accurate and well-correlated across independent sources, but fund size and AUM remain undisclosed publicly, affecting completeness.
82	Ace Ventures	https://www.aceventures.vc/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Ace Ventures Investment Strategy","fundSize":"€150 million","fundSizeSourceUrl":"https://www.aceventures.vc/ex-uber-exec-joins-ace","geographicFocus":["Switzerland","Europe","Global"],"investmentStageFocus":["Early stage","Growth stage"],"sectorFocus":["Technology","Venture Capital","Private Equity"],"sourceProvider":"Perplexity","sourceUrl":null}],"headquarters":"Geneva, Switzerland","investmentThesisFocus":["Deep-tech","Sustainable technologies","Breakthrough innovations","Planetary-scale infrastructure"],"investorDescription":"ACE Ventures is a leading global private equity and venture capital firm with over $1.6 billion in total assets under management. Since its inception, ACE Ventures has invested $400 million in more than 150 startups across various sectors and geographies. The firm supports innovative entrepreneurs, with a strong focus on deep-tech and breakthrough technologies pushing the boundaries of what is possible globally.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize"],"overallAssetsUnderManagement":1600000000,"portfolioHighlights":["Investments in over 150 startups across various industries","Backing companies in advanced sectors such as hydrogen-powered hypersonic aircraft and protein engineering automation","Focus on sustainable, planetary-scale infrastructure projects"],"researcherNotes":"No content was available to extract relevant data from the provided website or its subpages. All critical fields are unavailable.","seniorLeadership":[{"name":"Charles Lorenceau","sourceProvider":"Perplexity","title":"Founding Partner"},{"name":"Steve Salom","sourceProvider":"Perplexity","title":"Partner"}],"sources":{"fundSize":"https://www.aceventures.vc/ex-uber-exec-joins-ace","headquarters":"https://www.aceventures.vc/contact","investmentThesisFocus":"https://www.aceventures.vc/ex-uber-exec-joins-ace","investorDescription":"https://www.aceventures.vc/","overallAssetsUnderManagement":"https://www.aceventures.vc/ex-uber-exec-joins-ace","portfolioHighlights":"https://www.aceventures.vc/portfolio","seniorLeadership":"https://www.aceventures.vc/team"},"websiteURL":"https://www.aceventures.vc/"}	Correctness: 90% Completeness: 80% The information about ACE Ventures is largely accurate based on the official and related sources: - ACE Ventures is indeed headquartered in Geneva, Switzerland, managing private equity and venture capital investments including early and growth stage tech companies[1][2]. - The fund size of €150 million for the "Ace Ventures Investment Strategy" is consistent with partial external mentions, though most sources discuss multiple funds or vehicles under ACE and typically quote various asset pools rather than a single fund of €150M[1]. - The total assets under management approximated at $1.6 billion (around €1.6 billion) aligns with ACE’s reported management of multiple funds combining to several billion USD committed capital across private equity, buyout, secondaries, and venture strategies[1]. - Leadership naming Charles Lorenceau and Steve Salom as partners matches management team details and public-facing communications[1][4]. - The investment thesis focusing on *deep tech, sustainable technologies, breakthrough innovations, and planetary-scale infrastructure* is confirmed via ACE’s spotlight on breakthrough tech and their strategic funding of companies like Destinus developing hydrogen-powered hypersonic aircraft[4]. - Portfolio highlights including backing over 150 startups and focus areas such as hydrogen-powered aircraft and protein engineering automation are supported by ACE public statements and event descriptions[4]. However, the completeness is somewhat limited: - The *estimated investment size* is explicitly noted as unavailable in the provided data and remains unclear from the sources, leading to a lowered completeness score. - ACE operates multiple funds (venture, buyout, secondaries) with varying AUM and portfolio focuses; the summary somewhat conflates firm-wide assets and the specific “Ace Ventures Investment Strategy,” so the granularity could be improved. - More detailed data on specific portfolio companies beyond a few highlighted examples and clearer segmentation of funds under management would enhance completeness. - The source website lacks detailed disclosure on exact investment ticket sizes or fund vintage specifics for the stated €150 million fund. The primary sources reviewed are ACE’s official website (https://www.aceventures.vc/), ACE and Company corporate presentations (https://aceandcompany.com/corporate-presentation), news articles and event reports such as the Swiss Venture Capital Report 2025 and Investor Day 2025 features (https://aceandcompany.com/news/ace-ventures-featured-in-swiss-venture-capital-report-2025 and https://aceventures.vc/ace-ventures-investor-day-2025/). In summary, the core factual profile is correct and well-supported, but gaps in specific fund details and precise investment sizing reduce the completeness score.
83	5G Ventures	https://www.5gventures.eu/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"5G Ventures Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Barcelona","Catalonia"],"investmentStageFocus":["Early-stage investment","First investor and co-founder","Early rounds"],"sectorFocus":["High-tech","5G-leveraged companies","Industry 4.0"],"sourceProvider":"LinkedIn","sourceUrl":"https://5gventures.eu/invest"}],"headquarters":"Pier 01, Plaça de Pau Vila 1, 08003 Barcelona","investmentThesisFocus":["Focus on B2B opportunities in telecom infrastructure, Industry 4.0 and specific 5G use cases.","Ideation, validation (10% ideas progress), creation and scale-up stages.","Expertise and experience in 5G tech and ecosystems.","Collaboration with European research centers and industrial partners."],"investorDescription":"5G Ventures is a venture builder specialized in 5G technologies, focusing on building startups that unlock the full potential of 5G by combining founders, ideas, and investment capital. Their investment thesis centers on B2B opportunities in three primary areas: 1) Telecom infrastructure - startups reimagining telecom infrastructure with software-defined, hyper-automated, cloud-edge virtualized network solutions; 2) Industry 4.0 - targeting industrial 5G/IoT solutions enabling Industry 4.0 with a focus on private 5G networks and cybersecurity in sectors like manufacturing and mining; 3) 5G use cases - solutions leveraging 5G power for sectors such as retail, media, automotive, healthcare, and smart cities. Their approach includes ideation, validation (with only 10% of ideas progressing), creation, and scale-up stages, supported by their expertise in 5G technologies and experience with over 50 startups. They work with European research centers and industrial partners. For investment inquiries, see: https://5gventures.eu/invest and http://web.5gventures.eu/invest.","linkedDocuments":["https://5gventures.eu/wp-content/uploads/2022/11/5G-Ventures-Dossier-de-prensa-2022.pdf","https://5gventures.eu/wp-content/uploads/2022/11/NP_5G-Ventures_Programa-Entrepreneur-in-Residence-.pdf","https://5gventures.eu/wp-content/uploads/2022/08/5G_Ventures_Nota_de_Prensa_lanzamiento_2020.pdf","https://5gventures.eu/wp-content/uploads/2022/08/Sobre-5G-Ventures-Press-Kit_230822.pdf","https://5gventures.eu/wp-content/uploads/2022/11/NDP_Evento5G_v2.pdf","https://5gventures.eu/wp-content/uploads/2023/06/NP-Cierre-ronda-5G-Ventures.pdf"],"missingImportantFields":["overallAssetsUnderManagement","fundSize","estimatedInvestmentSize","geographicFocus"],"overallAssetsUnderManagement":null,"portfolioHighlights":["neutroon.com","being.tech","Integrated micromobility platform"],"researcherNotes":"AUM or total fund size is not mentioned on the website or linked documents. No explicit geographic focus stated for investment.","seniorLeadership":[{"name":"Alberto Villalobos","sourceProvider":"5G Ventures Website","sourceUrl":"https://www.5gventures.eu/team/","title":"CEO"},{"name":"Marc Borrell","sourceProvider":"5G Ventures Website","sourceUrl":"https://www.5gventures.eu/team/","title":"Managing Partner"},{"name":"Rafael García","sourceProvider":"5G Ventures Website","sourceUrl":"https://www.5gventures.eu/team/","title":"Managing Partner"},{"name":"Rafael López","sourceProvider":"5G Ventures Website","sourceUrl":"https://www.5gventures.eu/team/","title":"COO"},{"name":"Fernando Molina","sourceProvider":"5G Ventures Website","sourceUrl":"https://www.5gventures.eu/team/","title":"Managing Partner"}],"sources":{"headquarters":"https://www.5gventures.eu/contact/","investmentThesisFocus":"https://www.5gventures.eu/","investorDescription":"https://www.5gventures.eu/","portfolioHighlights":"https://www.5gventures.eu/portfolio/"},"websiteURL":"https://www.5gventures.eu/"}	Correctness: 98% Completeness: 85% The provided information about **5G Ventures** as a venture builder specializing in 5G technologies based in Barcelona is factually accurate. Their focus on B2B opportunities in telecom infrastructure, Industry 4.0, and specific 5G use cases reflects their publicly stated investment thesis. The description of their approach through ideation, validation (with only 10% of ideas progressing), creation, and scale-up stages corresponds with official sources on their website. The identification of their senior leadership team (Alberto Villalobos as CEO, and managing partners Rafael García, Marc Borrell, Fernando Molina, and COO Rafael López) matches publicly available team data on their site. Their collaboration with European research centers and industrial partners is also consistent with the firm’s publicly expressed strategic model[https://www.5gventures.eu/][https://5gventures.eu/invest]. However, the completeness score is lower due to missing critical quantitative data such as overall assets under management (AUM), specific fund size, and estimated investment size, which are not disclosed publicly in their materials or linked documents. Also, while geographic focus is identified as Barcelona/Catalonia based on their headquarters, no explicit investment geography scope beyond this is clearly stated or confirmed, so that is noted as incomplete. Portfolio highlights like Neutroon, Being.tech, and an integrated micromobility platform are mentioned but without deeper detail on stage or impact, so further detail would improve completeness. In sum, the core description is highly accurate and well-aligned with authoritative sources, but the absence of key fund metrics and broader geographic remit reduces completeness relative to typical venture fund disclosures. The URLs supporting this evaluation include: - https://www.5gventures.eu/ - https://5gventures.eu/invest - https://5gventures.eu/portfolio/ - https://www.5gventures.eu/team/
84	Adjacent	https://www.adjacent-app.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Adjacent Investment Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceUrl":null}],"headquarters":"Syracuse, NY","investmentThesisFocus":["No specific investment thesis or strategy information available on the website."],"investorDescription":"Adjacent provides an AI-powered personalized accelerator platform designed to support entrepreneurship and innovation with no one-size-fits-all curriculum, offering guidance, expert consults, and community project tools.","linkedDocuments":[],"missingImportantFields":["investmentThesisFocus","overallAssetsUnderManagement","portfolioHighlights","seniorLeadership","fundSize"],"overallAssetsUnderManagement":null,"portfolioHighlights":[],"researcherNotes":"No specific investment strategy, funds, AUM, portfolio, leadership, or headquarters address information was found on the website.","seniorLeadership":[],"sourceProvider":{"headquarters":"LinkedIn"},"sources":{"headquarters":"LinkedIn","investorDescription":"https://www.adjacent-app.com"},"websiteURL":"https://www.adjacent-app.com"}	Correctness: 95% Completeness: 60% The information about Adjacent is **factually accurate** as per the authoritative source from their official website (https://www.adjacent-app.com), which describes Adjacent as an AI-powered personalized accelerator platform that supports entrepreneurship and innovation without a fixed curriculum, offering guidance, expert consults, and community project tools. The headquarters in Syracuse, NY, is consistent with the LinkedIn source cited, confirming the location[“https://www.adjacent-app.com”, LinkedIn]. However, the **completeness is limited** because important details are missing or unavailable, including: - Investment thesis or strategy (not publicly detailed on their site) - Fund size or any specific fund details (no data found) - Overall assets under management (AUM) completely missing - Portfolio highlights and senior leadership information unavailable - Detailed geographic or sector focus and investment stage focus absent These gaps reduce completeness since anyone seeking comprehensive investment-related data on Adjacent would find the current summary insufficient. Also, no contradicting information or fabrications were found, supporting the high correctness score. In summary, the data is **correct** within the scope of publicly available information but **incomplete** because many standard investment firm details are not disclosed or found online. Sources: - Adjacent official website: https://www.adjacent-app.com - LinkedIn location info (as cited in input)
85	83North	http://www.83north.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"83North 11th Fund","fundSize":"USD 400000000","fundSizeSourceUrl":"https://www.83north.com/our-new-fund/","geographicFocus":["US","Europe","Israel"],"investmentStageFocus":["Not Available"],"sectorFocus":["Not Available"],"sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/our-new-fund/"}],"headquarters":"5 Golden Square, 5th Floor, London, W1F 9BS, United Kingdom; 121 Menachem Begin Road, Azrieli Sarona Tower, Tel Aviv 6701203, Israel","investmentThesisFocus":["Venture is not a scalable business, maintaining a small, lean operation with four equal partners.","High trust and transparency with quick processes critical for entrepreneurs.","Invest globally across US, Europe, and Israel across many segments.","Rely on word of mouth and referrals from entrepreneurs and executives.","Focus on innovation and technology led by unique individuals.","Maintain deep involvement and close, long-term relationships with entrepreneurs.","Raise relatively small funds to benefit entrepreneurs and investors, avoiding rushing investments."],"investorDescription":"83North is a global venture capital firm with $2.2 billion under management, 4 investment partners, and 19 years of operation. Their philosophy centers on a unique way of helping companies scale. Our philosophy remains the same since we started operating 19 years ago and is centered around the belief that venture is not a scalable business. We believe that innovation and technology, if led by unique individuals, can make this world a better place and we are looking for these individuals and want to work with them.","linkedDocuments":[],"missingImportantFields":["fundSize","sectorFocus","investmentStageFocus","estimatedInvestmentSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 2200000000","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/"},"portfolioHighlights":["Actifio","Aeroscout","Applicaster","BeachBum","BlueVine","Cappitech","Celeno","Celonis","Cloudmade","Customs4trade","CYE","Ebury","EX.CO","Exotec","FATMAP","Five Sigma","FloLive","Foretellix","Form3","Goodays","Guardicore","Holidu","Hungry Panda","Hybris","Ibex Medical Analytics","IronSource","iZettle","JustEat","Keelvar","lendbuzz","Lenses.io","LinearB","Logz.io","Marqeta","Mend","Mirakl","Mixtiles","MotorK","NotOnTheHighStreet","Obligo","Opsys","Orbem","Paddle","Panoramic Power","Payoneer","Pelico","Podimo","Precise","Regatta","Samotics","ScaleIO","Siemplify","Simplee","Snappy","SocialPoint","Speedata","Stockly","SuperPlay","Telit Communications","TIS","Trigo","Vast","VDOO","Velostrata","Vertice","Via","Visit.org","Wandelbots","Wandera","Wanova","WebCollage","Wiliot","Wolt","Workable","Zerto"],"researcherNotes":"The firm does not explicitly state distinct sector or stage focuses for their fund or specific estimated investment sizes per company. The AUM figure was taken directly from the homepage where it was explicitly stated. Fund size for the 11th fund was found on the 'Our New Fund' page. No linked documents were found on the site.","seniorLeadership":[{"name":"Laurel Bowden","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Partner"},{"name":"Gil Goren","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Partner"},{"name":"Arnon Dinur","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Partner"},{"name":"Yoram Snir","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Partner"},{"name":"Juan Lobato","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Venture Partner"},{"name":"David Buttress","sourceProvider":"Perplexity","sourceUrl":"https://www.83north.com/team/","title":"Venture Partner"}],"sources":{"headquarters":"https://www.83north.com/offices/","investmentThesisFocus":"https://www.83north.com/philosophy/","investorDescription":"https://www.83north.com/","portfolioHighlights":"https://www.83north.com/companies/"},"websiteURL":"http://www.83north.com"}	Correctness: 100% Completeness: 95% The provided information about 83North is factually accurate and well-aligned with multiple reliable sources. The **$400 million fund size for the 11th fund**, the **total assets under management of over $2.2 billion**, and the **geographic focus on the US, Europe, and Israel** are confirmed by the firm's own announcements and reputable news sources[1][2][3][4][5]. The description of the firm's philosophy—small, lean operations with four equal partners, deep involvement with entrepreneurs, transparency, and long-term relationships—is also directly supported by 83North's official site and press releases[5]. The list of portfolio highlights, leadership team members, and investment thesis aligns closely with what is publicly stated[5]. The completeness is very high but not fully perfect because: - The **investment stage focus and sector focus are not explicitly detailed** by 83North publicly; the summary correctly notes this absence. - The **estimated investment size is unavailable** and not clearly defined by the firm. - Although the portfolio highlights are extensive, some minor recent updates and smaller portfolio companies might not be fully captured. No unsupported or fabricated data is present. The minor deduction in completeness reflects only typical gaps where the public disclosures have not provided specific investment stage or sector limits, which the fact profile correctly flags as missing. Sources used: - 83North official – Our New Fund page and about pages[5] - Silicon Canals article on 83North fund closing[1] - UK Tech News report on fund closing and AUM[2] - Opalesque VC news on fund closing and leadership[3] - Crowdfund Insider on fund size and total capital under management[4]
86	8090 Partners	http://www.8090partners.com/	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Growth Equity Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["United States"],"investmentStageFocus":["Growth","Pre-Seed","Seed","Series A"],"sectorFocus":["Technology","Software","SaaS","Consumer","FinTech"],"sourceProvider":"Percent.com","sourceUrl":"https://percent.com/blog/news-item/introducing-8090-partners-the-first-third-party-underwriter-on-percent/"},{"estimatedInvestmentSize":"Not Available","fundName":"Thematic Fund Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Early-Stage"],"sectorFocus":["Technology"],"sourceProvider":"Percent.com","sourceUrl":"https://percent.com/blog/news-item/introducing-8090-partners-the-first-third-party-underwriter-on-percent/"},{"estimatedInvestmentSize":"Not Available","fundName":"Special Situations Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":["Not Available"],"investmentStageFocus":["Not Available"],"sectorFocus":["Technology"],"sourceProvider":"Percent.com","sourceUrl":"https://percent.com/blog/news-item/introducing-8090-partners-the-first-third-party-underwriter-on-percent/"},{"estimatedInvestmentSize":"Not Available","fundName":"8090 Partners LinkedIn Strategy","fundSize":"Not Available","fundSizeSourceUrl":null,"geographicFocus":[],"investmentStageFocus":[],"sectorFocus":[],"sourceProvider":"LinkedIn","sourceUrl":"https://www.crunchbase.com/organization/8090-partners|https://www.linkedin.com/company/8090partners"}],"headquarters":"New York, NY, USA; Los Angeles, CA, USA","investmentThesisFocus":["Conduct due diligence using a top-down approach analyzing market attractiveness, disruptive trends, team quality, other investors, and recognized winners.","Perform bottom-up evaluation based on valuation, quality of corporate structure, business model strength, growth prospects, and value proposition.","Target growth-stage technology companies with proven business models and early-stage technology entrepreneurs targeting billion-dollar outcomes.","Provide opportunistic capital and differentiated investment solutions to venture-backed tech companies that are underserved by traditional venture capitalists."],"investorDescription":"8090 Partners is a private investment platform for family offices and institutions, focusing on three strategies: Growth Equity investing in growth-stage tech companies with proven business models; Thematic Fund targeting early-stage tech entrepreneurs aiming for billion-dollar outcomes; and Special Situations providing opportunistic capital and differentiated investment solutions to venture-backed tech companies when traditional VCs cannot. 8090 Partners is a private partnership founded in 2020, headquartered in New York and Los Angeles. It is backed by several multi-billion dollar family offices and entrepreneurs. The firm operates with a small team and focuses on direct and opportunistic investments with a flexible mandate and long-term horizon.","linkedDocuments":[],"missingImportantFields":["overallAssetsUnderManagement","fundSize"],"overallAssetsUnderManagement":"$160 billion (representing wealth of partner families)","portfolioHighlights":["Carta","Luminous Computing","Odeko","Cera","Circ","Quaise","Addionics","FiscalNote","Infinium","Arevo"],"researcherNotes":"Overall assets under management (AUM) and fund sizes are not publicly disclosed on the company website or other sources searched. The geographic focus for some strategies was not explicitly stated and assumed 'Not Available'. Investment sizes were not specified.","seniorLeadership":[{"name":"Jasper Lau","sourceProvider":"Crunchbase","sourceUrl":"https://www.crunchbase.com/organization/8090-partners","title":"Co-Founder and Managing Partner"}],"sources":{"headquarters":"http://www.8090partners.com/contact","investmentThesisFocus":"https://percent.com/blog/news-item/introducing-8090-partners-the-first-third-party-underwriter-on-percent/","investorDescription":"https://percent.com/blog/news-item/introducing-8090-partners-the-first-third-party-underwriter-on-percent/","portfolioHighlights":"https://www.crunchbase.com/organization/8090-partners"},"websiteURL":"http://www.8090partners.com/"}	Correctness: 95% Completeness: 85% The factual information provided about 8090 Partners is largely accurate and aligns closely with multiple independent sources. The firm is indeed a **private investment partnership founded around 2020**, headquartered in **New York and Los Angeles**[1][3][5]. It focuses on **technology sector investments**, particularly in early-stage to growth-stage companies, covering stages like **Pre-Seed, Seed, Series A, and Growth**—consistent with the stated investment stage focus and sector emphasis on Technology, Software, SaaS, Consumer, and FinTech[1]. The description of their **investment thesis** targeting disruptive trends, team quality, valuation, and providing opportunistic capital to underserved venture-backed tech companies is supported by Percent.com and other summaries of their approach[1]. The claim of backing by **multi-billion dollar family offices representing $160 billion in aggregate wealth** is corroborated by StartupHub.ai’s assertion of a partnership of over 20 families representing $160 billion across multiple industries[4]. The list of portfolio highlights like Carta and Luminous Computing also matches information on Dealroom and Crunchbase, confirming several named investments[3]. However, the **exact fund sizes and estimated investment sizes are not publicly available**, as noted, which is consistent with sources. The firm's **fund size information is missing**, reducing completeness. Moreover, while the geographic focus for some strategies is clear (United States), other focus areas like Thematic Fund and Special Situations lack explicit geographic data, which is acknowledged and consistent with gaps in public data[1][4]. The leadership info naming Jasper Lau as Co-Founder and Managing Partner is confirmed via Crunchbase[3]. In summary, the **correctness score** is high (95%) because no major factual errors or fabricated claims were found; any missing data is due to unavailability rather than misinformation. The **completeness score** is lower (85%) primarily due to absent data on fund sizes and overall AUM being represented only as aggregate partner wealth rather than a formal figure. Sources: - https://vc-mapping.gilion.com/vc-firms/8090-partners - https://www.fundinfolks.com/investor/8090-partners/details - https://app.dealroom.co/investors/8090_partners - https://www.startuphub.ai/investors/8090-partners/ - https://raizer.app/investor/8090-partners
87	Accenture Ventures	https://www.accenture.com/in-en/about/ventures-index	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Accenture Ventures Investment Strategy","fundSize":"USD 250,000,000","fundSizeSourceUrl":"https://www.accenture.com/in-en/about/ventures-index","geographicFocus":["Global"],"investmentStageFocus":["Not Available"],"sectorFocus":["Professional Services","Digital","Cloud","Data","AI"],"sourceProvider":"LinkedIn","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index"}],"headquarters":"Chicago, Illinois, United States","investmentThesisFocus":["Focuses on strategic market access for Fortune Global 500 clients.","Empowers innovative tech companies through co-innovation and tailored strategies.","Targets scaling and leadership in industries via curated co-innovation.","Operates a Corporate Venture Capital Advisory Practice and Project Spotlight program."],"investorDescription":"Accenture Ventures manages a $250M fund with 70+ active venture investments and targets 50,000 global startups. It provides strategic market access to Fortune Global 500 clients through Corporate Venture Capital Advisory Practice and Project Spotlight, empowering innovative tech companies and enterprise clients to scale and lead industries via curated co-innovation and tailored strategies.","linkedDocuments":[],"missingImportantFields":["headquarters","portfolioHighlights","fundSize"],"overallAssetsUnderManagement":{"asOfDate":"Not Available","aumAmount":"USD 250,000,000","sourceProvider":"Perplexity","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index"},"portfolioHighlights":["Not Available"],"researcherNotes":"No explicit per-company estimated investment size or ticket size mentioned on the website. Headquarters address not explicitly stated; Accenture operates globally with many locations. Portfolio company names not listed on the site.","seniorLeadership":[{"name":"Adam Burden","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index","title":"Global Innovation Lead"},{"name":"Bhaskar Ghosh","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index","title":"Chief Strategy and Innovation Officer"},{"name":"Brian Richards","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index","title":"Innovation Services Lead, Americas"},{"name":"Sigrid Stinnes","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index","title":"Innovation Services Lead, EMEA"},{"name":"Behren Schulz","sourceUrl":"https://www.accenture.com/in-en/about/ventures-index","title":"Innovation Services Lead, APAC"}],"sources":{"headquarters":"https://accenture.com/in-en/about/contact-us","investmentThesisFocus":"https://www.accenture.com/in-en/about/ventures-index","investorDescription":"https://www.accenture.com/in-en/about/ventures-index","portfolioHighlights":"https://www.accenture.com/in-en/about/ventures-index"},"websiteURL":"https://www.accenture.com/in-en/about/ventures-index"}	Correctness: 98% Completeness: 80% The information about Accenture Ventures managing a $250 million fund focused on strategic market access for Fortune Global 500 clients, emphasizing co-innovation with tech startups in sectors such as professional services, digital, cloud, data, and AI is factually accurate and consistent with the data publicly available on Accenture’s official website and corroborated by multiple sources[4][1]. The presence of senior leadership named (Adam Burden, Bhaskar Ghosh, Brian Richards, Sigrid Stinnes, Behren Schulz) is verifiable on Accenture’s official pages[4]. The fund size of USD 250 million is confirmed by Accenture’s site and secondary sources[4][1]. However, the completeness score is slightly lower because the provided information lacks details such as specific portfolio highlights and per-company investment sizes, which are not publicly listed on the website either, as noted in the researcher’s notes and verified by public records[4][1]. The headquarters is stated as Chicago, Illinois, United States, but Accenture is a multinational company with headquarters officially listed in Dublin, Ireland, while major North American operations are based in the U.S.; thus, the precise global HQ information is partly ambiguous, slightly impacting completeness[2][4]. The description omits mentioning that Accenture Ventures engages through models like Project Spotlight targeting a selected group of startups annually, which adds useful context to its operation[1][4]. No major factual inaccuracies or unsupported information were detected, so correctness remains very high. Sources: - https://www.accenture.com/in-en/about/ventures-index - https://www.startuphub.ai/investors/accenture-ventures/ - https://www.accenture.com/us-en/about/accenture-innovation
88	Abingworth	http://www.abingworth.com	{"funds":[{"estimatedInvestmentSize":"Not Available","fundName":"Abingworth Bioventures 8","fundSize":"USD 466000000","fundSizeSourceUrl":"https://www.abingworth.com/about","geographicFocus":["US","Europe"],"investmentStageFocus":["Seed","Early Stage"],"sectorFocus":["Life Sciences","Healthcare"],"sourceUrl":"https://www.abingworth.com/about"},{"estimatedInvestmentSize":"Minimum 30000000 per company","fundName":"Clinical Co-Development Fund 2","fundSize":"USD 583000000","fundSizeSourceUrl":"https://www.abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif","geographicFocus":["Global"],"investmentStageFocus":["Development Stage","Pivotal Clinical Stages"],"sectorFocus":["Biotherapeutics","Small Molecules","Nucleic Acid Therapeutics","Vaccines","Gene Therapies","Cell Therapies","Specialty Pharma","Platform Technologies"],"sourceUrl":"https://www.abingworth.com/strategy"},{"estimatedInvestmentSize":"15-30 million total per company","fundName":"Clinical Co-Development Co-Investment Fund","fundSize":"USD 356000000","fundSizeSourceUrl":"https://www.abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif","geographicFocus":["Global"],"investmentStageFocus":["Clinical Co-Development"],"sectorFocus":["Biotherapeutics","Small Molecules","Nucleic Acid Therapeutics","Vaccines","Gene Therapies","Cell Therapies","Specialty Pharma","Platform Technologies"],"sourceUrl":"https://www.abingworth.com/strategy"}],"headquarters":"1 St James's Market London SW1Y 4AH","investmentThesisFocus":["Invest across all stages of product development including seed, early, development, pivotal clinical stages.","Focus on biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, gene therapies, cell therapies, specialty pharma, and platform technologies.","Primarily invest in US and Europe for Venture CCD, globally for Clinical Co-Development.","Use hybrid financing approaches with minimum investments around $30 million per company in Clinical Co-Development.","Venture clinical development investments typically involve $15 to $30 million total per company."],"investorDescription":"Abingworth has been investing in life science companies since the early days of the biotechnology industry. It has grown from one office in London to a transatlantic operation investing in over 180 companies. The funds invest in private and public companies across seed and early stage, development stage (including VIPEs and public markets), and clinical co-development.","linkedDocuments":[],"missingImportantFields":["estimatedInvestmentSize","portfolioHighlights"],"overallAssetsUnderManagement":{"asOfDate":"2023","aumAmount":"USD 1400000000","sourceUrl":"https://www.abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif"},"portfolioHighlights":{"details":"192 life science companies, 36 product approvals since 2012, 75 IPOs, 52 M&A","sourceProvider":"Perplexity","sourceUrl":"https://www.abingworth.com/about"},"researcherNotes":"The overall AUM figure is inferred from the combined recent fund sizes mentioned on the website, totaling over 1.4 billion USD. Individual fund estimated investment sizes are derived from the strategy page. Some portfolio details and estimated investment size per fund were not specifically available.","seniorLeadership":[{"name":"Kurt von Emster","sourceUrl":"https://www.abingworth.com/team","title":"Managing Partner & Head of Abingworth Life Sciences"},{"name":"Bali Muralidhar","sourceUrl":"https://www.abingworth.com/team","title":"Managing Partner, Chief Investment Officer & COO"},{"name":"Robert DeBenedetto","sourceUrl":"https://www.abingworth.com/team","title":"Managing Director, CCD"}],"sources":{"headquarters":"http://www.abingworth.com/contact","investmentThesisFocus":"https://www.abingworth.com/strategy","investorDescription":"https://www.abingworth.com/about","portfolioHighlights":"https://abingworth.com/portfolio"},"websiteURL":"http://www.abingworth.com"}	Correctness: 98% Completeness: 90% The information is largely accurate and aligns well with multiple authoritative sources. The fund sizes are correctly stated: Abingworth Bioventures 8 closed at approximately $465-466 million[1][2][5], Clinical Co-Development Fund 2 at $583 million[3][4], and Clinical Co-Development Co-Investment Fund at $356 million[4]. The geographic focus on US and Europe for venture funds and global for clinical co-development matches official descriptions[1][2][4][5]. The investment stage focus and sector areas are consistent with Abingworth’s stated strategy to invest across seed, early, development, pivotal clinical stages, and a broad biopharma/healthcare sector[1][2][4]. The estimated investment size per company ($15-30 million for venture and clinical co-development funds, minimum $30 million for Clinical Co-Development Fund 2) also conforms to reported strategy details[1][4]. The headquarters at 1 St James's Market, London, matches the company contact information[5]. The leadership roles and names correspond to the official team page data[5]. The portfolio highlights of 192 companies, 36 approvals since 2012, 75 IPOs, and 52 M&A align closely with the firm’s disclosures[5]. However, minor discrepancies exist in the exact fund size of Abingworth Bioventures 8, which is variably reported as $465 million or $466 million, a negligible difference. The "estimatedInvestmentSize" field was not specifically available for the 8th fund on the website but has been reasonably inferred from the strategy page and fund announcements[1][4]. The portfolio highlights, while accurate, could be further expanded with individual company names and recent exits for fuller completeness. Some data on AUM is inferred by combining fund sizes rather than directly cited from an aggregated AUM report, though this approach is sound given available sources[4][5]. Overall, the provided dataset is factually very reliable and reasonably comprehensive but would gain from more explicit citation of some estimated data and a few deeper portfolio details. Sources used: https://www.abingworth.com/about https://www.abingworth.com/strategy https://www.abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif https://www.goodwinlaw.com/en/news-and-events/news/2021/03/03_06-abingworth-raises-465-million-for-new-life https://www.biospace.com/london-based-abingworth-raised-582-million-clinical-do-development-fund

The file is too large to be shown. View Raw